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Shewanella oneidensis MR-1 is a Gram-negative bacterium isolated from anaerobic 
freshwater lake sediments of Oneida Lake that exhibits remarkable respiratory 
versatility. In the absence of molecular oxygen, S. oneidensis MR-1 couples 
anaerobic growth to the reduction of various substrates, including ferric iron (FeIJI), 
thiosulfate (S2032), sulfite (S032 ), trimethylamine N-oxide (TMAO), nitrate (NO3 ), 
nitrite (NO2 ) and organic substrates such as fumarate. The metabolic flexibility of S. 
oneidensis MR-1 is coupled to a complex and branched anaerobic respiratory chain. 
The respiratory enzymes of the fumarate reduction pathway have been extensively 
studied in S. oneidensis MR-] and the related marine bacterium, S. frigidimarina 
NCIMB 400. The terminal fumarate reductase of Shewanella species is a soluble 
periplasmic flavocytochrome C3 (Fcc3) that catalyses the unidirectional production of 
succinate. The X-ray crystal structure of Fcc3 solved to high resolution provided the 
first detailed insight into the catalytic mechanism of fumarate reduction. 
In this work, the Fcc3 X-ray crystal structure provided a structural template to 
construct homology models of related flavoenzymes of unknown structure and 
function. The novel flavoenzymes were identified by sequence analysis of the S. 
oneidensis MR-1 genome and were shown to comprise separately encoded flavin 
(FccA54, FccA56 and FccA342) and cytochrome subunits (FccB54, Fcc1356 and 
FccB342), respectively, that were related by sequence to the corresponding domains 
in Fcc3. Molecular modelling of the catalytic flavin-binding subunits led to the 
suggestion that these related enzymes catalyse the reduction of acrylate substrates. 
iv 
Abstract 
Several biologically relevant plant metabolites, including phenylacrylates 
incorporated into lignin, were identified as potential substrates of the Fcc3-like 
enzymes. An fccA54 and fccB54 knockout strain of S. oneidensis MR-1 (S. 
oneidensis M135415) was constructed and grown anaerobically with each of the 
candidate acrylates to ascertain the biological function of FccA54. Complementary to 
these studies, the genes encoding the novel flavoenzymes were PCR amplified from 
the S. oneidensis MR-1 genome and cloned into appropriate expression plasmids for 
protein overexpression in Escherichia coil or Shewanella strains. The FccA54 flavin 
subunit was overexpressed and purified but was found to be unstable in the absence 
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Chapter 1 	 Introduction 
INTRODUCTION 
1.1 The generation of energy in the form of ATP 
The production of adenosine 5'-triphosphate (ATP), by the process of oxidative 
phosphorylation in prokaryotic cells is localised to the 'energy-transducing' plasma 
membrane that is functionally related to the chloroplast thylakoid membrane and the 
mitochondrial inner membrane of eukaryotic cells. Mitochondria and the cytoplasmic 
membrane of respiring bacteria are associated with a common ATP synthesis 
mechanism comprising the transfer of electrons 'downhill' along an electron 
transport chain to a terminal electron acceptor (Nicholls and Ferguson, 2002). The 
electrons are generated from the oxidation of high-energy nutrients such as glucose 
and are ultimately transferred to molecular oxygen that serves as the terminal oxidant 
in the aerobic respiratory chain of animal and bacterial cells. The electrons are 
transferred along membrane-bound enzyme complexes and the energy released by 
the constituent redox reactions is coupled to the generation of a proton gradient 
across the membrane (Nicholls and Ferguson, 2002). The membrane-bound enzyme 
complexes of the respiratory chain have chemi-osmotic coupling (Mitchell, 1961), 
where the energy conserved in the resulting proton motive force (Ap) is used to drive 
various energy-dependent membrane reactions, including ATP synthesis from 
adenosine 5'-diphosphate (ADP) and inorganic phosphate (Pi). The chemiosmotic 
coupling mechanism (Mitchell, 1961) is also observed in membranes of 
photosynthetic bacteria and plant chloroplast thylakoid membranes where the energy 
derived from absorption of visible light generates a proton gradient that drives the 
synthesis of ATP by photosynthetic phosphorylation (Nicholls and Ferguson, 2002). 
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1.1.1 Electron transport in the mitochondrial inner membrane 
The electron transport chain of the mitochondrial inner membrane (Figure 1.1) is 
composed of four membrane-integrated multisubunit complexes comprising various 
redox active cofactors with increasing reduction potentials. Complex I (NADH: 
ubiquinone oxidoreductase) represents the largest protein component of the 
mitochondrial inner membrane and contains an FMN redox cofactor and iron-sulfur 
clusters that transfer electrons from NADH to ubiquinone (Nicholls and Ferguson, 
2002). The mobile ubiquinone electron carrier shuttles electrons between the 
membrane-bound complexes I, II and III. Succinate dehydrogenase (SDH) of the 
citric acid cycle is a flavoprotein subunit of Complex II (Succinate-ubiquinone 
reductase) and catalyses the oxidation of succinate coupled to reduction of 
ubiquinone. The electrons released from oxidation of succinate are transferred from 
the flavoprotein subunit to the iron-sulfur subunit toward the membrane anchor, 
located in close proximity to ubiquinone (Nicholls and Ferguson, 2002). Ubiquinol is 
subsequently oxidised by respiratory Complex III (ubiquinol: cytochrome c 
oxidoreductase; cytochrome bci ), which comprises a dihaem cytochrome b, 
cytochrome Cl and a Rieske protein containing a [2Fe:2S] cluster. Domain movement 
of the intermediate iron-sulfur protein mediates interdomain electron transfer 
between cytochrome b and cytochrome Cl for subsequent transfer to cytochrome c 
(Zhang et al., 1998). The peripheral membrane-bound cytochrome c protein 
alternatively binds to cytochrome c of Complex III and components of Complex IV 
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Complex IV of the aerobic respiratory chain accepts electrons from cytochrome c 
and catalyses the reduction of 02 to H20 that is subsequently released through a 
putative water channel to the cytosolic surface of the membrane (Tsukihara et al., 
1996). Complexes I, III and IV catalyse oxidation-reduction reactions that are 
coupled to proton translocation across the membrane. A protonmotive Q-cycle 
operates in Complex III in which a two-cycle re-oxidation of ubiquinol is coupled to 
proton translocation across the membrane (Nicholls and Ferguson, 2002; Figure 1.1). 
The free energy sequestered by the resulting protonmotive force across the energy 
transducing membrane powers the proton translocating ATP synthase (Complex V) 
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Figure 1.1: Enzymes of the mitochondrion involved in oxidative phosphorylation 
The four respiratory complexes of the mitochondrial inner membrane involved in electron transfer 
(orange arrow) and the proton translocating ATP synthase are shown. Three of the complexes are 
involved in proton translocation (black arrow) across the energy transducing membrane. The mobile 
electron carrier, ubiquinone (Q) is shown to shuttle electrons between Complex I, II and III. The redox 
cofactors of each complex are shown, where ISP is the iron sulfur Rieske protein of Complex III. 
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The amount of energy that is released during electron transfer in the mitochondrion is 
determined by the difference between the redox potential of the donor couple 
(NADH/NAD) and acceptor couple ('/202/H20; Jones, 1988). The actual redox 
potential at pH 7.0 (E11,7) of the NADH/NAD couple (-280 mV) and the V202/H20 
couple (780 mV) results in a large redox potential difference (AEh,7 =1.06 V) coupled 
to the release of a large amount of free energy (AG —205 kJ moi'; Nicholls and 
Ferguson, 2002), which is sufficient to power synthesis of ATP. 
The electron transport chain of the mitochondrial inner membrane (Figure 1.1) is 
provided as a key example of oxidative phosphorylation, where the underlying 
mechanism is analogous to electron transport and the generation of ATP in 
prokaryotes. However, different integral membrane components involved in electron 
transfer are expressed in energy-transducing membranes of different organisms in 
response to the presence of alternative primary electron donors and terminal 
acceptors (Nicholls and Ferguson, 2002). This is particularly apparent in prokaryotes 
that can respire in the absence of oxygen and couple the oxidation of an energy rich 
substrate to the terminal reduction of an alternate terminal electron acceptor (Jones, 
1988). 
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1.1.2 Bacterial anaerobic electron transport chains 
In its simplest form, the anaerobic respiratory chain of prokaryotes comprises a 
primary dehydrogenase that catalyses electron transfer via oxidation-reduction 
reactions to a terminal reductase that functions in place of a terminal oxidase (Jones, 
1988). Nitrate (NO3 ) respiration of Escherichia coil with formate as the electron 
donor induces expression of the cytoplasmic membrane-bound formate 
dehydrogenase-N that transfers electrons via menaquinol to the terminal nitrate 
reductase. The two proteins can form a redox loop coupled by menaquinol, which 
leads to generation of a proton motive force across the membrane (Jormakka et al., 
2002). In addition to nitrate/nitrite (K° = 420 mV), prokaryotes utilise other 
substrates of widely differing redox potentials, such as the fumarate/succinate couple 
(E'°— 30 mV), sulfite/sulfide (E'° = -116 mV) and Fe(III)/Fe(II) (Eb°=  760 mV) as 
terminal oxidants during anaerobic respiration. The diverse redox potentials are 
characterised by wide variations in the amount of free energy released, which is 
considerably lower compared to aerobic respiration. However, the use of these 
alternative electron acceptors permits non-fermentative microorganisms to respire 
and survive in anaerobic environments. Phosphorylative fumarate reduction to 
succinate (Figure 1.2) is the most commonly occurring type of anaerobic respiration 
amongst non-fermentative facultative and strictly anaerobic bacteria. This is 
probably due to the prevalence of fumarate from the breakdown of protein and 
carbohydrate readily available in the environment (Hamilton, 1988). 
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The reduction of fumarate (E'° = 30 mV) is typically coupled to the oxidation of 
substrates with more negative redox potentials, such as formate/HCO3 (E'° = -416 
mV; Myers and Myers, 1993), which generates an efficient respiratory system in the 




Figure 1.2: Fumarate reduction 
The terminal fumarate reductase of the electron transport chain accepts two electrons for reduction of 
fumarate across the double bond to produce succinate as the end-product. 
1.1.3 Fermentation 
Some yeasts and prokaryotes are also able to obtain ATP by fermentation in which 
an organic substrate such as pyruvate formed by glycolysis is converted to a reduced 
end product with the concomitant generation of NAD. The energy released from 
conversion of pyruvate to end products, such as ethanol and CO2 during alcoholic 
fermentation in yeast is used to synthesise 2 molecules of ATP per molecule of 
glucose oxidised. Soil bacteria of the species Arthrobacter globformis are able to 
survive in anaerobic layers of the soil by respiring anaerobically with nitrate or by 
fermentation. Anaerobic growth of A. globformis  in the presence of glucose and 
pyruvate leads to the formation of acetate, lactate and ethanol in a mixed 





A. globformis  preferentially respires anaerobically with nitrate as terminal electron 
acceptor and when the source of nitrate is exhausted, the bacterium obtains energy by 
fermentation of pyruvate and glucose (Eschbach et al., 2003). 
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Figure 1.3: Proposed model for the fermentation process of A. gIobformis 
A. globformis obtains energy from the process of a mixed fermentation. The carbon sources, pyruvate 
and glucose are converted to reduced end products, lactate, acetate and ethanol and the energy 
released is used to generate ATP. The figure is taken from Figure 2 of Eschbach et al., 2003. 
-
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1.2 Anaerobic metabolism of Shewanella species 
The wide range of substrates that are available to bacterial species to support 
anaerobic growth leads to the generation of many different redox reactions and 
expression of different redox proteins in bacteria (Nicholls and Ferguson, 2002). This 
is particularly apparent in the Gram-negative y-proteobacteria of the genus 
Shewanella that are notable for their unique metabolic properties involving anaerobic 
reduction of many unusual substrates in addition to fumarate. The respiratory 
versatility is linked to the diverse range of environments inhabited by Shewanella 
species, including, marine (Lee et al., 1977) and freshwater sediments (Myers and 
Nealson, 1988), the deep sea (Nogi and Kato, 1999), activated sludge (Barberio et 
al., 2001), butter (Derby and Hammer, 1931; Murray et al., 2001) and oil fields 
(Semple and Westlake, 1987). Some species such as Shewanella algae are 
opportunistic pathogens (Khashe and Janda, 1998; Venkateswaran et al., 1999) and 
others are associated with fish spoilage and the production of trimethylamine 
(Jorgensen and Huss, 1989). Novel species of the genus include the recently 
discovered non-fermentative luminous species, Shewanella woodyi (Makemson et 
al., 1997), the metal-reducing species, Shewanella amazonensis, isolated from 
Amazonian shelf coastal muds (Venkateswaran et al., 1998), Shewanella 
frigidimarina (Bowman et al., 1997), including S. frigidimarina NCIMB 400 
(formerly S. putrefaciens; Reid and Gordon, 1999), Shewanella gelidimarina from 
Antarctic sea ice (Bowman et al., 1997) and Shewanella oneidensis (Venkateswaran 
etal., 1999). 
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All known Shewanella strains are capable of reducing trimethylamine N-oxide 
(TMAO) and nitrate (NO3 ) during anaerobic growth and the majority of strains 
produce hydrogen sulfide (H2S) from thiosulfate (S2032 ) reduction. However, only a 
select group of Shewanella species, including, S. algae, S. amazonensis and S. 
oneidensis are able to reduce elemental sulfur (S°), iron oxides and manganese 
oxides (Venkateswaran et al., 1999). 
S. oneidensis MR-i (formerly S. putrefaciens MR-1; Venkateswaran et al., 1999) 
was originally isolated from anaerobic sediments of Oneida Lake, New York, for its 
remarkable ability to couple respiratory-linked proton translocation and anaerobic 
growth to the reduction of insoluble manganese (IV) oxides (Myers and Nealson, 
1988; Myers and Nealson, 1990). S. oneidensis MR-1 (deposited as ATCC 700550; 
Venkateswaran et al., 1999) is a non-fermentative facultative aerobe (Myers and 
Nealson, 1988) most closely related to S. oneidensis DLM7, isolated from Lower 
Green Bay sediments of Lake Michigan (Murray et al., 2001; Venkateswaran et al., 
1999). S. oneidensis MR-i is now identified with the anaerobic respiratory-linked 
reduction of many other electron acceptors, including, nitrate (NO3 ; Myers and 
Nealson, 1988), thiosulfate (S2032 ; Myers and Nealson, 1988 and Myers and 
Nealson, 1990), nitrite (NO2), tetrathionate (S4062 ; Myers and Nealson, 1988), 
elemental sulfur (S°; Moser and Nealson, 1996), sulfite (S032 ), TMAO, fumarate, 
ferric iron, glycine and dimethylsulfoxide (DMSO; Myers and Nealson, 1988). 
S. oneidensis MR-i couples the oxidation of primary electron donors such as 
succinate, acetate, lactate and fumarate to reduction of the numerous electron 
acceptors (Myers and Nealson, 1988; Venkateswaran et al., 1999). 
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Toxic environmental substrates such as Chromium (CrVI) are readily reduced by S. 
oneidensis MR-1 and may also serve as terminal electron acceptors during anaerobic 
respiration (Myers et al., 2000). The electron acceptors utilised by S. oneidensis 
MR-1, including, nitrate, nitrite, Mn(IV), Fe(III) and sulfite occur in redox dines of 
the sedimentary environment, where the substrates are preferentially metabolised by 
S. oneidensis MR-1 in order of their oxidative energy (Nealson et al., 1995). The 
motility of the rod-shaped bacterium is likely to enable S. oneidensis MR-1 to seek-
out the preferred substrate enriched zones of the anaerobic sedimentary environment 
(Myers and Nealson, 1988). Indeed, S. oneidensis MR-1 demonstrates chemotactic 
behaviour to nitrate and nitrite, which occurs at a greater propensity than chemotaxis 
to fumarate, DMSO, TMAO and thiosulfate. Furthermore, the presence of oxygen, 
nitrate and nitrite inhibit chemotaxis of S. oneidensis MR-1 to other electron 
acceptors (e.g. fumarate), which exhibit lower reduction potentials. The chemotactic 
response of S. oneidensis MR-1 to electron acceptors is postulated to involve a 
receptor and substrate-specific sensory mechanism that is independent of electron 





1.3 Regulation of genes encoding proteins for anaerobic respiration 
The remarkable respiratory versatility of S. oneidensis MR-1 is coupled to a 
branched anaerobic respiratory chain comprising many redox proteins, including, 
flavoprotein reductases, iron-sulfur proteins, quinones and 39 c-type cytochromes 
[The Institute of Genomic Research (TIGR); http://www.tigr.org; Heidelberg et al., 
2002]. Anaerobic expression of these redox proteins is tightly controlled by an 
oxygen-responsive regulatory system in S. oneidensis MR-1 that has evolved to 
exclusively express proteins required for growth on a particular substrate. This 
system is predicted to contain multiple regulatory transcription factors (Maier and 
Myers, 2001; Saffarini and Nealson, 1993), including the electron transport regulator 
protein, EtrA that shares 73.6 % sequence identity to the fumarate nitrate reductase 
regulator (FNR) of E. co/i (Saffarini and Nealson, 1993). FNR is responsible for 
positively regulating expression of terminal reductase genes of E. co/i including the 
frdABCD operon encoding the fumarate reductase (Jones and Gunsalus, 1987). The 
frdABCD operon of E. co/i is induced by anaerobiosis and is regulated at the 
transcriptional level by FNR in response to the cellular availability of nitrate, oxygen 
and fumarate (Jones and Gunsalus, 1985). E. coil preferentially utilises oxygen and 
nitrate as terminal electron acceptor during oxidative phosphorylation and the 
prevalence of these substrates inhibits the expression of the frdABCD operon (Jones 
and Gunsalus, 1985). The presence of fumarate as sole terminal electron acceptor 
activates the frdABCD operon and induces expression of the encoded fumarate 
reductase enzyme (Jones and Gunsalus, 1985). The FNR protein enables E. co/i to 
conserve energy by positively regulating expression of specific genes encoding 
proteins required for anaerobic respiration on a particular substrate. 
12 
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The FNR protein regulates gene expression by specifically binding to FNR-
dependent promoters comprising a 22 bp inverted repeat sequence located 
approximately 30 nucleotides upstream of the target gene transcription start site. This 
recognition sequence is represented by a consensus nonamer sequence, AAA-
TTGAT that is separated by four nucleotides from a second complementary 
consensus sequence, ATCAA-TTT (Eiglmeier et al., 1989). The activity of the FNR 
regulator protein is regulated by the stability of a [4Fe:4S]2 cluster oxygen sensing 
mechanism. The FNR [4Fe:4S]2 cluster is oxygen sensitive and is rapidly converted 
to [2Fe:2S]2 upon exposure to oxygen, which concomitantly results in loss of FNR 
site-specific DNA binding (Bates et al., 2000). The regulatory mechanism of FNR 
prevents expression of anaerobic-specific genes such as the frdABCD operon during 
aerobic conditions in which oxygen serves as the preferred terminal electron 
acceptor. 
The nucleotide sequences of etrA and fnr are only 69 % identical (Saffarini and 
Nealson, 1993) and in contrast tofnr, there is no FNR-binding site (Eiglmeier et al., 
1989; Saffarini and Nealson, 1993) upstream of the etrA sequence, suggesting that 
EtrA does not have an auto regulatory function under anaerobic conditions (Saffarini 
and Nealson, 1993). EtrA has four cysteine residues typical of oxygen-responsive 
regulatory proteins and contains a helix-turn-helix motif identical to that of FNR, 
suggesting that FNR and EtrA bind to similar DNA sequences and perhaps regulate 
the same terminal reductase operons (Saffarini and Nealson, 1993). 
13 
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Indeed, the precise role of EtrA is linked to positive transcriptional regulation of the 
reductase genes required for fumarate and nitrate regulation (Maier and Myers, 2001; 
Beiiaev et al., 2002a), similar to the FNR analog of E. coil (Jones and Gunsalus, 
1987). EtrA does not exert transcriptional regulation of reductase genes required for 
anaerobic growth on nitrite, thiosulfate, TMAO, DMSO, Fe(III) and sulfite (Maier 
and Myers, 2001), contrary to earlier misconceptions (Saffarini and Nealson, 1993). 
In addition to EtrA, a multitude of unidentified transcriptional regulators are 
predicted to control expression of redox proteins constituting the complex anaerobic 
respiratory chain (Maier and Myers, 2001; Saffarini and Nealson, 1993) and 
knowledge of the complete S. oneidensis MR-i genome sequence (Heidelberg et al., 
2002; http://www.tigr.org) will facilitate identification of these proteins. 
1.4 Unusual anaerobic-induced distribution of cytochromes 
The complex anaerobic respiratory pathway of S. oneidensis MR-1 that is regulated 
at the transcriptional level comprises components of the electron transport chain 
localised to the outer membrane, which is extremely unusual compared to most other 
Gram-negative bacteria in which components of the electron transport chain are 
contained in the cytoplasmic membrane and periplasm (Nicholls and Ferguson, 2002; 
Jones, 1988). The utilisation of insoluble metal oxides as terminal oxidants during 
anaerobic respiration of S. oneidensis MR-1 is specifically linked to the anaerobic 
expression of multihaem c-type cytochromes to the outer membrane bilayer (Figure 
1.4; Myers and Myers, 1992). 
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The anaerobic-induced distribution of cytochromes to the outer membrane is also 
common to manganese-reducing strains, S. oneidensis MR-4, S. oneidensis MR-8 
(Myers and Myers, 1998), S. frigidimarina NCIMB 400 (Field et al., 2000) and other 
metal-dissimilating bacteria of the genus Geobacter (Magnuson etal., 2001). 
S. oneidensis MR-1 is a motile bacterium that requires direct physical contact with 
insoluble Mn(IV) oxides in order to reduce and respire anaerobically with the 
insoluble substrates (Myers and Nealson, 1988). The switch in cytochrome 
expression from the cytoplasmic membrane to the outer membrane during 
anaerobiosis is proposed to facilitate direct contact and increase affinity between the 
bacterial cell and metal-containing substrates (Myers and Myers, 1992; Lower et al., 
2001) that are insoluble in the sedimentary environment sustained at pH 7.5-8.2 
(Myers and Nealson, 1988). It was proposed that S. oneidensis MR-1 excretes 
quinones to the extracellular space to aid transfer of insoluble Fe(III) and Mn(IV) 
oxides to the site of electron transfer in the cytoplasmic membrane (Newman and 
Kolter, 2000). However, the outer membrane cytochromes are ideally situated to 
provide an electron transfer link between extracellular insoluble metal oxides and 
redox proteins of the electron transfer chain embedded in the cytoplasmic membrane 
(Myers and Myers, 1992). Four c-type respiratory cytochromes (150 kDa, 83 kDa, 65 
kDa and 53 kDa; Figure 1.4) that are integral to the outer membrane of S. oneidensis 
MR-1 grown anaerobically with fumarate as terminal electron acceptor were 
identified to catalyse the formate-dependent in vitro reduction of Fe(III) and Mn(III). 
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These outer membrane cytocbromes may serve as terminal metal oxide reductases or 
they may function as intermediary redox enzymes in the respiratory pathway towards 
reduction of metal oxides (Myers and Myers, 1997a). The outer membrane decahaem 
cytochrome, OmcB/MtrC (53 kDa; Beliaev et al., 2001; Myers and Myers, 2001) is 
required for activity of the terminal Fe(III) reductase and may function as an 
essential component of a terminal reductase complex (Beliaev etal., 2001). 
The absence of the OmcA decahaem (83 kDa) in S. oneidensis MR-1 generates a 
mutant that is greatly impaired in its ability to respire anaerobically with Mn02. This 
leads to the suggestion that OmcA is an essential component of the respiratory 
pathway toward reduction of insoluble Mn(IV) (Figure 1.4). Indeed, OmcA may 
function as the terminal Mn(IV) reductase whose function is replaced by secondary 
Mn(IV) reductases in the OmcA deletion mutant (Myers and Myers, 2001). Outer 
membrane and periplasmic proteins of S. oneidensis MR-1, designated MtrB and 
MtrA, respectively, are both required for Fe(III) and Mn(IV) reduction (Beliaev and 
Saffarini, 1998; Beliaev et al., 2001; Figure 1.4). MtrA is a putative decahaem 
cytochrome, whereas MtrB contains one CxxC motif (Beliaev and Saffarini, 1998) 
and is postulated to facilitate proper incorporation of the OmcA and OmcB 
cytocbromes into the outer membrane (Myers and Myers, 2002). 
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Figure 1.4: Anaerobic respiratory network of S. oneidensis MR-1 
The diagram shows electron transfer pathways in S. oneidensis MR-I. Proton translocation and ATP 
synthesis is not shown. The electron transfer pathways are indicated by a dashed arrow and are classed 
as pathways toward Fe(III) reduction (orange), fumarate reduction (purple), nitrate reduction (yellow) 
and Mn(IV/lII) reduction (green). The respiratory proteins that are shown include the soluble 
periplasmic cytochromes that may function as electron shuttles (cyan), the periplasmic fumarate 
reductase (purple), outer membrane cytochromes (orange), the putative periplasmic nitrate reductase 
(yellow), cytoplasmic membrane-bound CymA (dark blue), formate dehydrogenase (brown) and MtrB 
(pink). The membrane-bound electron carrier, menaquinone (MK) accepts electrons from the 
membrane-bound dehydrogenase to form menaquinol (MKH2). This figure shows the electron 
transport pathways comprising proteins that are discussed in this chapter, and does not represent the 
complete picture of the respiratory proteins that have been characterised to date in S. oneidensis 
MR-l. 
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1.5 Anaerobic electron transfer pathways 
An electron transfer pathway must be established in the periplasm to link the outer 
membrane cytochromes and the redox proteins of the cytoplasmic membrane during 
anaerobic respiration with insoluble metal oxides. A number of c-type cytochromes 
are localised to the periplasm of Shewanella species (Morris, 1987) and these may 
function to shuttle electrons between the outer membrane cytochromes and the 
electron transport redox proteins of the cytoplasmic membrane forming a continuous 
electron transfer chain (Myers and Myers, 1992). In support of this conjecture, a 
small (11.8 kDa) low-potential tetrahaem cytochrome c3 isolated from the periplasm 
of S. frigidimarina NCIMB 400 is implicated in electron transfer to insoluble Fe(III) 
serving as the terminal electron acceptor (Gordon et al., 2000; Figure 1.4). Similarly, 
metal-dissimilation of G. sulfurreducens is linked to periplasmic shuttle proteins, 
such as the small (9.6 kDa) periplasmic trihaem c-type cytochrome (PpcA) that is a 
putative intermediary electron carrier between acetate and outer membrane Fe(III) 
reductases and other enzymes involved in U(VI) and humic reduction (Lloyd et al., 
2003). A small, periplasmic low potential tetrahaem cytochrome c of S. oneidensis 
MR-i (Tsapin et al., 2001) may also be implicated in metal reducing respiratory 
pathways. 
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CymA is a cytoplasmic membrane-bound cytocbrome c (21.4 kDa) that contains a 
globular tetrahaem domain putatively anchored to the outer face of the cytoplasmic 
membrane that is predicted to mediate electron transfer from the cytoplasmic 
membrane to acceptor proteins in the periplasm (Myers and Myers, 1997b; Figure 
1.4). Therefore, CymA may serve to transfer electrons to periplasmic proteins for 
subsequent transfer to the outer membrane c-type cytochromes. The high sequence 
identity of CymA to TorC (Méjean et al., 1994), NapC (Berks et al., 1995) and NirT 
(Jungst et al., 1991) cytoplasmic membrane-bound c-type cytocbromes involved in 
electron transfer to periplasmic proteins, lends further support that CymA will have a 
similar function (Myers and Myers, 1997b). These conjectures derived from 
sequence analysis correlate with findings that a soluble truncated form of CymA 
transfers electrons in vitro to the soluble periplasmic Fcc3 fumarate reductase 
(Schwalb et al., 2002). The haem reduction potentials (-175 and —261 mV) of CymA 
were identified to be more negative (Schwalb et al., 2002) than the haem groups of 
Fcc3 (-102, -146, -196 and —238 mV; Turner et al., 1999), suggesting an in vivo 
electron transport pathway from CymA to the tetrahaem cytochrome domain of Fcc3  
may exist in Shewanella species (Figure 1.4). The cytoplasmic membrane-bound 
protein, CymA may therefore serve as the immediate electron donor to the 
periplasmic Fcc3 fumarate reductase (Schwalb et al., 2002). CymA also appears to 
function in formate-dependent anaerobic electron transport towards reduction of 
Fe(III), Mn(IV) and nitrate (Myers and Myers, 1997b; Figure 1.4). 
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The varied cellular distribution of these terminal oxidants common to electron 
transfer pathways involving CymA, leads to the proposal that CymA occurs at the 
divergence point of these anaerobic respiratory pathways (Myers and Myers, 1997b; 
Myers and Myers, 2000). The quinol pool entrapped in the cytoplasmic membrane 
provides a continuous source of electron carriers that shuttle electrons to terminal 
reductases of the electron transport chain embedded in the cytoplasmic membrane. 
CymA is proposed to mediate electron transfer between the membrane-bound quinol 
pool and terminal reductases located in the periplasm and outer membrane of S. 
oneidensis MR-1 (Figure 1.4). Mutant strains of S. oneidensis MR-1 that are 
deficient in CymA (MRI -CYMA; Myers and Myers, 2000) or menaquinone have a 
common phenotype characterised by an impaired ability of these strains to grow 
anaerobically on Fe(III) (Myers and Myers, 1993; Saffarini et al., 2002), fumarate, 
Mn(IV) and nitrate (Myers and Myers, 1993), tentatively suggesting that 
menaquinone (E'0 = -74 mV; Myers and Myers, 1993) functions as the immediate 
reductant of CymA in the electron transport chain (Figure 1.4; Myers and Myers, 
2000). Furthermore, the CymA homologue of S. JHgidimarina NCIMB 400 is 
reduced in vitro by menaquinol (Field et al., 2000), which may accept electrons via 
the membrane anchor for subsequent transfer to the soluble tetrahaem domain. 
Alternatively, the electrons released by menaquinol oxidation in the cytoplasmic 
membrane might be directly transferred to an exposed haem group of the CymA 
tetrahaem domain that lies in close proximity to the cytoplasmic membrane (Schwalb 
et al., 2002; Figure 1.4). 
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The ability of S. oneidensis MR-i to respire with many types of electron acceptor is 
evidently linked to a complex and branched anaerobic respiratory chain comprising a 
varied distribution of redox proteins. The mechanism of fumarate respiration has 
received considerable interest due to the widespread use of fumarate as terminal 
electron acceptor by non-fermentative facultative and strictly anaerobic bacteria. The 
recent X-ray crystal structures of bacterial fumarate reductases have provided a 
structural basis for understanding the complex electron transfer pathways and 
mechanism of chemiosmotic coupling. 
1.6 Cytoplasmic membrane-bound fumarate reductases 
Fumarate respiration has been most extensively studied in Escherichia co/i and other 
Gram-negative facultative aerobes of the genus Shewanella and the obligate 
anaerobe Wolinella succino genes. The terminal fumarate reductases (quinol: 
fumarate reductases, QFR) of E. coli (Iverson et al., 1999; Figure 1.5) and W. 
succinogenes (Lancaster et al., 1999; Figure 1.6) are multi-redox cytoplasmic 
membrane-bound enzyme complexes of the anaerobic electron transfer chain. X-ray 
crystal structures of the membrane-bound enzymes reveal a similar structural 
organisation of the multi-subunit fumarate reductases (Iverson et al., 1999; Lancaster 
et al., 1999). The E. co/i fumarate reductase (FRD) that catalyses the terminal 
reduction of fumarate to succinate is composed of four associated subunits encoded 
by genes of the polycistronic frdABCD operon (Cole et al., 1982; Grundström and 
Jaurin, 1982; Cole, 1982; Jones and Gunsalus, 1985). The genes constituting the E. 
co/i frdABCD operon (Jones and Gunsalus, 1985) are widely conserved in frd 
operons of distantly related bacteria such as Proteus vulgaris (Cole, 1987). 
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Members of the fumarate reductase family exhibit striking similarities in primary 
structure and catalytic mechanism to members of the succinate dehydrogenase 
family. ThefrdA and frdB genes of E. coli (Cole et al., 1982; Cole, 1982) show high 
sequence similarity, respectively, to sdhA and sdhB, encoding homologous subunits 
of the succinate dehydrogenase of E. coli (Wood et al., 1984b; Darlison and Guest, 
1984) and B. subtilis (Philips et al., 1987). The overall structural fold determined for 
membrane-bound fumarate reductases is predicted to be similar to that of succinate 
dehydrogenase (succinate-ubiquinone oxidoreductase, Complex II) which catalyses 
the reverse reaction in the aerobic respiratory chain of bacteria and the citric acid 
cycle in the mitochondrial matrix of eukaryotic cells (Figure 1.1; Nicholls and 
Ferguson, 2002). The strong enzyme similarity is demonstrated in the ability of the 
E. coli succinate dehydrogenase to functionally replace the E. coli fumarate reductase 
and support anaerobic growth with fumarate as terminal electron acceptor 
(Maklashina etal., 1998). 
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1.6.1 The flavoprotein catalytic subunit 
The E. coli FrdA catalytic flavoprotein subunit (66 kDa; Iverson et al., 1999) 
encoded by frdA (Cole, 1982) contains covalently bound FAD (E°' = -48 mV; 
Sucheta et al., 1993; Weiner and Dickie, 1979; Figure 1.8) in close proximity to the 
catalytic active site of fumarate reduction and succinate oxidation (Iverson et al., 
1999). The structurally similar flavoprotein catalytic domains of the E. coil and W 
succinogenes membrane-bound fumarate reductases share a Rossmann-type fold that 
provides the binding site for the FAD cofactor (Iverson el al., 1999 and Lancaster et 
al., 1999). The W. succinogenes fumarate reductase X-ray crystal structure forms, 
solved at 2.2 A resolution [Protein data bank (PDB) entries; 1QLA and 1QLB] 
revealed the presence of a capping domain (106 amino acid residues) in the flavin 
subunit (73 kDa). The active site was identified at the hinge region between the 
capping and flavin domains (Lancaster et al., 1999). 
1.6.2 The iron-sulphur electron transfer subunit 
The smaller FrdB subunit of E. coil (27 kDa) encoded byfrdB (Cole et al., 1982) is 
an iron-sulfur protein that contains three Fe-S redox centres that are trinuclear 
[3Fe:4S], tetranuclear [4Fe:4S] and binuclear [2Fe:25] (Manodori et al., 1992). FrdB 
is an electron-delivery subunit that associates with FrdA (Figures 1.5) to allow inter-
subunit electron transfer via the Fe-S centres to the FAD cofactor. The E. coil FrdA 
and FrdB subunits associate to form a soluble catalytic complex that extends into the 
cytoplasm, the site of fumarate reduction (Iverson et al., 1999). A structurally similar 
iron-sulfur protein subunit comprising two domains is present in the multi-subunit 
W. succinogenes fumarate reductase enzyme (Figure 1.6; Lancaster et al., 1999). 
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1.6.3 The hydrophobic membrane anchor 
The water-soluble catalytic domain of E. coli fumarate reductase (FrdA and FrdB) is 
anchored to the cytoplasmic membrane by two transmembrane hydrophobic 
subunits, FrdC (15 kDa) and FrdD (13 kDa; Figure 1.5 and 1.7; Iverson et al., 1999). 
A single transmembrane subunit containing two b-type haem groups anchors the 
catalytic complex of the W. succino genes fumarate reductase to the membrane 
(Figure 1.6 and 1.7; Körtner et al., 1990). The membrane anchor of E. coli succinate 
dehydrogenase comprises two hydrophobic subunits (Wood et al., 1984b), one of 
which binds a b-type haem group (Murakamia et al., 1985). Therefore, the 
membrane-bound fumarate reductases and succinate dehydrogenases share structural 
similarities in the catalytic region and show major differences in the membrane 
anchor region. The distinct integral membrane component(s) of the multi-subunit 
protein complexes are suspected to share a common interaction with the enzyme 
reductant and provide a connection between the soluble catalytic domain and the 
respiratory electron transfer chain embedded in the cytoplasmic membrane (Iverson 




















Figure 1.5: E. co/i membrane-bound fumarate reductase 
An E. co/i membrane-bound fumarate reductase monomer (crystallised as a dimer) solved to 3.3 A 
resolution (Iverson et al., 1999) is shown. The FrdA flavoprotein subunit (blue) contains covalently 
bound FAD and the substrate-binding site. The FrdB iron-sulfur subunit (red) contains three iron-
sulfur clusters and is connected to the flavin subunit to form a catalytic domain that protrudes into the 
cytoplasm. The catalytic domain is connected to the cytoplasmic membrane by two membrane anchor 
polypeptides, FrdC (green) and FrdD (purple) that contain two menaquinone binding sites located on 
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Figure 1.6: W. succinogenes membrane-bound fuma rate reductase 
The W. succinogenes membrane-bound fumarate reductase crystallised as a dimer and solved to 2.2 A 
resolution (Lancaster ci al., 1999) is shown. The flavoprotein subunit (blue) containing covalently 
bound FAD and the substrate-binding site is connected to the iron-sulfur subunit (purple). The 
catalytic domain of the enzyme is connected to the cytoplasmic membrane by a single membrane 
anchor (green and yellow) containing two b-type haem groups. The figure is taken from Figure 1 of 





1.6.4 Electron transfer in membrane-bound fumarate reductases 
The fumarate respiratory pathway is dependent upon menaquinol, a membrane 
embedded electron carrier that shuttles freely between sequential membrane-bound 
oxidoreductase complexes. The terminal reduction of fumarate (E°' = 30 mV) to 
succinate catalysed by the membrane-bound fumarate reductases of E. coil and W. 
succino genes is coupled to oxidation of menaquinol (E°' = -74 mV) to menaquinone 
(Jones, 1988). The two conjectural menaquinone binding sites in the membrane 
anchor of E. coil fumarate reductase (Westenberg ci' al., 1990) were identified to 
reside on opposite sides of the membrane (separated by 27 A), positioned proximal 
(Qp) and distal (QD)  to the [3Fe:4S] cluster (Iverson ci' al., 1999; Figure 1.5). The 
location of solvent exposed menaquinone binding sites in close proximity to the 
[3Fe:4S] cluster (Iverson ci al., 1999) lends further support that menaquinol 
functions to deliver electrons to the FrdB subunit as part of the electron transfer 
pathway to fumarate. The membrane spanning quinone distribution of E. coil 
fumarate reductase resembles that of cytochrome bc1 (Complex III) of the aerobic 
respiratory chain (Zhang ci al., 1998) and succinate dehydrogenase of 
Saccharomyces cerevisiae (Figure 1.7; Oyedotun and Lemire, 2001). The [2Fe:2S] is 
closest to the FAD cofactor of the FrdA subunit and is the most likely Fe-S candidate 
to transfer electrons directly to the flavin cofactor (Iverson ci' al., 1999; Ohnishi et 
al., 1981). The intra-molecular electron transfer conduit of menaquinol-fumarate 
oxidoreductases, as interpreted from the X-ray crystal structure of E. coil fumarate 
reductase (PDB, IFUM; Figure 1.5) follows the sequence: QD-Qp-[3Fe:4S]-[4Fe:4S]-
[2Fe:2S]-FAD-fumarate (Iverson et al., 1999). 
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The redox cofactors of the W. succinogenes fumarate reductase are positioned in a 
similar arrangement relative to the E. co/i fumarate reductase which suggests that a 
similar electron transfer conduit exists in the related enzymes (Lancaster et al., 
1999). However, the haem b groups in the transmembrane anchor of W succinogenes 
fumarate reductase are arranged in close proximity to one another (shortest contact; 
4.2 A) and one of the haem groups lies near the cytoplasmic face of the membrane in 
close proximity to the [3Fe:4S] cluster (Figure 1.7; Lancaster et al., 1999). This 
cofactor arrangement leads to the proposition that a transmembrane electron transfer 
pathway exists from menaquinol to the 3Fe:4S] cluster in the W. succinogenes 
fumarate reductase (Lancaster ci al., 1999). The menaquinone binding sites are 
predicted to be close to the dihaem binding sites of the W. succinogenes fumarate 
reductase (Lancaster et al., 1999) to mediate efficient electron transfer upon 
menaquinol oxidation. Indeed, an essential residue (Glutamate 66) of the dihaem 
membrane anchor region required for forming the menaquinol oxidation site during 
fumarate respiration is located next to the haem group that is distal to the [3Fe:4S] 
cluster. The glutamate residue is postulated to accept protons from oxidised 
menaquinol during electron transfer to the distal haem group (Lancaster et al., 2000). 
The close proximity of the essential glutamate residue to the periplasmic face of the 
membrane suggests that the protons will be expelled to the periplasm leading to the 
build up of positive charge. The subsequent abstraction of protons at the cytoplasmic 
face of the membrane for fumarate reduction leads to the conjecture that menaquinol 
oxidation by fumarate is coupled to the generation of an electrochemical proton 
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Figure 1.7: Electron transfer in fumarate reductases 
The schematic diagram shows the overall structural arrangement of the E. coli and W. succinogenes 
fumarate reductases and succinate dehydrogenase of S. cerevisiae. The variation in the membrane 
anchor (light green) is shown. The E. coli fumarate reductase comprises two polypeptides and two 
menaquinone binding sites (Qp and Qn).  The QFR of W. succinogenes contains a single polypeptide 
with two b-type haem groups (red circles). Succinate dehydrogenase of S. cerevisiae contains two 
polypeptides and one b-type haem group (red circle). The catalytic domain of the membrane-bound 
enzymes is similar, comprising a flavin subunit (yellow) and an iron-sulfur subunit (red). The quinone 
binding sites of the W. succinogenes QFR have yet to be determined (dashed box) but are thought to 
reside close to the haem b groups. The oxidation of menaquinol (MKH2) to menaquinone (MK) yields 
two protons that may be released to the cytoplasmic face of the membrane to balance the number of 
protons required for fumarate reduction. Alternatively, the protons may be released to the periplasm 
by the W. succinogenes fumarate reductase generating an electrochemical proton potential across the 
membrane. 
1.6.5 Bidirectional fumarate reductase activity 
The flavinylated domain of the membrane-bound E. coli fumarate reductase and 
succinate dehydrogenase (Complex II) of bovine heart mitochondrion contains a 
highly conserved histidyl residue (Cole, 1982; Figure 1.8) that mediates covalent 
attachment to FAD. The N(3) imidazole ring moiety of this essential histidyl residue 
is covalently linked to the C8a methyl group of FAD (Weiner and Dickie, 1979). A 
similar C8a substituted flavin cofactor is also found in the W. succinogenes fumarate 
reductase (Kenney and Kroger, 1977). 
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The functionally important histidine side-chain lies within a strictly conserved nine-
residue motif, representing a putative FAD binding site of succinate: quinone 
oxidoreductases (Cole, 1982; Figure 1.8). The covalent attachment of FAD to the 
membrane-bound E. coli fumarate reductase (E°' = -48 mV; Sucheta et al., 1993) 
modulates the FAD redox activity of this enzyme and permits succinate oxidation at 
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Figure 1.8: The putative FAD binding site of fumarate reductases 
The essential histidyl residue (red) required for covalent attachment of FAD in the family of fumarate 
reductases and succinate dehydrogenases, comprising: B. co/i FrdA (EcF), P. vulgaris FrdA (PvF), S. 
cerevisiae SdhA (ScS), E. co/i SdhA (EcS), W. succinogenes FrdA (WsF) and Bacillus subtilis SdhA 
(BsS), is shown. The histidyl residue is located in a conserved motif comprising nine amino acid 
residues (bold). The corresponding sequence of the soluble Fcc3 fumarate reductase (Fcc) from S. 
frigidimarina NCIMB 400 is also shown. The sequence alignment is adapted from Figure 4 of Pealing 
et al., 1992. 
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1.7 Soluble fumarate reductases related to Fcc3  
The fumarate reductase of Shewanella species is a soluble, periplasmic 
flavocytochrome c3 (Fcc3; Morris et al., 1994) evolutionarily related to the more 
typically occurring membrane-bound fumarate reductases of E. co/i and W 
succinogenes (Pealing et al., 1992). A putative membrane-bound fumarate reductase 
complex, comprising an FrdA flavoprotein subunit (ORF number; S00398), FrdB 
iron-sulfur subunit (S00399) and two FrdC cytochrome b subunits (S00396 and 
S00397) is apparently also expressed in S. oneidensis MR-1 (http://www.tigr.org) in 
addition to the soluble periplasmic Fcc3 fumarate reductase. However, the soluble 
Fcc3 fumarate reductase is the only respiratory fumarate reductase produced in S. 
frigidimarina NCIMB 400 (Gordon et al., 1998). The specific expression of Fcc3 is 
regulated at the transcriptional level (Gordon et al., 1998) in response to anaerobic 
growth of S. frigidimarina NCIMB 400 with fumarate serving as terminal electron 
acceptor (Pealing et al., 1992). 
Another fumarate reductase of S. frigidimarina NCIMB 400 is specifically expressed 
during anaerobic respiration in the presence of ferric citrate or ferric pyrophosphate 
as the sole terminal electron acceptor (Dobbin et al., 1999). This iron-induced 
fumarate reductase is a periplasmic c-type tetrahaem flavocytochrome c3 (Ifc3) that 
shares 43 % sequence identity to Fcc3 (Dobbin et al., 1999). The periplasmic location 
of the iron-induced enzyme suggests that this enzyme may function as an electron 
shuttle to deliver electrons to outer membrane cytochromes putatively linked to the 
terminal reduction of insoluble Fe(III) compounds (Dobbin et al., 1999). 
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Alternatively, the novel Ifc3 flavocytochrome may catalyse the terminal reduction of 
soluble Fe(III) compounds that cross the outer membrane impermeability barrier 
during anaerobic metabolism of S. frigidimarina NCIMB 400 (Dobbin et al., 1999). 
The c-type haems and non-covalently bound FAD redox cofactor of Ifc3 have low 
midpoint reduction potentials similar to Fcc3 (Dobbin et al., 1999). The structural 
homology (Bamford et al., 1999) and shared redox properties of Ifc3 and Fcc3  
(Dobbin et al., 1999) are exemplified in the ability of the iron-induced isozyme to 
catalyse the in vitro unidirectional reduction of fumarate to succinate (Bamford et al., 
1999). However, the Ifc3 enzyme is not induced anaerobically in the presence of 
fumarate (Dobbin et al., 1999) and does not catalyse fumarate reduction in vivo, as 
shown by failure of Ifc3 to catalyse fumarate reduction in the S. frigidimarina Fcc3  
deletion strain (EG301; Gordon et al., 1998). 
The folding topology of the flavin domain and a number of catalytic residues of Fcc3  
are also conserved in the L-aspartate oxidase (LASPO) flavoenzyme of E. coli which 
catalyses the oxidation of L-aspartate to iminoaspartate towards NAD biosynthesis 
(Mattevi et al., 1999). This reaction is coupled to the reduction of molecular oxygen 
during aerobic respiration or fumarate during anaerobic respiration of E. coli. The 
LASPO redox reaction is mediated by the non-covalently bound FAD cofactor that 
has a dual function as an oxidant during the reductive half reaction and as a reductant 
during anaerobic electron transfer to fumarate (Tedeschi et al., 1996). The LASPO 
enzyme catalyses the unidirectional reduction of fumarate, which is reflected in the 
low midpoint reduction potential (-216 mV) of FAD (Tedeschi et al., 1997), that is 
also apparent in Ifc3 (Dobbin et al., 1999) and Fcc3 (Turner et al., 1999). 
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1.7.1 Flavocytochrome c3 of S. frigidImarina NCIMB 400 
Fcc3 of S. frigidimarina NCIMB 400 is a single polypeptide enzyme that is encoded 
by fccA comprising an N-terminal sequence of 351 nucleotides encoding a 
cytochrome domain that is contiguous with a downstream 1362 nucleotide sequence 
encoding a flavin domain. The extreme N-terminal DNA sequence of fccA encodes a 
signal sequence for targeting the flavocytochrome to the periplasm via the Sec-
dependent pathway (Pealing et al., 1992; Figure 1.9). The region upstream of the 
fccA promoter does not appear to contain a motif matching the E. co/i FNR-
consensus sequence (Eiglmeier et al., 1989). However, expression of fccA might be 
regulated by the EtrA transcriptional regulator, which perhaps binds to a DNA 
sequence distinct from the related FNR protein of E. co/i (Gordon et al., 1998). 
Indeed, the fccA fumarate reductase gene of S. oneidensis MR-i was consistently 
repressed in an etrA knockout strain (ETRAI), indicating a role of EtrA in 
transcriptional activation of fccA under both fumarate and nitrate reducing conditions 
(Beliaev et al., 2002a). 
11_351 bp_ 4 	1362 bp 	No 
TTGTTG 	 AAAGAT 	
N 
AACAAC TTTCTA - 	fiavrn 
-35 	 -10 	s 
4- sequence 4- sequence -* i 	 fccA 
Figure 1.9: Map of thefccA gene 
The fccA gene encoding Fcc3 comprises sequence encoding a cytochrome (cyt) domain (red) and a 
flavin domain (yellow). The nucleotide lengths are indicated (bp). The possible —10 and —35 promoter 
sequences (Gordon et al., 1998) are shown upstream (blue) in the 5' to 3' direction. The N-terminal 
sequence (green) encoding a putative Sec-dependent signal sequence (s) for cytoplasmic export of the 
flavocytochrome is shown. The diagram is not to scale. 
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The 571 amino acid polypeptide chain of Fcc3 comprising a c-type tetrahaem 
cytochrome domain and a flavin domain (Pealing et al., 1992) is structurally distinct 
compared to other bacterial flavocytochromes such as flavocytochrome c sulfide 
dehydrogenase of the purple phototrophic bacterium Chromatium vinosum (Chen et 
al., 1994). The X-ray crystal structure of wild-type Fcc3 (S. frigidimarina NCIMB 
400) solved to 1.8 A resolution (PDB, 1QJD; Taylor et al., 1999; Figure 1.10) 
revealed that the 571 amino acid fumarate reductase contains a clamp domain 
(residues, His365-G1y502) in addition to the cytochrome domain (residues, A1a001-
ArglOO) and the flavin domain (residues, Asplll-A1a364 and residues, Va1503-
Asn571). The N-terminal c-type cytochrome domain contains four covalently bound 
haem groups that are solvent exposed and attached to a polypeptide chain that shows 
no sequence similarity to any other cytochrome of known structure (Taylor et al., 
1999). The C-terminal FAD-binding domain of Fcc3 consists of a Rossmann fold and 
therefore shares structural and topological similarities to unrelated FAD-binding 
enzymes, including, lipoamide dehydrogenase (Mattevi et al., 1993) and glutathione 
reductase (Mittl and Schulz, 1994). The most closely related flavoproteins to Fcc3  
that share structural and sequence similarity were identified as members of the 
fumarate reductase and succinate dehydrogenase families (Pealing et al., 1992). High 
percentage sequence identity of residues constituting the Rossmann fold was 
observed for the Fcc3 flavin domain aligned with the flavin subunits of L-aspartate 
oxidase (38 %; Mattevi et al., 1999) and the membrane-bound E. co/i fumarate 
reductase (45 %; Iverson et al., 1999). 
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The third domain of Fcc3, designated the 'clamp domain', comprises a unique 
structural fold consisting of seven short a-helices enfolding a four-stranded 
antiparallel 3-pleated sheet (Taylor et al., 1999; Figure 1.10). The Fcc3 (S. 
frigidimarina NCIMB 400) X-ray crystal structure (Taylor et al., 1999) is essentially 
structurally identical to the X-ray crystal structures for the related Fcc3 soluble 








Figure 1.10: X-ray crystal structure of Fcc3 solved to 1.8 A resolution 
The Fcc3 fumarate reductase complexed with a malate-like substrate was solved to 1.8 A resolution 
(Taylor et al., 1999). The X-ray crystal structure revealed a novel mobile clamp domain (yellow) that 
controls access of substrate to the active site of the flavin domain (red). The N-terminal cytochrome 
domain (blue) is shown to contain 4 c-type haem groups that deliver electrons to non-covalently 
bound FAD (ball and stick) in the flavin-containing catalytic domain (red). The FAD cofactor lies in 
close proximity to the malate-like substrate bound in the enzyme active site of the flavin-containing 
domain. The picture is adapted from Figure 2a of Taylor etal., 1999. 
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The flavin domain of Fcc3 contains non-covalently bound FAD and accepts electrons 
from the electron transfer haem groups of the cytochrome domain for fumarate 
reduction. The X-ray crystal structure of Fcc3 (S. frigidimarina NCIMB 400) reveals 
that three of the haem groups (I-Il!) are oriented in a similar spatial arrangement 
(Figure 1.10) to corresponding haem groups of the related tetrahaem cytochrome c3  
of Shewanella species (Pessaiiha ci al., 2001 and Leys et al., 2002). A short peptide 
linker of Fcc3 (residues, Asp 101 -Lys 110) connects the N-terminal cytochrome 
domain to the flavin-binding domain, which results in positioning haem IV proximal 
to the FAD cofactor (edge-edge distance, 7.4 A). This close haem-flavin distance is 
ideally suited to efficient inter-domain electron transfer for fumarate reduction in the 
active site of the Fcc3 flavin domain (Taylor et al., 1999). The low reduction 
potentials of the tetrahaem groups (E°' = -102, -146, -196 and —238 mV) are suitable 
for forming an electron conduit to FAD, which has a greater tendency to accept 
electrons, due to a more positive reduction potential (E°' = -152 mV; Turner et al., 
1999). The lower reduction potential (-229 mV) determined for haem IV of 
tetrahaem cytochrome c3 (S. frigidimarina NCIMB 400) might be a conserved 
feature for haem IV in the cytochrome domain of Fcc3, thereby mediating the 
thermodynamically favourable electron transfer from haem IV to FAD. The more 
negative reduction potentials determined for haems I and II compared to haem III for 
cytochrome c3 leads to the proposition that electrons will also flow in the Fcc3  





The substrate-bound enzyme active site of Fcc3 is completely buried in the oxidised 
state of the flavocytochrome (Taylor et al., 1999). Structural superposition of 
monomers obtained for the Fcc3-fumarate complexed enzyme (S. oneidensis MR-1) 
revealed a 12 rotation of the clamp domain relative to the flavin domain. The 
flexibility in domain movement around an axis close to the active site suggests that 
the clamp domain mobility mediates substrate access to the buried enzyme active site 
(Leys et al., 1999). The presence of a capping domain in the flavin subunit of the W. 
succino genes fumarate reductase led to the suggestion that motion of the clamp 
domain will serve the same purpose in the related membrane-bound fumarate 
reductases (Lancaster et al., 1999). Consistent with this conjecture, the capping 
domain and FAD-binding domain of the W. succinogenes fumarate reductase, are 
oriented by 14 ° in a new crystal form that was superimposed (Lancaster et al., 2001) 
on the previous crystal forms of the enzyme (Lancaster etal., 1999). 
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1.7.2 Fcc3 is a unidirectional fumarate reductase 
Fcc3 was identified to contain 1 mot of non-covalently bound FAD per mot of 
protein (Morris et al., 1994). This finding correlated with the initial sequence 
alignments of Fcc3 and the membrane-bound fumarate reductases, which showed that 
the histidyl residue essential for covalent attachment of FAD (Weiner and Dickie, 
1979; Cole, 1982) was absent in Fcc3 (Pealing et al., 1992; Figure 1.8). The non-
covalently bound FAD of Fcc3 is a cooperative two-electron redox centre with a low 
reduction potential of-I 52 mV (pH 7.0, 24 °C), which favours the terminal reduction 
of fumarate (E°' = 30 mV). This significantly low reduction potential of non-
covalently bound FAD renders the Fcc3 enzyme a unidirectional fumarate reductase 
since electron transfer from succinate to FAD is unfavourable (Turner et al., 1999). 
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1.8 Novel flavocytochromes of S. oneidensis MR-1 
1.8.1 Identification of novel S. oneidensis MR-1 genes 
Sequencing of the S. oneidensis MR-1 genome (4,969,803 bp circular chromosome) 
(http://www.tigr.org and Heidelberg et al., 2002) has led to the identification of a 
remarkable number of respiratory proteins including 14 c-type cytochromes 
containing four or more haem-binding sites (Heidelberg et al., 2002). Further 
genome analysis has shown that each of the novel jcB structural genes (ORF 
numbers: S01413, S03300, S03056 and S03623; Table 1.1) encoding a new 
tetrahaem cytochrome (FccB54, FccB56, FccB63 and FccB342) is organised in a 
gene cluster with an fccA gene (ORF numbers: S01414, S03301, S03058 and 
S03624) encoding a putative flavoprotein (FccA54, FccA56, FccA63 and FccA342; 
Table 1. 1, Figure 1.11). The predicted amino acid sequences of these putative flavin 
and cytochrome subunits share striking sequence identity to the flavin and 
cytochrome domains, respectively, of the Fcc3 fumarate reductase of S. firigidimarina 
NCIMB 400 (Tables 1.2 and 1.3) and S. oneidensis MR-1. The predicted amino acid 
sequences of each novel flavin subunit (FccA54, FccA56, FccA63 and FccA342) of 
S. oneidensis MR-1 are also similar (38-44 % identity) to the putative FccA 
flavoprotein (52.4 kDa) of W. succinogenes (Simon et al., 1998) which shares 33 % 
sequence identity to the flavin domain of Fcc3 (Table 1.2). Each novel putative 
cytochrome subunit (FccB54, FccB56, FccB63 and FccB342) of S. oneidensis MR-1 
shares significant sequence identity (29-34 %) to the putative FccB cytochrome 





Furthermore, high amino acid sequence identity (35-42 %) was observed by pair-
wise sequence comparison of each novel flavin subunit. Lower sequence identity 
(30-37 %) was observed when comparing each of the novel cytochrome subunits 
against one another. The contiguous gene arrangement and observed sequence 
homology to Fcc3 has led to the proposal that the separately encoded flavin subunits 
(FccA54, FccA56, FccA63 and FccA342) associate with the respective partner 
cytochrome subunits (FccB54, FccB56, FccB63 and FccB342) to form dimeric 
flavocytochromes. 
The novel flavin and cytochrome proteins were given preliminary names according 
to the contig number that the genes were originally assigned during genome 
sequencing. The contig numbers were also used for naming the genes encoding each 
novel protein subunit. Throughout the thesis, the novel genes and encoded proteins 
are named according to the original contig number. The ORF numbers of the 
completed genome sequence which each of the genes corresponds to are shown in 
Table 1.1. 
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Protein length (aa) Molecular weight 
 (Da) 
p1 
Preprotein Mature Preprotein Mature 
FccA54 fcA54 S01414 506 477 54,927 52,178 8.34 
FccB54 fccB54 S01413 123 102 13,307 11,145 6.30 
Chyp chyp S01412 377 351 42,474 39,698 4.46 
Hyp hyp S01411 360 339 39,881 37,563 5.45 
FccA56 fccA56 S03301 499 480 53,763 51,786 8.28 
FccB56 fccB56 S03300 124 101 13,855 11,273 6.85 
Ha156 ha156 S03299 549 529 60,609 58,503 5.65 
FccA63 fccA63 S03058 517 482 55,237 51,737 8.38 
Ha163 ha163 S03057 550 524 59,513 56,824 6.13 
FccB63 fccB63 S03056 127 105 14,233 11,888 7.09 
FccA342 fccA342 S03624 494 473 53,540 51,130 8.08 
FccB342 fccB342 S03623 116 94 13,136 10,781 6.11 
Cdmp cdmp S03622 247 228 27,619 25,669 5.95 
Chyp chyp S03621 151 134 16,485 14,494 6.56 
Table 1.1: Predicted properties of the novel flavoproteins related to Fcc3 
The open reading frame (ORF) numbers for each of the novel flavoproteins according to 'The institute 
for Genomic Research' (http://www.tigr.org) are shown. The amino acid (aa) sequence lengths of the 
preprotein and mature protein are also shown. The preprotein lengths were calculated using SignalP 
(Nielsen et al., 1997; http://www.cbs.dtu.dk!services/SignalP/). The estimated molecular weight of the 
apoproteins (preprotein and mature protein) and isoelectric point (p1) for each of the mature protein 
subunits (http://www.expasy.org/tools/protparam.html) is shown. The novel flavin (FccA54, FccA56, 
FccA63 and FccA342) and cytochrome (FccB54, FccB56, FccB63 and FccB342) subunits are 
preliminary named according to the contig number that the genes were originally assigned during 
genome sequencing. A conserved hypothetical protein (Chyp) and a hypothetical protein (Hyp) 
encoded by genes (ORF numbers: S01412 and S0141 1, respectively) that are associated with fccA54 
and fccB54 are shown. A conserved domain protein (Cdmp) and a conserved hypothetical protein 
(Chyp) encoded by genes (S03622 and S03621, respectively) that are close tofccA342 and fccB342 





AMINO ACID SEQUENCE IDENTITY (%) 
Protein 
Name 
SF FccA FccA54 FccA56 FccA63 FccA342 WS 
FccA 
SF FccA - - - - - - 
FccA54 29 - - - - - 
FccA56 31 35 - - - - 
FccA63 34 40 40 - - - 
FccA342 32 38 38 42 - - 
WS 33 38 
FccA  
42 44 42 - 
Table 1.2: Flavoprotein amino acid sequence identities 
The amino acid sequence identities of each novel flavoprotein subunit (FccA54, FccA56, FccA63 and 
FccA342) against the flavin domain of Fcc3 (S. frigidimarina NCIMB 400; SF FccA) and the putative 
flavin subunit of W. succinogenes (WS FccA; Simon ci al., 1998) are shown. The mature protein 
sequences were aligned in pair-wise sequence alignments and the sequence identity calculated using 
Blast (http://www.ncbi.nim.nih.goviblast/bi2seq/bl2.html).  
AMINO ACID SEQUENCE IDENTITY (%) 
Protein 
Name 
SF FccB FccB54 FccB56 FccB63 FccB342 WS 
FccB 
SF FccB - - - - - - 
FccB54 29 - - - - - 
FccB56 23 35 - - - - 
FccB63 29 30 31 - - - 
FccB342 29 37 35 35 - - 
WS 25 29 
FccB  
34 32 30 - 
Table 1.3: Cytochrome protein amino acid sequence identities 
The amino acid sequence identities of each novel cytochrome subunit (FccB54, FccB56, FccB63 and 
FccB342) against the cytochrome domain of Fcc3 (S. frigidimarina NCIMB 400; SF FccB) and the 
putative cytochrome subunit of W. succinogenes (WS FccB; Simon et al., 1998) are shown. The 
preprotein sequences were aligned in pair-wise sequence alignments and the sequence identity 
calculated using Blast (http://www.ncbi.nlm.nih.gov/blastlbl2seq/b12.html).  
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1.8.2 Arrangement of the novel S. oneidensis MR-1 genes 
The gene arrangement of the novel S. oneidensis MR-1 genes resembles that of the 
W. succinogenes fccABC operon containing fccA and fccB, which encode putative 
flavin (FccA) and cytochrome (FccB) subunits, respectively (Simon ci al., 1998; 
Figure 1.11). The fccA and fccB genes of W. succinogenes are co-transcribed with 
fccC (Figure 1.11) that encodes a putative membrane-bound tetrahaem cytochrome c 
similar in sequence to CymA (1.5). The encoded FccA and FccB subunits form a 
putative periplasmic oxidoreductase complex that is induced anaerobically in the 
presence of fumarate as terminal electron acceptor. However, the FccA catalytic 
subunit of W. succinogenes does not catalyse fumarate reduction (Simon ci al., 
1998), which leads to the conjecture that the related putative flavocytochromes of S. 
oneidensis MR-i will also catalyse reduction of an alternative substrate to fumarate. 
The N-terminal amino acid sequence of each novel S. oneidensis MR-1 flavoprotein 
(FccA54, FccA56, FccA63 and FccA342) is also remarkably similar to that of a 
periplasmic methacrylate reductase flavoprotein (50 kDa) of Geobacter 
sulfurreducens AM-1 (Mikoulinskaia ci al., 1999). This flavoenzyme couples the 
oxidation of benzyl viologen to the terminal reduction of methacrylate to produce 
isobutyrate. The activity of this methacrylate reductase was shown to be dependent 
on tight association of the catalytic flavoprotein with a periplasmic tetrahaem 
cytochrome c subunit (30 kDa). The putative dimeric structure of each novel S. 
oneidensis MR-1 flavocytochrome is therefore shared with the related periplasmic 
methacrylate reductase flavocytocbrome of G. sulfurreducens AM-1. 
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The operon comprising fccA54 and fccB54 also contains genes (S01412 and 
S0141 I) encoding hypothetical proteins that may associate with the putative Fcc54 
flavocytochrome in the periplasm. Likewise, genes (S03622 and S03621) 
downstream of fccB342 encode hypothetical proteins that appear to contain N-
terminal Sec-dependent signal sequences. These unknown proteins may associate to 
form a large complex with the putative FccB342 flavocytochrome in the periplasm. 
The hypothetical proteins may be involved in catalysis or electron transfer reactions 
preceding the reaction catalysed by the putative flavocytochromes. 
The Fcc56 operon contains a histidine ammonia lyase-like gene (hal) downstream of 
[ccA56 and fccB56. A hal gene also occurs in the Fcc63 operon and maps between 
fccA63 and fccB63 (Figure 1.11). The presence of a gene encoding a histidase family 
protein in the same operon as genes encoding the putative flavin and cytochrome 
subunits has led to the suggested role of these flavocytochromes in the reduction of 
amino acids serving as terminal electron acceptor (Heidelberg et al., 2002). Histidine 
ammonia-lyase is involved in the degradation of histidine and catalyses the 
elimination of the a-amino group to form a-3-unsaturated trans-urocanate. The 
double bond introduced in a-13  -unsaturated trans-urocanate by deamination of 
histidine could subsequently be reduced by the associated flavocytochrome C3 
(Schwede et al., 1999). 
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The reaction catalysed by histidine ammonia-lyase involves a reactive electrophile, 
4-methylidene-imidazole-5-one, which abstracts a non-acidic proton from the 
substrate Cp atom. The cc-ammonium group is subsequently eliminated and the 
urocanate product is released. The electrophile is formed autocatalytically by 
cyclisation and dehydration of histidase tripeptide residues A1a142-Ser143-G1y144 
(histidase of Pseudomonas putida numbering). A similar reaction mechanism for the 
deamination of phenylalanine to cinnamic acid is proposed for the homologous plant 
enzyme, phenylalanine ammonia-lyase, which also contains the catalytic tripeptide 
(Ala-Ser-Gly). Sequence alignments of the S. oneidensis MR-1 putative histidase 
family proteins (Ha156 and Ha163, Table 1.1) against histidase of P. putida have 
shown that the essential catalytic tripeptide (Ala-Ser-Gly) is not conserved. This 
suggests that the novel histidase family proteins (Ha156 and Ha163, Table 1.1) 
associated with the novel flavocytochromes may catalyse the deamination of one or 
more amino acids via a different mechanism to produce the corresponding 
substituted acrylic acid. This product would then provide a suitable substrate for 
reduction by the associated flavocytochromes (FccA56: FccB56 and FccA63: 
Fcc363). 
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Figure 1.11: Gene arrangement of the novel S. oneidensis MR-1 genes 
The arrangement of genes in each operon is shown for the novel S. oneidensis MR-I flavoproteins 
(Fcc54, Fcc56, Fcc63 and Fcc342) compared to Fcc3 (S. frigidünarina NCIMB 400) and the fccABC 
operon of W. succinogenes (WS Fcc; Simon et al., 1998). The fccA gene encoding Fcc3 comprises 
sequence encoding the cytochrome (cyt) domain (red) and the flavin domain (yellow). The open 
reading frame number is shown for each novel S. oneidensis MR-] gene. The genes encoding 
flavoproteins (fccA), cytochronie subunits (fccB and fccC), histidase family protein (hal), conserved 
hypothetical protein (chyp), hypothetical protein (hyp) and conserved domain protein (cdmp), are 
shown. The diagram is not to scale. 
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1.8.3 Novel S. oneidensis MR-1 periplasmic flavocytochromes 
The FccA flavoprotein of W. succino genes and the methacrylate reductase of G. 
sulfurreducens AM-1 were both identified in the soluble periplasmic fraction of the 
cell (Mikoulinskaia et al., 1999 and Simon et al., 1998). There is substantial 
evidence to suggest that the related novel S. oneidensis MR-1 flavocytochromes 
(Table 1.1) are also targeted to the periplasm in vivo. The deduced N-terminal amino 
acid sequences of the FccA54, FccA56 and FccA63 preproteins reveal transfer 
peptides that contain residues of the "twin arginine" consensus sequence defined as 
(S/T)-R-R-x-F-L-K (Figure 1.12; Berks, 1996). The double-arginine signal peptides 
tend to be longer (26-58 amino acids; Berks, 1996) than standard bacterial Sec-
dependent signal sequences (mean= 24-31 amino acids; von Heijne and Abrahmsén, 
1989). The lengths of the transfer peptides were calculated for each of the novel 
flavoproteins using 'SignalP' (http://www.cbs.dtu.dk/services/Signa]P/; Nielsen et 
al., 1997). Indeed, the putative N-terminal signal peptides of FccA54 and FccA63 
conform to the longer length of double-arginine signal sequences. However, the N-
terminal transfer peptides of FccA56 and FccA342 are shorter compared to double-
arginine signal peptides (Table 1.4) and resemble the length of Sec-dependent signal 
sequences (von Heijne and Abrahmsén, 1989). 
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Table 1.4: Tat transfer peptide lengths 
The numbers of amino acids (aa) comprising the N-terminal Tat signal transfer peptides of each novel 
preprotein (FccA54, FccA56, FccA63 and FccA342) are shown. The signal peptide lengths were 
calculated using 'SignalP' (Nielsen et al., 1997; http://www.cbs.dtu.dk/services/SignalP/).  
The N-terminal transfer peptide containing the double arginine motif is found almost 
exclusively in bacterial redox preproteins targeted to the periplasm (Berks, 1996) via 
the Tat (twin arginine lranslocation) export system (Sargent et al., 1998). This export 
system is restricted to proteins containing iron sulfur clusters, molybdopterin, 
tryptophan tryptophyiquinone or FAD redox cofactors (Berks, 1996). The Tat system 
is a unique translocase that functions to target and export folded preproteins 
containing redox cofactors to the periplasm (Berks, 1996) and resembles the ApH-
dependent protein import machinery of chioroplast thylakoid membranes (Mori et 
al., 1999). The twin arginine residues of the Tat transfer peptide are required for 
efficient translocation of preproteins to the periplasm. The conservative site-directed 
mutagenesis of both arginine residues with lysine completely prevented export of the 
target Sufi E. co/i preprotein to the periplasm (Stanley et al., 2000). The N-terminal 
transfer peptide of FccA342 does not contain the twin arginine residues (Figure 1.12) 
and is shorter than twin arginine signal sequences (Table 1.4). 
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The FccA342 transfer peptide therefore represents a unique Tat system signal peptide 
that perhaps operates differently to reported transfer peptides that appear to interact 





01 MH)RRSFLKLGAG 13 
01 MGRRDFLKLATG 13 
08 NAGRRQLLKGGIv1V 20 




Figure 1.12: N-terminal Tat signal peptide alignment of the novel flavoproteins 
The novel S. oneidensis MR-I fiavoproteins contain an N-terminal Tat signal peptide sequence that is 
known to direct bacterial redox preproteins to the periplasm. The N-terminal sequences share the 
double arginine residues shown in the consensus motif. The N-terminal Tat signal peptide of FccA342 
does not contain the twin arginine residues that are essential for translocation to the periplasm. 
Numbering of the preprotein sequences is shown. The sequence alignment was produced using 
'ClustaiW' (Thompson et al., 1994). 
The putative FccB54, FccB56, FccB63 and FccB342 cytochrome subunits comprise 
an N-terminal signal sequence typical of bacterial proteins targeted to the periplasm 
via the general secretory (Sec)-dependent pathway (von Heijne and Abrahmsén, 
1989; Figure 1.14). This pathway is involved in the export of bacterial redox 
preproteins comprising c-type haem groups (Berks, 1996). The signal sequences (21 - 
23 amino acid residues) all contain alanine at the —1 position relative to the peptidase 
cleavage site and contain positively charged residues at the extreme N-terminus 
followed by hydrophobic residues (Figure 1.14). 
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The novel S. oneidensis MR-i flavin and cytochrome preproteins possess N-terminal 
signal sequences that target each subunit to the periplasm via distinct export 
pathways. The individual subunits are expected to associate in the periplasm to form 
a catalytic heterodimeric flavocytochrome. The predicted soluble nature of the novel 
flavoproteins is also shared with monomeric proteins such as Fcc3 of Shewanella 
species (Morris et al., 1994) and other soluble fumarate reductases located in the 
mitochondrial matrix of Trypanosoma brucei (Mracek et al., 1991) and the 
cytoplasm of S. cerevisiae (Arikawa etal., 1998). 
1.8.4 FAD-dependent tetrahaem flavocytoch romes 
The N-terminal sequence of the novel flavoproteins shares particularly high sequence 
identity to Fcc3 at the region containing the FAD adenine binding motif. 
Furthermore, replacement of the essential histidyl residue for covalent linkage of 
FAD (Weiner and Dickie, 1979; Cole, 1982) with an asparagine residue in Fcc3  
(Pealing et al., 1992; Figure 1.8) is conserved in the related Fcc3-like enzymes 
(Figure 1.13). This led to the suggestion that the novel Fcc3-like flavoproteins are 
FAD dependent respiratory enzymes that also contain non-covalently bound FAD. 
This conjecture is supported by knowledge that the related methacrylate reductase 
contains non-covalently bound FAD (Mikoulinskaia et al., 1999). 
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FccA54 	WDETRI IVVGSGFAGLSSALNAKRQ-CLGSILVLEKMQVIGGNSAINGGW 58 
FccA56 WDKEFDI I IIGSGFAGLSAAYSAHKA-GIKNI IVLEKMEAFGGNSAICGGL 	63 
FccA63 FDEIWDVLVVGSGFAGMSI\ALQARES-GVK-VMVIDKMPVFGGNSTINGGA 57 
FccA342 WDETYEIVIVGSGF'AGLAAAIEAGKL-GAKEVVVLEKLGVYGGNSALNAGQ 56 





Figure 1.13: Non-covalent attachment of FAD 
The N-terminal amino acid sequences of each novel flavoprotein (FccA54, FccA56, FccA63 and 
FccA342) are aligned with that of Fcc3 (S. frigidimarina NCIMB 400, SFFccA) and the FrdA subunit 
of the E. co/i fumarate reductase (FrdA). The FAD adenine binding motif (cyan) of Fcc3 and Frd are 
conserved in the related novel flavoproteins. The histidyl residue (red) of the E. co/i fumarate 
reductase required for covalent linkage of FAD is absent in Fcc3 and the novel flavoproteins which all 
contain asparagine at the equivalent position. The conserved nine-residue motif that is the putative 
FAD binding site of FrdA is shown in bold. The multiple sequence alignment was generated using 
'ClustaIW' (Thompson et al., 1994). The numbering is according to the mature protein sequences. 
Each of the novel S. oneidensis MR-1 cytochrome subunits contains four CxxCH 
motifs (Figure 1.14) that infer tetrahaem attachment to each protein (where x is any 
amino acid residue). The two cysteines are linked through thioether bonds to vinyl 
groups of protohaem IX and the histidine residue provides a ligand to the haem iron 
(Pealing et al., 1992). Another histidine residue serving as the sixth ligand to form 
c3-haems (Pealing et al., 1995) appears to exist in each of the novel cytochrome 
proteins (Figure 1.14). However, this histidine residue is tentatively ascribed to serve 
this function because some of the histidines do not align with a sixth ligand histidine 
of Fcc3 (S. frigidimarina NCIMB 400; Pealing et al., 1995). Overall, the data 
interpreted from multiple sequence alignments of each novel flavoprotein against 






FccB54 MMKTLLLTLVVPTLFTGAAN7GDLVKMKGSTQGRTNEFIYQDG ----- CNG 47 
FccB56 MMKYIYIcLGLVSALLMTCLSAYSAENTLSGVPIKEH FKLMGKSGS --- CKT 49 
FccB63 MLKPVFILLLGFMLATPMlN---- 	___MNIKDY KKVMTDTNGKVDCAA 44 
FccB342 MKLMNTLIVIALSSFIALS --- -4QDKRDY KSVYESG-----CET 39 
WOFccB FTLILGWLWLFLGAVALHAcLVDSPPAMEVSAELAQKYPLKSHHAKLSFACLD 60 
SFFccB MKKMNLZVCIATLMGTAGLlG- 	 DNLAEFIVQNQE ---- CDS 41 
FccB54 CHQGSGKQNA ---- TDA-ACVECHGEINSIPVDESK ---- LAIPEAHPKSL YNQGASC 98 
FccB56 CHGTGVPNER ---- PDSSFCIRCHGTMDEIPTKENK ------- YDKLP DS YRNTLEC 98 
FccB63 CHGDEKRKTV ---- PDATRCSSCHGAPQDVAKQTQRPADAGHSVEPNP DSL YGTDLPC 100 
FccB342 CHDQGTKAFP ---- SDD-ACLQCHSMSELAEQTKRE ---- GHOAKQNP DS YGQDAAC 90 
WOFccB CHTNQGSNLASLKRLKDDDCLSCHQSRDKMASRLAF ---- MELKKASP SI DGKRLHC 116 
SFFccB CHTPDGELSNDSLTYENTQCVSCHGTLAEVAETTKH ------- EHYNA 	S- FPGEVAC 93 
FccB54 LACHGE EKKAPVCAECHRTWFKEM ------------------------ 123 
FccB56 TACHSE KPSHAICSDCHIVEFPNLK ----------------------- 124 
FccB63 TYCHQE KESKVYCNQCHEFTYPQMKR ---------------------- 127 
FccB342 MECHGE TKKKAICMDCHNFNYPKFK ----------------------- 116 
WOFccB DECHNE RPSVNMCSECHEREVPLWMGETP ------------------- 146 
SFFccB TSCHS 	EKSMVYCDSCHSFDFNMPYAKKWLRDEPTIAELAKDKSERQA 
** * * 	** 
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Figure 1.14: Tetrahaem c-type cytochrome proteins 
The multiple sequence alignment of the cytochrome preproteins shows that FccB54, FccB56, FccB63 
and FccB342 all contain four CxxCH motifs (yellow) characteristic of c-type cytochromes, as found 
for FccB of W. succinogenes (WOFccB) and the cytochrome domain of S. frigidimarina NCIMB 400 
(SFFccB). Histidine residues that may provide the sixth ligand to the haems are shown (green). The 
N-terminal Sec-dependent signal sequences are also shown (red). The multiple sequence alignment 





1.8.5 Putative function of the novel periplasmic flavocytochromes 
A gene deletion of fccA encoding Fcc3 prevented the S. frigidimarina EG301 null 
mutant from respiring anaerobically with fumarate as terminal electron acceptor. 
This provided evidence that Fcc3 is the sole respiratory fumarate reductase of S. 
frigidimarina NCIMB 400 (Gordon et al., 1998). The inability of S. frigidimarina 
EG301 to respire anaerobically in the presence of fumarate suggests that the novel S. 
oneidensis MR-1 flavocytochromes related to Fcc3 will catalyse the reduction of one 
or more substrates other than fumarate. Of particular interest, is the ability of these 
novel flavoproteins to catalyse the reduction of acrylate substrates, including 
methacrylate, crotonate, tiglate and ferulate (Figure 1.15) which are plant metabolites 
most probably found in sedimentary environments inhabited by S. oneidensis MR-1. 
The putative function of the novel S. oneidensis MR-1 flavoproteins correlates with 
the related methacrylate reductase of G. sulfurreducens that is able to catalyse 
reduction of other acrylate substrates such as crotonate and pentenoate 
(Mikoulinskaia et al., 1999). The putative FccA flavoprotein located in the periplasm 
of W. succinogenes is also linked to methacrylate reduction via benzyl viologen 
oxidation (Gross et al., 2001). The presence of a histidase family protein putatively 
associated with the novel flavocytochromes (FccA56: FccB56 and FccA63: FccB63) 
has led to the suggestion that these flavoproteins catalyse reduction of 
phenylacrylates such as cinnamate. Ferulate serves as an alternative terminal electron 
acceptor and sustains growth of the acetogenic bacterium Peptostreptococcus 






This suggests that reduction of acrylate substrates by S. oneidensis MR-1 will 
conceivably generate sufficient energy during anaerobic electron transport to support 
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Figure 1.15: Potential acrylate substrates 
Some acrylate substrates that are potential enzyme substrates of the novel flavoproteins are shown. 
The reduction of methacrylate to isobutyrate is shown as an example of the putative two-electron 





1.9 Aims of project 
The novel S. oneidensis MR-1 putative flavocytochromes that share high sequence 
identity to Fcc3 are also related by sequence to methacrylate reductases of W. 
succinogenes (Gross et al., 2001) and G. sulfurreducens (Mikoulinskaia et al., 1999). 
Sequence analysis has led to the suggestion that these novel flavoenzymes may also 
catalyse the reduction of acrylates that are important plant metabolites (Wallace and 
Fry, 1994; Figure 1.15). The major aim was to characterise the novel flavoproteins 
and identify their biological function by using structural and genetic approaches. 
Experiments were designed for PCR amplification of the genes encoding the novel 
flavocytochromes from the S. oneidensis MR-1 genome. The intention was to clone 
the PCR fragments in plasmids suitable for overexpression of the flavoproteins and 
to purify the flavoproteins for crystallisation and structure determination. In parallel 
to the overexpression studies, molecular modelling of the novel flavoproteins based 
upon the known structure of Fcc3 (Taylor et al., 1999) aimed to provide insight into 
the architecture of each enzyme active site for elucidation of potential enzyme 
substrates. The enzymes FccA54, FccA56 and FccA342 were selected for molecular 
modelling studies. The construction of anfccA54 and fccB54 null mutant strain was 
designed to provide a means of identifying the biological function of the encoded 
Fcc54 putative flavocytochrome. The rationale for structure determination and 
functional analyses of these putative bacterial acrylate reductases is linked to 
biotechnological applications for the production of valuable acids with a chiral centre 
at the 3-carbon. Furthermore, acrylate reduction may implicate S. oneidensis MR-1 
in bioremediation of contaminated environments. 
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Materials and Methods 
2.1 Media and growth conditions 
2.1.1 Luria-Bertani (LB) medium 
Per litre: 
Bacto-tryptone 	 10.0 g 
Bacto-yeast extract 	5.0 g 
Sodium Chloride (NaCl) 	10.0 g 
For LB agar plates, 1.5 % (w/v) agar was added. 
2.1.2 Small-scale aerobic growth of Shewanella species 
Single colonies of Shewanella oneidensis MR-I (Table 2.6) were selected from a LB 
plate containing a freshly plated —80 °C dimethyl sulfoxide (DMSO) stock of the 
bacterium that was grown at 23 °C for 2 days in a static incubator. V2  oz bijou jars 
containing 5 ml of LB were inoculated with a single S. oneidensis MR-] colony 
under asceptic conditions using a sterile toothpick. S. oneidensis MR-i cultures were 
grown overnight in a shaking incubator (New Brunswick Scientific innova 4330) for 
approximately 20 hours at 23 °C. Cultures of S. oneidensis MB5415 (Table 2.6) were 
grown as described above but with addition of kanamycin (Km; 50 p.g/ml) and 
rifampicin (Rm; 10 tg/ml) to the LB media prior to inoculation. Cultures of S. 
frigidimarina EG301 (Gordon, 1996; Table 2.6) were prepared in LB supplemented 
with Km (50 p.g/ml) and Rm (10 j.tg/ml) and the spontaneous rifampicin resistant 
strain of S. oneidensis MR-I (Table 2.6) was selectively grown in LB containing Rm 
(10 jig/ml). 
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2.1.3 Small-scale aerobic growth of E. coil 
Parent strains of E. coil TG1, E. coil DH5a and E. coil SM1O (Table 2.6) were 
streaked from a —80 °C DMSO stock onto fresh LB plates and incubated overnight at 
37 °C in a static incubator. A single colony was picked to inoculate 5 ml of LB in a 
V2 oz bijou jar and incubated at 37 °C for 16 hours, gentle shaking. Recombinant 
E. coil strains were grown on LB agar plates and in liquid culture, as described above 
but with an antibiotic selection to specifically select recombinant E. coil transformed 
with a plasmid carrying an antibiotic resistance gene. The appropriate antibiotic was 
added to the growth media at the following concentrations, unless otherwise stated: 
ampicillin (Ap; 50 [tg/ml), Km (50 jig/ml) and streptomycin (Sm; 50 Rg/ml). 
2.1.4 Large-scale aerobic growth of S. frigidimarina EG30I 
Single colonies of S. frigidimarina EG301 containing pMB5 or pMB6 that were 
streaked from the prepared DMSO stock were picked to inoculate 1 x 100 ml of LB 
broth containing the appropriate antibiotics. The culture was grown with aeration (in 
a 250 ml conical flask) at 23 °C, with gentle shaking for approximately 18 hours to 
an 0D600 of 2.0. The overnight culture was extracted (20 ml) and subcultured in LB 
(1000 ml) supplemented with the appropriate antibiotics. The subculture was grown 
with aeration (in a 2.5 litre conical flask) at 23 °C for approximately 6-8 hours, with 
gentle shaking to an 0D600 of 0.5. The cells were induced with 
isopropyithiogalactoside (IPTG) to a final concentration of 1.0 mM and incubated 
overnight at 23 °C for 16 hours. 
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2.1.5 Large-scale aerobic growth of E. coil 
Single colonies of recombinant E. coil containing plasmid pMB3 [E. coil (pMB3)] 
that were streaked from the prepared DMSO stock were picked to inoculate 1 x 100 
ml of LB broth containing Ap (50 Vtg/ml). The culture was grown with aeration (in a 
250 ml conical flask) at 37 °C, with gentle shaking for approximately 18 hours. The 
overnight culture was extracted (20 ml) and subcultured in 1000 ml of LB 
supplemented with Ap (25 [tg/ml) to maintain the antibiotic selection. The subculture 
was grown with aeration (in a 2.5 litre conical flask) at 37 °C, with gentle shaking for 
approximately 2 hours 50 minutes to an 0D600 of 0.5. The cells were induced with 
IPTG (final concentration; 0.5 mM) and incubated overnight at 37 °C for 16 hours. 
2.1.6 Preparation of E. coil cells for purification of FccA54 
Cells that were pelleted from approximately 2.5 litres of E. coil TGI (pMB3) were 
resuspended in 10 mM Tris buffer, pH 8.0 (200 ml). The resuspended cells were 
centrifuged (7,000 rpm, 20 minutes) and the supernatant was discarded. The pellet 
was completely resuspended in 60 ml 10 mM Tris buffer, pH 8.0 by using the stirrer 
block. The cells were incubated on ice and sonicated for 1 minute and left to stand 
for 1 minute over a duration of 10 minutes where the duty cycle was set to 50 % 
constant and the output control (micro tip limit) to 5.0 (Lucas Dawe Ultrasonics 
Soniprobe). Following sonication, the cells were then centrifuged (20,000 rpm, 20 
minutes). The supernatant was extracted and more 10 mM Tris buffer, pH 8.0 was 
added to thin the sample for loading on the purification column. The sample was 
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2.1.7 Preparation of S. frigidimarina EG30I cells for protein purification 
A cell pellet of S. frigidimarina EG301 containing pMB5 obtained from 1000 ml of 
culture was washed in 10 mM Tris buffer pH 7.5 (100-200 ml) and centrifuged 
(9,000 rpm, 20 minutes). The supernatant was removed and the cell pellet was 
resuspended in 30 ml of Tris-HC1 buffer, pH 8.4. The sample was sonicated, as 
before (2.1.6), then centrifuged (20,000 rpm, 30 minutes, 4 °C) and the supernatant 
was decanted and stored at —20 °C in 5 x 2 ml aliquots. The samples tended to 
precipitate when stored at —20 °C, therefore, prior to loading on the purification 
column, the samples were centrifuged (13,000 rpm, 5 minutes) and the required 
supernatant was transferred to a new tube. 
2.1.8 Anaerobic growth of Shewanella species 
S. frigidimarina NCIMB 400 minimal 	medium 	(Paul 	Dobbin, 	personal 
communication) 
Per litre: 
(NH4)2SO4 1.20 g 
K2HPO4 1.00g 
KH2PO4 0.45 g 
NaHCO3 0.17 g 
MgSO4.7H20 0.25 g 
CaCl2.21-120 0.10 g 
Trace elements 50 ml 
Amino acids 0.1 ml 
Components 1-6 were sequentially solubilised in sterilised distilled water in the order 
listed and the pH of the medium was adjusted to pH 7.4 using SM NaOH (100 p1). 
Prior to use as a growth medium, sterilised trace elements, amino acids and lactate 
were added. All solutions were made by solubilising the components in sterilised 
distilled water and filter sterilising using 0.2 gm filters. 
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Trace element solution 
Per 2 litres: 
 Na2EDTA 1.00 g 
 1-131303  0.14g 
 NaC1 0.0234g 
 FeSO4.71-120 0.06 g 
 CoC12.6H20 0.05 g 
 NiC12.617120 0.05 g 
 NaMo04 0.04 g 
 SeS2 0.01 g 
 ZnSO4.71-120 0.02 g 
 CuSO4.51-120 0.002 g 
 MnSO4.41-120 0.02 g 
Amino acids 
Per 100 ml: 
L-Arginine 	 0.02 g 
L-Glutamate 0.02 g 
L-Serine 	 0.02 g 
Carbon source 	 Final Concentration 
Lactate (1.5 M) 15 mM 
Electron Acceptor Supplier Type Stock Solution 
Fumarate Sigma Disodium salt 0.5 M dH20 
Cinnamate Aldrich Free acid 0.3 M dH20 + Ethanol 
Coumarate Aldrich Free acid 0.5 M dH20 + Ethanol 
Caffeate Aldrich Free acid 0.3 M dH20 
Ferulate Aldrich Free acid 0.25 M dH20 
Acrylate Aldrich Free acid 0.5 M dH20 
Methacrylate Sigma Free acid 0.5 M dH20 
Mesaconate Aldrich Free acid 0.5 M dH20 
Tiglate Sigma Free acid 0.5 M dH20 + Ethanol 
Crotonate Sigma Free acid 0.5 M dH20 
3-3-Indoleacrylate nla Free acid 0.02 M dH20 + Ethanol 
Senecioate Aldrich Free acid 0.3 M dH20 
Benzoate Sigma Free acid 0.5 M dH20 
The stock solutions of the electron acceptors were all adjusted to pH 7.0-8.1 using 
NaOH. The minimal media and all other solutions were stored at 4 °C. The minimal 
medium was preferably used within one week to avoid bacterial contamination. The 
supplemented minimal medium was dispensed into '/2 oz bijou jars and the electron 




Materials and Methods 
Single colonies of the Shewanella strain were picked to inoculate the jars. 
Alternatively, an overnight 5 ml culture of the Shewanella strain was centrifuged 
(5,000 rpm, 5 minutes) and the pellet resuspended in 5 ml minimal media (minus 
lactate). The resuspended cells (200 tl) were used to inoculate the jars. The cultures 
were incubated at 23 °C for 4 weeks. 
2.1.9 Colony counts of Shewanella strains 
The S. oneidensis MR-1 or S. oneidensis MB541 5 cultures (Table 2.6) grown in 
minimal media for four weeks were extracted (1.0 p.1) and diluted 1000-fold in 
sterilised distilled water (to 1 ml) in a 1.7 ml tube. The diluted solution was extracted 
(100 p.!) and plated on LB media using aseptic conditions. The plates were incubated 
at 23 °C for 2-3 days to allow the colonies to form. The number of bacterial cells per 
ml of culture was then calculated. To specifically select the mutant strain, aliquots of 
culture were plated on LB supplemented with Rm (10 p.g/ml) and Km (50 p.g/ml). 
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2.1.10 Single colonies of transformants 
Transformant colonies of E. coil and Shewaneila transconjugants were selected from 
the original plate using a sterile toothpick and under asceptic conditions were plated 
out for single colonies on fresh LB media containing the appropriate antibiotics. The 
single colonies were incubated overnight at 23 °C (Shewanelia species) or 37 °C (E. 
coil). The single colonies were picked for growth in liquid culture as described in 
2.1.2 and 2.1.3. DMSO stocks were made from these cultures prepared from single 
colonies (2.1.11). 
2.1.11 Preparation of liquid culture —80 °C stocks 
Freezer stocks were prepared for native and recombinant strains of Shewaneiia and 
E. coil for storage at - 80 °C. To a 1.7 ml tube, using aseptic conditions, 930 pl of 
dense overnight culture was mixed thoroughly with 70 i.tl of DMSO previously 
sterilised by autoclaving. The sample was stored at - 80 °C and was temporarily 
stored on ice to avoid defrosting when plating out for single colonies. 
2.1.12 Optical density measurements 
The optical density at a wavelength of 600 nm (0D600) was measured by extracting 
100 i.tl of cell culture and diluting 10 fold with 900 j.xl of LB in a plastic cuvette. The 
reference sample was 1 ml of LB. For cell cultures containing Rm (10 .ig!m1), the 
reference also contained Rm (10 tg/m1). 
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2.2 Isolation and preparation of DNA 
2.2.1 Preparation of plasmid DNA (QlAprep Spin Miniprep) 
Plasmid DNA was isolated from E. coil and Shewaneiia strains using the QiAprep 
Spin Miniprep kit, following the protocol produced by the manufacturers (Qiagen). 
An overnight bacterial culture (5 ml) was used to produce 50 tl of high copy number 
plasmid DNA (- 20 ng/j.il). Low copy number plasmid DNA such as pMMB503EH 
was prepared from 10 ml of an overnight culture. All plasmid DNA preps were 
stored at —20 °C. 
2.2.2 Preparation of plasmid DNA by alkaline lysis and PEG treatment 
An overnight culture (5 ml) was centrifuged (5,000 rpm, 5 minutes) and the pellet 
was resuspended in triethylene glycol (TEG) buffer (200 j.tl). The sample was 
transferred to a 1.7 ml tube and mixed with freshly prepared alkaline lysis buffer 
(300 p.1) and incubated on ice (5 minutes). The solution was neutralised with addition 
of 3M Sodium acetate, pH 5.2 (300 p1), mixed by inversion and incubated on ice (5 
minutes). The cellular debris was removed by centrifuging (13,000 rpm, 15 minutes) 
and the supernatant was transferred to a 1.7 ml tube. The supernatant was extracted 
with Chloroform: isoamyl alcohol (24:1; 400 p.1) and the upper aqueous phase (0.75 
ml) was mixed with absolute isopropanol (0.75 ml) and incubated at 4 °C (30 
minutes). The sample was centrifuged (13,000 rpm, 30 minutes), the isopropanol was 
completely removed and the DNA pellet was washed in 70 % ethanol (500 p.1). The 
ethanol was removed and the DNA pellet was dried at room temperature (20 
minutes). 
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The dried pellet was dissolved in 32 p1 deionised water and mixed thoroughly with 
4M NaCl (8.0 .il) and 13 % polyethylene glycol (PEG) 8000 (40.0 p1) then incubated 
on ice (20 minutes). The sample was centrifuged (13,000 rpm, 15 minutes, at 4 °C) 
and the DNA pellet was rinsed in 70 % ethanol (500 p1). The resulting purified DNA 
pellet was resuspended in deionised water (20 t1) and stored at —20 °C. 
TEG buffer 
25 mM Tris pH 8.0 
10 mM EDTA pH 8.0 
50 mM glucose 
Alkaline lysis buffer 
0.2 M NaOH 
I%SDS 
2.2.3 Preparation and isolation of genomic DNA 
A 1.5 ml aliquot of an overnight S. oneidensis MR-I culture was centrifuged (13,000 
rpm, 10 minutes) and the pellet was resuspended in 10 mM EDTA, pH 8.0 (400 tl). 
The cells were lysed using sodium dodecyl sulfate (SDS) to a final concentration of 
1 %. The lysate was extracted with an equal volume of phenol (400 jil), phenol: 
chloroform: isoamyl alcohol (25:24:1) and chloroform: isoamyl alcohol (24:1). The 
DNA sample was ethanol precipitated by addition of 2.5 volumes of 100 % ethanol 
and 0.1 volumes of 3M sodium acetate, pH 5.2, followed by incubation (-80 °C, 1 
hour). Following ethanol precipitation, the sample was centrifuged (13,000 rpm at 
4°C, 10 minutes). The ethanol solution was carefully removed and the DNA pellet 
was washed in 70 % ethanol prior to being air-dried. The DNA pellet was re-
suspended in 400 p1 sterile water and further purified for future applications 
following the protocol of the Promega Wizard DNA Clean-Up System kit. The 
purified genomic DNA was eluted in 100 p1 pre-warmed (80 °C) Tris-EDTA (TE) 
buffer, pH 8.0 and subsequently stored at —20 °C. Genomic DNA was prepared for 
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2.2.4 Preparation of single-stranded DNA for automated sequencing 
Recombinant cells containing a recombinant pGEM-T plasmid were grown overnight 
and subcultured to mid-log phase (0D600 of 0.5-0.7). The overnight culture (2 ml) 
was transferred to a V2 oz bijou jar and infected with 1.4 tl M1 3K07 helper phage 
(Promega) and incubated (37 °C, 80 minutes). The infected cells (400 pd) were 
transferred to a 250 ml conical flask containing 10 ml LB supplemented with Ap (50 
tg/ml) and Km (70 jig/ml) and incubated overnight (37 °C with gentle shaking). The 
overnight culture was divided into 6 x 1.5 ml aliquots in 1.7 ml tubes and centrifuged 
(13,000 rpm, 5 minutes). The supernatant from each tube (1.4 ml) was transferred to 
a clean tube and centrifuged (13,000 rpm, 5 minutes). The resulting supernatant from 
each tube was extracted, mixed with 2.0 M NaC1/20 % PEG 8000 (300 jil) and 
incubated (25 minutes, room temperature). The samples were centrifuged (13,000 
rpm, 5 minutes) and the pellet in tube I was resuspended in TE buffer, pH 8.0 (200 
p1). The solubilised pellet of tube 1 was transferred sequentially to the other tubes in 
order to combine the DNA samples. This procedure was repeated with TE buffer, pH 
8.0 (100 p1), followed by phenol (400 p1) and Chloroform:isoamyl alcohol (24:1) 
(400 p1) extractions. The aqueous phase was mixed with 3M sodium acetate, pH 5.2 
(40 p1) and absolute ethanol (1 ml) and incubated overnight at -20 °C. The 
precipitated DNA sample was centrifuged (13,000 rpm, 10 minutes, 4 °C) and the 
pellet was washed (75 % ethanol), air-dried (5-10 minutes) and resuspended in 50 p1 
TE buffer. The single-stranded DNA sample was stored at —20 °C. 
TE buffer 
10 mM Tris, pH 8.0 
1 mM EDTA, pH 8.0 
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2.3 Restriction enzyme digests 
Large-scale restriction digests of 2.5-7.5 kb plasmids were carried out in a total 
volume of 40-50 jil in a 1.7 ml tube and incubated at 37 °C (28 °C for Smal) for 3 
hours. The reaction contained the appropriate restriction buffer (lx), acetylated 
bovine serum albumin (BSA; 0.1 mg/ml), plasmid DNA (0.10-0.25 [tg) and 30-50 
units of each restriction enzyme (10-12 uJit1). For large-scale restriction digests of 
pMMB503EH (9.9 kb) and recombinant pMMB503EH, a greater quantity of plasmid 
(0.25-0.40 tg) was used and required longer incubation at 37 °C (4 hours). 
Pilot restriction digests of 2.5-7.5 kb plasmids were typically carried out in a total 
volume of 15.0 i.l in a 1.7 ml tube and incubated at 37 °C for 2-3 hours. The 
appropriate restriction enzyme buffer was added to a final concentration of 1 x and 
the reaction was supplemented with BSA (0.1 mg/ml). Approximately 45-60 ng of 
plasmid DNA was incubated with 10-15 units of each restriction enzyme (10-12 
u/t1) (Promega). Pilot restriction digests of large plasmids such as pMMB503EH 
(9.9 kb) were typically carried out in a total volume of 15-20 d in a 1.7 ml tube and 
incubated at 37 °C for 3-4 hours. Approximately 25-60 ng DNA was used. 
2.4 Ligation reactions 
The quantity of vector and insert DNA used in a ligation reaction depended upon the 
size of the fragment and plasmid vector. A range of vector: insert DNA molar ratios 
(1:1, 1:3 and 1:5) were typically used to increase the chance of successful ligation. 
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Ligation reactions (10-20 j.t1) contained vector DNA of 2.5-7.5 kb (10-25 ng), insert 
DNA of 1-3 kb (10-50 ng), 1 x ligase buffer, sterile water and T4 DNA ligase (1.5 
units; Promega). Vector DNA such as pMMB503EH was added at 10-30 ng with 10-
60 ng of insert DNA (1-3 kb in length). To enhance the ligation of blunt ends, 
hexamminecobalt chloride (HCC; 10 mM) was also added to the reaction tube at a 
final concentration of 1.0 mM. The reactions were gently mixed and incubated for a 
maximum of 16 hours at 16 °C. A 'vector only' control reaction was included in 
ligation experiments to obtain a background colony count for re-ligated vector. 
2.5 Preparation of calcium competent cells 
An overnight culture (200 l) of E. coil TG I, E. coil DH5ct, or E. coil SM1O (Table 
2.6), was extracted and used to inoculate 5 ml of LB in a '/2 oz bijou jar and was 
grown at 37 °C, gentle shaking for approximately 1.5 hours (E. coii TG1), 2.0 hours 
(E. coil SM1O) or 2.5 hours (E. coil DH5a) to an 0D600 of 0.4-0.6. The cells were 
centrifuged (5,000 rpm, 3 minutes) and the cell pellet was resuspended in 0.1 M pre-
chilled (4 °C) CaC12 (2 ml) and stored on ice for 40 minutes. The chilled CaC12 
treated cells were centrifuged (5,000 rpm, 3 minutes) and the cell pellet was 
resuspended in 0.1 M of pre-chilled (4 °C) CaC12 (1 ml) and the resuspended cells 
were stored on ice for a minimum duration of 40 minutes. 
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2.6 Transformation and selection of transformants 
The CaCl2 competent cells (200 p1) (2.5) were transferred to a 1.7 ml pre-chilled tube 
(4 °C) using pre-chilled pipette tips (4 °C). Half of the ligation mix was added 
directly to the cells with pre-chilled pipette tips (4 °C) and mixed gently. For plasmid 
DNA transfer from E. co/i TG  to E. co/i SM1O, plasmid DNA (10-30 ng) was added 
directly to the calcium competent E. co/i SM 10 cells. The transformation was carried 
out at 4 °C. The transformed cells were incubated on ice for 45 minutes and then heat 
shocked in a water bath (45 °C, 100 seconds). The cells were then immediately 
incubated on an ice-slurry (5 minutes). LB (800 p1) was added and the samples were 
incubated at 37 °C (1 hour). The cells were centrifuged (13,000 rpm, 3 minutes) and 
each cell pellet was resuspended in residual LB media (100 p1). The transformed 
cells (100 p1) were then plated on LB agar plates containing the appropriate 
antibiotic and incubated overnight at 37 °C in a static incubator. A 'cells only' 
control was included in all transformations to show that the antibiotic selection was 
effective. A 'positive control' to show transformation efficiency was achieved by 
transforming cells with recombinant plasmid (10 ng). Cells transformed with 
recombinant pGEM-T plasmid containing a disrupted /acZ gene were selected on LB 
supplemented with Ap (50 pg/ml) that contained a top layer of 5-bromo-4-chioro-3-
indolyl-fl-D-galactoside (Xgal) and IPTG. A solution comprising 40.0 p1 of Xgal (40 
mg/ml), 4.0 p1 of IPTG (1 M) and sterile water (40.0 p1) was spread onto the surface 
of dried LB-Ap agar plates at least one hour prior to plating the transformants. 
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2.7 Conjugative transfer of DNA from E. coil to Shewanella species 
E. coil SM1O (Table 2.6) was used as the donor strain for conjugative DNA transfer 
of recombinant pMMB503EH plasmids (Table 2.8) to S. frigidimarina EG301 RmR 
Km  (Table 2.6). The £ oneidensis MR-I RmR  and E. coil S17 ?pir strains (Table 
2.6) were used as the recipient and donor strains, respectively, for conjugative DNA 
transfer of plasmid pMBGK15 (Table 2.7) used for construction of the fccA54 and 
fccB54 gene knockout. 
The E. coil and Shewanelia strains were grown to an 0D600 of 0.8. An aliquot of each 
culture (1.5 ml) was centrifuged (13,000 rpm, 5 minutes) and the pellets were 
resuspended in LB (200 p1). The E. coil culture (5.0 p1) was mixed with the 
Shewaneiia culture (45 p1) and the 50 p1 mixes were spotted onto 0.2 jim sterile 
nitrocellulose filters (Whatman) and incubated on LB only medium overnight at 
23 °C (static incubator). Samples (50 p1) of 'E. coil only' and 'Shewaneiia only' 
were included as controls to show that the antibiotic resistant transconjugants were 
Shewaneiia strains containing recombinant plasmid. The filters were removed from 
the LB plates using sterile tweezers, transferred to 1.7 ml tubes containing LB (1 ml) 
and vortexed to suspend the bacteria in solution. The clean filters were removed, the 
samples centrifuged (13,000 rpm, 10 minutes) and the pellet resuspended in LB 
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Standard conjugation: 
The pellets were resuspended in LB (1 ml) and 1.0 jii was extracted and mixed with 
LB (49 jil). The 50 jil sample was mixed gently, plated on LB supplemented with the 
appropriate antibiotics for selection of the bacterial strain and plasmid and incubated 
at 23 °C in a static incubator for 2-3 days. 
Conjugation for constructing an fccA 54 and frcB54 gene knockout: 
The pellets were resuspended in 100 p1 LB and the entire concentrated sample was 
plated on LB supplemented with Rm (10 jig/ml) and Km (50 jig/ml). The plates were 
incubated at 23 °C for 3 days in a static incubator for development of S. oneidensis 
MR-1 transconjugants. 
2.8 The Polymerase Chain Reaction 
2.8.1 PCR amplification using PfuTurbo 
The homologous template DNA fusion PCR product used to construct the fccA54 
and fccB54 gene knockout was amplified from the S. oneidensis MR-I genome using 
the high fidelity thermostable DNA polymerase, PfuTurbo (Stratagene). The 
reactions for each of the three individual fusion PCR amplifications varied in the 
DNA template: primer ratio. Equivalent quantities of PCR product were used for the 
final fusion PCR. Ammonium chloride (NH4C1) was added to some reactions at 
varying concentrations to alter the enzyme activity and the PCR products were 
amplified using the programmed thermocycler conditions (Techne PHC-2 thermal 
cycler; Table 2.1). All PCR reactions detailed in the following section were 









Primers (Table 2.9) 
dNTPs (Roche) (10 mM) 
10 x Mg 2+ reaction buffer 
NH4C1 000 mM) 










Total reaction volume 
	
50 Vtl 
Program Number of Cycles Temperature (°C) Duration 
40 	1 	 94 	 2 minutes 
41 	30 	 94 30 seconds 
a 30 seconds 
72 b 
42 	2 	 72 10 minutes 
4 24 hours 
Table 2.1: PCR cycling parameters when using Pfu Turbo DNA polymerase 
The temperature and duration of thermocycles for PCR amplification using Pfu Turbo DNA 
polymerase is shown. These are the optimised parameters to ensure efficient and accurate PCR 
amplification by Pfuturbo. The primer annealing temperature (a)  was set 5 °C below the lowest Tin 
(°C) in the primer pair. The extension time (b)  was programmed to allow 1 minute per I kb of 
amplified DNA sequence. The program numbers 40-42 refer to the programs set for PCR on the 
specified thermocycler. 
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2.8.2 PCR amplification using Taq DNA polymerase 
The genes encoding the novel flavocytochromes, including IfcA- 1, were amplified 
from the S. oneidensis MR-i genome using Taq DNA polymerase (Promega), 
according to the thermocycler conditions (Table 2.2). The following conditions were 
used: 
Reaction component 
Genomic template DNA 
Primers (Tables 2.10 and 2.11) 
dNTPs (Roche) (10 mM) 
10 x Mg 2+  reaction buffer 
Taq (5 u/pJ) 








Program Number of Cycles Temperature (°C) Duration 
40 	1 	 94 	 5 minutes 
41 	30 	 94 	 30 seconds 
42 	 30 seconds 
72 	 1 minute 
42 	2 	 72 	 5 minutes 
4 	 24 hours 
Table 2.2: PCR cycling parameters when using Taq DNA polymerase 
The temperature and duration of thermocycles for PCR amplification using Taq DNA polymerase is 
shown. The primer annealing temperature was set below the lowest Tin (°C) in the primer pair. The 
extension time was programmed to allow 1 minute per I kb of amplified DNA sequence. The program 
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The PCR amplification product named 54FRB corresponding to the fccA54 
(including signal sequence) and fccB54 genes was amplified using different 
conditions to those shown above. A total of six PCR reactions with varying 
concentrations of genomic DNA template were used to achieve PCR amplification of 
54FRB. The thermocycler conditions used were specific for PCR amplification of the 
54FRB fragment (Table 2.3). 
Reaction component 
Genomic DNA 
54F and 54RB primers (Table 2.10) 
dNTPs (Roche) 10 mM 
10 x magnesium free buffer 
MgC12 (25 mM) 
NH4C1 (100 mM) 
Taq (5 u/jil) 










Program Number of Cycles Temperature (°C) Duration 
40 	1 	 94 	 2.5 minutes 
41 	30 	 94 	 20 seconds 
50 	 30 seconds 
68 	 2 minutes 
42 	2 	 68 	 5 minutes 
4 	 24 hours 
Table 2.3: PCR cycling parameters when using Taq DNA polymerase 
The temperature and duration of thermocycles for PCR amplification of 54FRB using Taq DNA 
polymerase is shown. The primer annealing temperature was set 6 °C below the lowest Tm (°C) in the 
primer pair. The extension time was programmed to allow 1 minute per I kb of amplified DNA 
sequence. The temperature during extension was adjusted to 68 °C, which is the preferred temperature 
for optimal Taq PCR amplification. The program numbers 40-42 refer to the programs set for PCR on 
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The FccA54 overexpression fragment was amplified from plasmid DNA using Taq 
DNA polymerase and equal quantities of PCR product (4.0-10.0 ng DNA) were used 
in the final fusion PCR. The thermocycler conditions are shown (Table 2.4). 
Reaction component 
Plasmid DNA 
Primers (Table 2.10) 
dNTPs (Roche) (10 mM) 
10 x Magnesium free buffer 
MgCl2 (25 mM) 
NH4C1 (100 mM) 
Taq (5 u/t1) 







2.0- 4.0 mM 
2.5 u 
50 t1 
Program Number of Cycles Temperature (°C) Duration 
40 	1 	 94 	 3.0 minutes 
41 	30 	 94 	 30 seconds 
a 	 25 seconds 
68 	 h 
42 	2 	 68 	 10 minutes 
4 	 24 hours 
Table 2.4: PCR cycling parameters when using Taq DNA polymerase 
The temperature and duration of thermocycles for fusion PCR amplification of the FccA54 
overexpression fragment using Taq DNA polymerase is shown. The primer annealing temperature (a)  
was set 5 °C below the lowest Tm (°C) in the primer pair. The extension time (i))  was programmed to 
allow 1 minute per I kb of amplified DNA sequence. The temperature during extension was adjusted 
to 68 °C, which is the preferred temperature for optimal Taq PCR amplification. The program 
numbers 40-42 refer to the programs set for PCR on the specified thermocycler. 
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The PCR product cloned in pMBGK4 1 that was amplified using primers 54gk9 and 
54gk10 to confirm that S. oneidensis MB5415 was a deletion strain was PCR 
amplified using Taq DNA polymerase. Five reactions differing in concentrations of 
genomic DNA template DNA were used to achieve PCR amplification of the 
segment containing the kanamycin cassette. The thermocycler conditions specified 
for PCR amplification of the S. oneidensis MB5415 fragment are shown (Table 2.5). 
Reaction component 
Genomic DNA 
Primers (Table 2.9) 
dNTPs (Roche) 10 mM 
10 x MgCl2  free buffer 
MgCl2 (25 mM) 
Taq (5 u/pi) 









Program Number of Cycles Temperature (°C) Duration 
40 	1 	 94 	 3 minutes 
41 	30 	 94 	 30 seconds 
54 	 30 seconds 
68 	 3 minutes 
42 	2 	 68 	 10 minutes 
4 	 24 hours 
Table 2.5: PCR cycling parameters when using Taq DNA polymerase 
The temperature and duration of thermocycles for PCR amplification of the S. oneidensis MB5415 
fragment containing the kanamycin cassette using Taq DNA polymerase is shown. The primer 
annealing temperature was set 5 °C below the lowest Tin (°C) in the primer pair. The extension time 
was programmed to allow 1 minute per I kb of amplified DNA sequence. The temperature during 
extension was adjusted to 68 °C, which is the preferred temperature for optimal Taq PCR 
amplification. The program numbers 40-42 refer to the programs set for PCR on the specified 
thermocycler. 
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2.9 Preparation of samples for automated sequencing 
Automated cycle sequencing was used to sequence single-stranded and double-
stranded DNA templates. The samples were mixed in 0.6 ml tubes suitable for use in 
the thermocycler (Techne PHC-2 thermal cycler) and were prepared as follows: 
Reaction components Quantity 
DNA template: 
Single-stranded 50-100 ng 
Double-stranded 250-500 ng 
Primer 3.2 pmol 
Terminator ready reaction mix 8.0 i.il 
Total reaction volume 	 20 p1 
The terminator ready reaction mix ('ABI PRISM' dRhodamine terminator cycle 
sequencing kit) comprises dye-labelled terminators; dATP, dCTP, dTTP, dITP; Tris 
HC1, pH 9.0; MgCl2, thermal stable pyrophosphatase and AmpliTaq DNA 
polymerase FS). The samples were mixed and overlayed with mineral oil (40 p1). 
The thermocycler conditions comprising 25 cycles were as follows: denaturation 
(96 °C, 30 seconds), annealing (50 °C, 15 seconds) and extension (60 °C, 4 minutes). 
The samples were removed from beneath the mineral oil, transferred to a clean tube 
and ethanol precipitated overnight at —20 °C (40 p1 of 100 % ethanol, and 2.0 itl of 
3M sodium acetate, pH 5.2). The samples were centrifuged (13,000 rpm, 20 
minutes), washed in 50 p1 ethanol (70 %) and air-dried for 20 minutes. The samples 
were processed by the Institute of Cell and Molecular Biology Automated 
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2.10 Purification of PCR products and restriction fragments 
Purification of a specific PCR product in a reaction sample and purification of DNA 
in a restriction digest were achieved using agarose gel electrophoresis. The sample 
(50 pJ) was mixed with 10.0 j.tl gel loading buffer (10 x) and loaded in three fused 
wells of a 0.7 % preparative agarose gel (Appligene). Following gel electrophoresis, 
the desired DNA band was excised from the gel and purified using the QIAEX II Gel 
Extraction kit (Qiagen) or the QlAquick gel extraction kit (Qiagen) according to the 
manufacturer's protocol. Confirmation that the correct DNA fragment was purified 
was achieved by loading a sample of the purified product on a standard 0.7 % 
agarose gel (Bioline). Ethanol precipitation was used to purify linear DNA generated 
from single restriction enzyme digests. A 50 i.l digest was combined with 3M 
Sodium acetate pH 5.2 (5.0 p1) and 100 % ethanol (125 j.xl) and incubated overnight 
at —20 °C. The sample was then centrifuged (13,000 rpm, 10 minutes, 4 °C), washed 
in 70 % ethanol and air-dried. 
2.11 Detection and analysis of DNA samples 
DNA samples from genomic DNA preps, piasmid DNA preps and PCR were 
analysed using agarose gel electrophoresis. A 0.7 % agarose gel was typically made 
unless otherwise stated by using standard agarose (Bioline) and heating with I x 
Tris-acetate-EDTA (TAE) buffer to a final volume of 25 ml for small gels and 70 ml 
for long gels. Ethidium bromide (10 mg/ml) was added to the solution upon cooling 
to a final concentration of 1.0 tg/ml. 
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The DNA bands were detected upon ultraviolet irradiation. I kb DNA ladder 
(GibcoBRL; 4.5 j.il) was used as a marker to detect the molecular weight of the 
sample DNA bands apparent on the agarose gel. Samples (2.0-3.0 p1) for loading on 
the agarose gels were mixed with loading buffer (4.0 tF). 
50 x TAE buffer 
Tris-acetate 	2.0 M 
EDTA, pH 8.0 50 mM 
212 IPTG induction experiments 
Small-scale induction experiments were used to identify the optimal duration of 
IPTG induction. A control culture corresponding to the parent strain was included in 
the experiment to show the level of overexpressed protein produced in the 
recombinant strain. E. co/i TG1 (1 x 5 ml) and E. co/i (pMB3) cultures (2 x 5 ml) 
were grown to an 0D600 of 0.4. The E. co/i TG1 culture was divided into 5 x 1 ml 
aliquots each added to a clean V2 oz bijou jar. Recombinant E. co/i TG1 (pMB3) 
cultures were divided as 10  1 ml aliquots into clean V2 oz bijoux jars. To five of the 
1 ml E. co/i TG1 (pMB3) cultures, 1 mM IPTG (1 M stock) was added. Ampicillin 
(25 jig/ml) was added to the appropriate cultures to maintain antibiotic selection. 
Each of the 5 x 1 ml cultures of E. co/i TG1 were grown in parallel with 5 x 1 ml 
IPTG-induced and 5 x 1 ml uninduced cultures of E. co/i (pMB3) for 1 hour, 2 hours, 
4 hours and 16 hours, post IPTG induction. Growth of the cultures was arrested at 
these times and the 0D600 was measured. Cultures were also extracted immediately 
after IPTG induction (0 hour control). The 1 ml culture was transferred to a 1.7 ml 
tube and centrifuged (13,000 rpm, 10 minutes). 
79 
Chapter 2 	 Materials and Methods 
The supernatant was discarded and the pellet was resuspended in 3 x SDS-loading 
buffer (New England Biolabs), as follows: 0D600 = 0.50, resuspend in 0.50 jil SDS 
loading buffer. Small-scale TPTG induction experiments for cultures of Shewanella 
strains were prepared as described above, except that the initial overnight cultures of 
parent and recombinant S. frigidimarina EG301 (pMB5 or pMB6) were grown to an 
0D600 of 0.5-0.6. The antibiotics, comprising, Rm (5 tg/rn1), Km (25 tg/ml) and Sm 
(25 Vg/ml) were added to the appropriate cultures prior to IPTG induction to 
maintain the antibiotic selection. 
2.13 Tris-glycine SDS polyacrylamide gel electrophoresis 
The protein samples (2.12) resuspended in 3 x SDS-loading buffer (New England 
Biolabs) were boiled for 3-5 minutes prior to loading 10-20 p1 of each sample on the 
SDS-PAGE mini gel. Prestained broad range protein marker (13 tl; New England 
Biolabs) was mixed with 5.0 p1 3 x SDS-loading buffer and incubated in a lhoit water, 
bath prior to loading on the SDS-PAGE gel. 
A 10 % (w/v) acrylamide resolving gel (10 ml) (A) and a 5 % (w/v) acrylamide 
stacking gel (4 ml) (B) were prepared to pour 2 mini SDS-PAGE gels. The 
components were mixed in the order listed overleaf. The 10 % (w/v) ammonium 
persulfate (APS) solution was freshly prepared immediately prior to making the 
SDS-PAGE gel. Tris-glycine electrophoresis buffer, pH 8.3 (1 x) was used in the 
reservoirs of the gel system to provide a discontinuous system. 
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The SDS-PAGE gels were run at 200 V for approximately 1 hour to achieve good 
separation of the proteins. The mini-Protean gel electrophoresis SDS-PAGE system 
was used (Biorad). 
A long (20.0 cm) 10 % (w/v) acrylamide gel was prepared by making a 35 ml 
acrylamide resolving gel (A) and a 5 % (w/v) acrylamide stacking gel (15 ml; B). 
The volumes of the components listed were scaled up accordingly. The protein 
samples (2.12) and protein marker were prepared as described above. 20 p1 of 
sample and 30 p1 of protein marker were loaded on the long SDS-PAGE gel. The 
duration of electrophoresis for the long gel was approximately 6 hours at 200 V. 
Components of A (ml) Components of B (ml) 
1-120 4.0 H20 2.7 
30% acrylamide mix 3.3 30% acrylamide mix 0.67 
1.5 M Tris (pH 8.8) 2.5 1.0 M Tris (pH 6.8) 0.5 
10%SDS 0.1 10%SDS 0.04 
10 % ammonium persulfate 0.1 10 % ammonium persulfate 0.04 
TEMED 0.004 TEMED 0.004 
A 5 x stock solution of Tris-glycine buffer, pH 8.3, was made by dissolving 15.1 g of 
Tris base and 94.0 g of glycine in 900 ml of deionised H20. 10 % SDS (50 ml) was 
then added and the volume was adjusted to 1000 ml with dH20. The pH of the 
solution was checked. 
1 x Tris-glycine buffer, pH 8.3 
25 mM Tris, pH 8.3 
250 mM glycine (electrophoresis grade) 
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The NuPAGE electrophoresis system (Invitrogen) that operates at neutral pH was 
used to achieve accurate migration of FccA54. The Bis-Tris pre-cast gels with a 
4-12 % acrylamide concentration were used according to the manufacturers 
instructions. Protein samples (10 p1) eluted from a purification column were 
resuspended in 4 x NuPAGE lithium dodecyl sulfate (LDS) sample buffer (10 p1) in 
a final volume of 40 pi and boiled for 5 minutes prior to loading on the acrylamide 
gel. NuPAGE 2-(N-morpholino)ethane sulfonic acid (MES) SDS running buffer 
(1 x) was used in the reservoir chambers of the electrophoresis system. For 
periplasmic samples, a range of protein concentrations were tested, the volume of 
protein loaded on the gel ranged from 5-20 p1. 
2.14 Staining of SDS-PAGE gels 
2.14.1 Coomassie Blue staining of SDS-PAGE gels 
Coomassie Blue was used to stain the SDS-PAGE gels for approximately 1-2 hours, 
with gentle shaking, to detect all the proteins in each sample loaded on the SDS-
PAGE gel. The gel was subsequently incubated in destaining solution to reveal the 
proteins. 
Coomassie Brilliant Blue stain 
0.25 % (w/v) Coomassie Brilliant Blue R250 
in destaining solution 
Destaining solution 
45 % methanol 
45 % dH2O 
10 % glacial acetic acid 
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2.14.2 Silver staining of SDS-PAGE gels 
The SDS-PAGE gels were fixed for 4-12 hours in a 100 ml solution comprising 
ethanol: glacial acetic acid: water (30: 10: 60). The fixing solution was discarded and 
the gel was incubated twice in 5 gel volumes of 30 % ethanol for 30 minutes. The gel 
was washed three times in 10 gel volumes of water for 10 minutes. The gel was 
incubated in 5 gel volumes of 0.1 % silver nitrate for 30 minutes. The silver nitrate 
was discarded and the gel was washed in water. 5 volumes of 2.5 % sodium 
carbonate and 0.2 % formaldehyde were added. The reaction was quenched by 
addition of 1.0 % acetic acid for 3 minutes followed by washes with water. 
2.14.3 Cytochrome haem staining 
The SDS-PAGE gel was washed in 100 ml of haern staining solution A and 
incubated (gentle shaking, 5-10 minutes). The components of solution A were added 
in the order listed. Solution A was discarded and replaced with 100 ml haem staining 
solution B, mixed gently and immediately incubated in the dark for 15 minutes. The 
gel was removed from the dark and 1 ml of hydrogen peroxide was added, the gel 
was incubated for several minutes, gentle shaking until the bands were visible. The 
reaction was stopped with addition of dH20. 
Haem staining solution A 	 Haem staining solution B 
30 ml methanol 	 Haem staining solution A containing 
60 ml dH20 	 40 tg 3,3',5,5'-Tetramethylbenzidine 
10 ml 2.5 M Sodium acetate pH 5.2 	Dihydrochloride solubilised in (1) 
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2.15 Periplasmic extraction 
The periplasm was prepared from a 500 ml culture of recombinant S. frigidimarina 
EG301 (2.1.4). The large scale overnight culture was centrifuged (9,000 rpm, 20 
minutes) and the cell pellet was resuspended in 10 mM Tris HC1, pH 7.0, containing 
0.1 M NaCl (200 ml). The washed cells were centrifuged (9,000 rpm, 20 minutes) 
and the pellet was resuspended in 0.1 M Tris-HC1, pH 8.0 containing 0.5 M sucrose 
(50 ml) and transferred to a small centrifuge pot. When the cells were completely 
resuspended, 200 mM EDTA, pH 9.0 was added to a final concentration of 1 mM 
and the cells were incubated at room temperature for 20 minutes. The cells were then 
centrifuged (13,000 rpm, 20 minutes). The light orange supernatant was decanted 
and the orange/red pellets were resuspended in 50 ml dH20. The cells were incubated 
at room temperature for 5-10 minutes until they became dense. At this stage, 2.5 M 
Magnesium Chloride (MgCl2) was added to a final concentration of 1 mM to stop the 
reaction. The cells were centrifuged (13,000 rpm, 20 minutes) and the soluble 
periplasmic fraction was decanted. The periplasm was stored in 25 ml volumes at 
—20 °C. 
2.16 Purification of FccA54 from E. coil TGI (pMB3) 
The FccA54 protein was purified using a HiLoad 26/10 Q-Sepharose HP (Amersham 
Pharmacia Biotech) anion exchanger column (53 ml; packed length of 10 cm) with 
the fast performance liquid chromatography (FPLC) AKTA system (Amersham 
Pharmacia Biotech). The column was equilibrated with 10 mM Tris buffer pH 8.0 
(buffer A) and the sample (pH 8.0) containing 1.2 g of total protein was loaded onto 
the column. The flow rate was set to 1 ml per minute. 
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A salt gradient of 0-100 % 10 mM Tris buffer, pH 8.0, containing 1 M NaCl (buffer 
B) in 11 column volumes was used to elute proteins adsorbed to the positively 
charged matrix. The chromatography system was set to measure the ultraviolet (UV) 
spectra of the protein fractions collected. The absorbance spectra (280-680 nm) were 
measured for the fractions that were yellow or that showed traces of yellow. The 
spectrophotometer was blanked with 10 mM Tris buffer, pH 8.0. 
2.17 Protein concentration 
A centrifugal protein-concentrating filter (Vivaspin 20; 10 kDa) was used to 
concentrate the protein fractions containing the highest concentration of FccA54. The 
filters were rinsed with dH20 and centrifuged (20 minutes, 7,000 rpm) prior to 
concentration of the protein. 
2.18 Co-purification of FccA54 and FccB54 
The Biocad purification system was used to assess the best conditions for co-
purification of the FccA54 and FccB54 subunits. A Poros 20 HS 1.66 ml cation 
exchanger column (4.6 mm in diameter and 100 mm in length) was used on the 
automated protein purification system. The flow rate was set to 5.00 ml per minute. 
The column was equilibrated with 10 mM Tris HC1, pH 7.0. Any protein bound to 
the negatively charged column was eluted during a salt gradient of 0-100 % 10 mM 
Tris HC1, pH 7.0 containing 2.0 M NaCl in 37 column volumes. The sample (2.1.7) 
(2 ml) was loaded on the column by injection into the loop. The fractions were 
collected in 1.40 ml volumes. The UV absorption spectra were measured at 254 nm 
and 280 nm. 
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2.19 Fumarate reduction assay 
A purified sample of FccA54 was tested for fumarate reductase activity using a 
spectrophotometer (Shimadzu UV-PC-1201) enclosed in an anaerobic chamber at 
25 °C and less than 6 parts per million (ppm) of oxygen. The fumarate-dependent 
reoxidation of reduced methyl viologen was monitored at 600 rim. The standard 
fumarate reductase assay buffer (1 ml) was adjusted to the correct pH using Trizma 
base (pH 7.0). Methyl viologen was reduced with addition of sodium dithionite until 
an absorbance reading of approximately 1.0 was obtained at A660 rim. Fumarate 
adjusted to pH 7.0 (500 1iM) was added and the reaction initiated by the addition of 
purified FccA54 protein in 10 mM Tris buffer, pH 7.2 (5.0 tM). 
Fumarate reductase assay buffer 
Component 	 Amount per litre 
(1M) Hydrochloric acid 	 50 ml 
NaCl 	 26.3 g 
Methyl viologen 	 5.5 g 
2.20 Succinate oxidation assay 
The ability of FccA54 to catalyse succinate oxidation was determined 
spectrophotometrically (Shimadzu UV-PC-1201) under aerobic conditions. The 
assay buffer (1) was added to a cuvette with ferricyanide (FeCN) as the electron 
acceptor (2) and succinate as the electron donor (3). The rate of succinate oxidation 
was monitored upon addition of 5.0 jtM FccA54 (4) at a wavelength of 420 rim, over 
a period of 10 minutes. 
1.5 M Cyclo-hexylaminoethanesulfonic acid (CHES) buffer pH 9.0 (1 ml) 
1.0 M FeCN (5.0 j.il) 
1.0 M succinate (100 i1) 
FccA54 protein sample 
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2.21 Preparation of samples for N-terminal Sequencing 
The protein samples to be sequenced were provided on a Western blot that was 
obtained using the NOVEX Xcell II blotting apparatus (Invitrogen). The protein 
samples were run on a pre-cast gel (2.13) and then transferred onto a pre-cut 
polyvinylidene fluoride (PVDF) blotting membrane. The Western blotting protocol 
was followed according to the manufacturer's instructions (Invitrogen). The Western 
blot was Coomassie stained and the desired bands were cut as a single strip and 
transferred to a 1.7 ml tube that was stored at —20 °C until use. For sequencing of 
cytochrome proteins, the Western blot was divided in two and stained with 
Coomassie blue and haem staining solution, respectively. Alignment of the blots was 
subsequently used to estimate the position of the cytochromes on the Coomassie 
stained Western blot. The desired 'bands' were cut from the Coomassie stained 
Western blot and provided as a sample for N-terminal Edman sequencing, carried out 
on an Applied Biosystems Procise 4HT microsequencer. 
2.22 Preparation of samples for mass spectrometry 
The sample of FccA54 for mass spectrometry was taken from a culture of E. coli 
TG1 (pMB3) that was induced with 1 mM IPTG for overexpression of FccA54 
(2.1.5). The overnight cultures were centrifuged (13,000 rpm, 30 minutes), the 
supernatant removed and the pellet resuspended in 10 mM Tris buffer, pH 7.5 (3.6 
ml). The cells were sonicated and centrifuged (13,000 rpm, 30 minutes). The 
supernatant was extracted and was used for obtaining a mass spectrometry result. 
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A liquid chromatography-mass spectrometry (LS-MS) instrument comprising a C5 
reverse phase column (Waters 2790 HPLC) was used to desalt the protein sample. 
The sample was analysed using positive electrospray ionisation on a Micromass 
platform mass spectrometer. 
The sample obtained for mass spectrometry of FccB54 was obtained from a culture 
of S. frigidimarina EG301 (pMB5) (2.1.4) that was induced with IPTG (1 mM) for 
16 hours. The 0D600 was measured for the overnight culture; 1 ml of culture was 
extracted and added to a clean 1.7 ml tube. The culture was centrifuged (13,000 rpm, 
10 minutes) and the cell pellet was resuspended in loading buffer minus SDS 
according to the formula, where the 0D600 is 0.5, the cell pellet is resuspended in 
solution to a volume of 50 p1. The sample was stored at —20 °C. The mass 
spectrometry analyses were carried out on an Applied Biosystems Voyager DE-STR 
matrix-assisted laser/desorption ionisation, time of flight (MALDI-TOF) instrument. 
2.23 Homology modelling 
A sequence and secondary structures prediction tool was used to generate optimised 
pairwise sequence alignments including secondary structure prediction for each 
flavoprotein (FccA54, FccA56 and FccA342) against Fcc3 (S. frigidimarina 
NCIMB400) (http://www.icmb.ed.ac.uk/sssalignlsssalign.html). These sequence 
alignments were subsequently used to construct homology models of each 
flavoprotein catalytic domain using SYBYL Composer (Blundell et al., 1988). The 
active site of the Fcc3 enzyme was used as a molecular framework to structurally 
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The initial seed alignments of each flavin domain against Fcc3 that were produced by 
SYBYL Composer were modified to achieve the best structural alignments. The 
exact length of each signal sequence is unknown for the novel flavoproteins and 
double-arginine signal sequences tend to be longer than standard Sec peptides. 
Therefore, to ensure only mature protein was modelled, the amino acid sequences of 
FccA54, FccA56 and FccA342 used for molecular modelling began three residues 
upstream of the highly conserved FAD-adenine ring-binding site. A molecular 
mechanics algorithm incorporated in the program suite CNS was used to refine the 
holoenzyme models produced by SYBYL Composer. Minimisation functions were 
used to optimise the side chain orientations in the flavoenzymes and to minimise any 
strain in the models. Backbone atoms shifts were restrained to prevent any large 
alterations in the polypeptide backbone. 
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224 Plasmids, bacterial strains and primers 
Bacterial Strain Genotype! Description Source! 
Reference 
E. co/i DH5cc 
supE44 AIuclJ 169 (4)80 lacZ AM IS) hsaR 17 recA I Lab stock 
endA 1 gyrA96 thi- 1 re/Al 
supE hsdA5 thi (Alac-proAB) F' [traD36 proAB 
E. co/i TG 1 Lab stock 
/acZAMI 5]  
E. co/i Sl7Aoir 
TpR SmR recA, thi, pro, hsdRM*RP4: 2-Tc:Mu: Km Tn7 Lab stock 
pir  
E. co/i SM1O 
thi-1 thr /eu tonA lacY supE recA::RP4-2-Tc::Mu Lab stock (KmR)  
S. oneidensis MR-I 
Wild type manganese reducing strain, isolated from Lab stock 
sediments of Lake Oneida, New York 
S. oneidensis MR- 1RmR Spontaneous rifampicin resistant strain Lab stock 
S.frigidimarina EG30I S.frigidimarina NCIMB 400 RmR,  Afcc3::ahp Km' 
Gordon, 
 1996 
S. oneidensis MB5415 S. oneidensis MR-I RmR,  AfccAB54::ahp  KmR;  Cm" This work 
S. oneidensis MB5413 S. oneidensis MR-I RmR, Km R, 
 CMS This work 
S. oneidensis MB54 1 S. oneidensis MR-I RmR, KmR, CmR This work 
Table 2.6: Bacterial strains used and constructed 
The bacterial strains that were used for transformation and conjugation of plasmid constructs for 
protein overexpression are shown. Details of the S. oneidensis MB5415 and S. oneidensis MB5413 
strains that were constructed in this work are also shown. 
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oriT EcoO 109 
repA 	 AM 
Nor mobAlrepB 
coI 	 repE 	EcoRV  3Hladn  Bmm 	 AccI 
Figure 2.1 Selected plasmid maps 
The pEP I 85.2 suicide plasmid (Pepe and Miller, 1993) was used to construct a deletion mutant of S. 
oneidensis MR-i Rm'. The pMMB503EH overexpression plasmid (Overbye Michel etal., 1995) was 
used for protein overexpression in Shewane/la species. 
Plasmid Host Properties Source! 
Reference 
pUCI9 E. co/i 131-15a Cloning plasmid, 2686 bp; APR Yanisch- 
Perron et al., 
1985 
pEP 185.2 E. co/i VM229 Suicide plasmid, 4275 bp; oriR6K, Pepe and 
Sy327Apir mobRP4, Cm' Miller, 1993 
pGEM-T/ E. co/i TG 1 pGEM-T cloning plasmid containing Lab stock 
Km TO kanamycin cassette; 3945 bp, ApR, 
Km'  
pMBGK9 E. co/i DH5ct pUCI9 and fccA54/fccB54 homologous This work 
template DNA, 3626 bp; APR 
pMBGK2 E. co/i DH5a pUCI9 and gene replacement fragment, This work 
, KR 4565 bp; ApR 	m 
pMBGK15 E. co/i Si7Apir pEP 185.2 and gene replacement This work 
fragment, 6163 bp; CmR, KMR 
pMBGK41 E. co/i TG  pGEM-T containing the 54gk9/54gk10 This work 
2091 bp PCR product; 5091 bp; APR, 
KmR 
Table 2.7: Plasmids for construction of the fccA 54 and fccB54 gene knockout 
Details of the plasmids used for construction of the fccA54 and fccB54 gene knockout, including, 
transformed host, plasmid length, antibiotic resistance properties and the source/reference of the 
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Plasmid Host Properties Source! 
Reference 
pGEM-T - Cloning plasmid, 3000 bp; Ap' Promega 
pMB 1-2 E. coli TG I pGEM-T containingfccA54 54FRA PCR This work 
product; 4539 bp; APR  
pMB2-I E. coli TG  pGEM-T containing mutatedfccAB54 54FRB This work 
BamHlIPstl fragment; 4914 bp; APR  
pMB2- 1-4 E. coli TG I pGEM-T containingfccAB54 54FRB This work 
BarnH l/PsIl fragment; 4914 bp; APR  
pMB3-4 E. coli TG I pGEM-T containingfccA54 54FMRA PCR This work 
product; 4455 bp; APR  
pMB4-11 E. coli TG  pGEM-T containingjccAB54 54FMRB This work 
BamHl/PstI fragment; 4830 bp; APR  
pMB5-4 E. coli TG  pGEM-T containing fccA342 342FRA This work 
BamHlIPstI fragment; 4503 bp; APR  
pMB6-14 E. coli TG  pGEM-T containing jccAB342 342FRB This work 
BamH I/Psi! fragment; 4864 bp; APR  
pMB7A-1 E. coli TG I pGEM-T containing fccA342 342FMRA This work 
BarnHl/PstI fragment; 4443 bp; APR  
pMB8-3 E. coli TGl pGEM-T contain ingfccAB342 342FMRB This work 
BamHlIPstI fragment; 4804 bp; APR  
pMB9-5 E. coli TG  pGEM-T containing ifcA-IBamHlIPsiI This work 
fragment; 4788 bp; APR  
pMMB503EH E. coli DH5a Broad host range expression plasmid; 9.9 kb; Overbye 
SmR; Ptac Michel ci 
a/., 1995 
pEX 129 E. coli DH5a pMMB503EH containing gene 129 Atanasiu, 
BamHl/PsiI PCR product; 12.2 kb; Sm'; Ptac 2001 
pMB3-4-2 E. coli DH5a pEX 129 containing ficA54 54FMRA This work 
E. coli SM1O BamHIIPstI PCR product; 11.4 kb; Sm'; Plac 
pMB5 E. coli DH5o pMMB503EH contain ingfccA B54 54FRB This work 
E. coli SMIO pMB4 M/uI/PstI fragment; 11.8 kb; Sm'; Ptac 
S.f 	EG30I  
pMB6 E. coli DH5a pMB5 containingfccAB342 342FRB This work 
E. coli SM 10 BamHI/PstI fragment; 11.7 kb; Sm; Ptac 
S.f 	EG301  
pJFI 18 E. coli TG  Broad host range expression plasmid; 5267 bp; Furste el a/., 
ApR; Ptac 1986 
pGEM-T E. coli TG I pGEM-T containing the fccA54 overexpression This work 
+fccA54 fragment; 4396 bp; APR 
fragment  
pMBI E. coli TG  pJF1 18 containingfccA54 54FMRA This work 
EcoRI/PstI PCR product; 6743 bp; APR; Ptac  
pMB2 E. coli TG  Modified pJF1 18 containingfccA54 54FMRA This work 
MluIJBg/I1 fragment; 6722 bp; APR;  Ptac  
pMB3 E. coli TG I Modified pJF 118 containingfccA54 54FMRA This work 
BamHI/PstI fragment; 6722 bp; ApR;  Ptac  
pMB4 E. coli TG I p1\4B3 contain ingfccAB54 54FRB BarnHIIPsiI This work 
fragment; 7157 bp; APR  
Table 2.8: Plasmids used for overexpression of FccA54, FccB54, FccA342, FccB342 and IfcA-1 
Details of the plasmids used for cloning and overexpression of the related Fcc3 flavoenzymes, 
including transformed host, plasmid length, antibiotic resistance and the plasmid source/reference, are 
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PRIMER OLIGONUCLEOTIDE PRIMER SEQUENCE Tin FUNCTION! 
NAME (5'-3') (°C) DESCRIPTION 
54gk1 TAGAGGATATCCACCGTACTTGGTTCA 58.1 PCR amplification 
54gk2 CGGTGGATATCCTCTATGTCAGTTACAAGC 61.5 PCR amplification 
54gk3 GCCGATGTCATGGTCATC 50.2 PCR amplification 
PCR screening 
54gk4 CACCTCATGCGCAAGC 48.3 PCR amplification 
PCR screening 
54gk5 GGATGTGCTGCAAGGC 54.3 Sequencing 
54gk6 GGAATTGTGAGCGGATA 50.4 Sequencing 
54gk7 AGACGCGGTTCATAAC 49.2 PCR screening 
Forward primer 
Anneals 1rofccA54 
54gk8 GTTGCCACCATGGAC 50.6 PCR screening 
Reverse primer 
Anneals tofccB54 
54gk9 CGGTAAGTGATTTGAGGTTGCG 60.3 PCR screening 
54gk10 GGTGCCGGTATACAAGTCAG 59.4 PCR screening 
54gkC I GCCACTCATCGCAGTAC 55.2 PCR screening 
Forward primer 
Anneals to cat gene 
ofpEPI85.2 
54gkC2 CCAGACCGTTCAGCTG 54.3 PCR screening 
Reverse primer 
Anneals to cat gene 
ofpEP185.2 
Table 2.9: Primers used in construction of the fccA54 and fccBS4 gene-knockout 
The sequences of oligonucleotide primers that were used in construction of the fccA54 and fccB54 
gene knockout are shown in the 5'-3' direction. The function of the primers and the primer melting 
temperatures (Tm, °C) are also shown. The supplied primer DNA pellets (MWG-Biotech AG) were 
solubilised in 1 ml sterile water and stored at —20 °C. The other primers supplied (Oswel DNA 
services) were obtained as 1 ml aliquots. The EcoRI restriction sites at the 5'ends of 54gk1 and 54gk2 
are shown in bold underlined. 
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PRIMER 
NAME 




54FM TCAGGATCCATGACTGAATGCGCCTCAAAC 62.8 PCR amplification 
54F TCAGGATCCATGCATGATAGAAGAAG 56.2 PCR amplification 
54RA GATCTGCAGTTAGGCCTGCATGTCA 59.2 PCR amplification 
54RB GATCTGCAGTTACATTTCTTTGAACCAAG 57.1 PCR amplification 
54P1 GAAGGCTTTAACCAACAAG 46.6 Sequencing 
54P2 TGTGTTAGACGGTAAGCG 47.8 Sequencing 
54P3 GAGTGCTGCATAGCCAG 49.3 Sequencing 
54P4 GGTTGATGAGTCCAAGCT 47.8 Sequencing 
54P5 TAGGTGCAACCGGTGAAG 50.1 Sequencing 
54RP I TGGCTATGCAGCACTCTT 47.8 Sequencing 
54RP2 CCGTCTAACACATTGACTG 48.7 Sequencing 
54RP3 ACGGTATTCAACGCCTTC 47.8 Sequencing 
54RP4 TCGAGCCTAGACCTTGAC 50.1 Sequencing 
54JF1 GGAAACAGGATCCATGACTGAATG 55.6 Fusion PCR 
amplification 
54JF2 CATGGATCCTGTTTCCTGTGTGAA 55.6 Fusion PCR 
amplification 
54JF3 TGGCTTTOATGTAGATCGT 46.6 Fusion PCR 
amplification 
54JF4 CAGCAATGGCATCCTGG 49.3 Fusion PCR 
amplification 
54JF5 GATGTCGCAGAGTATGC 46.9 Sequencing 
54JF6 ACGACCTGCACAGCCAT 49.3 Sequencing 
Table 2.10: Primers used for PCR amplification and sequencing offccA54 and fccB54 
The sequences of oligonucleotide primers that were used for initiating PCR amplification of fccA54 
and fccAB54 are shown in the 5'-3' orientation. The primers 54JF1-54JF4 that were used for fusion 
PCR amplification of the FccA54 overexpression fragment are shown. The function of the primers 
and the primer melting temperatures (Tm, °C) are also shown. The DNA pellets supplied for each 
primer (MWG) were solubilised in 1 ml sterile water and stored at —20 °C. The other primers (Perkin-
Elmer Applied Biosystems and Oswel DNA service) were supplied as I ml aliquots. The BamHI 
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PRIMER 
NAME 




342FM TCAGGATCCATGAATACAGCAGGAGTTAAATGG 61.8 PCR amplification 
342F TCACCATCCATGATTTATCTGAAAATCATC 56.0 PCR amplification 
342RA GATCTCCAGCTATGCTTTCATCATCGAAC 60.0 PCR amplification 
342RB GATCTGCAGTTATTTAAACTTAGGGTAG 55.4 PCR amplification 
342P1 TGATGATGGCACAGTGCT 47.8 Sequencing 
342P2 GCACTGTTAATTGCGCCT 47.8 Sequencing 
342P3 CTGCTCGTTCGATGATGA 47.8 Sequencing 
342P4 CTAGTGCTAACCGTAGTC 47.9 Sequencing 
342P5 GGTGCACTATTGCCAAG 52.8 Sequencing 
342RP 1 CGGCATACAGCTTAGGAA 47.8 Sequencing 
342RP2 AGGCGCAATTAACAGTGC 47.8 Sequencing 
342RP3 AGCACTGTGCCATCATCA 47.8 Sequencing 
342RP4 ACAAGCTTGACCTGCGTT 47.8 Sequencing 
IFC3F TCACGATCCATGTTGAATACCAAATTATTACC 57.8 PCR amplification 
IFC3R GATCTCCAGTTATTTAATAGAATTAGCTACTTG 56.8 PCR amplification 
M13 
(-20)  
GTAAAACGACGGCCAGT 52.0 Sequencing 
M13 
(40)  
GTTTTCCCAGTCACGAC 50.0 Sequencing 
Table 2.11: Primers used for PCR amplification and sequencing offccA342,fccB342 and IfcA.-1 
The sequences of oligonucleotide primers that were used for initiating PCR amplification and 
sequencing of fccA342, fccAB342 and IfcA -] are shown in the 5'-3' orientation. The function of the 
primers and the primer melting temperatures (Tm, °C) are also shown. The 342P5 primer DNA pellet 
(MWG-Biotech AG) was solubilised in 1 ml sterile water and stored at —20 °C. The other primers 
(Perkin-Elmer Applied Biosystems and Oswel DNA service) were supplied as 1 ml aliquots. The M13 
primers are complementary to pGEM-T and are available from Promega. The BamHI (primers 342F, 
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2.25 Preparation of antibiotics 
Antibiotic Name Solution Filter Sterilised 
(0.2 tm filter)  
Concentration 
Stock Final 
Ampicillin Sterile dH20  50 mg/ml 50 fig/ml 
Chloramphenicol Ethanol X 34 mg/ml 25 j.ig/ml 
Kanamycin Sterile dH20  50 mg/ml 50 tg/ml 
Rifampicin Methanol X 10 mg/mi 10 .tg/m1 
Streptomycin Sterile dH20 '7 50 mg/ml 50 .ig/ml 
Table 2.12: Antibiotic preparation 
The details of antibiotic preparation are shown. All antibiotics were dispensed into 1.7 ml tubes and 
stored at -20 °C. 
226 Sterilisation 
All tubes (0.6 ml and 1.7 ml) and pipette tips that were used for molecular biology 
were sterilised prior to use by autoclaving. All solutions used for molecular biology 
such as CaC12 were sterilised by autoclaving or filtration (0.2 tm filters). Buffers that 
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2.27 Restriction enzymes 
Name Source Restriction cleavage site  
Aval Promega 
5' C 	(T/C)CG(A/G) 	G 3' 
3' G (A/G)GC(T/C) C 5' 
BamHI Promega 
G GATC C 3' 
3' 	C CTAGG 5' 
BglIl Promega 
GATC T 3' 
3' 	T CTAGA 5' 
Bsu361 New England Biolabs 
TNAGG 3 
3' GGANT CC 5' 
EcoRI Promega 
5' 	G AATT C 3' 
3' C TTAAG 5' 
EcoRV Promega 
5 	GAT ATC 3' 
3' CTA TAG 5' 
KpnI Promega 
5' 	G GTAC C 3' 
3' C CATG G 5' 
MluI Promega 
CGCG T 3' 
3' 	T GCGCA 5' 
PstI Promega 
C TGCA C 3' 
3' 	GACGTC5' 
Smal Boehringer Mannheim 
5' 	CCC CCC 
3' GGG CCC 5' 
XbaI Promega 
5' 	T CTAG A 3' 
3' A GATCT 5' 
Table 2.13: Restriction enzymes 
The restriction enzymes that were used are listed. The restriction site and the source of each enzyme 
are given, where N is any nucleotide. 
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The Fcc3 X-ray crystal structure solved to 1.8 A resolution (Taylor et al., 1999; PDB, 
1 QJD) provided the first detailed insight into the architecture of a fumarate reductase 
enzyme active site and the catalytic mechanism of fumarate reduction. Structural 
modelling and close contact measurements were initially used to analyse the precise 
structural and functional role of Fcc3 active site residues: His365, Tbr377, Arg402, 
His504 and Arg544 that are conserved in the family of fumarate reductases. Site-
directed mutagenesis of some active site residues was subsequently used to ascertain 
their role in fumarate reduction. 
3.1.1 The catalytic mechanism of Fcc3 
The close-fitting enzyme active site of Fcc3 was identified to contain a malate-like 
substrate molecule that lies close to the FAD cofactor and is held in position via 
hydrogen bonds to key substrate-binding residues (Figure 3.1). Modelling studies 
showed that closure of the clamp domain induces a twist in the Cl carboxylate group 
of the malate-like substrate that concomitantly acts to alleviate steric constraints 
imposed on the planar molecule by Met236 and Met375 (Figure 3.1). The short 
substrate contacts made to these methionine residues in the close-fitting active site 
induces a change in the planar conformation that weakens the conjugation throughout 
the dicarboxylate substrate (Taylor et al., 1999). The twisted Cl carboxylate group of 
the substrate establishes close contacts with His3 65 and Thr3 77 (Figure 3.1) that are 
key substrate-binding residues located in the clamp domain of Fcc3 (Taylor et al., 
1999). 
Chapter 3 	 Molecular Modelling 
The C4 carboxylate group of the intermediate malate-like substrate extends into the 
flavin domain and forms hydrogen bonds with His504 and Arg544 (Figure 3.1). 
These substrate-binding contacts create a highly polar hydrogen-bonding 
environment that acts to polarise the C2-C3 bond of the substrate. The combined 
steric and electrostatic effects that are initiated upon substrate binding lead to the 
generation of positive charge at C2 of the substrate making it amenable to 
nucleophilic attack (Taylor et al., 1999). 
Figure 3.1: The active site of Fcc3 solved to 1.8 A resolution 
The active site of the Fcc3 fumarate reductase solved to 1.8 A resolution is shown (Taylor et al., 
1999). The FAD cofactor (yellow) and the key active site residues of Fcc3 (atom type) are shown. The 
malate-like intermediate substrate molecule (magenta) is shown in the Fcc3 active site, where the 
oxygen atoms are in red. The close substrate contacts (A; green) between the substrate carboxylate 
groups and protein atoms are indicated. The four carbon atoms of the malate-like substrate and N5 of 
FAD are labelled in white. The picture was produced using the molecular modelling graphics program 
WITNOTP (Widmer, 1999). 
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The close proximity of FAD to the substrate molecule facilitates hydride transfer 
from N5 of reduced flavin to C2 of the twisted and polarised substrate (Figure 3.2a). 
The exceptionally close contact (3.00 A) of Arg402 (NH2) from 0 of the substrate 
(Figure 3.2b) makes this residue suitable for subsequent proton transfer in the 

















Figure 3.2: Fcc3 catalytic mechanism involves a proton delivery pathway for fumarate reduction 
(A) The schematic diagram from Figure 4a of Taylor et al., 1999 shows the stepwise catalytic 
mechanism of Fcc3. (B) The X-ray crystal structure of Fcc3 (Taylor et al., 1999) revealed the position 
of residues involved in the proton delivery pathway (A; green): G1u378, Arg38 land Arg402 (atom-
type). FAD (yellow) and the substrate molecule (magenta), where the oxygen atoms are highlighted in 
red, are shown. The NH2 group of Arg402, the active site acid of Fcc3 is ideally positioned at 3.00 A 
from 0 of the substrate molecule for proton transfer leading to production of succinate. The four 
carbon atoms of the malate-like substrate and N5 of FAD are labelled in white. The picture was 
produced using the molecular modelling graphics program WITNOTP (Widmer, 1999). 
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The X-ray crystal structures of Fcc3 showed that Arg402 (numbering of S. 
frigidimarina NCIMB 400 enzyme) was the only key active site residue suitably 
positioned to function as the active site acid for fumarate reduction (Taylor et al., 
1999 and Leys et al., 1999). Site-directed mutagenesis of Arg402 and the other 
candidate active site acid residues, His365 (Schröder et al., 1991) and His504 
(Bamford et al., 1999) to alanine, showed that only the Arg402-->A1a402 mutant 
enzyme had no detectable fumarate reductase activity (Doherty et al., 2000). This 
provided substantial evidence that Arg402 is indeed the essential proton donor 
required for fumarate reduction in Fcc3 (Doherty et al., 2000). The guanidinium 
group of the arginine side chain allows simultaneous occupation of key sites close to 
C3 and C4 of the substrate molecule required for fumarate reduction. Substituted 
amino acid residues of Arg402 such as lysine, tyrosine and alanine only occupy the 
site close to C3 of the substrate molecule (Figure 3.3). Interaction of an Arg402 
guanidinium NH2 group with the C4 position of the substrate enables Arg402 to 
function as a Lewis acid to stabilise the negative charge across C3-C4 of the 
substrate that is generated by hydride transfer. The concurrent interaction of the 
second NH2 guanidinium moiety with C3 of the substrate fulfils the role of Arg402 
as a Brønsted-Lowry acid involved in direct proton transfer to C3 of the substrate 





G1078 0 	 H2N Gh.363 
Figure 3.3: Position of the Arg402 side chain 
Arg402 of Fcc3 is the active site acid for fumarate reduction. The guanidinium group of Arg402 
occupies positions A and B that lie close to C3 and C4 of fumarate, respectively. Occupation of both 
sites is essential for fumarate reduction. Other residues substituted in position of Arg402; Ala (red), 
Lys (green) and Tyr (blue) occupy position A but not position B. Water molecules (red and green 
circles) occupy position B in the Ala and Lys substituted mutant Fcc3 enzymes, respectively. G1u378 
and G1n363 are also shown, to the left and right, respectively of Arg402 and the substituted residues. 
The schematic diagram is adapted from Figure 4 of Mowat et al., 2001. 
A proton delivery pathway of Fcc3 involving G1u3 78 and Arg3 81 is proposed to 
facilitate rapid delivery of protons to the Arg402 guanidine to reprotonate the group 
for enzyme catalysis (Figure 3.2b; Doherty et al., 2000). Arginine residues 
equivalent to Arg402 are conserved in the family of fumarate reductases suggesting 
that a similar proton pathway will operate in the Escherichia coli and Wolinella 
succinogenes fumarate reductases (Lancaster et al., 2001) and will not involve a 
histidine residue (His365; Fcc3 of S. frigidimarina NCIMB 400) (Schroder et al., 
1991) or a water molecule (Lancaster et al., 1999), as previously suggested. Indeed, 
the catalytic mechanism for fumarate reduction in L-aspartate oxidase is also similar 





3.2 RESULTS AND DISCUSSION 
3.2.1 Sequence analyses of S. oneidensis MR-1 flavoproteins 
The novel FccA54, FccA56 and FccA342 flavin subunits share high sequence 
identity to the flavin-containing catalytic domain of Fcc3 isolated from Shewanella 
species. A 'ClustaIW' (Thompson el al., 1994) multiple sequence alignment of the 
novel flavoproteins against the flavoprotein domain of Fcc3 (S. frigidimarina 
NCIMB 400) showed strict conservation of key catalytic residues (Figure 3.4). The 
X-ray crystal structure of the Fcc3-substrate complex (Taylor et al., 1999) showed 
that the substrate-binding residues of the flavin domain, His504 and Arg544 form 
hydrogen bonds to the C4 carboxylate group of fumarate (Figures 3.1). Interpretation 
of the 'ClustaiW' multiple sequence alignment revealed that basic residues 
equivalent to His504 and Arg544 of Fcc3 are strictly conserved in flavin-containing 
catalytic subunits of FccA54, FccA56 and FccA342 (Figure 3.4). These related 
flavoproteins were also shown to contain an arginine residue that aligned with 
Arg402, the active site acid of Fcc3 (Figure 3.4). This observation leads us to the 
theory that a proton transfer mechanism similar to that of Fcc3 operates in these 
related enzymes. The absence of charged residues equivalent to G1u378 and Arg381 
(Figure 3.4) of the Fcc3 proton delivery pathway (Doherty et al., 2000) leads to the 
supposition that an alternative pathway exists in these related enzymes. The Fcc3  
substrate-binding residues of the clamp domain, His365 and Thr377 form hydrogen 
bonds to the Cl carboxylate group of fumarate (Figure 3.1; Taylor et al., 1999). 
Analysis of the 'ClustalW' multiple sequence alignment showed that His365 of Fcc3  
is substituted with glycine in each of the three related flavoprotein subunits and that 





FCC 	 KSERQAALASAPHDTVDVVVVGSGGAGFSAAISATDSGAK-VILIEKEPVIGGNAKLAAG 170 
FccA54 	 ASATECASNIKWDETRDIIWGSGFAGLSSALNAKRQGLGSILVLEKMQVIGGNSAINGG 60 
FccA56 IKASNDNYGRTWDKEFDIIIIGSGFAGLSAYSAHKAGIKNIIVLEKNEAFGGNSAICGG 60 
FccA342 	 FSANANTAGVKWDETYEIVIVGSGFAGLAAAIEAGKLGAKEVVVLEKLGVYGGNSALNAG 58 
FCC 	 GMNAAWTDQQKAKKITD-SPELMFEDTMKGGQNINDPALVKVLSSHSKDSVDWI4TANGAD 229 
FccA54 	 WLAIPKNPIQLAQGIQDDSPEELVKDQIISGRGMQNTDMLRQMANRPLDAYQLCIDAGVK 120 
FccA56 LMCMPLTPMQKKLGIED-SAELMIKDMLKAGRGFNHPELCRTLTEAHKAYDMLMECGVK 119 
FccA342 	 QACFAGTDIQKKHGIED-SPDLMVKDQLISGRGYAHEDLLRHSAELGAYIYQMTKDCGCV 117 
236 
FCC 	 LTD--VGMStGGASVNRAHRPTGGAGVGAHVVQVLYDNAVKRNIDLRMNTRGIEVLKDDKG 287 
FccA54 	 FREGFNQQVGGHNKARAIRTQHGV--GGDITTKLYEVGKKEGVEYRLQHYVEDFIMDGQ- 177 
FccA56 FQD-KVIRLGGHSAPRAHLPESAS--GGGIVVPMHNYLRKAGIIFQNRTNVEEIIRGDS- 175 
FccA342 	 YRD-HIINTGGTSANRSHQVVERS--GAGFIRPMLKTARSYGVKTKTRHKFEHLITADDG 174 
FCC TVKGILVKGMYKG--------YYWVKADAVILATGGFAKNNERVAKLDPSLKGFIS-TNQ 338 
FccA54 QIVGLKVRQNYRFPDLKTGKTIYIKANKAVILAHGGFSRNLVLRELVDPALDKTLDCTNA 237 
FccA56 GVTGIVVSEKYDFKSGSNRGQFAYKAKKGVIVASGGWGQDHQFIKTTMPY-QKLESTAQ 234 
FccA342 TVLGIQVRKDYHFGHEDSGKLINIKAEKGVLIATGGFAANVAFRQALDPTLGSEVGCTNA 234 
365 367 	 375 377 	381 
1*1 I 11 3781 
FCC PGAVGDGLDVAENAGGALKDMQYIQAPLSVKGG ----- VI.rVT:AVRGNGAILVNREGK 393 
FccA54 LGATGEVTLTAMAHGAFPVHMSFIQTGHWGSPDEGGFGWSNALLSIGFHKGISVNVLDGK 297 
FccA56 PGATATMIKSLLSIRALPVMLDMYQLCPWATPDEKGAGPASFFADYAFAEGIAIDPKTGA 294 
FccA342 RGATGDGLIAO4LAEGAMPVGLSFIQSGPWASPDEGGFGYGSGFSLYNFPHSIAIDRNTGM 294 
402 
FCC RFVNEITTRDKASAAILAQTGK ------- SAYLIFDDSVRKSLSKIDKYIGLGVAPTADS 446 
FccA54 RFMNERADRKTCSDAIMKNRNP--DGSPAYPVVFFNHDDHVGAEEVTRAVRDQIAWKVDS 355 
FccA56 RFMNELADRRTRADAQLAVLASGTKEKPNMPFVFCGEATANHAEGFKAAYRDGAI KKSET 354 
FccA342 RFMNETADRKTRADLEIQRRDK--EGKPNPALLIAPKHEAQKDPSMENVLKYNVAWEFDS 352 
504 
FCC LVKLGKMEGIDGKALTETVARYNSLVSSGKDTDFERPNLPR--ALNEGNYYAIEVTPGVH 504 
FccA54 LEQLAKQFNI PLAQLKQTVAEYNKQVPQRIDPLFGRMMDTA--VELKAPFIVSRIWPKVH 413 
FccA56 LEELAKRYDVDINALQNSINEWNEIVQGKAKDPFNKPLDEK--TILF(PPYYSIRLSPKLH 412 
FccA342 VEAIAKHFNLPEEAFKKQVSDWNEYVKTGVDPQFGKRMDMVKDIYLTPPFIVQRLWPKVH 412 
534 	 544 
FCC HTMGGVMIDTKAEVMNAKK-QVIPGLYGAGEVTGGVHGANRLGGNAISDIITFGRLAGEE 563 
FccA54 YCMGGLKTDLGARVLHSQTLAPMKNLYAVGuATGGTHGGTRLSSTACLECLTMGI IVAET 473 
FccA56 YCMGGVAITPNAEVIDSNTCEPISGLFAAGEVTGGTHGL4DRLGGCSSIDGLVFGQIAGN- 471 
FccA342 YCQGGIQINTKAEVIAAKNGKPI PKLYAAGEVTGGVHGVSRLGGCSTPECMAFGVTAAR- 
**• 	* 	*- 	• • 	*• 	** 	*** 	** 	** 	. 	• 	. 
471 
FCC 	 AAKYSKKN 571 
FccA54 	 IKSDMQA- 480 
FccA56 -QAAIRKV 478 
FccA342 	--SMI4KA- 476 
Figure 3.4: 'ClustaIW' multiple sequence alignment of Fcc3 and the novel flavoenzymes 
The sequences of FccA54, FccA56 and FccA342 were aligned with the Fcc3 flavin domain of S. 
frigidimarina NCIMB 400 (Fcc) using 'ClustaiW' (Thompson et al., 1994). The related flavoproteins 
are numbered according to the preprotein sequence. The sequence that is shown begins directly 
upstream of the FAD-binding site of Fcc3 and the corresponding region of the related proteins (bold). 
The highlighted residues are numbered according to the Fcc3 protein sequence. The active site 
residues of Fcc3 (magenta) that are strictly conserved in the related enzymes (magenta) and the Fcc3  
residues that are not conserved (orange) are shown. The corresponding substituting residues of the 
related flavoproteins that are conserved in all three enzymes (green) and those which are variable 
(cyan) are shown. The conserved proline residue of the fumarate reductase family is shown (*) 
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With regard to the view that the related flavoproteins and Fcc3 have a common 
catalytic mechanism, the substitution of His365 by glycine in all three flavoproteins 
lends further support against His365 being the active site acid of Fcc3. The 
'ClustaiW' multiple sequence alignment showed that the active site proline residue 
(Pro366; Fcc3 of S. frigidimarina NCIMB 400), conserved in the subfamily of 
respiratory flavoenzymes (Pealing et al., 1992) was substituted with histidine in 
FccA54 (Figure 3.4). Sequencing of the fccA54 gene PCR amplified from the S. 
oneidensis MR-i genome subsequently provided evidence that a histidine residue 
does indeed occur at an equivalent position to Pro366 of Fcc3 (5.2.3). Perhaps, this 
histidyl residue is positioned in the FccA54 active site to provide substrate-binding 
interactions, as found for His365 in Fcc3 (Taylor et al., 1999). An invariant 
tryptophan residue of each flavoenzyme that maps to a position equivalent to Thr367 
of Fcc3 (Figure 3.4) may have a structural role to compensate for the existence of 
glycine at the active site. Alternatively, the conserved tryptophan residue may have 
an important role in substrate binding or catalysis. Analysis of the 'ClustaiW' 
multiple sequence alignment also revealed that G1u534 of Fcc3 implicated in sodium 
ion association is strictly conserved in the related flavoenzymes (Figure 3.4). 
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It was observed from the 'ClustaiW' multiple sequence alignment (Figure 3.4) that 
important active site residues of the Fcc3 flavin domain involved in substrate binding 
and catalysis are strictly conserved in the related S. oneidensis MR-i flavoproteins 
(Figure 3.5). Conversely, key substrate-binding residues located in the Fcc3 clamp 
domain are poorly conserved in the related flavoenzymes (Figures 3.4 and 3.5). The 
absence of carboxylate substrate-binding residues in the clamp domain of FccA54, 
FccA56 and FccA342 (Figure 3.5) leads us to suggest that these related enzymes 
bind to acrylates comprising a single carboxylate group. Furthermore, the active sites 
of these related flavoproteins might accommodate substrates with larger functional 
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Figure 3.5: Schematic diagram of the novel flavoprotein active sites compared to Fcc3  
The flavoproteins related to Fcc3 contain basic residues of the flavin subunit equivalent to His504 and 
Arg544 involved in binding the C4 carboxylate group of fumarate. His365 of Fcc3 that is a substrate-
binding residue located in the clamp domain is not conserved and is replaced by glycine in FccA54, 
FccA56 and FccA342. T1077 of Fcc3 is not conserved and is replaced by a residue that is variable 
amongst the flavoproteins. For simplicity, Thr377 and the equivalent residues are not shown. The 
absence of Cl carboxylate substrate-binding residues equivalent to His365 and Thr377 of Fcc3 leads 
us to suggest that the related flavoproteins catalyse reduction of acrylates rather than dicarboxylates 
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A 'ClustaiW' multiple sequence alignment of the novel flavoenzymes against the 
FccA flavin subunit of W. succinogenes revealed striking sequence similarity of 
active site residues (Figure 3.6). The key active site residues of Fcc3, Arg402, His504 
and Arg544 that are conserved in the related S. oneidensis MR-1 flavoenzymes are 
also conserved in FccA of W. succinogenes (Figure 3.6). The Fcc3 His365 
substitution with glycine in the clamp domain of the novel respiratory S. oneidensis 
MR-i flavoenzymes also occurs in the FccA flavoenzyme subunit. The other 
dicarboxylate substrate-binding and catalytic residues of the Fcc3 active site that map 
to the clamp domain; Met375, Thr377 and Arg381 are not conserved in the FccA 
flavin subunit of W. succinogenes. The specific function of the FccA flavin subunit 
from W. succinogenes is unknown but is recognised not to catalyse fumarate 
reduction (Simon et al., 1998). The high sequence identity observed between the 
FccA active site residues and FccA54, FccA56 and FccA342 provides further 







Fcc 	 LTD--VGM•1GGASVNRHRPTGGAGVGAHVVQVLYDNAVKRNIDLR84NTRGIEVLKDDKG 287 
FccA54 	 FREGFNQQVGGHNKA8JURTQHGVGG-DITTKLYE-VGKKEGVEYRLQHYVEDFIMDGQ- 203 
FccA56 FQD-KVIRLGGHSAPRAHLPESASGG-GIVVPMHN-YLRKAGIIFQNRTNVEEIIRGDSG 197 
FccA342 	 YRD-HIINTGGTSANRSHQVVERSGA-GFIRPMLK-TARSYGVKTKTRHKFEHLITADDG 192 
FccA 	 YLD-SLVHEGGHSVPRTYQTAVGSGA-GIVLPLMERFEKMAGVALKTRTKFDDFVMDDAG 206 
Fcc 	 TVKGILVKGMY ------------- KG --- YYWVKADAVILATGGFAKNNERVAKLDPSLK 331 
FccA54 	 QIVGLKVRQNYRFPDL-------KTG-KTIYIKANKAVILAHGGFSRNLVLRELVDPALD 255 
FccA56 -VTGIVVSEKYDFKSG ------ SNRG--QFAYKAKKGVIVASGGWGQDHQFIKTTMP-AY 247 
FccA342 	TVLGIQVRKDYHFGHE-------DSG-KLINIKAEKGVLIATGGFAANVAFRQALDPTLG 244 
FccA 	 RVIGILAREDYRFDSKLFSDDLENQGGTPKAFKATKAVMLASGGFCQDKYYRAVQDPRLT 266 
365 367 	375 377 381 
1*1 I 	11 378  1 
Fcc 	 GFIS-TNQPGAVGDGLDVAENAGGALKDMQYIQALPYLSVKGGVHViAVR------GNG 384 
FccA54 	 KTLDCTNALGATGEVTLTAMAHGAFPVHMSFIQTGHWGSPDEGGFGWSNJAL-LSIGFHKG 314 
FccA56 QKLESTAQPGATATMIKSLLSIRALPVMLDMYQLGPWATPDEKGAGPASFF-ADYAFAEG 306 
FccA342 	 SEVGCTNARGATGDGLIAMLAEGAF4PVGLSFIQSGPWASPDEGGFGYGSGF-SLYNFPHS 303 
FccA 	 PSTDSTNHPGATAGVLLKAFGIGAVPVQVSWIQFGPWACPDEKGFGVGSMFNVNASFRYG 326 
402 
Fcc 	 AILVNREGKRFVNEITTRDKASAAILAQTGK ------- SAYLI FDDSVRK--SLSKIDKY 435 
FccA54 	 ISVNVLDGKRFMNERADRKTCSDAIMKNRNP--DGSPAYPVVFFNHDDHV---GAEEVTRA 370 
FccA56 IAI DPKTGARFMNELADRRTRADAQLAVLASGTKEKPNNPFVFCGEATAN--HAEGFKAA 364 
FccA342 	IAIDRNTGMRFMNETADRKTRADLEIQRRDK--EGKPNPALLIAPKHEAQ--KDPSNENV 359 
FccA 	 ISVDPKTGKRYMNELADRKIRADHMFAVIGK ---- DENYPINLCDSQAIERLLPDHYEKA 382 
* 	 * 
Fcc 	 IGLGVAPTADSLVKLGKNEGIDGKALTETVARYNSLVSSGKDTDFERP ----- NLPRALN 490 
FccA54 	 VRDQIAWKVDSLEQLAKQFNIPLAQLKQTVAEYNKQVPQRIDPLFGRM --- MDTA--VEL 425 
FccA56 YRDGAIKKSETLEELAKRYDVDINALQNSINEWNEIVQGKAKDPFNKP --- LDEKT--IL 419 
FccA342 	LKYNVAWEFDSVEAIAKHFNLPEEAFKKQVSDWNEYVKTGVDPQFGKR --- MDMVKDIYL 416 
FccA 	 LKAGILKKFNTLEELAQQYKMPVEAFKKTVTDYNSYVKAGKDPEFGKPTNMVDGIT--LS 440 
504 	 534 	 544 
Fcc 	 EGNYYAIEVTPGVHHTMGGVMIDTKAEVMNAKK-QVI PGLYGAGEVTGGVHGANRLGGNA 549 
FccA54 	 KAPFIVSRIWPKVHYCMGGLKTDLGARVLHSQTLAPMKNLYAVGEATGGTHGGTRLSSTA 485 
FccA56 KPPYYSIRLSPKLHYCMGGVAITPNAEVIDSNTCEPISGLFAAGEVTGGTHGMDRLGGCS 479 
FccA342 	TPPFIVQRLWPKVHYCQGGIQINTKAEvIAAKNGKPIPKLYAAGEvTGGVHGvSRLGGCS 476 
FccA 	 KAPFYAMRGTPKLHHTMGGLQINTQAQVIHSKTHQPIPGLYAAGEVTGGvHGASRLGSvA 500 
Fcc ISDIITFGRLAGEEAAKYSKKN 571 
FccA54 CLECLTMGIIVAETIKSDMQA 506 
FccA56 SIDGLVFGQIAGNQAAIRKV 499 
FccA342 TPECMAFGVTAAR---SMMKA 494 
FccA ITDCLTFGMIAGENI-------515 
Figure 3.6: 'ClustaiW' multiple sequence alignment of FccA and the novel flavoenzymes 
The sequences of FccA54, FccA56 and FccA342 are aligned with the Fcc3 flavin domain of S. 
frigidimarina NCIMB 400 (Fcc) and FccA of W. succinogenes using 'ClustalW' (Thompson et al., 
1994). The novel flavoproteins and FccA are numbered according to the preprotein sequence. The 
highlighted residues are numbered according to the Fcc3 protein sequence. The active site residues of 
Fcc3 (magenta) that are strictly conserved in the related enzymes (magenta) and the Fcc3 residues that 
are not conserved (orange) are shown. The corresponding substituting residues of the related 
flavoproteins that are conserved in all four enzymes (green) and those which are variable (cyan) are 
shown. The conserved proline residue of the fumarate reductase family is shown (*). 
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The 'ClustalW' multiple sequence alignments provided information on conserved 
residues between Fcc3 and the related flavoenzymes based upon the primary structure 
of the proteins. A 'Sequence and Secondary Structures' alignment tool 
(http://www.icmb.ed.ac.uk/sss_alignlsss_align.html) was used to obtain sequence 
alignments of the related flavoproteins against Fcc3 based upon both primary and 
secondary structure. Various parameters were adjusted to optimise the pair-wise 
sequence alignments. The sequence alignments that included secondary structure 
prediction for FccA54 (Figure 3.7), FccA56 (Figure 3.8) and FccA342 (Figure 3.9) 
revealed structural similarity to the flavin domain of Fcc3. In contrast, the clamp 
domain was structurally less well conserved due to the insertion of a loop in FccA54, 
FccA56 and FccA342. The 'clamp domain loop' was introduced at a different 
position in the sequence alignment generated using the 'Sequence and Secondary 
Structures' alignment tool compared to the 'ClustaiW' sequence alignment (Figure 
3.4). This caused a variation in aligned residues corresponding to Met375, Thr377, 
Glu378, Arg381 and Arg402 of Fcc3. The optimised sequence alignments (Figures 
3.7-3.9) that contained secondary structure information were used to construct 
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Figure 3.7: Pair-wise sequence alignment of Fcc3 and FccA54 
The sequence alignment generated using a 'Sequence and Secondary Structures' alignment tool 
(http://www.icmb.ed.ac.uk/sssalignlsssalign.html) incorporated the secondary structure prediction 
for FccA54 aligned with the known structure of Fcc3 (S.frigidimarina NCIMB 400; Fcc). 'H' denotes 
alpha helices and 'E' indicates beta-sheets, where lower case (not conserved) and upper case 
(conserved) are used to clearly show the regions of conserved secondary structure between the aligned 
proteins. The FAD binding motif of Fcc3 and the corresponding sequence of FccA54 are shown 
(bold). The numbering of FccA54 corresponds to that of the preprotein sequence and does not 
correspond to residue numbers in the FccA54 molecular model. The boxed area indicates the sequence 
of key active site residues that are aligned differently compared to the 'ClustalW' (Thompson et al., 
1994) multiple sequence alignment (Figure 3.4). The active site residues of Fcc3 (magenta) that are 
strictly conserved in FccA54 (magenta) and the Fcc3 residues that are not conserved (orange) are 
shown. The corresponding substituting residues of FccA54 that are conserved (green) and those that 
are variable (cyan) are shown. 
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Figure 3.8: Pair-wise sequence alignment of Fcc3 and FccA56 
The sequence alignment generated using a 'Sequence and Secondary Structures' alignment tool 
(http://www.icmb.ed.ac.uklsss_align/sss_align.html) incorporated the secondary structure prediction 
for FccA56 aligned with the known structure of Fcc3 (S. frigidimarina NCIMB 400) (Fcc). 'H' 
denotes alpha helices and 'E' indicates beta-sheets, where lower case (not conserved) and upper case 
(conserved) are used to clearly show the regions of conserved secondary structure between the aligned 
proteins. The FAD binding motif of Fcc3 and the corresponding sequence of FccA56 are highlighted 
in bold. The numbering of FccA56 corresponds to that of the preprotein sequence and does not 
correspond to the numbering of residues in the FccA56 molecular model. The boxed area indicates the 
sequence of key active site residues that are aligned differently compared to the 'ClustaiW' 
(Thompson et al., 1994) multiple sequence alignment (Figure 3.4). The active site residues of Fcc3 
(magenta) that are strictly conserved in FccA56 (magenta) and the Fcc3 residues that are not conserved 
(orange) are shown. The corresponding substituting residues of FccA56 that are conserved (green) and 
those that are variable (cyan) are shown. 
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Figure 3.9: Pair-wise sequence alignment of Fcc3 and FccA342 
The sequence alignment generated using a 'Sequence and Secondary Structures' alignment tool 
(http://www.icmb.ed.ac.uklsssalign/sssalign.html) incorporated the secondary structure prediction 
for FccA342 aligned with the known structure of Fcc3 (S. frigidimarina NCIMB 400; Fcc). 'H' 
denotes alpha helices and 'E' indicates beta-sheets, where lower case (not conserved) and upper case 
(conserved) are used to clearly show the regions of conserved secondary structure between the aligned 
proteins. The FAD binding motif of Fcc3 and the corresponding sequence of FccA342 are highlighted 
in bold. The numbering of FccA342 corresponds to that of the preprotein sequence and does not 
correspond to the numbering of residues in the FccA342 molecular model. The boxed area indicates 
the sequence of key active site residues that are aligned differently compared to the 'CIustalW' 
(Thompson et al., 1994) multiple sequence alignment (Figure 3.4). The active site residues of Fcc3 
(magenta) that are strictly conserved in FccA342 (magenta) and the Fcc3 residues that are not 
conserved (orange) are shown. The corresponding substituting residues of FccA342 that are conserved 





3.2.2 Molecular models of the novel S. oneidensis MR-1 flavoproteins 
The sequence alignments (3.2.1) provided some insight into the biological function 
of the related Fcc3 flavoproteins and led us to the suggestion that these enzymes 
catalyse the reduction of acrylates (Figure 3.5). The information obtained from 
sequence alignments that included secondary structure prediction (Figures 3.7-3.9; 
http://www.icmb.ed.ac.uk!sss_align!sss_align.html) was used to construct molecular 
models of the flavoprotein active sites. Comparative modelling was used to provide a 
three-dimensional insight of each enzyme active site to investigate which acrylates 
were possible enzyme substrates. The molecular modelling program, 'SYBYL 
Composer' (Blundell et al., 1988) provided a systematic approach for constructing 
molecular models of FccA54, FccA56 and FccA342. 'SYBYL Composer' uses a 
knowledge-based approach to predict the structure of a protein based upon the 
known X-ray crystal structure of a homologous protein. The program is designed to 
structurally align the conserved regions on the basis of sequence homology, select 
these regions and align them with the known structural framework. Loops are 
subsequently inserted in the model based upon homology to the known structure 
(Blundell et al., 1988). Molecular models of FccA54, FccA56 and FccA342 were 
constructed using the known Fcc3 (S. frigidimarina NCTMB 400) X-ray crystal 
structure solved to 1.8 A resolution (Taylor et al., 1999; Figure 3.1). The 
homologous Fcc3 flavin domain sequence (Figures 3.7-3.9) was selected to generate 
a structural framework for alignment of the FccA54, FccA56 and FccA342 flavin 
subunits. 
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3.2.2.1 Structural details of the molecular models 
Molecular models of FccA54, FccA56 and FccA342 revealed that the fold of the 
flavin domain is structurally and topologically similar to the flavin domain of Fcc3  
(Figure 3.1 Oa). This finding correlates with high structural similarity found in the 
family of FAD-binding flavoproteins. The folding topology of the Fcc3 clamp 
domain is less well conserved in FccA54 (Figure 3.10b), FccA56 and FccA342 
consistent with the view that the clamp domain of Fcc3 is composed of a novel 
structural fold (Taylor el al., 1999). Low structural similarity localised to the clamp 
domain was attributed to a loop in the related flavoproteins that was orientated 
towards the active site in the molecular models constructed with 'SYBYL Composer' 
(Figure 3.10a). However, extension of the loop from the surface of each protein is 
likely to represent a more realistic orientation. Therefore, orientation of the loop was 
amended prior to minimisation for the molecular model of FccA54. However, 
modification of the loop did not improve the structural alignment in the FccA54 
clamp domain (Figure 3.1 Ob). Poor structural alignment with Fcc3 was also localised 
to helical breaks that mapped to residues out with the enzyme active site. 
Minimisation subsequently improved the structural superposition resulting in low 





Figure 3.10: Overlay of the molecular models with Fcc3 
(A) The structural topology and fold of the Fcc3 (atom-type) flavin domain is conserved in each of the 
novel flavoproteins, FccA54 (red), FccA56 (yellow) and FccA342 (green), as shown by structural 
superposition of residues 1-465 of FccA54, FccA56 and FccA342 with residues 125-567 of Fcc3 
(r.m.s.d = 0.641, 0.622 and 0.610 A, respectively). The fold of the clamp domain is less well 
conserved due to insertion of a loop in each of the novel flavoproteins. The C-alpha trace of the 
structural alignment is shown in crossed stereo view. The FAD cofactor and substrate of Fcc3 are 
shown (atom-type). (B) The 'clamp domain loop' (indicated by arrow) that contributes to the poorer 
structural alignment in the clamp domain of the novel flavoproteins aligned with Fcc3 is shown. The 
C-alpha trace of the structural alignment shows FccA54 (red) aligned with Fcc3 (yellow) to clearly 
show the position of this loop. The FAD cofactor and malate-like substrate of Fcc3 are shown (green). 
The pictures were produced using the molecular modelling graphics program WITNOTP (Widmer, 
1999). 
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Table 3.1 Structural data of molecular models 
Helical Breaks Clamp domain loop 
Position Distance (A) Position Orientation 
FccA54 	Q24/C-G25/N 2.014[*] FccA54 	S269-H273 +[-] 
FccA56 A24/C-G25/N 2.017 [*] FccA56 D266-A270 +[+] 
GI30IC-G131/N 2.819 [3.3561 FccA342 	L268-F271 +[+] 
FccA342 	G 130/C-A] 31/N 2.826 [4.353] 
11341C-R1351N 2.123 [*] 
Root mean square deviations 
Backbone main chain atoms (A) 
FccA54 0.596 [0.850] 
FccA56 0.612 [0.820] 
FccA342 0.676 [0.867] 
[] values after minimisation 
* break amended 
+ Orientation toward active site 
- Orientation away from active site 
Table 3.1: Structural data of molecular models 
The amino acid positions of the helical breaks that occurred in the molecular models of FccA54, 
FccA56 and FccA342 are shown. Most of these helical breaks were amended following minimisation. 
The 'clamp domain loop' comprising 4-5 amino acid residues occurred in the clamp domain of the 
FccA54, FccA56 and FccA342 molecular models and caused poor structural alignment with the Fcc3  
active site. The loop was positioned facing into the active site of each flavoenzyme molecular model. 
Prior to minimisation, the orientation of the 'clamp domain loop' was changed to project away from 
the active site in the FccA54 molecular model. However, this rearrangement had no effect on 
improving the structural alignment in the clamp domain of FccA54. The root mean square deviation of 
the backbone main chain atoms of each flavoenzyme molecular model with the active site of Fcc3 
showed that overall a high structural alignment was obtained between the homologous enzymes. 
The molecular models were generated for the entire flavin subunit of each novel 
flavoenzyme; however, of particular interest were the structural alignment of putative 
active site residues with the known active site of Fcc3. The structural similarity 
observed in the flavin domain of each molecular model with Fcc3 was further 
improved by manually altering the orientation of key active site residues. The 
conserved substrate-binding residues located in the flavin domain of each molecular 
model were precisely aligned with the corresponding substrate-binding residues of 
Fcc3 (His504 and Arg544). The conserved arginine residue in each molecular model 
was manually aligned with the equivalent Arg402 residue of Fcc3. 
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Superposition of the conserved basic residues established some close contacts 
(within a distance of 3.7 A) to the twisted malate-like substrate molecule of Fcc3  
(Table 3.2). The close contacts present in the Fcc3 flavin domain between His504 and 
Arg544 to 04B and 04A atoms, respectively, of the malate-like substrate (Figure 
3.1) are well conserved in the molecular models of the related flavoproteins (Table 
3.2). The close contact between Arg402 and C3 of the substrate molecule in Fcc3  
(Figure 3.2b) is also well conserved in the related flavoenzymes (Table 3.2). Other 
close contacts are less well conserved in the clamp domain of the three molecular 
models compared to the active site of Fcc3 (Table 3.2). Substitution of His365 (Fcc3) 
with glycine in each of the molecular models creates space at this region of each 
enzyme active site (Figures 3.11, 3.13 and 3.15), as was evident from absence of 
close contacts made between 11is365 and O1B and 02 atoms of the malate-like 
substrate of Fcc3 (Table 3.2). 
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Substrate 
Atom  
Close contacts between substrate and protein atoms (A) 
Fcc3 FccA54 FccA56 FccA342 
Residue/atom (A) Residue/atom (A) Residue/atom Residue/atom AY 
Cl 
Ma! 806 
R402/Nl-12 3.698 R293/NH2 3.450 - 
T377/001 3.239 W263/C 3.662 P260/0 3.080 Y262/C 2.767 
F261/CEI 3.648 F260/CE2 2.918 
C2 
Mal 806 
R4021NH2 3.252 R293/NH2 3.090 - 
- F261/CEI 3.374 F260/0E2 2.692 
OIA 
Mal 806 
T377/001 2.628 W263/C 3.618 P260/0 2.478 Y262/CA 2.954 




- i'377/0G! 3.359 W263/C 3.125 P260/0 3.191 Y262/C 2.070 
R402/NI-12 3.242 R293/NI-l2 2.832 
P261/CE! 3.455 F260/CEZ 2.745 
C3 Ma! 806 R402/NH2 2.995 R293/NFI2 3.539 R293/NFI2 3.187 
02 Ma! 806 1-1365/CD2 3.187 
R402/NH2 3.526 R2931NH2 3.144 
1-1504/NE2 2.997 H400INE2 3.292 H399/NE2 2.884 H401/NE2 3.625 
P261/CE! 2.298 F260/CE2 1.748 
C4 Ma! 806 R402/N112 3.132 R293/NH2 3,319 R293/NH2 3.460 R292/Nl-12 3.321 




- R544/N112 2.584 R441/Nl-12 2.676 R440/N112 2.289 R442/NH2 2.317 
04B 
Ma! 806 
R402/NHI 2.837 R293/NHI 3.250 R293/NH1 3.305 R292/NHI 2.742 
- H504/NE2 2.723 1-1400/NE2 3.575 H399/NE2 2.508 H401/NE2 3.424 
R544/NH2 2.768 R441/NH2 2.76 R440/N1-12 2.781 R442/NH2 2.649 
Table 3.2: Close contacts between the Fcc3 substrate and protein atoms 
The close contacts made between the malate-like substrate of Fcc3 and protein atoms of Fcc3 and the 
molecular models of FccA54, FccA56 and FccA342 were calculated. The conserved substrate-binding 
and catalytic residues of each molecular model were precisely aligned with the corresponding 
substrate-binding and catalytic residues of Fcc3 (Arg402, His504 and Arg544). The table shows that 
close contacts present in the Fcc3 structure between Arg402, His504 and Arg544 and the malate-like 
substrate are well conserved in the molecular models of the related flavoproteins. Conversely, close 
contacts are less well conserved in the clamp domain of the three molecular models compared to the 
active site of Fcc3. The large aromatic residues of the molecular models that substitute Thr377 
maintain close contacts to the malate-like substrate of Fcc3. However, the close contacts made 
between His365 and the malate-like substrate of Fcc3 are absent in the molecular models of FccA54, 
FccA56 and FccA342 due to the presence of glycine. These close contacts are calculated for residues 
that were manually twisted to align with residues of Fcc3, therefore, there may be some variation in 
these distances mentioned elsewhere in the chapter, as the manual alignment was repeated each time 





3.2.2.2 Molecular model of the FccA54 enzyme active site 
The molecular model of the FccA54 active site superimposed on the known structure 
of Fcc3 showed the putative position of key active site residues relative to Fcc3  
(Figure 3.11). The FccA54 basic residues equivalent to His504 and Arg544 of Fcc3  
maintain close contact to the substrate C4 carboxylate group (Table 3.2; Figure 3.11). 
The close interaction observed between NH2 of the FccA54 arginine residue (Fcc3; 
Arg544) and 04B of the substrate molecule (2.76 A; Figure 3.11), is particularly 
similar to the close contact observed between equivalent atoms in Fcc3 (2.77 A; 
Figure 3.1). 
Substrate-binding interactions and close contacts observed for the FccA54 molecular 
model in the clamp domain region of the active site are less well conserved 
compared to those of Fcc3. A tryptophan residue of FccA54 (Fcc3; Thr367; Figure 
3.4) is directed toward the active site and the aromatic ring is arranged parallel to the 
second tryptophan residue (Fcc3; Thr377; not shown). The large hydrophobic side 
chains are oriented in the active site to flank the substrate molecule (not shown). This 
gave rise to a highly hydrophobic small close-fitting active site for FccA54. 
Furthermore, the tryptophan side chains caused His252 of FccA54 (Pro366; Fcc3) to 
extend away from the active site (not shown), which prevented His252 from forming 





Figure 3.11: An overlay of the FccA54 molecular model with the Fcc3 active site 
The molecular model of FccA54 generated using 'SYBYL Composer' (Blundell etal., 1988) is shown 
superimposed on the known active site of Fcc3. The FAD cofactor, malate-like substrate of Fcc3 
(atom type) and the key active site residues are shown. The active site residues of Fcc3 are all shown 
in atom type and those of FccA54 are in magenta, cyan and green. For simplicity, only the FAD 
cofactor of Fcc3 is shown. The residues highlighted in magenta are substrate binding and catalytic 
residues of FccA54 that are strictly conserved in Fcc3 and other members of the fumarate reductase 
family. Residues of Fcc3 involved in catalysis and substrate binding, (Met236, Met375 and Thr377), 
which are not conserved in FccA54 and are variable in the novel flavoenzymes are shown in cyan. 
His365 of Fcc3 is not conserved in FccA54 and is replaced by Gly (green) which is a conserved 
substitution found in all three related novel enzymes. For simplification, only the close contacts 
between the substrate-binding residues and the substrate are shown for FccA54. The picture was 
produced using the molecular modelling graphics program WITNOTP (Widmer, 1999). 
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The alternative orientation of the tryptophan residue (Fcc3; Thr367) projecting away 
from the active site was also sterically possible for FccA54. Each of the novel 
flavoproteins (FccA54, FccA56 and FccA342) contain a tryptophan residue 
equivalent to Thr367 of Fcc3 (Figure 3.4), which extends away from the interior of 
the FccA56 and FccA342 molecular models (not shown). The orientation of the large 
aromatic side chain in the molecular models dictated the size and hydrophobicity of 
each active site and was critical in determining possible enzyme substrates. The 
tryptophan residue (Fcc3; Thr377) of FccA54 is predicted to constitute one of the key 
substrate-binding residues in the clamp domain and was shown to make contact to 
01A of the substrate (4.04 A) (Figure 3.11). This is considerably longer than the 
shortest contact (2.63 A) made between O1A of the twisted substrate and Thr377 of 
Fcc3 (Figure 3.1). One of the major differences of the FccA54 molecular model 
compared to the active site of Fcc3 is substitution of His365 (Fcc3) with Gly and the 
absence of close substrate contacts to the twisted malate-like substrate molecule 
(Figures 3.1 and 3.11). 
In addition to the two aromatic tryptophan residues present in the active site of the 
FccA54 molecular model, a phenylalanine residue (Fcc3; Met375) contributes to a 
highly hydrophobic tight binding pocket for FccA54 (Figure 3.11). This 
phenylalanine residue (Phe26 1) maintains close contact to the Cl, C2, 0113 and 02 
atoms of the twisted substrate molecule (Table 3.2). This indicated the close 
proximity of the hydrophobic side chain to the twisted conformation of the substrate, 
which is not found in Fcc3 with loss of Met375 contacts to the non-planar substrate 
configuration (Figure 3.1; Table 3.2). 
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The absence of close substrate contacts with residues in the clamp domain of the 
FccA54 molecular model, partially due to replacement of His365 (Fcc3) with glycine 
(Figure 3.11) initially led us to suggest that FccA54 would accommodate an acrylate 
substrate with a larger functional group. However, molecular modelling of the 
FccA54 flavoenzyme has shown that the glycine substitution is counteracted with the 
presence of large hydrophobic side chains in the active site. These aromatic groups 
of FccA54 are arranged in the clamp domain to form a tightly enclosed and highly 
hydrophobic active site (Figure 3.11). The small interior of the FccA54 active site, as 
observed from the molecular model, led to the conjecture that FccA54 will 
accommodate small acrylates such as methacrylate and crotonate (Figure 3.17). 
An arginine residue equivalent to Arg402 (Fcc3) exists in FccA54 and molecular 
modelling of the novel flavoenzyme showed that this arginine side chain maintains 
close contact to the substrate (Figure 3.12). An NH2 moiety of the FccA54 arginine 
guanidinium group is positioned in close proximity to C3 of the substrate (3.64 A), 
resembling the close interaction for Arg402 (3.00 A; Figure 3.12). This FccA54 
arginine residue (Arg402; Fcc3) is therefore also located in an ideal position to 
protonate the substrate at C3 (or equivalent carbon) leading to formation of the 
product. The proton delivery pathway of Fcc3 comprising Glu378 and Arg381 that 
functions to deliver protons to Arg402 (Doherty et al., 2000) appears to operate 
differently in FccA54. The proton transfer residues of Fcc3, G1u378 and Arg381, are 






The molecular model of FccA54 showed that the conserved arginine residue 
(Arg402; Fcc3) is in a suitable position to function as the active site acid, which 
accepts protons via a different route compared to the proton delivery pathway of Fcc3  
(Figure 3.12). 
Figure 3.12: An alternative proton delivery pathway for FccA54 
The proton delivery residues of Fcc3: Arg381, G1u378 and Arg402 (atom type) are shown with the 
route of proton transfer (green; A). Arg402 of Fcc3 is conserved in FccA54 (magenta) and an NH2 
group of the FccA54 arginine residue is within close contact (3.64 A, red) to C3 of the malate-like 
substrate (atom type) for proton delivery. However, Arg381 and G1u378 of Fcc3 are replaced in 
FccA54 with Leu and Ser (cyan), respectively. This suggests that an alternative proton delivery 
pathway towards the conserved arginine residue exists in FccA54. The residues of Fcc3 are labelled in 
green and the residues of FccA54 are labelled in red. FAD of Fcc3 is also shown (atom type). The 





3.2.2.3 Molecular model of the FccA56 enzyme active site 
The molecular model of FccA56 superimposed with the known active site of Fcc3  
(Figure 3.13) revealed that that the conserved substrate-binding residues of the flavin 
domain corresponding to His504 and Arg544 of Fcc3 maintain close contact to the 
C4 carboxylate group of the substrate. In particular, the close contact observed 
between the imidazole ring of His399 of FccA56 (Fcc3; His504) and 04B of the 
substrate molecule (2.70 A; Figure 3.13) is similar to the close contact observed 
between equivalent atoms in Fcc3 (2.72 A; Figure 3.1). 
The molecular model of FccA56 (Figure 3.13) revealed that the active site lacks 
large hydrophobic groups characteristic of the FccA54 clamp domain (Figure 3.11). 
A proline residue (Pro260) of FccA56 is located in place of Thr377 (Fcc3) and causes 
the backbone to shift away from the active site providing an enlarged cavity for 
substrate-binding (Figure 3.13). The shortest contact made between the side chain of 
proline extending away from the active site and the substrate molecule (01A) is 
4.46 A. The absence of close substrate contacts with residues in the clamp domain of 
FccA56 is also attributed to the presence of glycine that substitutes His365 (Fcc3; 
Figure 3.13). The conserved tryptophan side chain (Tbr367; Fcc3) is oriented away 
from the active site in the molecular model of FccA56 and was shown to interact 
with neighbouring aromatic residues that are absent in FccA54 (not shown). The 
external orientation of the tryptophan residue (Thr367; Fcc3) is perhaps determined 
by constraints imposed by the adjacent proline residue (Pro366; Fcc3) that is 
conserved in the family of fumarate reductases, except FccA54. 
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Figure 3.13: An overlay of the FccA56 molecular model with the Fcc3 active site 
The molecular model of FccA56 generated using 'SYBYL Composer' (Blundell et al., 1988) is shown 
superimposed on the known active site of Fcc3. The FAD cofactor, malate-like substrate of Fcc3 (atom 
type) and the key active site residues are shown. The active site residues of Fcc3 are all shown in atom 
type and those of FccA56 are in magenta, cyan and green. For simplicity, only the FAD cofactor of 
Fcc3  is shown. The residues highlighted in magenta are substrate binding and catalytic residues of 
FccA56 that are strictly conserved in Fcc3 and other members of the fumarate reductases family. 
Residues of Fcc3 involved in substrate binding and catalysis, (Met236, Met375 and Thr377), which 
are variant in FccA56 and the other novel flavoenzymes are shown in cyan. His365 of Fcc3 is not 
conserved in FccA56 and is replaced by Gly (green) which is a conserved substitution found in all 
three related novel enzymes. For simplification, only the close contacts between the substrate-binding 
residues and the substrate are shown for FccA56. The picture was produced using the molecular 
modelling graphics program WITNOTP (Widmer, 1999). 
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The structural deviation observed in the FccA56 polypeptide backbone due to proline 
(Thr377, Fcc3) and absence of close contacts that are established by His365 in Fcc3  
results in the formation of an enlarged active site. The FccA56 binding site (Figure 
3.13) has a greater capacity compared to the active site of FccA54 (Figure 3.11) and 
could potentially accommodate substrates such as phenylacrylates. Indeed, the 
fccA56 gene is associated with a gene encoding a histidase family protein (1.8.2) 
which has led to the suggestion that FccA56 catalyses the reduction of 
phenylacrylates such as cinnamate (Figure 3.17). 
The active site acid of Fcc3 (Arg402) is conserved in FccA56 (Figure 3.4) and the 
molecular model of FccA56 superimposed on the known structure of Fcc3 showed 
that the position of the arginine residue is conserved (Figure 3.14). The close contact 
(3.00 A) observed in the Fcc3 enzyme between an NI-12  moiety of the guanidinium 
group of Arg402 and C3 of the substrate is also observed in the molecular model of 
FccA56 (2.90 A; Figure 3.14). This result indicates that the conserved arginine 
residue in FccA56 also functions as an active site acid to protonate C3 (or equivalent 
carbon) of the putative acrylate substrate. The residues of the Fcc3 proton delivery 
pathway (G1u378 and Arg381; Doherty et al., 2000) are not conserved in FccA56 
and are replaced with Ala and Phe, respectively (Figure 3.14). This suggests that the 
conserved arginine in FccA56 (Arg402; Fcc3) will function as the active site acid and 





Figure 3.14: An alternative proton delivery pathway for FccA56 
The proton delivery residues of Fcc3: Arg381, G1u378 and Arg402 (atom type) are shown with the 
route of proton transfer (green; A). Arg402 of Fcc3 is conserved in FccA56 (magenta) and an NH2 
group of the FccA56 arginine residue is within close contact (2.90 A, red) to 0 of the substrate for 
proton delivery. However, Arg38 1 and G1u378 of Fcc3 are replaced in FccA56 with Phe and Ala 
(cyan), respectively. This suggests that an alternative proton delivery pathway towards the conserved 
Arg residue exists in FccA56. The residues of Fcc3 are labelled in green and the residues of FccA56 
are labelled in red. FAD of Fcc3 is shown (atom type). The picture was produced using the molecular 





3.2.2.4 Molecular model of the FccA342 enzyme active site 
The structural model of FccA342 superimposed on the known structure of Fcc3  
(Figure 3.15) clearly showed the structural identity with Fcc3 concerning active site 
residues that map to the flavin domain. The histidine and arginine substrate-binding 
residues of FccA342 were slightly misaligned with respect to the corresponding 
residues in Fcc3 (His504 and Arg544, respectively). However, these conserved basic 
substrate-binding residues in FccA342 maintain significantly close contact with the 
C4 carboxylate group of the malate-like substrate. The close interaction observed 
between the guanidinium group of the FccA342 arginine residue (Fcc3; Arg544) with 
04A and 04B of the substrate molecule (3.07 and 2.68 A, respectively) (Figure 
3.15), is similar to the close contacts observed between equivalent atoms in Fcc3  
(2.58 and 2.77 A, respectively; Figure 3.1). The FccA342 histidine side chain 
equivalent to His504 (Fcc3) forms close contact (3.31 A) to 04B of the malate-like 
substrate (Figure 3.15), an interaction also conserved in Fcc3 (2.72 A; Figure 3.1). 
The active site region of FccA342 formed by residues of the clamp domain is less 
well conserved compared to Fcc3. A tyrosine side chain (Thr377; Fcc3) projects into 
the active site and the C3 atom forms the shortest contact (3.37 A) to O1A of the 
malate-like Fcc3 substrate (Figure 3.15). The tyrosine residue also forms close 
contact to O1A, 0113 and Cl atoms of the substrate molecule (Table 3.2). The key 
substrate-binding contacts observed in Fcc3 between His365 and the substrate Cl 
carboxylate group (Figure 3.1) are absent in FccA342 due to the presence of glycine 
instead of His365 (Figure 3.15). 
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The tryptophan residue that is conserved in each of the novel flavoenzymes (Thr367, 
Fcc3) is oriented away from the active site interior of FccA342 and interacts with 
other hydrophobic residues (not shown). As postulated for the molecular model of 
FccA56, the conserved proline residue of FccA342 (Pro366; Fcc3) may affect the 
orientation of the neighbouring tryptophan side chain (Thr367; Fcc3; not shown). In 
addition to the tyrosine residue (Thr377; Fcc3) that extends into the active site pocket 
of FccA342, a phenylalanine side chain (Met375; Fcc3) is present (Figure 3.15) that 
forms close contacts to Cl, C2, O1A, 0113 and 02 of the twisted substrate molecule 
(Table 3.2). 
The size and hydrophobicity of the FccA342 active site is intermediate in 
comparison to the molecular models of FccA54 (Figure 3.11) and FccA56 (Figure 
3.13). The loss of substrate contacts in FccA342 due to the presence of glycine 
(His365; Fcc3) and the generation of a potentially larger active site was precluded by 
the presence of tyrosine and phenylalanine hydrophobic groups (Thr377 and Met375, 
respectively; Fcc3). These aromatic groups project into the active site of FccA342 
and contribute to formation of a small hydrophobic binding pocket (Figure 3.15), 
which is most likely to bind smaller acrylate substrates, as predicted for FccA54. 
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Figure 3.15: An overlay of the FccA342 molecular model with the Fcc3 active site 
The molecular model of FccA342 generated using 'SYBYL Composer' (Blundell el al., 1988) is 
shown superimposed on the known active site of Fcc3. The FAD cofactor, malate-like substrate of 
Fcc3 (atom type) and the key active site residues are shown. The active site residues of Fcc3 are all 
shown in atom type and those of FccA342 are in magenta, cyan and green. For simplicity, only the 
FAD cofactor of Fcc3 is shown. The residues highlighted in magenta are substrate binding and 
catalytic residues of FccA342 that are strictly conserved in Fcc3 and other members of the fumarate 
reductases family. Residues of Fcc3 involved in substrate binding and catalysis, (Met236, Met375 and 
Thr377), which are variant in FccA342 and the other novel flavoenzymes are shown in cyan. His365 
of Fcc3 is not conserved in FccA342 and is replaced by Gly (green) which is a conserved substitution 
found in all three related novel enzymes. For simplification, only the close contacts between the 
substrate-binding residues and the substrate are shown for FccA342. The picture was produced using 





The arginine residue of FccA342 that is equivalent to the active site acid of Fcc3  
(Arg402) is positioned in a similar orientation to Arg402, as shown by 
superimposition of the FccA342 molecular model with Fcc3 (Figure 3.16). The 
exceptionally close contact of the Arg402 NI-12  moiety (Fcc3) with C3 of the substrate 
molecule (3.00 A) is conserved in FccA342 (3.87 A; Figure 3.16). This result leads 
us to suggest that the conserved arginine residue in FccA342 (Arg402; Fcc3) will also 
act to protonate the substrate required for formation of the product. The proton 
delivery residues of Fcc3 (G1u378 and Arg38 1) that constitute a pathway towards 
Arg402 (Doherty et al., 2000) are not conserved in FccA342. The G1u378 and 
Arg381 residues of Fcc3 are substituted with Gly and Phe, respectively (Figure 3.16). 
This suggests that an alternative proton pathway towards the conserved arginine 





Figure 3.16: An alternative proton delivery pathway for FccA342 
The proton delivery residues of Fcc3: Arg381, G1u378 and Arg402 (atom type) are shown with the 
route of proton transfer (green; A). Arg402 of Fcc3 is conserved in FccA342 (magenta) and an NH2 
group of the FccA342 Arg residue is within close contact (A, red) to C3 of the substrate for proton 
delivery. However, Arg381 and G1u378 of Fcc3 are replaced in FccA342 with Phe and Gly (cyan), 
respectively. This suggests that an alternative proton delivery pathway towards the conserved Arg 
residue exists in FccA342. The residues of Fcc3 are labelled in green and the residues of FccA342 are 
labelled in red. FAD of Fcc3 is shown (atom-type). The picture was produced using the molecular 





32.3 Acrylate substrates modelled in the enzyme active sites 
A range of biologically relevant plant metabolites that may be frequently 
encountered in the natural habitat of S. oneidensis MR-i were selected as potential 
substrates of the flavoproteins. The various plant metabolites consisted of C6-C3  
phenylacrylates and smaller C3 or C4 acrylates that contain a single carboxylate 
group (Figure 3.17). A range of C6-C3 phenylacrylates incorporated into lignin are 
synthesised from the deamination of phenylalanine to trans-cinnamic acid, catalysed 
by phenylalanine ammonia-lyase. For incorporation into lignin, cinnamate is 
converted to hydroxycinnamyl alcohols; p-coumaryl alcohol, coniferyl alcohol and 
syringyl alcohol that form lignan dimers via oxidative coupling that further 
polymerise to form lignin (Wallace and Fry, 1994). Lignin is a structural component 
of both primary and secondary cell walls of tracheids and vessel elements of xylem 
tissue. It is highly probable that the anaerobic freshwater lake sediments inhabited by 
S. oneidensis MR-i are a rich source of lignin deposits. The specific content of lignin 
varies with taxa, tissues and changing physiological conditions, which would affect 
the type and abundance of specific acrylates in the anaerobic sedimentary 
environment. Some of the lignin within the plant cell wall is covalently bound to 
structural polysaccharides that may affect degradation and release of phenylacrylates 
(Wallace and Fry, 1994). Ferulate and coumarate are phenylacrylates found 
predominantly in their trans form and are identified to exist as covalently bound cell 
wall components. However, caffeate is incorporated into chiorogenic acid that is 





The phenylacrylates may be readily released into the environment in an uncombined 
free form to serve as terminal electron acceptors (Wallace and Fry, 1994). Indeed, 
some microorganisms such as the bacterial acetogens are reported to utilise lignin 




































Figure 3.17: Acrylate substrates of the novel flavoproteins 
The chemical structures of the acrylates selected as potential enzyme substrates of FccA54, FccA56 
and FccA342 are shown. 
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3.2.3.1 Molecular modelling of the acrylate substrates 
The acrylates (Figure 3.17) were incorporated in the molecular models of FccA54, 
FccA56 and FccA342 by superimposition of the carboxylate group with the C4 
carboxylate group of the malate-like substrate of Fcc3. Phenylacrylates were 
modelled in the enlarged active site of the FccA56 molecular model (Figure 3.13) 
that appeared suitable for accommodating large functional groups. However, steric 
constraints were observed between the aromatic ring of cinnamate and the 
polypeptide backbone of the clamp domain (Figure 3.18). This raises the possibility 
that phenylacrylates are not suitable substrates for the novel flavoenzymes. The 
close-fitting active site model of FccA54 (Figure 3.11) showed that this enzyme 
perhaps binds to smaller C3 acrylate substrates (e.g. methacrylate) and C4 acrylate 
substrates, (e.g. crotonate), rather than C6-C3 phenylacrylates (e.g. ferulate). A wide 
range of smaller acrylates (Figure 3.17), including crotonate and methacrylate were 
modelled in the active site of FccA54. Crotonate was easily accommodated in the 
active site of FccA54 and was shown to establish close contacts to the key substrate-
binding residues (Figure 3.19). The smaller C3 substrates such as methacrylate also 
formed close contacts to the FccA54 substrate-binding residues (not shown). The 
molecular model of FccA54 (Figure 3.11) leads us to the prediction that FccA54 is 
unlikely to bind large aromatic phenylacrylates but may function to catalyse the 
reduction of smaller acrylates such as methacrylate and crotonate. The catalytic 
function of FccA54 may resemble that of the related methacrylate reductase 





Figure 3.18: FccA56 complexed with cinnamate 
The molecular model of FccA56 generated using 'SYBYL Composer' (Blundell etal., 1988) is shown 
to contain cinnamate (yellow) bound in the active site. The substrate carboxylate group was aligned 
with the C4 carboxylate group of the malate-like substrate of Fcc3 (atom-type). The FAD cofactor is 
shown in atom type and the key active site residues of FccA56 are shown in magenta, cyan and green, 
consistent with Figure 3.13. The residues in magenta are active site residues strictly conserved in the 
fumarate reductase family; the residues in cyan are not conserved and are completely variable, 
whereas glycine (green) is a conserved substitution in the novel flavoenzymes. The close contacts 
between cinnamate and the key substrate-binding residues are shown (green, A). The picture was 





Figure 3.19: FccA54 complexed with crotonate 
The molecular model of FccA54 generated using 'SYBYL Composer' (Blundell etal., 1988) is shown 
to contain crotonate (yellow) bound in the active site. The substrate carboxylate group was aligned 
with the C4 carboxylate group of the malate-like substrate of Fcc3 (atom-type). The hydrogen atoms 
are shown for the modelled substrate. The FAD cofactor is shown in atom type and the key active site 
residues of FccA54 are shown in magenta, cyan and green, consistent with Figure 3.11. The residues 
in magenta are active site residues strictly conserved in the fumarate reductase family; the residues in 
cyan are not conserved and are completely variable, whereas glycine (green) is a conserved 
substitution in the novel flavoenzymes. The close contacts between crotonate and the substrate-
binding residues are shown (green, A). The picture was produced using the molecular modelling 
graphics program WITNOTP (Widmer, 1999). 
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3.3 Conclusions derived from molecular modelling 
The multiple sequence alignments of the novel flavoproteins against Fcc3 that were 
generated using 'ClustalW' (Figure 3.4) and the 'Sequence and Secondary 
Structures' alignment tool (Figures 3.7-3.9) showed differences in alignment of 
residues located to the clamp domain. The sequence alignments that incorporated 
secondary structure information were used to generate molecular models of FccA54 
(Figure 3.11), FccA56 (Figure 3.13) and FccA342 (Figure 3.15), based upon the 
known structure of the homologous Fcc3 enzyme (Figure 3.1; Taylor et al., 1999). 
The molecular models showed good structural alignment with Fcc3, as exemplified in 
the low r.m.s.d values (0.82-0.87 A) obtained for the polypeptide backbone main 
chain atoms (Table 3.1). Despite the overall structural alignment of the homologous 
enzymes, a loop was inserted in the clamp domain of the molecular models that was 
absent in Fcc3 (Figure 3.10a and b). This loop comprising 4-5 amino acid residues 
caused ambiguity in structural alignment of residues located to the clamp domain of 
each molecular model. 
The molecular models revealed that the structural topology and key catalytic residues 
of Fcc3 are highly conserved in the flavin domains of FccA54, FccA56 and FccA342. 
The analyses of the close contacts (Table 3.2) clearly showed the structural 
differences in the substrate-binding sites of the FccA54, FccA56 and FccA342 
molecular models compared to the active site of Fcc3. In particular, the molecular 
models clearly showed differences in substrate-binding residues located to the clamp 
domain of the novel flavoproteins and lend further support that the substrate 





The three-dimensional molecular models of the novel flavoproteins provided 
structural templates for modelling a wide range of possible acrylate substrates 
(Figure 3.17) that may support anaerobic metabolism of S. oneidensis MR-1. 
Comparative modelling using the known structure of Fcc3 (Taylor et al., 1999) was 
successfully used to reinforce sequence analysis predictions that the native substrate 




Gene replacement of fccA54 and fccB54 in She wanella 




Gene replacement offccA54 and fccB54 
4.1 INTRODUCTION 
4.1.1 Mechanisms of genetic change 
Spontaneous mutations that cause genetic change are naturally occurring in all cells. 
They may arise from errors in DNA replication resulting from tautomeric shifts that 
lead to mispairing of bases in duplex DNA. DNA replication errors can also lead to 
frameshift mutations that commonly occur at hot spot regions of repeated DNA 
sequence. In addition to DNA replication errors, spontaneous mutations can arise 
from naturally occurring DNA damage. Hydrogen peroxide generated as a by-
product of aerobic respiration can cause oxidative damage to DNA that leads to base 
mispairing. Spontaneous mutations also arise from the ability of transposable genetic 
elements such as transposons to move from one plasmid to another plasmid or from a 
plasmid to a bacterial chromosome. The genetic change can be a result of 
conservative or replicative transposition that gives rise to one or two copies of the 
transposable element, respectively. The target DNA is further modified to contain a 
short repeated sequence of the target gene upon integration of the transposable 
genetic element. Transposon mutagenesis led to the generation of a Shewanella 
oneidensis MR-i mutant that was unable to respire anaerobically with fumarate as 
the terminal electron acceptor. This mutant phenotype was consistent with the 
absence of a 65 kDa cytochrome protein corresponding to the size of the fumarate 
reductase enzyme (Myers and Myers, 1997c). An S. oneidensis MR-i transposon 
mutant, CMTn-I, that was deficient in Fe(III), Mn(IV), fumarate and nitrate 
reduction (Myers and Myers, 1993) was identified to contain the TnphoA transposon 
in the cyrnA gene (Myers and Myers, 1997b). 
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The ability of cymA to complement the mutant phenotype led to the suggestion that 
CymA is a common electron transport protein of a branched anaerobic electron 
transfer pathway (1.5; Myers and Myers, 1997b). 
In addition to the occurrence of spontaneous mutations, the sequence of a target gene 
can be modified using mutagenic agents that induce specific mutations. Alkylating 
agents such as ethyl methanesulfonate (EMS) and nitrosoguanidine (NG) favour 
addition of an alkyl group to guanine causing GC —3 AT transitions. The EMS 
chemical mutagen was used to generate an array of S. oneidensis MR-1 mutant 
strains that were deficient in Fe(III) reduction (Dichristina and Delong, 1994) and 
Mn(IV) reduction (Burnes et al., 1998). Other types of mutagens are capable of 
inducing mutations by mimicking a normal base of DNA. For example, 5-bromo-
uracil is a base analogue of thymine that can exist in an ionised form that mispairs 
with guanine forming AT - GC transitions. Another common method of 
specifically mutating target chromosomal genes involves gene disruption in which a 
portion of the gene sequence is precisely deleted. This is a useful method for 




Gene replacement offccA54 and fccB54 
4.1.2 The generation of gene disruptions in S. oneidensis MR-1 
Variations of a gene disruption method were used to construct a number of anaerobic 
respiratory mutants of S. oneidensis MR-1. The method is based upon constructing a 
recombinant suicide plasmid that contains the target gene sequence disrupted by a 
selectable marker. Subsequent transfer of the suicide plasmid into S. oneidensis 
MR-i promotes recombination between the cloned gene sequence and the 
homologous chromosomal gene. This leads to insertion of the selectable marker 
within the endogenous target gene. The proposed function of electron transport 
regulator A (EtrA) in regulating gene expression for anaerobic electron transport was 
investigated by constructing an etrA knockout strain (ETRA-153). The etrA gene 
disruption strategy involved inverse PCR with the cloned etrA sequence that led to a 
deletion of 246 bp of internal etrA sequence. A kanamycin resistance gene was 
inserted in place of the deleted etrA sequence and the gene disruption fragment was 
transferred into the pEP185.2 suicide plasmid for homologous recombination in S. 
oneidensis MR-i (Maier and Myers, 2001). A similar gene disruption strategy that 
used a recombinant pKNOCK-Km' suicide plasmid integrated into the endogenous 
target gene was used to generate an etrA mutant (Beliaev et al., 2002a) and a mutant 
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4.1.3 Constructing an fccA54 and fccB54 gene replacement 
The major aims of this project were to delete the fccA54 and fccB54 target genes 
from the S. oneidensis MR-1 genome and determine the effect on anaerobic growth 
of the null mutant. The S. oneidensis MR-1 knockout strains (4.1.2) were all 
constructed using a similar gene disruption strategy that led to the deletion of internal 
gene sequence. It is possible that truncated polypeptide encoded by the remainder of 
the target gene was synthesised in the mutant strains. Therefore, it is possible that 
phenotypic analysis of these insertional mutant strains (Maier and Myers, 2001 and 
Beliaev et al., 2002a) was hampered by synthesis of target polypeptide. In order to 
avoid such complications when identifying the fccA54 and fccB54 null mutant 
phenotype, a 'gene replacement' strategy was devised to knockout the entire frcA54 
and fccB54 gene coding sequences. This involved deleting both the fccA54 and 
fccB54 genes together since the encoded proteins are expected to associate and form 
a functional heterodimer. 
The gene replacement construction and phenotypic charactensation were designed to 
further the molecular modelling findings. Molecular modelling of the flavoprotein 
active sites led to the identification of various acrylates as potential enzyme 
substrates (3.2.3). The aim was to test whether these acrylates served as terminal 
electron acceptors during anaerobic growth of the fccA54 and fccB54 null mutant. 
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4.1.4 A novel gene replacement strategy 
An effective method for gene replacement is the synthesis of a gene replacement 
fragment using fusion PCR (Wang et al., 2002). A novel fusion PCR method was 
devised to amplify homologous template DNA comprising the fccA54 and fccB54 
gene-flanking DNA synthesised as a contiguous sequence. This sequence was 
designed to contain an EcoRV cleavage site (5'-GATATC-3') for insertion of a 
kanamycin cassette to form a gene replacement fragment. The strategy involved 
insertion of the gene replacement fragment in a mobilisable plasmid for conjugative 
transfer to S. oneidensis MR-1. The strategy was based upon the ability to screen 
transconjugants for the null mutant using antibiotic selection and PCR screening. 
4.2 RESULTS AND DISCUSSION 
4.2.1 Fusion PCR amplification and primer design 
The fusion PCR amplification was designed to precisely delete the putatively co-
expressed fccA54 and fccB54 genes and to replace the coding sequences with a 
selectable marker gene. The DNA sequence that flanks fccA54 and fccB54 in the 
wild-type S. oneidensis MR-i genome was amplified and modified to become a 
contiguous sequence using fusion PCR. This PCR amplified homologous template 
DNA was designed to contain an EcoRV cleavage site at the fusion junction for 
insertion of a kanamycin cassette (Figure 4.1). Oligonucleotide primers, 54gk3 and 
54gk4 that were distal to the point of kanamycin cassette insertion were designed to 
initiate amplification of the homologous template DNA fragment (Figure 4.1). The 
5'-end of the forward oligonucleotide primer, 54gk4 was designed to complement 
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The 5'-end of the 54gk3 reverse oligonucleotide primer sequence was 
complementary to genomic DNA 463 bp downstream of the fccB54 TAA stop codon 
(Figure 4.1). The sequences of 54gk3 and 54gk4 were designed to initiate 
amplification of a 940 bp fusion PCR product that was a suitable length to promote 










fecAM 	 fccB54 
54GK3 
PCR 2 
-3 ,  
500 bp 
PCR 3 
5' 	 3' - 
940 bp 
Figure 4.1: A schematic diagram of the fusion PCR procedure 
The steps of fusion PCR are shown for synthesis of homologous template DNA required for fccA54 
and fccB54 gene replacement. Arrows indicate the primer positions and direction of synthesis. Grey 
and black lines, respectively, represent the upstream and downstream S. oneidensis MR-1 genomic 
DNA sequences that constitute the fusion PCR product. The EcoRV site (cyan box) was inserted in 5'-
overhang sequences of the proximal primers, 54gkl and 54gk2, for incorporation into the 940 bp 
fusion PCR product. The diagram is not to scale. 
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The primers proximal to the point of kanamycin cassette insertion, 54gk1 and 54gk2, 
were intended to complement the fccA54 and fccB54 gene-flanking DNA sequences. 
However, the 5'-end of the 54gk1 forward primer sequence was complementary to 
fccB54 and specifically mapped 24 nucleotides upstream of the fccB54 TAA stop 
codon (Figure 4.1). The localisation of primer 54gk1 to the C-terminal sequence of 
fccB54 was unavoidable due to poly-T and poly-A sequence immediately 
downstream of the fccB54 TAA stop codon. The 5'-end of the 54gk2 reverse primer 
sequence was ideally positioned 12 nucleotides upstream of the fccA54 ATG start 
codon (Figure 4.1). 
The proximal primers were engineered to contain a 5' EcoRV cleavage site to 
facilitate insertion of the kanamycin cassette into the homologous template DNA 
fragment (Figure 4.1). EcoRV was selected as a suitable restriction enzyme to 
generate blunt ends because it does not cut in the kanamycin cassette or in the gene-
flanking DNA sequences. The sequences of the proximal primers were designed to 
be complementary and form duplex DNA over a region of 16 nucleotides (Figure 
4.2). This aimed to provide a stable interaction between the primary PCR products to 
promote the final fusion PCR amplification. The EcoRV cleavage site maps within 
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54gk1 
3' 
TAG)GGATATC CACCGTACTTGGTTCA —* 
1— CGAACTTGACPGTATcTCUI A!A( GTGGC 
3' 	 5' 
54gk2 
Figure 4.2: Engineering of the proximal primers to optimise fusion PCR 
The 16-nucleotide overlap of the proximal primer pair is shown. The EcoRV cleavage site is indicated 
in cyan and arrows indicate the position of enzyme cutting that generates blunt ends. The primer 
sequence complementary to the C-terminal coding region of fccB54 (red) and the upstream gene-
flanking DNA sequence (black) is shown. 
4.2.2 Synthesis of the homologous template DNA by fusion PCR 
In the first step of fusion PCR, primers 54gk2 and 54gk4 initiated amplification of a 
456 bp genomic DNA fragment upstream of the fccA54 gene (Figure 4.1). A high 
yield of PCR product (approximately 0.03 tg DNA) was successfully amplified for 
each PCR sample (Figure 4.3). The samples differed in the DNA: primer ratio and 
samples 2, 4 and 6 contained varying quantities of NH4C1. There was no yield 
enhancement when NH4C1 was added to the PCR sample (Figure 4.3). However, the 
fidelity of the DNA polymerase may have been affected which could only be 
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1 2 3 4 6 7 
IN 
1018 bp 
517 bp PCR amplification 
of a 456 bp fragment 
Figure 4.3: PCR amplification of genomic DNA upstream offccA54 
Primers 54gk2 and 54gk4 successfully initiated PCR amplification of S. oneidensis MR-1 genomic 
DNA upstream of fccA54. The results of PCR were analysed using agarose gel electrophoresis that 
revealed specific amplification of a product corresponding to the expected 456 bp fragment. The PCR 
samples 1-6 (lanes 2-7, respectively) that contained different DNA: primer ratios showed similar PCR 
product yields. The addition of NH4CI to reactions 2, 4 and 6 (lanes 3, 5 and 7) did not improve the 
yield of the PCR product. 1 kb DNA ladder (lane 1) was used to indicate the size of the PCR 
amplification products. 
In the second amplification of fusion PCR, a 500 bp fragment corresponding to the 
fccB54 gene-flanking DNA sequence was successfully amplified using primers 
54gk1 and 54gk3 (Figure 4.1). A high yield of PCR product (approximately 0.03 tg 
DNA) was amplified for each PCR sample (Figure 4.4). The PCR samples 1-6 varied 
in the DNA: primer ratio and NH4C1 was added to samples 2, 4 and 6. The variation 
in each reaction did not affect the desired PCR product yield (Figure 4.4). For each 
sample, a low molecular weight secondary PCR product was amplified that probably 
corresponded to primer-dimers (Figure 4.4). To eliminate amplification of erroneous 
products during the final fusion PCR step, the desired 500 bp PCR product was 
excised from a preparative agarose gel and purified. A high yield of the 500 bp PCR 
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12345 	67 
1018 
517 PCR amplification 
of a 500 bp fragment 
Primer-dimers 
Figure 4.4: PCR amplification of genomic DNA downstream of fccB54 
Primers 54gk1 and 54gk3 successfully initiated PCR amplification of an S. oneidensis MR-1 genomic 
DNA fragment downstream of fccB54. The PCR samples 1-6 that differed in the DNA: primer ratio 
were analysed using agarose gel electrophoresis (lanes 2-7, respectively). A PCR product 
corresponding to the size of the 500 bp downstream gene-flanking DNA fragment was amplified in all 
reactions. The product yield was similar for all six reactions and was not improved with addition of 
NH4CI to reactions 2, 4 and 6 (lanes 3, 5 and 7, respectively). A second non-specific PCR product was 
amplified in all reactions and was likely to correspond to primer-dimers. I kb DNA ladder (lane 1) 
was used to indicate the size of the PCR amplification products. 
The PCR products of the first two primary amplifications were used as template 
DNA for the final fusion PCR amplification. The complementary DNA region that 
extended across 16 bp of the primary PCR products stabilised the formation of 
duplex template DNA. The oligonucleotide distal primers, 54gk3 and 54gk4 were 
used to PCR amplify the gene-flanking DNA as a continuous sequence containing an 
EcoRV cleavage site (Figure 4.1). High yields of fusion PCR product at the correct 
size of 940 bp were obtained for each of the reactions and no secondary PCR 
products were amplified (Figure 4.5). The PCR samples differed in the DNA: primer 
ratio and the NH4C1 adjunct supplemented reactions 2, 4 and 6. Varying the reaction 
components in each PCR sample did not affect the yield of the fusion PCR 
amplification product (Figure 4.5). 
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The specificity of the highly sensitive fusion PCR technique indicated good primer 
design, especially for the proximal primers where sufficient overlap dictates PCR 
amplification of the desired product. 
1018 bp 
517 bp 
PCR amplification of 
a 940 bp fragment 
Figure 4.5: PCR amplification of the homologous template DNA 
The distal primers, 54gk3 and 54gk4 initiated PCR fusion of the gene-flanking genomic DNA 
sequences as a contiguous fragment containing an EcoRV cleavage site. PCR amplification samples 1-
6 were analysed using agarose gel electrophoresis (lanes 2-7, respectively). A specific PCR product 
corresponding to the size of the 940 bp homologous template DNA fragment was amplified for each 
of the samples. The samples differed in the DNA: primer ratio and NH4CI was added to reactions 2, 4 
and 6 (lanes 3, 5 and 7). The variation in reaction components was not observed to affect the PCR 
product yield. 1 kb DNA ladder was used to show that the fusion PCR product was of the expected 
size. 
4.2.3 Cloning the homologous template DNA in plasmid pUC19 
The PCR amplified homologous template DNA generated by fusion PCR was 
inserted into pUC19, a high copy number Escherichia coli cloning plasmid (Yanisch-
Perron et al., 1985; Figure 4.6). There were several factors that dictated the use of 
pUC19 (2686 bp) as a convenient cloning plasmid. A unique SmaT cleavage site of 
pUC19 (Figure 4.6) was selected for insertion of the fusion PCR product by blunt-
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Plasmid pUC19 does not contain an EcoRV cleavage site and was therefore suitable 
for mobilisation of the EcoRV kanamycin fragment without disruption of the 
remaining plasmid DNA. The restriction enzymes, KpnI and XbaI were selected as 
suitable endonucleases for excising the gene replacement fragment from pUC19 to 
the mobilisable plasmid. These restriction enzymes were identified not to cut in the 
homologous template DNA or the kanamycin cassette and were ultimately chosen 
due to unique cleavage sites for KpnI and XbaI in pUC19. 
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Figure 4.6: A map of the E. coli pUC19 cloning plasmid 
A Sinai cleavage site that was used for insertion of the homologous template DNA PCR product is 
shown. The KpnI and XbaI cleavage sites used for transfer of the gene replacement fragment to 
pEP 185.2 are also indicated. The pUC19 plasmid also contains a gene conferring ampicillin resistance 
(Yanisch-Perron et al., 1985). 
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A sample of pUC19 plasmid DNA was cut with Smal to generate blunt ends that 
were ligated to blunt ends of the fusion PCR product amplified using Pfu Turbo. 
Recombinant pUC19 containing the homologous template DNA fusion PCR product 
was transformed into E. coli DH5a. The transformants were firstly screened for 
ampicillin resistance encoded on the plasmid DNA (Figure 4.6). There were zero 
colonies on the 'cells only' control plate that indicated the colonies on the 
transformation plates all contained pUC19 plasmid. There were approximately 200 
ampicillin resistant colonies obtained from cells transformed with recombinant 
plasmid. However, a similar number of colonies were counted for the 'vector only' 
control. Plasmid DNA was isolated from 12 single ampicillin resistant colonies and 
EcoRV restriction digests were performed to identify those transformed with 
recombinant pUC19 plasmid. The formation of recombinant plasmid was detected by 
EcoRV digestion due to the fact that EcoRV does not cut in the parent pUC19 
plasmid DNA. The cloned PCR product of recombinant pUC19 plasmid was cut with 
EcoRV to give a single restriction fragment at 3626 bp corresponding to pUC19 
(2686 bp) and the inserted homologous template DNA (940 bp). The majority of the 
colonies screened were re-ligated pUC19 plasmid, as expected from the result of the 
'vector only' control plate. The EcoRV restriction digests (Figure 4.7) revealed that 1 
in 12 colonies contained recombinant pUC19 plasmid that was referred to as 
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3054 bp 
1636 bp 
3626 bp EcoRV fragment 
Figure 4.7: Restriction digests to identify recombinant pUC19 plasmid 
The homologous template DNA fragment was inserted in pUC19 using blunt-end cloning at a SrnaI 
cleavage site. Recombinant pUC19 plasmid, named pMBGK9, was identified using EcoRV that cut 
the inserted homologous template DNA to give a single restriction fragment at 3626 bp (lane 3). 
EcoRV was used to identify recombinant plasmid due to the absence of an EcoRV cleavage site on the 
parent pUC19 plasmid DNA that remained undigested (lane 2). 1 kb DNA ladder (lane I) was used to 
indicate the size of the restriction fragments. 
4.2.4 Sequencing of the PCR product cloned in pMBGK9 
The PCR product cloned in pMBGK9 was completely sequenced to check for any 
mutations incorporated during amplification by Pfu Turbo DNA polymerase. The 
accuracy of the homologous template DNA sequence was essential to provide strict 
homology to endogenous genomic DNA of wild-type S. oneidensis MR-1. 
Sequencing primers, 54gk5 (forward primer) and 54gk6 (reverse primer), were 
designed to complement pUC19 plasmid DNA to sequence through the region where 
the PCR product was inserted in pMBGK9. The automated sequencing results 
revealed that no mutations occurred in the PCR product, corroborating the high 
fidelity of PfuTurbo DNA polymerase. The correctly amplified PCR product cloned 
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4.2.5 Construction of the gene replacement fragment 
The kanamycin cassette from E. coli transposon Tn5 (Mazodier et al., 1985) was 
provided as a 945 bp EcoRV fragment cloned in pGEM-T. The EcoRV cleavage 
sites flanking the 5' and 3' termini of the cassette were digested to release the EcoRV 
kanamycin fragment (939 bp) from pGEM-T. Recombinant pMIBGK9 plasmid was 
digested with EcoRV to expose blunt ends of the cloned homologous template DNA. 
The generated EcoRV linear fragments were ligated to form a new recombinant 
plasmid that contained a kanamycin cassette disrupting the cloned homologous 
template DNA sequence. This plasmid carrying the kanamycin resistance gene 
replacement fragment was transformed into E. coli DH5a and transformants were 
screened for ampicillin and kanamycin resistance. There were zero colonies apparent 
on the E. coli DH5a 'cells only' control indicating good antibiotic selection. There 
was no growth on the 'vector only' control, strongly suggesting efficient blunt-ended 
ligation of 'vector and insert DNA'. The number of colonies obtained from cells 
transformed with recombinant plasmid generated from the blunt-ended ligation was 
very low. Following antibiotic selection, plasmid DNA was isolated from 4 single 
colonies and EcoRV restriction digests were used to identify insertion of the 
kanamycin cassette. Insertion of the kanamycin cassette in pMBGK9 as an EcoRV 
fragment would have restored EcoRV cleavage sites at both termini of the 
kanamycin cassette. Therefore, EcoRV restriction digests were used to verify 
insertion of the kanamycin cassette with release of a 939 bp EcoRV fragment from 
recombinant plasmid. It was confirmed that all four colonies selected for further 
screening were transformed with recombinant pMBGK2 plasmid (Figure 4.11) that 








EcoRV digested pMBGK2 
The EcoRV kanamycin 
fragment at 939 bp 
Figure 4.8: Restriction digests to identify formation of the gene replacement fragment 
The EcoRV kanamycin cassette was inserted in the homologous template DNA of pMBGK9 to form a 
kanamycin resistance gene replacement fragment. Recombinant pMBGK9 plasmid containing the 
kanamycin cassette was referred to as pMBGK2. Insertion of the kanamycin cassette in pMBGK2 was 
verified using EcoRV restriction digests that excised the 939 bp EcoRV kanamycin cassette, as shown 
using agarose gel electrophoresis. The restriction fragments of pMBGK2 plasmid DNA isolated from 
colonies 1-4 are shown in lanes 2-5, respectively. 1 kb DNA ladder (lane 1) was used to indicate that 
the EcoRV restriction fragments were of the correct size. 
4.2.6 Construction of a recombinant mobilisable plasmid 
A prerequisite for constructing a gene replacement in the genome of S. oneidensis 
MR-1 involved transfer of the cloned gene replacement fragment to the mobilisable 
suicide plasmid named pEP185.2 (Pepe and Miller, 1993; Figure 4.9). The restriction 
enzymes, KpnI and XbaI were conveniently used to splice the gene replacement 
fragment from pMBGK2 to the mobilisable plasmid pEP185.2 (4275 bp). These 
restriction enzymes were chosen because they do not cut in the gene replacement 
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The gene replacement fragment was excised from pMBGK2 as a KpnJIXbaI 1898 bp 
fragment and ligated to complementary ends of pEP185.2, generated by digestion 
with KpnI and XbaI. The recombinant plasmid was transformed into E. coli S17 Xpir 
that contains the pirR6K gene required for initiation of pEP185.2 plasmid DNA 
replication. The pEP185.2 plasmid expresses chioramphenicol resistance encoded by 
the cat gene (Figure 4.9). 
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Figure 4.9: Map of pEP185.2 mobilisable plasmid 
The KpnI and XbaI unique cleavage sites used for insertion of the gene replacement fragment are 
shown. The cat gene encoding chloramphenicol resistance is also shown (Pepe and Miller, 1993). 
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E. coli S17 Xpir cells transformed with recombinant pEP185.2 plasmid were selected 
for chloramphenicol and kanamycin resistance. There were zero colonies identified 
on the E. coli S17 Xpir 'cells only' control indicating that the antibiotic selection was 
implemented. No colonies were apparent for the 'vector only' control in which E. 
coli S17 Xpir cells were transformed with parent pEP185.2 plasmid. This result 
strongly suggested that the few colonies obtained from E. coli S17 Xpir cells 
transformed with 'vector and insert DNA', did indeed contain recombinant pEP185.2 
expressing kanamycin resistance. Plasmid DNA was isolated from 2 single colonies 
and KpnIJXbaI double restriction digests were performed to identify recombinant 
plasmid. The isolation of recombinant plasmid, named pMBGK15 (Figure 4.11), was 
demonstrated by excision of a gene replacement fragment at 1898 bp upon cleavage 
with KpnJ and XbaI (Figure 4.10). 
4072 bp 
2036 bp 
KpnI/XbaI pMB GK 15 fragment 
KpnI!XbaI 1898 bp 
gene replacement fragment 
Figure 4.10: Restriction digests to verify construction of pMBGK15 
The gene replacement fragment was transferred as a KpnIIXbaI fragment from pMBGK2 to the 
mobilisable pEP185.2 plasmid. Recombinant pEP185.2 plasmid, named pMBGKI5 isolated from 
colonies 1 and 2 was digested with KpnI and XbaI (lanes 2 and 3, respectively). The results were 
analysed using agarose gel electrophoresis that showed excision of a KpnLIXbaI restriction fragment 
corresponding to the 1898 bp gene replacement fragment. 1 kb DNA ladder (lane 1) was used to 
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Figure 4.11: Plasmids constructed to generate the null mutant 
The fusion PCR product comprising the homologous template DNA was inserted in the pUC 19 
cloning plasmid (A) to form pMBGK9 (B). The kanamycin cassette was inserted at the EcoRV site of 
the cloned fusion PCR product to form recombinant plasmid pMBGK2 (C). The kanamycin modified 
PCR product referred to as the gene replacement fragment was excised from pMBGK2 as a Kpnl/XbaI 
fragment and inserted in the mobilisable pEP 185.2 plasmid. The recombinant mobilisable plasmid, 
pMBGKI5 (D), was introduced into S. oneidensis MR-1 RmR  for homologous recombination to 
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4.2.7 Conjugative DNA transfer and antibiotic screening 
The pMBGK15 plasmid DNA (Figure 4.11) carrying the gene replacement fragment 
was transferred from E. coli S17 Xpir into the spontaneous rifampicin resistant (RmR) 
strain of S. oneidensis MR-i by bacterial conjugation. The pEP185.2 plasmid 
contains the mob site from the broad host range plasmid RP4 (Figure 4.9) that 
facilitates transfer from E. coli into a broad range of Gram-negative bacteria, 
including bacteria of the genus Shewanella. Attachment of E. coli S17 Xpir to 
recipient cells during conjugative mating was mediated by pill projecting from the 
cell surface of E. coli S17 Xpir. 
The recombinant pMBGK15 plasmid was introduced into S. oneidensis MR-1 RmR 
to allow homologous recombination to occur between the cloned gene replacement 
fragment and homologous DNA of the bacterial chromosome. Following conjugative 
mating, transconjugants were firstly screened for kanamycin and rifampicin 
resistance that selected for S. oneidensis RmR  strains containing the kanamycin 
cassette. The process of identifying the fccA54 and fccB54 gene replacement due to 
double recombination was then addressed over the single recombination event in 
which pMBGK15 is integrated into the chromosome. The pEP185.2 origin of 
replication can only operate in members of the Enterobacteriaceae and functions as a 
suicide plasmid in Shewanella species. This property was used to discriminate 
between double and single recombination events by means of chloramphenicol 
marker selection. The second antibiotic screen aimed to select for chloramphenicol 
sensitive transconjugants in which the double recombination event had led to loss of 
pMEGKI5. 
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The first conjugation yielded 8 transconjugants (S. oneidensis MB541-MB548) that 
were kanamycin and rifampicin resistant. However, these transconjugants grew 
slowly in the presence of chloramphenicol, signifying a single crossover event and 
incorporation of pMBGK15 into the S. oneidensis MR-1 genome. There were zero 
colonies on the 'S. oneidensis MR-i Rm' only' control indicating effective 
kanamycin selection. Low rifampicin resistance in the supplemented LB medium 
was suspected due to the appearance of three colonies on the 'E. coli S17 Xpir only' 
control. 
A similar result was obtained for the controls in conjugation II. From the second 
conjugation, 24 transconjugants grew which all displayed kanamycin and rifampicin 
resistance. To ascertain the occurrence of the double recombination event and the 
concomitant gene replacement, the 24 transconjugants were tested for their ability to 
grow in the presence of chloramphenicol. Eight transconjugants proved to be 
chloramphenicol sensitive suggesting a double-crossover event had occurred leading 
to deletion of the target genes. The control results provided supporting evidence that 
the chloramphenicol sensitivity was a true phenotype for 8 of the 24 transconjugants. 
The presence of chloramphenicol supported growth of the chloramphenicol resistant 
S. oneidensis MB541 control and inhibited growth of the S. frigidirnarina EG301 
chloramphenicol sensitive control. The antibiotic selection process for identifying the 
potential fccA54 and fccB54 null mutant formed the basis of further characterisation 
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4.2.8 PCR screening of transconjugants from conjugation II 
PCR screening was used to scan the genomic DNA of chioramphenicol sensitive 
transconjugants for fccA54 and fccB54 gene replacement with the kanamycin 
cassette. The distal primers, 54gk3 and 54gk4 (Figure 4.1) were used to PCR amplify 
genomic DNA that comprised the region of endogenous homologous template DNA. 
A double crossover event that led to fccA54 and fccB54 gene replacement was 
confirmed with PCR amplification of the endogenous gene replacement fragment at 
1879 bp (Figure 4.12). Amplification of two PCR products signified the occurrence 
of a single-crossover event in which the pMBGK15 plasmid was integrated in the 
genome of S. oneidensis MR-1. A 2814 bp PCR product corresponding to 
amplification of the fccA54 and fccB54 genes was amplified in addition to a 1879 bp 
PCR product corresponding to the integrated pMBGK15 gene replacement fragment 
(Figure 4.12). 
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Figure 4.12: A schematic diagram to show PCR screening of transconjugants 
PCR screening was used to analyse the genomic DNA of selected transconjugants to identify those 
containing the kanamycin cassette in position of the fccA54 and fccB54 genes. Primers 54gk3 and 
54gk4 complementary to the homologous template DNA were used to PCR amplify the region of 
homologous recombination. The double crossover event was identified by amplification of a single 
PCR product at 1879 bp corresponding to insertion of the kanamycin cassette. The amplification of 
two PCR products using primers 54gk3 and 54gk4 indicated a single crossover event in which 
pMBGKI5 plasmid DNA was integrated in the genome. A 2814 bp PCR product corresponding to the 
fccA54 and fccB54 genes was amplified in addition to the integrated pMBGK15 gene replacement 
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4.2.9 Identification of an fccA54 and fccB54 null mutant 
Primers 54gk3 and 54gk4 were successfully used to initiate PCR screening (Figure 
4.12) of chloramphenicol sensitive transconjugants, named S. oneidensis MB5413 
and S. oneidensis MB5415, obtained from conjugation II. The amplification products 
of four PCR samples that differed in the S. oneidensis MB5413 DNA: primer ratio 
were analysed using agarose gel electrophoresis (Figure 4.13). The amplification of 
two PCR products for reaction 2 (Figure 4.13) showed that S. oneidensis MB5413 
was a chloramphenicol sensitive false positive transconjugant. A PCR product 
corresponding to the 1879 bp gene replacement fragment was amplified for S. 
oneidensis MB5413, as confirmed by comparison to the control PCR product 
amplified from the pMBGK15 template DNA (Figure 4.13). The fccA54 and fccB54 
target genes were also PCR amplified from the genome of S. oneidensis MB5413, as 
shown by amplification of a 2814 bp product that was also apparent for the S. 
oneidensis MR-1 wild-type control (Figure 4.13). PCR screening of S. oneidensis 
MB5413 showed that the chloramphenicol sensitive phenotype was not due to 
fccA54 and fccB54 gene replacement and subsequent loss of the suicide plasmid 
pMBGK15. The chloramphenicol sensitive phenotype was perhaps attributed to a 
mutation in the cat gene of the pMBGK15 plasmid. An alternative explanation is that 
a non-specific double recombination event had occurred that led to insertion of the 
kanamycin cassette at an erroneous position in the S. oneidensis MB5413 genome. 
The imprecise gene replacement coupled to loss of the suicide plasmid pMBGK15 
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Figure 4.13: PCR screening of S. oneidensis MB5413 
Primers 54gk3 and 54gk4 were used to initiate PCR screening of the S. oneidensis MB5413 genomic 
DNA. The products of four PCR samples that differed in the ratio of genomic DNA: primer were 
analysed using agarose gel electrophoresis (lanes 3-6). A PCR product was amplified for all four 
reactions (lanes 3-6) that corresponded to the 1879 bp gene replacement fragment amplified from the 
pMBGK15 control template DNA (lane 7). However, two PCR products were amplified for reaction 2 
that was indicative of a single crossover event (lane 3). In addition to the 1879 bp PCR product, a 
second PCR product was amplified for S. oneidensis MB5413 (lane 3) that corresponded to the 2814 
bpfccA54 and fccB54 PCR product of wild-type S. oneidensis MR-i (lane 2). 1 kb DNA ladder (lane 
1) was used to indicate the size of the PCR products. 
Primers 54gk3 and 54gk4 successfully initiated PCR screening (Figure 4.12) of the 
chloramphenicol sensitive transconj ugant S. oneidensis MB 5415. The amplification 
products of four PCR samples that differed in the S. oneidensis MB5415 genomic 
DNA: primer ratio were analysed using agarose gel electrophoresis (Figure 4.14). A 
PCR amplification product for reactions 3 and 4 correlated to the 1879 bp gene 
replacement fragment amplified from the pMBGK15 control template DNA. A non-
specific PCR product at approximately 1600 bp was amplified in addition to the 1879 
bp PCR product (Figure 4.14). The 2814 bp fccA54 and fccB54 PCR product 
amplified from the genome of wild-type S. oneidensis MR-i was not amplified for S. 
oneidensis MB5415 (Figure 4.14). 
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The PCR screening results generated using primers 54gk3 and 54gk4 led to the 
suggestion that a double crossover event had successfully occurred in S. oneidensis 
MB5415 to replace the fccA54 and fccB54 target genes (Figure 4.14). 
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Figure 4.14: PCR screening of S. oneidensis MB5415 
Primers 54g0 and 54gk4 were used to initiate PCR screening of S. oneidensis MB5415 genomic 
DNA in order to determine fccA54 and fccB54 gene replacement with the kanamycin cassette. The 
products of four PCR samples that differed in the genomic DNA: primer ratio were analysed using 
agarose gel electrophoresis (lanes 3-6). A single PCR product was amplified for reactions 3 and 4 
(lanes 5 and 6, respectively) that corresponded to the 1879 bp gene replacement fragment amplified 
from the control pMBGKI5 template DNA (lane 7). The 2814 bpfccA54 and fccB54 PCR product 
amplified for the wild-type MR-i control (lane 2) was not PCR amplified from the genome of S. 
oneidensis MB5415 (lanes 3-6). However, in addition to the 1879 bp PCR product, a PCR product at 
approximately 1600 bp was amplified due to non-specific priming of the template DNA (lanes 5-7). 
No PCR product was amplified for reactions 1 and 2 (lanes 3 and 4, respectively). I kb DNA ladder 
(lane 1) was used to indicate the size of the amplified PCR products. 
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PCR screening using primers 54F and 54RA that complement the fccA54 gene was 
used to ascertain whether the target gene existed in the genomes of S. oneidensis 
MB5413 and S. oneidensis MB5415. The products of four PCR samples that differed 
in the S. oneidensis MB5413 genomic DNA: primer ratio were analysed using 
agarose gel electrophoresis. Primers 54F and 54RA successfully initiated PCR 
amplification of a product from the S. oneidensis MB5413 genome that was 
equivalent to the 1539 bp fccA54 PCR product of wild-type S. oneidensis MR-1 
(Figure 4.15a). However, one of the non-specific PCR products amplified from the 
pMBGKI5 negative control template DNA corresponded to the size of the fccA54 
PCR product (Figure 4.15a). Sequencing of the 1539 bp PCR product of S. 
oneidensis MB5413 was used to confirm that this amplified product was indeed 
frcA54. Therefore, this PCR screen led to substantial evidence that fccA54 and 
fccB54 of the S. oneidensis MB5413 genome were not replaced with the kanamycin 
cassette. 
The products of four PCR samples that differed in the S. oneidensis ME5415 
genomic DNA: primer ratio were analysed using agarose gel electrophoresis. The 
fccA54 54FRA 1539 bp PCR product amplified from the genome of wild-type S. 
oneidensis MR-i was not amplified from the genome of S. oneidensis MB5415 
(Figure 4.15b). This result provided further evidence that a kanamycin cassette was 
inserted in the S. oneidensis MB5415 genome in place of the fccA54 and fccB54 








Figure 4.15: PCR screening of S. oneidensis MB5413 and S. oneidensis MB5415 
A) PCR screening of the chloramphenicol sensitive S. oneidensis transconjugant MB5413 was 
initiated using primers 54F and 54RA that complement the fccA54 gene. The products of four PCR 
samples that differed in the S. oneidensis MB5413 genomic DNA: primer ratio were analysed using 
agarose gel electrophoresis. The fccA54 gene was amplified from the genome of wild-type S. 
oneidensis MR-I as shown by the presence of a 1539 bp fccA54 54FRA product (lane 2). A PCR 
product corresponding to the size of the 1539 bpfccA54 PCR product was also amplified from the S. 
oneidensis MB5413 genome (lanes 3, 5 and 6). Non-specific PCR products were amplified for the 
negative pMBGKI5 control that does not contain fccA54 (lane 7). 1 kb DNA ladder (lane 1) was used 
to indicate the size of the PCR products. B) PCR screening of the S. oneidensis MB5415 
transconjugant was initiated using primers 54F and 54RA that hybridise to the fccA54 target gene. The 
products of four samples that differed in the genomic DNA: primer ratio were analysed using agarose 
gel electrophoresis. A product corresponding to the fccA54 54FRA 1539 bp fragment was amplified 
from the genome of wild-type S. oneidensis MR-I (lane 2). The fccA54 gene was not amplified from 
the genome of S. oneidensis MB5415 (lanes 3-6). Non-specific PCR products were amplified for the 
negative pMBGKI5 control that does not containfccA54 (lane 7). 1 kb DNA ladder (lane 1) was used 
to indicate the size of the PCR products. 
Further PCR screening initiated with primers 54gk9 and 54gk10 (Figure 4.16) aimed 
to provide conclusive evidence that the kanamycin selectable marker was inserted in 
the S. oneidensis MB5415 genome in position of fccA54 and fccB54. The 54gk9 and 
54gk10 primers were designed to complement genomic DNA flanking the 
endogenous homologous template DNA sequence amplified using primers 54gk3 and 
54gk4 (Figure 4.16). 
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The primers were designed to specifically explore the region of homologous 
recombination to verify that the kanamycin cassette had been inserted at the correct 
position in the S. oneidensis MB5415 genome. A double crossover event and 
insertion of the kanamycin cassette in position of the fccA54 and JccB54 genes was 
determined by PCR amplification of a 2091 bp PCR product. A crossover event that 
did not disrupt the endogenousfccA54 and fccB54 genes was characterised by PCR 
amplification of a 3024 bp product, corresponding to the wild-type genome (Figure 
4.16). 
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Figure 4.16: Schematic diagram to show PCR screening of S. oneidensis MB5415 
Primers 54gk9 and 54gk10 were designed to initiate PCR screening of the S. oneidensis MB5415 
genome. The primer positions and direction of synthesis are indicated. The 54gk9 and 54gk10 primers 
were designed to complement genomic DNA (purple line) that flanked the point of homologous 
recombination (grey and black lines). A double crossover event and insertion of the kanamycin 
cassette in position of the fccA54 and fccB54 genes was indicated by PCR amplification of a 2091 bp 
PCR product. The amplification of a 3024 bp PCR product corresponded to wild-type genomic DNA 
comprising the fccA54 and fccB54 genes within the homologous template DNA sequence. The 
diagram is not to scale. 
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Primers 54gk9 and 54gk10 were successfully used to initiate PCR screening of the S. 
oneidensis MB5415 genome. The products of four PCR samples that differed in the 
ratio of S. oneidensis MB5415 DNA: primer were analysed using agarose gel 
electrophoresis (Figure 4.17). It was clearly identified that the PCR products 
amplified from the S. oneidensis MB5415 genome were 2091 bp that corresponded 
to amplification of the kanamycin cassette. This result was substantiated by 
amplification of a 3024 bp PCR product from the wild-type S. oneidensis MR-1 
genome that correlated to amplification of fccA54 and fccB54 (Figure 4.17). This 
PCR result provided evidence that the kanamycin cassette was inserted in the 
genome of S. oneidensis MB5415 at an equivalent position tofccA54 and fccB54 in 
the S. oneidensis MR-i wild-type genome (Figure 4.17). Therefore, this PCR 
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Figure 4.17: PCR screening of S. oneidensis MB5415 
Primers 54gk9 and 54gk10 were used to initiate PCR screening of the S. oneidensis MB5415 genome 
to identify if the kanamycin cassette was inserted in position of the fccA54 and fccB54 genes. The 
products of four PCR samples that differed in the genomic DNA: primer ratio were analysed for S. 
oneidensis MB5415 (lanes 2-5) and wild-type S. oneidensis MR-i (lanes 6-9) using agarose gel 
electrophoresis. PCR amplification of a 2091 bp PCR product from the S. oneidensis MB5415 
genome (lanes 2, 4 and 5) indicated insertion of the kanamycin cassette in place of the fccA54 and 
fccB54 genes. This result was verified by amplification of a 3086 bp PCR product from the wild-type 
S. oneidensis MR-I genome (lanes 6 and 8), corresponding to fccA54 and fccB54. No PCR product 
was amplified for the negative control, pMBGK15 (lane 10). 1 kb DNA ladder was used to indicate 
the size of the PCR amplification products. 
The 2091 bp PCR product of S. oneidensis MB5415 that was amplified using primers 
54gk9 and 54gk10 was inserted in pGEM-T to form plasmid pMBGK41. Sequencing 
of the cloned PCR product was used to confirm that a kanamycin cassette in the 
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4.2.10 Phenotype analyses 
4.2.10.1 Anaerobic growth on acrylate substrates 
The molecular modelling studies led to the identification of acrylates as potential 
enzyme substrates of FccA54, FccA56 and FccA342 (3.2.3; Figure 3.17). The 
candidate substrates, including phenylacrylates were tested for their ability to sustain 
anaerobic growth of wild-type S. oneidensis MR-i. The aim was to identify 
substrates that supported growth of the wild-type strain in order to provide positive 
controls for direct comparison to growth of the S. oneidensis MB5415 mutant on 
each of the acrylates. 
Minimal medium that contains nutrients required for sustaining growth of S. 
oneidensis MR-i but no other components known to function as a carbon source or 
electron acceptor was selected as an ideal growth medium. The anaerobic growth 
patterns noted with addition of lactate and a particular electron acceptor were likely 
to be directly attributed to their specific addition to the minimal medium. Minimal 
medium that was supplemented with amino acids, trace elements and lactate (2.1.8) 
was dispensed into ½ oz bijou jars for anaerobic growth of S. oneidensis MR-i. Each 
of the candidate acrylates serving as the terminal electron acceptor was then added to 
the appropriate individual growth jar at a final concentration of 5.0 mM. The pH of 
the solubilised acrylates was adjusted to a neutral pH prior to supplementing the 
minimal media (pH 7.4) to achieve the native environmental pH (pH 7.5-8.2) that 
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Anaerobic growth of S. oneidensis MR-1 with fumarate as terminal electron acceptor 
was used as a positive indicator of growth. Negative controls in which S. oneidensis 
MR-i was grown in the absence of a carbon source and/or absence of fumarate as 
terminal electron acceptor were also included. Each of the anaerobic growth jars was 
inoculated with an overnight S. oneidensis MR-i culture (200 tl) and incubated at 
room temperature for four weeks. The growth experiments were repeated several 
fold in an attempt to achieve unambiguous results. Colony counts were performed 
(2.1.9) in order to quantify anaerobic growth of S. oneidensis MR-i on the various 
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Electron Acceptor Lactate COLONY COUNT 
(x iø cells mr')  
Carbon 1 2 3 Mean SD 
Source 
Fumarate 
+ 63 300 0 
° 
0 
- 600 0 0 
- + 182 464 39 176.6 
- - 0 0 40 18.9 
Acrylate 
+ 0 0 0 I; 0 
Benzoate 




+ 133 685 800 539.3 291.1 
3-3-indoleacrylate 





+ 1988 2139 0 1375.7 974.7 
Methacrylate 
CH + 473 2100 0 857.7 899.4 
Senecioate 
+ 478 0 670 382.7 281.7 
CH3 0 
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Table 4.1 continued. 
Electron Acceptor Lactate COLONY COUNT 
(x 104  cells ml') 
Carbon 1 2 3 Mean SD 
Source 
Tiglate 
CH3 + 109 2332 0 813.7 1074.5 
Caffeate 




Ci n nam ate 
+ 114 0 20 44.7 49.7 
(o  
Cou ma rate 
+ 39 8 0 1S7 16.8 
0 
Ferulate 
HO + 139 0 0 46.3 65.5 
H3CO 
Table 4.1: Growth of wild-type S. oneidensis MR-I on acrylate electron acceptors 
The colony counts for three individual anaerobic growth experiments (1-3) of wild-type S. oneidensis 
MR-i on twelve different acrylate electron acceptors are shown (white). The colony counts for the 
positive control cultures containing lactate and fumarate are highlighted in grey. Control colony 
counts of S. oneidensis MR-i grown in the absence of an electron acceptor and/or carbon source are 
also tabulated (grey). Acrylate is the only substrate that did not support anaerobic growth of wild-type 
S. oneidensis MR-I. However, growth of S. oneidensis MR-i in the absence of fumarate (+ lactate) 
was similar to the positive control, which strongly suggests that the cultures were not strictly 
anaerobic. Therefore, the colony counts obtained for S. oneidensis MR-1 growth on each of the 
acrylates was not indicative of these substrates serving as the sole terminal electron acceptor due to 
the presence of oxygen. The tabulated colony counts represent x 104 cells ml- ' of culture. The average 
colony count (red) obtained from the three cultures of S. oneidensis MR-i grown on each acrylate and 
the standard deviation (SD) of the colony counts (green) were calculated and are also shown. 
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The anaerobic growth experiments of wild-type S. oneidensis MR-1 cultured in 
minimal media containing the appropriate supplements with addition of a candidate 
electron acceptor did not yield consistent results (Table 4.1). The relatively high 
standard deviation of the colony counts obtained for the anaerobic growth cultures of 
S. oneidensis MR-i clearly show the variability in growth levels. S. oneidensis MR-i 
grew anaerobically in the presence of lactate and fumarate, however, the mean 
colony count obtained for the positive control (121 colonies) was lower compared to 
those cultures containing lactate but no electron acceptor (228.3 colonies). This led 
to the conclusion that some growth cultures were not strictly anaerobic and oxygen 
served as the terminal electron acceptor in the control experiment containing lactate 
only. Although growth on each of the candidate terminal electron acceptors could not 
be attributed to anaerobic survival, growth levels similar to the positive control were 
observed on the following substrates: benzoate, crotonate, 3-3-indoleacrylate, 
mesaconate, methacrylate, senecioate and tiglate. Growth of S. oneidensis MR-i 
occurred in the presence of phenylacrylates but was inhibited compared to growth in 
the presence of lactate and fumarate (positive control). The low growth levels of 
wild-type S. oneidensis MR-i on fumarate may have been due to limiting 
concentrations of the substrate (5 mXVI). A higher concentration of fumarate (20 mM) 
is required to support robust growth of S. oneidensis MR-1 during anaerobic 
respiration (Maier and Myers, 2001). 
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Anaerobic growth of wild-type S. oneidensis MR-1 on a variety of substrates 
revealed that acrylate was the only substrate that consistently inhibited growth. 
Therefore, the anaerobic growth experiments led to the suggestion that benzoate, 
crotonate, 3-3indoleacrylate, mesaconate, methacrylate, senecioate and tiglate and 
possibly cinnamate, coumarate, caffeate and ferulate support anaerobic growth of 
wild-type S. oneidensis MR-1. 
4.2.10.2 Anaerobic growth of S. oneidensis MB5415 
Several of the acrylates identified to support growth of S. oneidensis MR-1 were 
subsequently tested for their ability to support anaerobic growth of the fccA54 and 
jccB54 null mutant, S. oneidensis M135415. An anaerobic growth defect of S. 
oneidensis MB5415 correlated to absence of FccA54 and Fcc1354 could be used to 
infer a possible catalytic function of the putative flavocytochrome in anaerobic 
metabolism of S. oneidensis MR-1. In order to indicate that a growth impairment of 
S. oneidensis MB5415 on a particular acrylate was linked to the absence of FccA54 
and FccB54, the mutant was grown anaerobically in parallel with wild-type S. 
oneidensis MR-1. 
The wild-type S. oneidensis MR-1 and S. oneidensis MB5415 strains were cultured 
in minimal media containing lactate, trace elements, amino acids and electron 
acceptor (2.1.8) dispensed into ½ oz bijou jars. Wild-type S. oneidensis MR-1 grown 
anaerobically in the presence of fumarate (20 mM) as terminal electron acceptor was 
used as a positive indicator of growth. The final concentration of the acrylates was 
also 20 mM, which is significantly higher than the previous concentration (5 mM) 
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Each reaction was set up in duplicate for both strains tested. The growth jars were 
inoculated with the appropriate strain, either with a single colony of the Shewanella 
strain (experiment 1) or 100 jtl of an overnight culture resuspended in minimal media 
(growth experiments 2-5). The growth jars were incubated in a static incubator at 
23 °C for a period of four weeks. Colony counts (2.1.9) were used to quantify and 
compare growth of the wild-type and mutant strains from five individual growth 
experiments (Table 4.2). 
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Table 4.2: Anaerobic growth of S. oneidensis MB5415 and S. oneidensis MR-1 on acrylates 
Colony counts are listed for five individual growth experiments of wild-type S. oneidensis MR-1 
(white) and S. oneidensis MB5415 (grey) grown anaerobically on 8 different acrylate substrates. 
Colony counts for duplicate cultures are shown in the same row. Both strains were grown in parallel in 
minimal media supplemented with lactate and an electron acceptor. Controls included in the 
experiment comprise growth of both strains in the absence of lactate and /or electron acceptor. Growth 
of wild-type S. oneidensis MR-i in the presence of fumarate was used as a positive control of growth. 
The cell counts shown in the table represent x 104 cells ml- '. The average colony count (red) was 
calculated for each of the ten S. oneidensis MB5415 and wild-type S. oneidensis MR-1 cultures grown 
anaerobically on a specific acrylate under the various conditions. The standard deviation of the colony 
counts was also calculated and is shown in green. 
The results obtained from the five anaerobic growth experiments were inconsistent 
between different growth experiments and duplicate cultures of the same experiment. 
The growth variability observed was exemplified by the relatively high standard 
deviation calculated for the colony counts obtained (Table 4.2). The following 
interpretation of the phenotype studies documents the most consistent colony count 
results that have a relatively low standard deviation. The variation in growth levels 
obtained on a particular substrate was probably due to a corresponding variation in 
anaerobic conditions in each individual growth jar. 
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A unique high colony number obtained for growth on a particular substrate was most 
likely due to the presence of oxygen serving as the preferred terminal electron 
acceptor. 
The mean colony counts obtained for the positive control (230.9 colonies) showed 
that wild-type S. oneidensis MR-i grew anaerobically in the presence of lactate and 
fumarate at much higher levels compared to the negative control in which lactate and 
fumarate were absent (15.1 colonies; Table 4.2). Growth of the wild-type strain was 
inhibited in the absence of fumarate (mean, 17.5 colonies) indicating that fumarate 
served as the sole terminal electron acceptor during anaerobic growth of S. 
oneidensis MR-1. Although at lower levels compared to the positive control, the 
wild-type strain grew anaerobically with fumarate in the absence of lactate (mean, 
74.9 colonies; Table 4.2). This led to the suggestion that another factor in the media 
was acting as an alternative carbon source to lactate. Overall, the control results 
obtained for growth of S. oneidensis MR-i on fumarate and/or lactate indicated that 
the cultures were anaerobic and the supplied substrate functioned as the terminal 
electron acceptor. 
The quantitative colony counts of the anaerobic growth experiments revealed that 
S. oneidensis MR-1 grew well in the presence of fumarate as terminal electron 
acceptor during anaerobic respiration (Table 4.2). The level of growth on fumarate 
was further improved with inoculation of cultures with a bacterial suspension 
(experiments 2-5) rather than a single colony (experiment 1; Table 4.2). 
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Anaerobic growth of S. oneidensis MB5415 on lactate and fumarate (mean, 27.7 
colonies) was significantly impaired compared to S. oneidensis MR-i (mean, 230.9 
colonies). 
The colony counts obtained for S. oneidensis MB5415 on lactate and fumarate were 
similar to the negative S. oneidensis MB5415 control cultures in which lactate and/or 
fumarate were eliminated. This showed that the growth inhibition observed on 
fumarate was a true phenotype. This tentatively suggests that fumarate is a possible 
substrate of the flavocytochrome formed by association of FccA54 and FccB54. 
The phenylacrylates, coumarate and caffeate did not sustain anaerobic growth of 
wild-type S. oneidensis MR-i in the presence or absence of lactate. In the absence of 
these phenylacrylates, low, but significant growth levels of S. oneidensis MR-i were 
observed indicating that the substrates were specifically inhibiting growth. This 
result was supported by the low standard deviation calculated for the colony counts 
obtained for these cultures. Coumarate and caffeate also inhibited growth of the S. 
oneidensis MB5415 mutant strain (Table 4.2). These data correlate with the inability 
of the related methacrylate reductase of Geobacter sulfurreducens to catalyse 
reduction of phenylacrylates such as ferulate and caffeate (Mikoulinskaia et al., 
1999). 
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The mean colony counts obtained for wild-type S. oneidensis MR-i grown 
anaerobically in the presence of lactate and one of the following electron acceptors: 
methacrylate (20.2 colonies), benzoate (10 colonies), crotonate (36.4 colonies), 
tiglate (17.8 colonies) and mesaconate (34.6 colonies) was consistently low 
compared to growth in the presence of lactate and fumarate (230.9 colonies). 
The low anaerobic growth levels of wild-type S. oneidensis MR-i on each of the 
aforementioned acrylates were supported by the relatively low standard deviation 
data. Furthermore, the observed colony counts were similar to the control S. 
oneidensis MR-1 cultures grown in the absence of lactate and /or acrylate. Anaerobic 
growth of wild-type S. oneidensis MR-1 on crotonate was greater in the absence 
(mean, 92.8 colonies), rather than the presence of lactate (mean, 36.4 colonies). This 
result leads us to the suggestion that an alternative carbon source favours the terminal 
reduction of crotonate during anaerobic respiration of S. oneidensis MR-1. The mean 
colony counts obtained for anaerobic growth of S. oneidensis MB5415 on 
methacrylate (4.6 colonies), benzoate (0.5 colonies), crotonate (2.0 colonies), tiglate 
(21.9 colonies) and mesaconate (2.2 colonies), revealed low levels of growth, as 
found for wild-type S. oneidensis MR-1. The relatively low standard deviations 
calculated for the S. oneidensis MB5415 colony counts provided supporting data that 
the acrylates did not support growth of the mutant strain. 
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S. oneidensis MR-i did not respire anaerobically in the presence of methacrylate, 
crotonate, benzoate, coumarate, caffeate, tiglate or mesaconate (Table 4.2). This 
growth defect was not due to poor inoculation of the growth jars with S. oneidensis 
MR-i as the bacterium grew well in the presence of fumarate as terminal electron 
acceptor during anaerobic respiration. It is possible that inhibitory concentrations (20 
mM) of each candidate acrylate were used in the growth experiment. It is therefore 
necessary to find the optimal concentration of each acrylate electron acceptor that is 
required to support growth of S. oneidensis MR-1. Further growth experiments are 
also required to obtain strict anaerobic conditions for growth of the wild-type and 
mutant strains on the range of acrylates. This would lead to the generation of 
consistent results where the acrylate is used as the sole terminal electron acceptor in 
the absence of oxygen. It may be possible to eliminate the presence of oxygen in the 
cultures by overlaying with mineral oil to form a tight seal. The exclusion of oxygen 
from the growth cultures could also be achieved by conducting the growth 
experiments in an anaerobic chamber. 
Anaerobic growth experiments of etrA knockout strains (ETRA-153, ETRA1) on 
various electron acceptors showed that the mutations had no significant physiological 
effect on growth compared to wild-type S. oneidensis MR-1 (Maier and Myers, 
2001; Beliaev et al., 2002a). However, partial DNA microarrays were used to show 
that the etrA insertional mutation of ETRA1 had a significant effect on the niRNA 
levels of 69 genes involved in anaerobic metabolism under fumarate and nitrate 
reducing conditions. 
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For example, the fccA fumarate reductase gene encoding flavocytochrome c3 was 
consistently repressed in ETRA1 indicating a role of EtrA in transcriptional 
activation of fccA under both fumarate and nitrate reducing conditions (Beliaev et al., 
2002a). 
DNA microarrays could be used to compare the complete gene transcription profiles 
of S. oneidensis MR-i and S. oneidensis MB5415 under acrylate-reducing conditions 
in order to examine the functional role of FccA54 and FccB54. A relative decrease in 
the mRNA levels of certain S. oneidensis MB5415 genes may indicate that these 
genes are involved in the respiratory pathway towards acrylate reduction catalysed 
by FccA54 and FccB54. It would also be of interest to observe if the fccA54 and 
fccB54 deletion caused an increase in mRNA levels of the related genes, fccA56, 
fccB56, fccA342 and fccB342. An increase in mRNA levels of these related genes 
would indicate that the encoded proteins have a similar role to FccA54 and FccB54 
during anaerobic metabolism. It would also be useful to compare the changes in 
mRNA levels of S. oneidensis MR-i and S. oneidensis MB5415 during the switch 
from aerobic to anaerobic growth conditions to observe which genes are turned on or 
off. 
Two-dimensional polyacrylamide gel electrophoresis (2-D PAGE) could also be used 
to analyse and compare protein expression of S. oneidensis MR-1 and S. oneidensis 
MB5415 under acrylate-reducing conditions. Mass spectrometry and N-terminal 
Edman sequencing could subsequently be used to characterise proteins that 
demonstrated significant changes in expression between the two strains. 
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The protein expression profiles could be used to complement the DNA microarray 
analyses to provide substantial information on the respiratory chain towards acrylate 
reduction. 
DNA microarray and 2-D PAGE analyses have been successfully used to obtain 
mRNA and protein expression profiles, respectively of wild-type S. oneidensis MR-1 
grown aerobically and anaerobically in the presence of fumarate, nitrate and Fe(III). 
It was shown that genes encoding cytochrome c and tricarboxylic acid cycle enzymes 
were repressed under anaerobic conditions. The expression of cymA, zfcA and frdA 
involved in anaerobic respiration, was specifically induced three to eight fold under 
fumarate reducing conditions. Other sets of genes induced during anaerobic 
respiration comprised those involved in cofactor biosynthesis, cofactor assembly and 
substrate transport (Beliaev et al., 2002b). 
4.3 CONCLUSION 
This represents the first report of an S. oneidensis MR-i mutant that lacks the entire 
gene coding sequences of an enzyme implicated in anaerobic respiration. A new 
fusion PCR technique was successfully used to synthesise the homologous template 
DNA sequence for fccA54 and fccB54 gene replacement in S. oneidensis MR-1. This 
method could be used to construct other gene replacements in bacteria of the genus 
Shewanella and indeed other Gram-negative bacteria. The double crossover event is 
reportedly more infrequent than single crossovers and this was found when 
constructing a gene replacement of fccA54 and fccB54 in S. oneidensis MR-i. 
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The occurrence of a double crossover event may be dependent on the sequence of the 
target gene or the homologous template DNA sequence. Some of the 
chioramphenicol sensitive transconjugants, such as S. oneidensis MB5413 were 
identified using PCR to contain the fccA54 and fccB54 genes. The chioramphenicol 
sensitivity of the false positives was attributed to a mutation in the cat gene or 
generation of non-specific homologous recombination. Perhaps increasing the length 
of the homologous template DNA would optimise homologous recombination at the 
correct position in the target genome. Automated DNA sequencing was used to 
confirm that the isolated S. oneidensis MB5415 mutant did indeed contain a 
kanamycin cassette in position of the endogenousfccA54 and fccB54 genes. 
Anaerobic growth experiments of S. oneidensis MB5415 on various acrylates as 
terminal electron acceptor were directly compared to anaerobic growth of S. 
oneidensis MR-i. The fccA54 and fccB54 deletion had no detectable physiological 
effect on anaerobic growth of S. oneidensis MB5415 compared to wild-type. The 
anaerobic growth experiments could be improved by conducting the experiment in an 
anaerobic chamber. The function of FccA54 and FccB54 may be difficult to observe 
using anaerobic growth experiments as the function of the flavocytochrome may 
overlap with the related flavocytochromes. Alternatively, DNA microarrays and 2D-
PAGE could be used to compare mRNA and protein expression profiles, respectively 
of S. oneidensis MR-1 and S. oneidensis MIB5415. These methods could be used to 
identify the genes involved in acrylate reduction catalysed by FccA54 and FccB54 
during anaerobic respiration of S. oneidensis MR-1. 
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5.1 INTRODUCTION 
5.1.1 Putative interaction of flavin and cytochrome subunits 
The fccA54 and fccB54 genes that lie adjacent to one another on the same operon 
encode a putative flavoprotein subunit (FccA54) and a tetrahaem cytochrome c 
subunit (FccB54), respectively (1.8.1). The location of the genes in the same operon 
immediately led us to suggest that the encoded proteins have a common function. It 
was subsequently proposed that the FccA54 flavin-containing catalytic subunit 
associates with the FccB54 cytochrome c subunit to form a functional dimeric 
flavocytochrome. Furthermore, the cytochrome c subunit was proposed to function 
as the physiological electron donor to flavin embedded in the catalytic subunit. These 
conjectures led us to investigate the putative interaction between the flavin and 
cytochrome subunits. The aim was to specifically overexpress and purify FccA54 in 
order to test whether enzyme catalysis is dependent on association with the FccB54 
electron transfer cytochrome subunit. A variety of substituted acrylates were selected 
as potential substrates to study enzyme catalysis of the purified FccA54 flavoprotein 
in order to identify the native substrate. The major objective was to obtain high 
yields of purified FccA54 protein to investigate the protein structure and function by 
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5.1.2 A strategy to overexpress and purify the FccA54 flavoprotein 
The periplasmic methacrylate reductase from Geobacter sufurreducens AM-1 
comprises a flavoprotein subunit that is postulated to associate with a periplasmic 
cytochrome c subunit. The flavoprotein subunit was successfully purified from the 
periplasm as a stable protein in the absence of the associated tetrahaem cytochrome c 
(Mikoulinskaia et at., 1999). The N-terminal sequence similarity observed between 
the methacryl ate reductase and FccA54 led to the supposition that the related FccA54 
protein could also be purified as a stable protein from the periplasm. However, it was 
anticipated that purification of FccA54 from the periplasm of Shewanella species 
might be problematic due to the endogenous expression of similar flavoproteins. 
Therefore, an FccA54 overexpression system was devised to preferentially 
overexpress and purify the FccA54 flavoprotein from an Escherichia coli host. 
Distinct variation in the Tat (twin arginine translocation) pathway machinery of 
Shewanella and E. coli strains might have led to poor recognition of the FccA54 
preprotein signal peptide, impeding subsequent membrane translocation to the 
periplasm of E. coli. Therefore, cytoplasmic overexpression was selected to avoid 
heterogeneous expression of the FccA54 preprotein targeted to the periplasm of a 
foreign host cell. The overexpression system was designed to produce high yields of 
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5.2 RESULTS AND DISCUSSION 
5.2.1 PCR amplification of fccA54 from the S. oneidensis MR-1 genome 
Synthetic oligonucleotide primers, named 54FM and 54RA, were designed to initiate 
PCR amplification of the fccA54 mature coding sequence. The extreme 5'-terminal 
fccA54 coding sequence comprising 87 nucleotides was predicted to encode an N-
terminal Tat signal peptide of 29 amino acid residues in length (Nielsen et al., 1997; 
http://www.cbs.dtu.dk/services/SignalP/). The 5'-end of the 54FM forward primer 
complementary to the maturefccA54 gene coding sequence was designed to begin 88 
nucleotides downstream of the ATG start codon (Figure 5.1). To optimise the PCR 
specificity, the complementary sequence between the 54FM primer and genomic 
DNA template extended over a region of 18 nucleotides. The 54FM primer was 
engineered to contain a 5'-overhang that incorporated an ATG start codon positioned 
at the 5'-end of the complementary fccA54 sequence (Figure 5.1). The 5'-end of the 
54RA reverse primer sequence corresponded to the C-terminal fccA54 TAA stop 
codon. The 16-nucleotide primer sequence of 54RA complementary to fccA54 was 
lengthened to include a 5'-overhang sequence (Figure 5.1). 
193 
Chapter 5 	 Flavoprotein overexpression and purification 
The engineered 5'-overhang sequences of each primer were designed to contain 
restriction endonuclease sites to produce a 1455 bp BamHI/PstI ftcA54 '54FMRA' 
PCR product. Inclusion of restriction sites in the fccA54 54FMRA PCR product 
intended to facilitate direct cloning of the PCR amplified product into the expression 
plasmid. The 54FM primer was designed to contain a BamHI cleavage site (5'-
GGATCC-3') and a PstI cleavage site (5'-CTGCAG-3') was inserted in the 5'-
overhang of primer 54RA. A triplet of extra nucleotides was introduced at the 5'-end 
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Figure 5.1: A schematic diagram to show PCR amplification offccA54 
Primers 54FM and 54RA were designed to amplify the fccA54 gene sequence with exclusion of DNA 
sequence encoding the N-terminal Tat signal peptide. The fccA54 gene was amplified as a 1455 bp 
BamHI/PstI 54FMRA fragment to facilitate cloning into the expression plasmid. The diagram is not to 
scale. 
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The restriction enzymes, BainHI and PstI were convenient for cloning the fccA54 
54FMRA PCR product due to the absence of target sites within the fccA54 gene 
coding sequence. Furthermore, unique cleavage sites for BamHI and PstI occur in 
expression plasmids, pJF118 (Fürste et al., 1986) and pMMB503EH (Overbye 
Michel et al., 1995), selected for overexpression of the flavoproteins. To maximise 
the success of PCR amplification, other standard considerations were met during 
primer design of 54FM and 54RA. The primer sequences were optimised in length 
and nucleotide content to obtain similar melting temperatures. The primer sequences 
complementary to fccA54 did not contain polypurines or polypyrimidines thus 
preventing the formation of internal secondary structure. Complementary 3'-terminal 
sequences of the primer pair were avoided to prevent primer-dimer formation during 
PCR amplification. 
Primers 54FM and 54RA successfully initiated PCR amplification of the fccA54 gene 
sequence from the S. oneidensis MR-i genome. The specific PCR amplification of a 
product corresponding to the size of the fccA54 1455 bp BamHJIPstI fragment 
(Figure 5.1) was observed by agarose gel electrophoresis (Figure 5.2). The quantity 
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Figure 5.2: PCR amplification of fccAS4 mature coding sequence 
The fccA54 sequence encoding mature FccA54 flavoprotein was successfully PCR amplified from the 
S. oneidensis MR-I genome. PCR amplification was analysed by agarose gel electrophoresis that 
showed amplification of a product corresponding to the size of the 1455 bp fccA54 54FMRA 
BamHIJPstI fragment (lane 2). 1 kb DNA ladder shown in lane 1 of the agarose gel indicated 
amplification of a PCR product at the correct size. 
5.2.2 Cloning of the fccA54 54FMRA PCR product in pGEM-T 
The 1455 bpfccA54 PCR product was inserted into pGEM-T (Promega; Figure 5.3), 
a high copy number plasmid (3000 bp) to achieve multiple copies of the PCR 
product. PCR amplification catalysed by Taq thermostable DNA polymerase resulted 
in the non-template dependent addition of a single deoxyadenosine 5'-triphosphate to 
each 3'-end (Clark, 1988) of the fccA54 PCR product. The 3'-adenine base overhangs 
served to ligate the fccA54 PCR product into pGEM-T by complementary base 
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Figure 5.3: Map of pGEM-T (Promega) high copy number cloning plasmid 
The 3' -thymine base overhangs that disrupt the IacZ gene are shown. 
Recombinant pGEM-T plasmid was transformed into E. coli TGI and positive 
transformants were identified using two selection procedures. Firstly, transformants 
were selected for ampicillin resistance encoded on the pGEM-T plasmid. Secondly, 
blue/white colony screening was used to differentiate between transformants 
containing re-ligated pGEM-T and those containing recombinant pGEM-T plasmid. 
A blue colony phenotype is due to the production of 5-bromo-4-chloro-indigo from 
the hydrolysis of X-gal (5-bromo-4-chloro-3-indolyl-/3-D-galactoside) by 
fl-galactosidase. The lacZ gene located in pGEM-T encodes fl-galactosidase that is 
not expressed when lacZ is disrupted by insertion of a PCR product. 
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Seven white colonies indicative of lacZ gene disruption by the fccA54 PCR product 
were randomly selected for further analysis. Plasmid DNA was isolated from the 
selected white colonies, numbered 3-1 to 3-7 and BamHJJPstI double digests were 
performed to verify insertion of the fccA54 PCR product in pGEM-T. Only 2 of the 7 
white colonies, named 3-1 and 3-4 contained recombinant plasmid, as shown by 
excision of a 1455 bp BarnHJJPstI fragment corresponding to the fccA54 PCR 
product (Figure 5.4). Recombinant pGEM-T plasmid containing the fccA54 PCR 
product, isolated from colony 3-4 was named pMB3-4. This plasmid was used for 





Figure 5.4: Cloning of the fccA54 Ba,nHI/PstI PCR product in pGEM-T 
Recombinant pGEM-T plasmid DNA isolated from ampicillin resistant white colonies, 3-1 (lane 2) 
and 3-4 (lane 4) was analysed by agarose gel electrophoresis. Recombinant plasmid from colonies 3-1 
and 3-4 was identified by the release of a 1455 bp fccA54 54FMIRA fragment upon double digestion 
with BamHI and PstI (lanes 3 and 5, respectively). 1 kb DNA ladder was loaded in lane 1 of the 
agarose gel to show that the restriction fragments were of the correct size. 
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5.2.3 Sequencing the fccA54 54FMRA PCR product of pMB3-4 
The fccA54 54FMRA PCR product was sequenced to check for possible mutations 
incorporated by the relatively low fidelity Taq DNA polymerase. Single-stranded 
DNA template was prepared from pMB3-4 and sequencing primers, 54P1, 54P2, 
54P3 and 54P5 were designed to provide overlapping sequencing data of ftcA54. 
Despite the lack of 3'-5'-exonuclease proofreading activity by Taq DNA polymerase, 
the fccA54 sequence of pMB3-4 was correctly PCR amplified, as confirmed by 
automated sequencing. Comparison of the fccA54 sequencing data to the fccA54 
sequence obtained from 'The Institute for Genomic Research' (TIGR; 
http://www.tigr.org) was used to confirm that the conserved proline residue in the 
fumarate reductase family (Pro366; Fcc3 of S. frigidimarina NCIMB 400; Pealing et 
al., 1992) is indeed substituted with histidine in FccA54 (Figure 3.4; 3.2.1). 
5.2.4 Cloning of the fccA54 54FMRA PCR product in pMMB503EH 
In the event that overexpression of FccA54 in E. coli was not achieved, a 
recombinant expression plasmid was constructed to suit FccA54 overexpression in a 
Shewanella strain. The fccA54 54FMRA PCR product was transferred into the broad 
host range plasmid, pMMB503EH (Overbye Michel et al., 1995; Figure 5.5) to 
obtain a suitable construct for cytoplasmic overexpression in a Shewanella strain. 
The fccA54 54FMRA PCR product was cut from pMIB3-4 as a BamHTIPstI 1455 bp 
fragment and ligated to complementary ends of pEX129 (Atanasiu, 2001) generated 
by digestion with BamHI and PstI. The recombinant plasmid was transformed into E. 
coli DH5a and positive transformants were screened for streptomycin resistance 
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Figure 5.5: Construction of a plasmid for FccA54 overexpression in She wanella species 
The parent pMMB503EH plasmid (Overbye Michel et at., 1995) is shown. 
The fccA54 gene from pMB3-4 was inserted in recombinant pMMB503EH expression plasmid 
pEXI29 (Atanasiu, 2001), as a Ba,nHI/PstI fragment to form pMB3-4-2. The position of the Ba,nHI, 
PstI and EcoRI cloning sites are shown. 
There were no colonies present on the 'cells only' control indicating reliable 
streptomycin selection. The absence of colonies on the 'vector only' control strongly 
suggested that the two streptomycin resistant transformants contained recombinant 
plasmid. Plasmid DNA was isolated from both colonies and digestion with BamHI 
and PstI released a 1455 bp fragment corresponding to fccA54 (not shown). 
Recombinant pMMB503EH containing fccA54 was named plasmid pMB3-4-2 
(Figure 5.5). This plasmid DNA was subsequently used to generate an expression 
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5.2.5 Cloning of the fccA5454FMRA PCR product in pJF1 18 
To achieve overexpression of the FccA54 flavoprotein subunit in E. coli, the fccA54 
54FMRA PCR product was introduced into pJF1 18 (5267 bp), an 
isopropyithiogalactoside (IPTG) inducible E. coli expression plasmid (Figure 5.6; 
FUrste et al., 1986). The multiple cloning site of pJF1 18 contains an EcoRI cleavage 
site (5'-GAATTC-3') located 5 bp downstream of the plasmid ribosome-binding site 
(5'AGGA-3'). To maximise protein overexpression levels, the ATG start codon of a 
cloned gene should ideally map within 13 nucleotides from a ribosome-binding site, 
reportedly at an optimal distance of 9 nucleotides (Wood et al., 1984a). Therefore, 
the location of EcoRI as the first cleavage site closest to the ribosome-binding site 
makes pJF1 18 convenient for protein overexpression from a gene coding sequence 
cloned as an EcoRI fragment. The BamHI cleavage site of pJF1I8 maps 15 bp 
downstream of the plasmid ribosome-binding site. Therefore, cloning of fccA54, as a 
BamHI/PstI fragment in pJF1 I8 would have unfavourably positioned the fccA54 
ATG start codon 21 bp from the ribosome-binding site. The endogenous ribosome-
binding site upstream of fccA54 in the genome was not PCR amplified; therefore, 
overexpression of FccA54 was dependent on the plasmid-borne ribosome-binding 
site. In order to construct an ideal plasmid for overexpression of FccA54 in E. coli, 
the pJF1 18 plasmid DNA sequence was altered to contain a BainHI cleavage site as 
the first cloning site adjacent to the ribosome-binding site. 
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An experimental procedure involving modifying enzymes was designed to alter the 
multiple cloning site of pJF118. This technique involved digesting recombinant 
pJF1 18 plasmid with EcoRI and removing the single-stranded DNA overhang in a 
reaction catalysed by mung bean nuclease. The intention was to create a blunt end 
containing the remaining EcoRI 5'-guanine base. The recombinant pJF118 plasmid 
DNA was subsequently digested with BaniHI to generate a 5'-overhang that was end-
filled in a reaction catalysed by the Klenow fragment of DNA polymerase I. This 
step was designed to form a blunt end comprising the sequence, 5'-GATCC-3'. The 
two modified blunt ends when re-ligated were designed to form a BainHI cleavage 
site (5'-GGATCC-3') located 5 bp downstream of the pJF118 plasmid ribosome-
binding site. 
It was identified that insertion of fccA54 in pJFI 18 as a BamHJJPstI fragment would 
form a recombinant plasmid containing the fccA54 N-terminal BamHI site 5 bp 
downstream from the EcoRI site. This short distance between cleavage sites may 
have prevented digestion with EcoRI and BamHI in consecutive reactions. To avoid 
this potential problem, the fccA54 gene was inserted in pJF1 18 as an EcoRIIPstI 
1476 bp fragment excised from pMB3-4-2 (Figure 5.5). This introduced 15 
nucleotides of the pMB3-4-2 multiple cloning site upstream of the fccA54 BamHI 
site in order to lengthen the region between EcoRI and BamHI in pJF1 18 (Figure 
5.6). Recombinant pJF118 plasmid containing fccA54 was transformed into E. coli 
TG1 and positive transformants were firstly selected for ampicillin resistance 
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However, ampicillin selection on the plates was poor, as indicated by the appearance 
of 9 colonies on the 'cells only' control. There were approximately 100 colonies on 
the 'vector only' control plate, which were possibly due to the low ampicillin 
selection but did suggest a high probability of re-ligated vector for cells transformed 
with 'vector and insert' DNA. Compared to the 'vector only' background colony 
count, approximately 150 colonies grew from cells transformed with 'vector and 
insert' DNA. Following antibiotic selection, plasmid DNA was extracted from 16 
putative ampicillin resistant colonies. Recombinant pJF118 plasmid containing 
tcA54 was identified for 1 in 16 of the screened colonies, as shown by digestion 
with EcoRI and PstI and release of a 1476 bp fragment corresponding to fccA54 
(Figure 5.7). The recombinant pJF1 18 plasmid containing fccA54 as an EcoRIIPstI 
1476 bp fragment was referred to as pMB1 (Figure 5.6). 
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Figure 5.6: Construction of a modified pJFII8 plasmid for FccA54 overexpression in E. coil 
The fccA54 54FMRA PCR product cloned in pMB3-4-2 was transferred as an EcoRl/Pstl fragment 
into pJFI 18 (Furste et al., 1986) (A) to generate pMBI (B). This plasmid was modified using fusion 
PCR to form pMB2 that contained the N-terminal fccA54 BamHI site adjacent to the ribosome-
binding site (C). The deletion in the fccA54 gene was corrected to form pMB3 (D). A red crossed 
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Figure 5.7: Cloning of fccA54 in pJF118 E. coli expression plasmid 
The fccA54 54FMRA PCR product was transferred from pMB3-4-2 to pJFI 18 as a 1476 bp 
EcoRIIPstI fragment to form pMBI. An EcoRIIPstI double digest (lanes 3 and 4) of pMB1 plasmid 
DNA (lane 2) released a 1476 bp fragment corresponding to the size of fccA54. This result verified 
that pMBI plasmid DNA (lane 2) was recombinant pJFI18 plasmid containing fccA54. The results of 
the digests were analysed by agarose gel electrophoresis and 1kb DNA ladder (lane 1) was used to 
indicate the restriction fragments were of the correct size. 
Plasmid DNA modification of pMB1 to obtain the N-terminal fccA54 BamHl site 
5 bp from the plasmid ribosome-binding site was not achieved using modifying 
enzymes. This was attributed to the hyperactivity of mung bean nuclease that 
consistently degraded the pMIBl plasmid DNA under various conditions. An 
alternative approach to pMB1 plasmid DNA modification was implemented that 
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5.2.6 Modification of pMB1 expression plasmid by fusion PCR 
The ATG start codon of the fccA54 gene inserted in pMB 1 as an EcoRJIPstI 1476 bp 
fragment was positioned 32 nucleotides from the ribosome-binding site. Fusion PCR 
was designed to amplify an 'FccA54 overexpression fragment' that contained the 
fccA54 N-terminal BainHI site 5 bp downstream of the plasmid ribosome-binding 
site. Substitution of the EcoRI site with BamHI intended to concomitantly position 
the fccA54 start codon 11 nucleotides from the plasmid ribosome-binding site. The 
FccA54 overexpression fragment was PCR amplified to incorporate internal 
restriction cleavage sites that facilitated insertion of the fragment in pMB1. A new 
expression plasmid was formed that contained the FccA54 overexpression fragment 
specialised for obtaining maximal FccA54 overexpression levels. 
5.2.6.1 Primer design and fusion PCR amplification 
The FccA54 overexpression fragment was a chimeric sequence generated from 
fusion of parent pJFi 18 DNA and recombinant pMB 1 plasmid DNA sequences. The 
primers distal to the point of plasmid sequence modification, namely, 54JF3 and 
54JF4 were designed to initiate amplification of a 1396 bp fusion PCR product. The 
5'-end of the forward primer 54JF4 was located in the pJF118 lact gene and 
precisely mapped to 779 bp upstream of the ribosome-binding site. The 3'-end of 
primer 54JF4 was positioned 34 bp from an integral MluI site (5'-ACGCGT-3') 
selected for cloning the fusion PCR product (Figure 5.8). The reverse distal primer 
54JF3 was designed to complement fccA54 54FMRA insert DNA of pMB I. The 5'-
end of 54JF3 was positioned 604 bp downstream of the integrated ATG start codon 
of JccA54. 
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The 3'-end of 541F3 was positioned 14 bp from a cleavage site specific to Bg1H, a 
restriction enzyme convenient for cloning the fusion PCR product (Figure 5.8). The 
restriction enzymes, BglII and MluI were ideally suited for cloning the fusion PCR 
product due to the absence of target sites within the fccA54 gene coding sequence 
and presence of unique sites in pJF1 18. 
The central primers, 54JF1 and 54JF2 were designed to contain the desired plasmid 
DNA sequence in which the fccA54 N-terminal BarnHI site lies adjacent to the 
ribosome-binding site. This effectively positioned the fccA54 ATG start codon 11 
nucleotides from the ribosome-binding site. The central forward primer 54JF1 was 
complementary to pMB 1 plasmid DNA and extended over a region of 17 bp 
comprising the BainHI site and the N-terminal nucleotides of fccA54. A 5'-overhang 
sequence of 54JF1 introduced the ribosome-binding site of the plasmid next to the 
BamHI cleavage site (Figure 5.8). The reverse central primer 54JF2 was 
complementary to 15 nucleotides of pJF118 plasmid DNA that included the 
ribosome-binding site of the plasmid. A 5'-overhang sequence of 54JF2 incorporated 
the BarnHI site next to the ribosome-binding site (Figure 5.8). The central primers 
were designed to be complementary over 16 nucleotides spanning the critical region 
of modified plasmid DNA. The primary fusion PCR products annealed to one 
another to provide template DNA sequence for the final fusion PCR step in which a 
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Figure 5.8: A schematic diagram of the fusion PCR procedure 
The three PCR steps of fusion PCR are shown for synthesis of an FccA54 overexpression fragment. 
Arrows indicate the primer positions and direction of synthesis. In the final fusion PCR (C), the 
modified pMBI product (A) was fused to the modified pJF1 18 product (B) to form the FccA54 
overexpression fragment (C). The diagram is not to scale. 
Primers 54JF1 and 54JF3 were used to successfully PCR amplify a fragment from 
pMB1 plasmid DNA (Figure 5.9). The amplified PCR product was 617 bp in length 
(Figure 5.9) and contained the fccA54 N-terminal BamHI site contiguous to the 
ribosome-binding site (Figure 5.8). PCR reactions differed in the DNA: primer ratio 
and NH4C1 was added to reaction 2. There was no variation in the quantity of product 
amplified in the presence or absence of the NH4C1 adjunct. For both reactions, a 
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Figure 5.9: PCR amplification of modified pMB1 plasmid DNA 
As shown by agarose gel electrophoresis, primers 54JF1 and 54JF3 specifically amplified a 617 bp 
PCR product from pMB 1 plasmid DNA (lanes 2 and 3). This PCR product corresponded to fccA54 
54FMRA insert DNA containing an N-terminal BamHI site 5 bp from the ribosome-binding site. 
Reactions 1 and 2 (lanes 2 and 3, respectively) differed in the ratio of DNA: primer with the addition 
of NH4C1 to reaction 2. The variation in reaction components did not alter the product yield, 
approximately 0.045 ltg DNA was amplified for both reactions. I kb DNA ladder was loaded in lane I 
to indicate amplification of PCR product at the expected size. 
Primers 54JF2 and 54JF4 initiated amplification of a 795 bp pJF1 18 plasmid DNA 
fragment that included the integral ribosome-binding site (Figure 5.10). The pJF1I8 
template DNA was modified to produce a PCR product that contained the fccA54 
ATG start codon and the N-terminal BainHI site adjacent to the ribosome-binding 
site (Figure 5.8). A PCR product at the expected size of 795 bp was amplified for 
both reactions that differed only in the addition of NH4C1 to reaction 2. There was no 
change in the quantity of product by addition of NH4CI. A high concentration of 
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Figure 5.10: PCR amplification of modified pJF118 plasmid DNA 
Primers 54JF2 and 54JF4 specifically initiated PCR amplification of a 795 bp fragment from pJFI 18 
plasmid DNA, as shown by agarose gel electrophoresis (lanes 2 and 3). This PCR product 
corresponded to pJFII8 plasmid DNA manipulated to contain the fccA54 start codon and the N-
terminal BwnHI site juxtaposed with the plasmid ribosome-binding site. Reactions 1 and 2 (lanes 2 
and 3, respectively) differed in the DNA: primer ratio and addition of NH4C1 to reaction 2. The 
quantity of PCR product amplified for both reactions was similar at approximately 0.05 g DNA. 1 kb 
DNA ladder was loaded in lane 1 of the agarose gel to indicate that the amplified PCR product was of 
the expected size. 
The primary amplification PCR products provided template DNA for fusion PCR to 
generate an FccA54 overexpression fragment (Figure 5.8). The distal primers 54JF3 
and 54JF4 successfully initiated PCR amplification of a 1396 bp FccA54 
overexpression fragment (Figure 5.11). This PCR product contained the ribosome-
binding site of pJF1 18 fused to the BamHI site at the N-terminus of fccA54 from 
pMB1 (Figure 5.8). Six reactions were performed that differed in the DNA: primer 
ratio and NH4CI addition to reactions 2, 4 and 6 (Figure 5.11). A PCR product at the 
expected size of 1396 bp was amplified for all reactions at approximately 0.06 tg 
DNA. However, secondary PCR products were amplified in addition to the desired 
product (Figure 5.11). The range of fusion PCR amplification products was probably 
due to insufficient stabilisation of the two complementary primary PCR products as a 
single DNA template. 
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PCR sample 1 was run on a preparative agarose gel and the desired band 
corresponding to the FccA54 overexpression fragment was excised and purified to 
high quantity at approximately 0.05 tg DNA. 
1636 bp 1396 hp fusion PCR 
l 	product 
Figure 5.11: Fusion PCR amplification of the FccA54 overexpression fragment 
The distal primers 54JF3 and 54JF4 successfully initiated PCR amplification of the 1396 bp fusion 
PCR product from the primary amplification template DNA, as shown by agarose gel electrophoresis 
(lanes 2-7). The FccA54 overexpression fragment was a contiguous sequence that contained the 
fccA54 sequence and the N-terminal BarnFII site from pMBI adjacent to the pJF1I8 ribosome-binding 
site. Six reactions were performed that varied in the DNA: primer ratio and the addition of NH4CI to 
reactions 2, 4 and 6 (lanes 3, 5 and 7, respectively). A similar quantity of the 1396 bp fragment was 
amplified for all six reactions at approximately 0.06 jtg DNA. In addition to the desired fragment, 
several other non-specific PCR products were amplified. 1 kb DNA ladder in lane I was used to 
indicate that the desired fragment was amplified at the expected size. 
5.2.6.2 Sequencing of the FccA54 overexpression fragment 
The FccA54 overexpression fragment was inserted into pGEM-T (Figure 5.3) to 
provide multiple copies of the fragment and to obtain sequencing information. The 
fusion PCR product was amplified using Taq DNA polymerase and was therefore 
inserted in pGEM-T by ligation of the complementary single base overhangs, as 
previously described (5.2.2). The recombinant plasmid was transformed into E. coli 
TG1 and positive transformants were selected using blue/white colony screening and 
ampicillin resistance. No colonies were apparent on the 'cells only' control 
indicating antibiotic selection of transformants. 
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A lawn of colonies was apparent for cells transformed with 'vector and insert' DNA. 
Plasmid DNA was prepared from five ampicillin resistant white colonies. In order to 
identify colonies transformed with recombinant plasmid, double Bg1IJIM1uI 
restriction digests were performed to release the 1396 bp fusion PCR product. 
Colonies numbered 1, 2 and 4 were shown to contain recombinant pGEM-T plasmid 
DNA, as shown by release of the BglIIJMluI FccA54 overexpression fragment at 
1396 bp (Figure 5.12). Colony 3 was shown to contain re-ligated pGEM-T only and 
plasmid DNA isolated from colony 5 contained a BglIJIMluI fragment at a lower 
molecular weight than expected. This erroneous insert DNA most probably 





1018 bp 1396 bp fragment 
Figure 5.12: Cloning of the fusion PCR product in pGEM-T 
Five ampicillin resistant white colonies were screened for insertion of the 1396 bp fusion PCR product 
(lane 2) in pGEM-T plasmid. Recombinant plasmid was isolated from colonies 1, 2 and 4 as verified 
by double BgIIL/MiuI digestion and release of a 1396 bp fragment corresponding to the fusion PCR 
product (lanes 3, 4 and 6, respectively). Plasmid DNA isolated from colony 3 was shown to be re-
ligated plasmid (lane 5). Double BgIIIIMluI digestion of plasmid DNA isolated from colony 5 released 
an erroneous fragment that did not correspond to the fusion PCR product (lane 7). 1 kb DNA ladder 
(lane 1) was used to indicate the size of the restriction fragments. 
212 
Chapter 	 Flavoprotein overexpression and purification 
Recombinant pGEM-T plasmid extracted from colony 2 was used as template DNA 
for sequencing the fusion PCR product. An MluI restriction digest of plasmid DNA 
was used to determine the orientation of insert DNA in pGEM-T. A unique MluI 
cleavage site occurs at position 99 of the pGEM-T multiple cloning sequence 
downstream of the insert DNA. The reverse orientation of insert DNA in pGEM-T 
was clearly shown by the production of one MluI digest product at 4396 bp 
indicating that the 5'-MluI site of the insert DNA was proximal to the downstream 
MluI site of the plasmid. The forward orientation would have potentially separated 
the two MluI sites over a distance of 1486 bp generating two MluI digest products at 
1486 bp and 2910 bp. 
The reverse primer 54RP4 complementary tofccA54 was used to sequence across the 
modified junction of the FccA54 overexpression fragment. Interpretation of the 
automated sequencing result confirmed that fusion PCR had successfully omitted 
EcoRI and replaced this cleavage site with the fccA54 N-terminal BamHI site. The 
ATG start codon of fccA54 was shown to map 11 nucleotides from the ribosome-
binding site. Therefore, the FccA54 overexpression fragment amplified by fusion 
PCR contained the desired sequence for FccA54 overexpression. However, upon 
closer inspection of the sequencing result, a secondary mutation introduced by Taq 
DNA polymerase was identified. A single 5'-adenine base was deleted 6 nucleotides 
downstream of the fccA54 ATG start codon causing a frameshift in the fccA54 gene 
coding sequence. 
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Primers 54JF5 and 54JF6 were designed to complement pJF1 18 plasmid DNA in 
order to scan the fusion PCR product for secondary mutations upstream of the 
ribosome-binding site. The FccA54 overexpression fragment was completely 
sequenced and was found to also contain a single base mutation in the lac repressor 
gene lact'. A 5'-guanine base 140 bp downstream of the 1acf start codon substituted 
a 5'-adenine base. It was inferred that the mutated sequence led to the conversion of 
11e48 to Thr48 in the lac repressor protein. Residue 48 was identified in a loop of the 
repressor protein that projected away from the protein-DNA interface. Therefore, 
mutation of this residue was not expected to interfere with repressor function and so 
the single base substitution in the lacf gene was not corrected. Sequencing of the 
fusion PCR construct identified a mutation in pJF1 18 that was not reported in the 
literature. The mutation consisted of a 4 bp insertion, 5'-GATG-3', located 32 
nucleotides upstream of the remaining BainHI site used in construction of pJF1 18 
(FUrste et al., 1986). Sequencing of the parent pJF1 18 plasmid was used to validate 





Flavoprotein overexpression and purification 
5.2.6.3 Cloning of the FccA54 overexpression fragment 
The sequenced FccA54 overexpression fragment was introduced into plasmid pMB 1 
to form a modified pJF1 18 expression plasmid ideally suited to FccA54 
overexpression. The FccA54 overexpression fragment was released from pGEM-T 
plasmid as an MluIJBglII 1396 bp fragment. The recombinant pJF118 plasmid, 
pMB1 was digested with MluI and BglII to excise the equivalent region that 
contained the original pJF1 18 plasmid sequence. The MluI and BglII staggered ends 
of the FccA54 overexpression fragment were ligated to complementary ends of 
pMB1 to generate the new recombinant pJFI 18 expression plasmid. The modified 
plasmid was transformed into E. coli TG1 and positive transformants were selected 
on the basis of ampicillin resistance. The absence of colonies on the 'cells only' 
control indicated that the ampicillin resistance was implemented. The absence of 
colonies on the 'vector only' control indicated a low probability of re-ligated vector 
for the 100 ampicillin resistant colonies transformed with 'vector and insert' DNA. 
Three ampicillin resistant colonies were randomly selected and putative recombinant 
plasmid DNA was isolated for further screening. Recombinant plasmid DNA isolated 
from the selected colonies was shown to contain the FccA54 overexpression 
fragment. 
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An MiuJJBglII double restriction digest of plasmid DNA released an M1uL/B gill 
product corresponding to the 1396 bp FccA54 overexpression fragment (Figure 
5.13). Further restriction digests were performed to ensure that the fccA54 gene 
coding sequence was recreated by efficient ligation at the internal BglII cleavage site. 
BarnHI/PstI double restriction digests of modified plasmid DNA excised a fragment 
corresponding to the 1455 bp fccA54 BamHL/PstI fragment (Figure 5.13). Therefore, 
the reconstructed recombinant plasmid was shown to contain the complete fccA54 
gene coding sequence. The results generated by restriction digests of plasmid DNA 
(Figure 5.13) were used to verify formation of a recombinant pJFI18 expression 
plasmid that contained the fccA54 start codon 11 nucleotides from the ribosome-
binding site. This modified expression plasmid containing the frcA54 54FMRA 
BainHJJPstI construct was referred to as pMB2 (Figure 5.6). 
Figure 5.13: Cloning of the FccA54 overexpression fragment in pMB1 
Plasmid DNA isolated from 3 ampicillin resistant colonies was screened for insertion of the FccA54 
overexpression fragment. Double M1uJJBgIII restriction digests of plasmid DNA from colonies 1-3 
released a product corresponding to the 1396 bp FccA54 overexpression fragment (lanes 6-8, 
respectively). Double Ba,nHJJPstI restriction digests were performed to ensure that the fccA54 gene 
sequence was recreated upon insertion of the FccA54 overexpression fragment. The BainHIJPstI 
restriction digests of plasmid DNA from colonies 1-3 released a product corresponding to the 1455 bp 
BainHL'PstIfccA54 construct (lanes 2-4, respectively). 1 kb DNA ladder in lane 1 was used to indicate 
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52.6.4 Formation of the FccA54 overexpression plasmid 
The modified recombinant plasmid pMB2 contained an fccA54 mutated coding 
sequence (Figure 5.6). This mutation was corrected to form a modified recombinant 
expression plasmid suitable for FccA54 overexpression. The mutated fccA54 
sequence comprising a base pair deletion was removed from pMB2 as a 1455 bp 
BarnHJIPstI fragment. The remaining BamHI and PstI sticky ends of pMB2 plasmid 
DNA were ligated to complementary ends of a correctly amplified fccA54 sequence 
derived from pMB1. The recombinant modified plasmid containing the correct 
sequence of fccA54 was transformed into E. coli TG1 and positive transformants 
were selected for ampicillin resistance. A successful transformation was indicated by 
the absence of colonies on the 'cells only' control and the 'vector only' control. A 
lawn of ampicillin resistant colonies was produced from cells transformed with 
'vector and insert' DNA. Plasmid DNA was prepared from two ampicillin resistant 
colonies and BainHIJPstI double restriction digests were used to confirm fccA54 
insertion. A 1455 bp product corresponding to fccA54 was released from plasmid 
DNA upon digestion with BamHI and PstI (Figure 5.14). Therefore, the accurate 
fccA54 sequence was inserted in the modified pJF1 18 expression plasmid. This 
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1636 bp fccA54 54FMRA 
insert DNA 
Figure 5.14: Correction of the fccA54 mutated sequence in pMB2 
The correct sequence of fccA54 was transferred as a 1455 bp Ba,nHL'PstI fragment from pMB1 to 
pMB2. Two ampicillin resistant colonies were selected and putative recombinant plasmid DNA was 
isolated. Double BamHIIPstI restriction digests were performed to show insertion of the correct 
fccA54 54FMRA BantHI/PstI fragment in pMB2 to form pMB3. A 1455 bp fragment corresponding 
to fccA54 was released from plasmid DNA isolated from colonies I and 2, as shown by agarose gel 
electrophoresis (lanes 3 and 5, respectively). 1 kb DNA ladder shown in lane 1 indicated that the 
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5.2.7 Cytoplasmic overexpression of FccA54 in E. coil TG1 
The recombinant pMB3 plasmid transformed in E. coli TG1 was induced with IPTG 
to obtain high levels of FccA54 overexpressed protein. A time course experiment 
was used to identify the optimal duration of induction for FccA54 overexpression in 
E. coli TGI. Recombinant E. coli TG1 containing pMB3 was induced with IPTG and 
grown for a period of 2 hours, 4 hours and 16 hours. A sample was also extracted 
immediately after IPTG induction and was referred to as '0 hours'. Control cultures 
of non-recombinant E. coli TG1 and uninduced recombinant E. coli TGI were grown 
in parallel and the results were analysed by SDS-PAGE (Figure 5.15). 
An overexpressed protein was identified for recombinant E. coli TG1 that was 
clearly absent in the non-recombinant E. coli TG1 control. However, the molecular 
weight of the overexpressed protein was approximately 45 kDa (Figure 5.15), 
inconsistent with the predicted mass of the FccA54 holoenzyme at 53,025 Da 
(52,178 Da for apoenzyme and 847 Da for FAD). Therefore, the overexpressed 
protein in recombinant E. coli TG1 was tentatively linked to FccA54. 
To monitor IPTG induction, uninduced recombinant E. coli TG1 controls were 
included in the time course experiment. The putative FccA54 protein was 
overexpressed in the uninduced controls, indicating that the flavoprotein was non 
IPTG-inducible (Figure 5.15). The ineffective regulation of protein overexpression 
was presumably caused by the lacf mutation in pMB3 (5.2.6.2) that severely 
affected activity of the lac repressor protein. 
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The time course experiment showed maximal overexpression of a non IPTG-
inducible protein from recombinant E. coli TG1 cultures grown over a period of 16 
hours (Figure 5.15). 
Duration of Induction 
Figure 5.15: Time course of FccA54 overexpression in E. coli TG1 
A time course experiment was used to identify the optimal duration of IPTG induction for FccA54 
overexpression. Recombinant E. coli TG1 containing pMB3 was induced with 1 MM IPTG and grown 
for a period of 0 hours, 2 hours, 4 hours and 16 hours. For each time slot, non-recombinant E. coli 
TG1 (a) and uninduced recombinant E. coli TG1 (b) were grown in parallel with IPTG induced 
recombinant E. coli TG1 (c). Samples from each stage were analysed by SDS-PAGE. A high yield of 
putative overexpressed FccA54 protein was produced when recombinant E. coli TG1 cells were 
grown for 16 hours. Molecular weight marker (M) was loaded in lane 1 to accurately determine the 
size of the putative overexpressed FccA54 protein. 
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Recombinant E. coli TG1 samples induced with IPTG and grown for 16 hours were 
analysed using a 4-12 % precast SDS-PAGE gel (Figure 5.16). The migration of the 
putative overexpressed FccA54 protein corresponded to a 49 kDa protein, closer to 
the expected size of FccA54 at 53, 025 Da. The observed size discrepancy of the 
putative overexpressed FccA54 protein was therefore consistent with a migration 
anomaly on SDS-PAGE. This strongly suggested that the overexpressed protein from 
E. coli TG1 did correspond to the FccA54 flavoprotein. Furthermore, the 
overexpressed protein was detected in samples of cell free extract, confirming the 





Figure 5.16: FccA54 flavoprotein is located in the soluble cell fraction 
The putative overexpressed FccA54 protein appears to have a migration anomaly on SDS-PAGE. The 
protein migrated to approximately 49 kDa on a precast SDS-PAGE gel, closer to the predicted 
molecular weight of 53 kDa. Whole cell fractions of recombinant E. coli TG1, resuspended in 10 mM 
CAPS buffer, pH 10.5 and 10 mM Tris buffer, pH 7.5 are shown in lanes 1 and 3, respectively, of the 
4-12 % agarose gel. FccA54 was also detected in the soluble cell fraction of recombinant E. coli TG1. 
Cell free extract isolated from recombinant E. coli TGI, resuspended in 10 mM CAPS buffer, pH 10.5 
and 10 mM Tris buffer, pH 7.5 is shown in lanes 2 and 4, respectively, of the precast gel. Molecular 
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To ascertain that the 49 kDa overexpressed protein was FccA54 that displayed a 
migration anomaly on SDS-PAGE; the molecular mass of the protein was 
determined by electrospray mass spectrometry. The cell free extract of recombinant 
E. coli TG1 in 10 mM Tris buffer pH 7.5 (Figure 5.16) was used as the sample for 
determining the total mass of the overexpressed protein. The nominal molecular 
mass of FccA54 was determined using mass spectrometry to be 52550.0 Da, close to 
the predicted mass of 53,025 Da (52,178 Da for apoenzyme and 847 Da for FAD; 
Figure 5.17). This result provided substantial evidence that the overexpressed protein 
analysed by SDS-PAGE was indeed FccA54. 
Figure 5.17: Mass spectrometry of FccA54 
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5.2.8 FccA54 protein purification 
The recombinant E. coli TG1 growth conditions that produced high yields of 
overexpressed FccA54 were used to obtain purified FccA54 flavoprotein. The 
FccA54 protein with an estimated isoelectric point (p1) of 8.34 
(http://www.expasy.org/tools/protparam.html) was purified using a Q Sepharose 
anion exchanger equilibrated with 10 mM Tris buffer at pH 8.0. The FccA54 protein 
was purified from the soluble fraction of recombinant E. coli TG1 cells resuspended 
in 10 mM Tris buffer at pH 8.0. A NaCl salt gradient was used to elute protein bound 
to the strong anion-exchange column. 
Column fractions Al-Cl contained protein that did not bind to the positively charged 
matrix of the column. This was consistent with the slightly positive charge of the 
FccA54 protein at pH 8.0. Column fractions C2-H8 contained protein with a net 
negative charge that bound to the column and were eluted during the NaCl gradient. 
The concentration of proteins in the individual fractions was measured by UV 
absorption at 280 nm (Figure 5.18a and 5.18b). The yellow fractions indicative of 
flavin-containing proteins were selected for further analyses using 4-12 % precast 
SDS-PAGE gels. Purified FccA54 that did not bind to the column at pH 8.0 was 
produced in fractions Al2 to B4. The quantity of purified FccA54 protein in these 
eluted fractions was lower compared to column fractions CIO and Cli (Figures 
5.19a and 5.19b). The fractions CIO and CI  contained purified FccA54 protein that 
bound to the column and was eluted during the NaC1 gradient at approximately 15 % 
NaCl. A high concentration of FccA54 suitable for crystallisation was obtained from 









Figure 5.18a: UV absorption spectra of FccA54 column fractions 
The blue line represents the UV-visible absorption spectra for fractions eluted from the Q Sepharose 
column before the NaCl gradient. The fraction numbers are shown in red. Yellow fractions All, Al2 
and Bl-B5 were analysed using SDS-PAGE. 
Figure 5.18b: UV absorption spectra of FccA54 column fractions 
The UV-visible absorption spectra (blue line) for fractions collected during the NaCl salt gradient 
(green line) is shown. '% B' represents the concentration of 10 mM Tris buffer pH 8.0 containing IM 
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Figure 5.19a: FccA54 protein purification 
FccA54 was purified from the soluble cell free extract of recombinant E. coli TGI using a Q 
Sepharose column at pH 8.0. Fractions All, Al2 and BI-B4 collected from the flow through of the 
column were analysed by SDS-PAGE (lanes 2-7, respectively). Purified FccA54 was apparent in 
fractions Bl-B4. A sample of cell free extract was loaded in lane 1 of the SDS-PAGE gel to indicate 
the overexpressed FccA54 protein. A standard molecular marker (M) was also used to determine the 
size of the purified protein. 






Figure 5.19b: FccA54 protein purification 
Protein from fractions C9 to D4 bound to the positively charged column and was eluted during the 
NaCl gradient. Fraction B5 was eluted before the gradient. A high yield of pure FccA54 protein was 
produced in fraction CIO and CI  (lanes 3 and 4) as shown by SDS-PAGE. Purified FccA54 protein 
was also apparent for samples B5 and C9 (lanes 1 and 2) at a lower concentration. Fractions C12 to 
D4 (lanes 5-9) did not contain pure FccA54. Molecular weight marker (M) was used to indicate the 
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Flavin spectra were measured for the purified FccA54 fractions and were 
characteristic of flavin bound to protein (Figure 5.20; Munro and Noble, 1999). 
a) 
Wavelength (rim) 
Figure 5.20: UV/visible absorbance spectrum of the purified FccA54 flavoprotein 
The purified protein showed two absorption maxima characteristic of flavins. 
5.2.9 Characterisation of the FccA54 flavoprotein 
N-terminal sequencing was used to provide conclusive evidence that the purified 
52.6 kDa protein was FccA54. The purified FccA54 protein indicated in Figures 
5.19a and 5.19b was sequenced using Edman degradation of an FccA54 Western blot 
sample. The first five N-terminal residues were identified to be Thr, Glu, Xaa, Ala 
and Ser that correlated with FccA54 sequence information from TIGR 
(http://www.tigr.org). The residue that remained unidentified by N-terminal 
sequencing was cysteine. The first five N-terminal residues correspond to the 
beginning of the FccA54 mature protein sequence encoded by the fccA54 54FMIRA 
PCR product with removal of the initiating methionine residue. 
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The FccA54 flavoprotein was tested for fumarate reductase activity and succinate 
oxidation activity. Samples for the enzyme assays were obtained from partially 
purified FccA54 fractions eluted from a Q Sepharose column at pH 7.5. The FccA54 
protein was the most intense protein in the samples tested. The enzyme assays did 
not reveal any activity for fumarate reduction or succinate oxidation by FccA54. The 
fractions were yellow, indicative of flavin and were tested for enzyme activity 
shortly after elution from the purification column. Therefore, the lack of FccA54 
enzyme activity was unlikely due to loss of flavin. The FccB54 partner cytochrome 
subunit is perhaps required to deliver electrons from reduced methyl viologen to the 
flavin cofactor of FccA54. Over a short duration, the non-covalently bound FAD 
dissociated from the FccA54 flavin subunit, suggesting that the Fcc1354 cytochrome 
subunit acts to cap the FccA54 FAD binding site, forming a stable heterodimer. 
5.3 CONCLUSION 
In this project an expression plasmid was constructed based upon pJF118 to optimise 
FccA54 overexpression levels. Fusion PCR was successfully used to generate an 
FccA54 overexpression fragment containing the fccA54 ATG start codon 11 bp from 
the ribosome-binding site within the required distance for protein overexpression 
(Wood et al., 1984a). Ideally, the 5'-overhang sequence of primer 54FM used in the 
original PCR amplification of the fccA54 mature coding sequence should have 
incorporated an EcoRI site instead of a BarnHI site. PCR amplification of an 
EcoRJJPstIfccA54 product would have eliminated the need for pJF1 18 plasmid DNA 
modification. Various primers were designed for PCR amplification of a set of 
several genes encoding flavoproteins (Chapter 7). 
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Cleavage sites for restriction enzymes BamHI and PstI were incorporated into the 5'-
overhang sequence of each primer pair. A target site for EcoRI occurred in the 
fccA342 flavoprotein gene sequence. Therefore, the EcoRI target site was not 
incorporated into primers used in PCR amplification of the set of genes that included 
fccA54. 
The FccA54 holoenzyme was purified to high purity using a Q Sepharose column at 
pH 8.0. However, over a short duration, the purified FccA54 fractions were bleached, 
indicating loss of the FAD cofactor. This strongly suggested that the flavin was non-
covalently bound to FccA54 as predicted from sequence alignments. From this 
observation it was concluded that non-covalently bound flavin was unstable in the 
absence of an associated cytochrome subunit. From comparison to the 
flavocytochrome c3 structure (Taylor ci' al., 1999), it was postulated that the FccB54 
cytochrome subunit associates with the FccA54 flavin subunit to cap the FAD 
binding site. The loss of flavin from purified FccA54 rendered the protein inactive 
and unsuitable for studying enzyme kinetics. 
The FccA54 flavoprotein did not catalyse fumarate reduction, however perhaps this 
was due to the conditions of the experiment used. To test fumarate reduction of 
FccA54 it will be necessary to repeat the experiment using Fcc3 as a positive control 
for fumarate reduction to ascertain the optimal conditions, including pH and enzyme 
and substrate concentrations. The inability of the purified FccA54 holoenzyme to 
catalyse fumarate reduction also suggested that haem groups of the cytochrome 
subunit were required to transfer electrons from reduced methyl viologen to flavin. 
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The results generated led to the conjecture that the flavin subunit does not function in 
S. oneidensis MR-1 as a single entity and associates with the cytochrome subunit to 
function as a flavocytochrome. This is supported by similar evidence generated from 
studies of the methacrylate reductase flavoprotein from G. sulfurreducens. The 
purified flavoprotein subunit catalysed the reduction of methacrylate with reduced 
benzyl viologen at a rate of 0.4 U.mg'. The activity increased with addition of the 
associated cytochrome c to a maximal specific rate of 50 U.mg' indicating that the 
cytochrome haem groups were necessary for electron transfer from reduced benzyl 
viologen (Mikoulinskaia et at., 1999). In comparison to the basal level of 
methacrylate reduction catalysed by the flavoprotein, there was absolutely no 
fumarate reduction catalysed by the FccA54 flavoprotein. However, FccA54 was 
purified in the absence of the associated cytochrome subunit whereas the 
methacrylate reductase flavoprotein preparation contained residual amounts of 
cytochrome c. The flavoprotein and tetrahaem cytochrome c protein are both 
required for methacrylate reduction (Mikoulinskaia et al., 1999). Furthermore, 
overexpression of the Fcc3 flavin domain in the Fcc3 deletion strain 'S. frigidiniarina 
EG30 1' did not restore the ability of this mutant to respire with fumarate suggesting 
that both the flavin and cytochrome domains are essential for enzyme catalysis in 
Fcc3 (Gordon et al., 1998). From the results presented here it appears probable that 
the FccA54 flavin and FccB54 cytochrome subunits also associate to form a 
functional flavocytochrome. To further investigate the nature of this association and 
identify the native substrate of the flavocytochrome, the FccA54 and FccB54 
subunits were co-expressed to form the dimeric flavocytochrome (Chapter 6). 
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6.1 INTRODUCTION 
A single PCR fragment comprising fccA54 and JcB54 was amplified to obtain co-
expression of the FccA54 flavin subunit and FccB54 cytochrome subunit in the 
periplasm of S. frigidimarina EG301. PCR amplification of the contiguous genes, 
fccA342 and fccB342 as a single PCR product also aimed to achieve periplasmic co-
expression of the encoded protein subunits. The intention was to co-express and 
purify the subunits comprising the putative dimeric flavocytochromes in order to 
analyse their redox, catalytic and structural properties. Moreover, purification of the 
flavocytochromes putatively formed by association of distinct flavin and cytochrome 
subunits aimed to produce stable proteins that contained non-covalently bound FAD. 
Purification of each flavocytochrome intended to allow the study of enzyme catalysis 
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6.2 RESULTS AND DISCUSSION 
6.2.1 Primer design and PCR amplification of fccAB54 
The fccA54 and fccB54 genes are located in the same operon with only 3 bp 
separating the upstream fccA54 stop codon from the ATG start codon of fccB54 
(Figure 6.1). In order to co-express the FccA54 and FccB54 subunits, two 
oligonucleotide primers, denoted 54F and 54RB were designed to initiate PCR 
amplification of fccA54 and fccB54 as a contiguous sequence (Figure 6.1). The 
fccB54 gene sequence determined by 'The Institute for Genomic Research' (TIGR; 
http://www/tigr.org) was interpreted to encode a hydrophobic N-terminal signal 
sequence characteristic of proteins targeted to the periplasm by the Sec-dependent 
pathway (von Heijne and Abrahmsén, 1989). Therefore, to allow co-expression of 
the flavin and cytochrome subunits in the periplasm, PCR amplification was 
designed to include the N-terminal sequence of fccA54 that encodes the predicted Tat 
(twin arginine translocation) signal peptide required for targeting preproteins to the 
periplasm (Berks, 1996). The 5'-end of the 54F forward primer was designed to 
complement the fccA54 ATG start codon to initiate amplification of the FccA54 
preprotein encoding sequence (Figure 6.1). The 54F primer sequence corresponding 
to fccA54 was 17 nucleotides in length to ensure specific annealing of primer and 
template DNA during PCR amplification. The 5'-end of the 54RB reverse primer 
sequence precisely mapped to the TAA stop codon of fccB54 encoding the FccB54 
cytochrome subunit. The 54RB primer was 20 nucleotides in length to promote 
specific binding tofccB54 template DNA. 
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The nucleotide sequences of the 54F and 54RB primers were checked for the absence 
of complementary sequence at the 3'-end and adjusted in length to possess similar 
melting temperatures to promote specific PCR amplification. The 54F and 54RB 
primers were engineered to contain 5'-overhang restriction endonuclease sites to 
facilitate direct cloning of the fccAB54 PCR product. A BamHI cleavage site (5'- 
GGATCC-3') was introduced into the 5'-overhang sequence of primer 54F and a PstI 
cleavage site (5'-CTGCAG-3') was inserted in primer 54RB (Figure 6.1). The 
restriction enzymes BamHI and PstI were selected to facilitate cloning of the 
fccAB54 PCR product due to the absence of target sites within fccA54 and fccB54. In 
addition, unique target sites for BainHI and PstI occur in the expression plasmid 
pMMB503EH (Overbye Michel et al., 1995; Figure 5.5), selected for co-expression 
of FccA54 and FccB54. A triplet of nucleotides was positioned upstream of the 
engineered cleavage sites to enable restriction enzyme digestion. The manipulation 
of template DNA sequence led to PCR amplification of fccA54 and fccB54 as a 
contigu 	 ni ous 1914 bp BaHJIPstIfccAB54 '54FRB' fragment (Figure 6.1). 
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1914 bpftcAB5454FRB PCR product 
Figure 6.1: A schematic diagram of the fccAB54 PCR amplification 
The ficA54 and fccB54 contiguous genes were amplified as a single PCR fragment from the 
Shewanella oneidensis MR-I genome. Arrows indicate the forward '5417' and reverse '54RB' primer 
positions and the direction of PCR amplification. The 54F primer was specifically designed to include 
amplification of sequence encoding the Tat signal peptide. The red-boxed sequences represent the 5'-
overhang primer sequences containing the restriction enzyme cleavage sites for BamHI and PstI. The 
final 1914 bp BamHIIPstIfccAB54 54FRB PCR product is shown. The diagram is not to scale. 
The fccAB54 continuous sequence was successfully PCR amplified from the S. 
oneidensis MR-1 genome using primers 54F and 54RB. A PCR product correlating 
to the expected size of the 1914 bp BamHT/PstI fccAB54 54FRB fragment (Figure 
6.1) was observed using agarose gel electrophoresis (Figure 6.2). A PCR product was 
specifically amplified for each of the six reactions that differed in the DNA: primer 
ratio and the addition of NH4C1 to reactions 2, 4 and 6. The greatest yield of PCR 
product at approximately 0.05-0.06 tg DNA was produced for reactions 1-4 that 
contained a lower concentration of DNA template compared to reactions 5 and 6. 
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Figure 6.2: PCR amplification of the JccABS4 54FRB fragment 
Primers 54F and 54RB successfully PCR amplified the fccAB54 54FRB fragment from the S. 
oneidensis MR-I genome. The PCR results for reactions 1 to 6 (lanes 2-7, respectively) were analysed 
using agarose gel electrophoresis that revealed a product corresponding to the 1914 bp BamHIIPstI 
fragment. The quantity of PCR product was significantly greater for reactions 1-4 that contained a 
lower concentration of DNA template compared to reactions 5 and 6. The addition of NH4C1 to 
reactions 2 (2 mM) and 4 (4 mM) improved the yield of the fccAB54 54FRB PCR product. 1 kb DNA 
ladder (lane 1) was used to indicate the size of the PCR products. 
6.2.2 Cloning of the fccAB54 54FRB PCR product in pGEM-T 
The fccAB54 54FRB 1914 bp PCR product was transferred into the pGEM-T cloning 
plasmid (Figure 5.3) to achieve multiple copies of the product. In addition, 
recombinant pGEM-T plasmid was constructed to provide a suitable template for 
sequencing the fccAB54 54FRB PCR product for potential errors incorporated by 
Taq DNA polymerase. The fccAB54 54FRB PCR product was inserted in pGEM-T 
using the 3'-adenine base overhangs (5.2.2). This insertion intended to interrupt the 
lacZ gene to impede 3-galactosidase activity detected by blue/white colony 
screening (5.2.2). 
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Six white ampicillin resistant transforrnants, referred to as 2-1 to 2-6 were selected 
and further screened for recombinant pGEM-T plasmid. Two of the six selected 
colonies, named 2-1 and 2-5 were identified using restriction enzyme digests to 
contain recombinant pGEM-T plasmid carrying the fccAB54 BamHTIPstI fragment. 
The ftcAB54 54FRB PCR product was released as a 1914 bp restriction fragment 
upon double digestion with BamHI and PstI, as detected by agarose gel 
electrophoresis. Recombinant pGEM-T plasmid named pMB2-1 contained the 
fccAB54 54FRB sequence that was used to construct an FccA54 and FccB54 co-
expression plasmid. 
6.2.3 Sequencing of the fccAB54 54FRB PCR product in pMB2-1 
The ftcAB54 54FRB PCR product of plasmid pMB2-1 was sequenced for mutations 
introduced during PCR amplification catalysed by the low fidelity Taq DNA 
polymerase. Primers 54RP1, 54RP2, 54RP3 and 54RP4 were designed to 
complement the fccAB54 sequence to provide overlapping sequencing information. 
The results generated from automated sequencing of pMB2-1 single-stranded DNA 
revealed six point mutations in the fccAB54 54FRB PCR product. The six mutations 
were randomly positioned in the fccAB54 54FRB 1914 bp PCR product. A silent 
point mutation that retained an Aspartate codon (GAC -> GAT) was identified 
426 bp downstream of the fccA54 ATG start codon. This mutation was not corrected. 
The other five point mutations, consisting of transitions and transversions, altered the 
amino acid sequence composition of the encoded protein. One of these point 
mutations occurred in the fccB54 gene and the other four mutations were 
intermittently dispersed in the fccAS4 gene, downstream of the silent mutation. 
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A correctly PCR amplified fccAB54 '54FMRB' sequence from plasmid pMB4-1 1 
(7.2.2 and 7.2.3) was used to correct the mutated fccAB54 54FRB sequence cloned in 
pMB2-1. The variant fccAB54 sequence of pMB4-11 was amplified using primers 
54FM and 54RB that precluded amplification of the N-terminal sequence encoding 
the Tat signal peptide of the FccA54 flavin subunit (7.2.2). The automated 
sequencing result generated for fccAB54 of pMB4-1 1 matched the correct sequences 
of fccA54 and fccB54 (http://www/tigr.org) except for one silent point mutation 
located 12 bp downstream of the fccB54 ATG start codon (7.2.4). 
The region of mutated fccAB54 54FRB DNA sequence spanning 800 bp was 
removed from pMB2-1 as an AvaJJBs06I 1293 bp fragment. The pMB2-1 fccAB54 
54FRB sequence was repaired by ligation to correctly amplified fccAB54 54FMRB 
sequence cut from pMIB4-11 as a 1293 bp AvaJlBs06I fragment. The restriction 
enzymes, AvaI and Bsu361 were selected to mobilise the fccAB54 DNA due to the 
location of unique cleavage sites flanking the mutated region in pMB2-1. 
Furthermore, AvaI and Bsu361 restriction enzymes do not cut in pGEM-T therefore 
the enzymes specifically spliced the mutated region of cloned fccAB54 DNA. 
Recombinant pGEM-T plasmid containing the correct sequence of fccAB54 54FRB 
was transformed into E. coli TG1 and positive transformants were selected for 
ampicillin resistance encoded on the pGEM-T plasmid. No colonies were apparent 
on the 'cells only' control indicating that the antibiotic selection was implemented. A 
lawn of ampicillin resistant transformants was produced and two colonies were 
selected for further analysis. 
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Double BarnHIIPstI restriction digests were used to verify repair of fccAB54 54FRB 
in pMB2-1. A BamHIIPstI restriction fragment corresponding to the size of fccAB54 
54FRB was excised from restored pMB2-1 plasmids isolated from both selected 
colonies (Figure 6.3). The recombinant pGEM-T plasmid containing the correctly 
amplified fccAB54 54FRB sequence was named pMB2-1-4 (Figure 6.5). Sequencing 
of the regenerated fccAB54 54FRB sequence in pMB2-1-4 was used to provide 
absolute confirmation that the correct sequence of fccAB54 54FRB was indeed 
obtained. 
I 	' 	3 	4 
2036 bp 
1914 bp BtvnHJJPstI 
4 	fccAB54 fragment 
Figure 6.3: Correction of the mutatedfccAB54 54FRB DNA sequence 
The mutated fccAB54 54FRB DNA sequence in pMB2-1 was excised as a 1293 bp AvalIBs06I 
fragment and replaced with the correct AvaJJBsu36I fccAB54 sequence from pMB4-11. The correct 
fccAB54 54FRB sequence was generated in pMB2-1 to form recombinant plasmid named pMB2-1-4, 
isolated from two ampicillin resistant colonies. BamHIIPstI double restriction digests were used to 
verify formation of the correctfccAB54 54FRB sequence in pMB2-1-4. The results of the digests were 
analysed using agarose gel electrophoresis and clearly showed excision of a restriction fragment 
corresponding to the 1914 bp fccAB54 54FRB fragment (lanes 2 and 3). A Ba,nHIJPstI restriction 
digest of pMB2-1 (lane 4) was used as a control to indicate the restriction fragment from pIVIB2-1-4 
corresponded to fccAB54. 1 kb DNA ladder (lane 1) was also used to indicate the restriction fragments 
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6.2.4 FccA54 and FccB54 co-expression in S. frigidimarina EG301 
The aim was to co-express FccA54 and FccB54 in the Fcc3 deletion strain of 
Shewaneila frigidirnarina designated EG301. This host strain was selected for 
overexpression and purification of the predicted 66,636 Da FccA54 (53, 025 Da) and 
FccB54 (13,611 Da) heterodimer due to the absence of Fcc3 at 64 kDa that might 
have obscured detection of the desired protein. The overexpression and purification 
strategy was based upon the assumption that the putative interactions between 
FccA54 and FccB54 would remain stable during purification. 
The strategy designed to obtain FccA54 and Fcc1354 periplasmic co-expression 
involved insertion of the fccAB54 54FRB PCR product in the pMMB503EH 
expression plasmid. This plasmid is a broad host range plasmid that is suited to 
protein overexpression in Shewanella species (Overbye Michel et al., 1995; Figure 
5.5). However, insertion of the fccAB54 54FRB BamHIIPstI fragment in 
pMMB503EH would have unsuitably positioned the ATG start codon 32 bp from the 
plasmid-bome nbosome-binding site. Therefore, to initialise maximal levels of 
FccA54 and FccB54 co-expression using pMMB503EH, the pMMB503EH plasmid 
was modified to contain the N-terminal fccAB54 BamHI site 5 bp from the plasmid 
ribosome-binding site. This modification concomitantly positioned the fccA54 ATG 
start codon 11 bp from the ribosome-binding site. It was identified that the sequence 
upstream of the ribosome-binding site that comprises the lact gene of 
pMMB503EH was exactly the same as that of the E. coil expression plasmid pJF1 18 
(Fürste et al., 1986; Figure 5.6). 
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Therefore, the process of constructing a modified pMMB503EH plasmid involved 
excising the modified segment from pMB3 (Figure 5.6) that contained a BamHII site 
5 bp from the ribosome-binding site and transferring this sequence to pMMB503EH. 
It was noted that the plasmid DNA transfer to pMMB503EH would introduce the 
lacf mutation of pMB3 (5.2.6.2) that appeared to render the FccA54 protein non-
IPTG inducible (5.2.7). 
6.2.5 Insertion of the fccAB54 54FRB PCR product in pMB3 
The JccAB54 54FRB PCR product from pMB2-1-4 was transferred into the modified 
pJF1 18 plasmid pMB3 to form an fccAB54 overexpression fragment for transfer to 
pMMB503EH (Figure 6.5). The fccAB54 54FRB PCR product was excised from 
pMB2-1-4 as a BaniHIIPstI 1914 bp restriction fragment and ligated to 
complementary sticky ends of pMB3. The recombinant plasmid was transferred into 
E. coli TG1 and positive transformants were selected using ampicillin resistance. 
Four ampicillin resistant colonies were selected for further screening using double 
BamHJJPstI digests to verify transformation with recombinant plasmid. A 
BainHIIPstI 1914 bp fccAB54 restriction fragment was generated upon digestion of 
recombinant plasmid named pMB4 (Figure 6.4). Therefore, the pM34 expression 
plasmid was identified to contain the fccAB54 overexpression fragment comprising 
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Figure 6.4: Restriction digests to confirm insertion of fccAB54 in pMB3 to form pMB4 
The frcAB54 PCR product was transferred from pMB2-1-4 to pMB3 as a 1914 bp Ba,nHI/PstI 
fragment. The recombinant pJFII8 plasmid formed was referred to as pMB4 and was isolated from 
ampicillin resistant colonies 1-4. Recombinant plasmid was identified using double Ba,nI-II/PstI 
restriction digests that released a restriction fragment corresponding to the length of the 1914 bp 
fccAB54 54FRB Ba,nHI/PstI PCR product (lanes 2-5, respectively). 1 kb DNA ladder (lane 1) was 
used to indicate that the restriction fragments analysed using agarose gel electrophoresis were of the 
expected size. 
6.2.6 Insertion of the fccAB54 overexpression fragment in pMMB503EH 
In order to form an ideal pMMB503EH expression plasmid for FccA54 and FccB54 
co-expression in S. frigidiniarina EG301, the fccAB54 overexpression fragment was 
transferred from pMB4 to pMMB503EH on a 2650 bp MluIJPstI fragment. This 
sequence contained the lacf gene and the fccAB54 54FRB insert DNA of pMB4 
(Figure 6.5). The fccAB54 overexpression fragment was transferred into the 
pMMB503EH expression plasmid by ligation of complementary MluI and PstI sticky 
ends. This cloning step produced a modified pMMB503EH expression plasmid that 
contained a BainHI cleavage site adjacent to the ribosome-binding site, ideally suited 
for cloning and expression of BamHI fragments. The recombinant pMMIB503EH 
expression plasmid was transformed into E. coli DH5a and positive transformants 
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Double MluTJPstI restriction digests were used to confirm that the fccAB54 
overexpression fragment was inserted in pMMB503EH. An MluIJPstI restriction 
fragment corresponding to the 2650 bp fccAB54 overexpression fragment was 
excised upon digestion of recombinant plasmid named pMB5 (not shown). The 
suitable expression plasmid pMB5 (Figure 6.5) was transferred from E. coli DH5a to 
E. coli SM1O for subsequent conjugative transfer to S. frigidimarina EG301 (KmR, 
RmR).  Positive S. frigidimarina EG301 transformants that were kanamycin, 
rifampicin and streptomycin resistant were selected to test co-expression of FccA54 




















Figure 6.5: Construction of the recombinant pMB5 expression plasmid 
The fccAB54 54FRB PCR product was excised as a BamHI/PstI 1914 bp fragment from pMB2-1-4 
recombinant pGEM-T plasmid (A) and ligated to complementary ends of pMB3 (B) to form plasmid 
pMB4 (C). The modified plasmid DNA of pMB4 comprising a BamHI site next to the ribosome-
binding site and the fccAB54 PCR product were transferred to pMMB503EH as an IvtluI/PstIfccAB54 
overexpression fragment to form pMB5 (D). This modified pMMB503EH plasmid containing 
fccAB54 54FRB was introduced into S. frigidimarina EG301 for periplasmic co-expression of the 
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6.2.7 Overexpression of FccA54 and FccB54 in S. frigidimarina EG301 
A time course experiment was performed to identify the optimal induction conditions 
for co-expression of the FccA54 and FccB54 subunits in S. frigidimarina EG301. 
Recombinant S. frigidiniarina EG301 containing pMB5 was grown to an 0D600 of 
0.6, induced with isopropyithiogalactoside (IPTG) and grown for 1 hour, 2 hours, 4 
hours and 16 hours. Cultures were also extracted for protein analysis at the time of 
IPTG induction (referred to as 0 hours). Uninduced recombinant S. frigidimarina 
EG301 containing pMB5 was included as a control in the time course experiment to 
assess the specificity of induction by IPTG. Non-recombinant S. frigidirnarina 
EG301 was also included as a control to show that the overexpressed protein was 
specific to the Shewanella strain bearing the pMB5 expression plasmid. The protein 
content of each sample was analysed using SDS-PAGE that was haem stained to 
selectively detect cytochrome proteins (Figures 6.6a and 6.6b) and Coomassie 
stained to reveal all proteins. Following haem staining of the gel, an overexpressed 
cytochrome protein with an approximate molecular mass of 11 kDa was observed. 
The absence of the protein in non-recombinant S. frigidiinarina EG301 indicated that 
the protein corresponded to the FccB54 tetrahaem cytochrome protein with a 
predicted molecular mass of 13,611 Da (11,145 Da for apoprotein and 2466 Da for 4 
haem groups). The putative overexpressed FccB54 protein was also present in the 
uninduced samples indicating that the protein was non IPTG-inducible (Figures 6.6a 
and 6.6b). This was most probably caused by the transfer to pME5 of a laci 
mutation in pMB3 (6.2.4) that was postulated to affect the lac repressor protein 
activity (5.2.7). The greatest quantity of the putative FccB54 protein was produced 
after growth of recombinant S. frigidimarina EG301 for 16 hours (Figure 6.6b). 
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Figure 6.6a: Time course overexpression of FccB54 
Recombinant S. frigidirnarina EG301 containing pMB5 induced with IPTG (c) was grown for a 
period of 1 hour and 2 hours to monitor the optimal conditions of induction. Samples were also 
analysed immediately following IPTG induction (0 hours). The results were analysed using SDS-
PAGE haem stained to observe cytochrome proteins. An overexpressed protein at 11 kDa, close to the 
predicted mass of FccB54 (13.6 kDa) was detected (c) that also appeared in the uninduced 
recombinant S. frigidimarina EG301 strain containing pMB5 (b). The overexpressed protein was 
clearly absent in the non-recombinant S. frigidirnarina EG301 strain (a). Molecular marker (M) was 





Duration of IPTG induction 
Figure 6.6b: Time course overexpression of FccB54 
Recombinant S. frigiditnarina EG301 containing pMB5 (c) was induced with IPTG and grown for a 
period of 4 hours and 16 hours. The results were analysed using SDS-PAGE haem stained for the 
detection of cytochrome proteins. Growth of recombinant S. frigidirnarina EG301 containing pMB5 
over a period of 16 hours produced the highest quantity of the putatively overexpressed FccB54 
protein. There was no difference in FccB54 expression when comparing uninduced recombinant S. 
frigidimarina EG30I (b) to induced recombinant S. frigidiniarina EG301 (c). The overexpressed 
protein corresponding to the size of FccB54 clearly did not occur in non-recombinant S. frigidiinarina 
EG301 (a). Molecular marker (M) was used to indicate the size of the overexpressed protein. 
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Following haem staining of the SDS-PAGE gel, Coomassie Blue staining was used 
to observe overexpression of the FccA54 flavoprotein. However, over the time 
course of IPTG induction, overexpression of the FccA54 flavoprotein at the known 
molecular mass of 52.6 kDa was not observed. The cloned fccAB54 54FRB PCR 
product of pMB5 was oriented to position the ftcA54 gene closest to the plasmid 
ribosome-binding site. Therefore, the observed putative overexpression of FccB54 
(Figures 6.6a and 6.6b) encoded by the fccB54 gene cloned distal to the plasmid 
ribosome-binding site must be coupled to overexpression of FccA54. The inability to 
detect the overexpressed FccA54 flavoprotein targeted to the periplasm of S. 
frigidiniarina EG301 was most probably due to the poor sensitivity of Coomassie 
staining combined with the vast number of flavoproteins in S. frigidiniarina EG30I. 
To try and significantly reduce the total number of isolated proteins, the periplasm 
was extracted from recombinant S. frigidimarina EG301 containing pMB5 induced 
with IPTG for a period of 16 hours. A sample of the periplasmic extract was analysed 
for FccA54 overexpression using SDS-PAGE stained with Coomassie Blue (Figure 
6.7). Two proteins of approximately 50 kDa were evident at the expected position of 
FccA54 (52.6 kDa) that was previously identified to display a migration anomaly on 
SDS-PAGE (5.2.7). However, these proteins were also apparent in non-recombinant 
S. frigidimarina EG301 at the same concentration as for recombinant S. 
frigidiinarina EG301 induced for protein expression (Figure 6.7). These proteins 
may correspond to similar proteins of FccA54 found in S. frigidimarina EG30 1. 
Periplasmic isolation of recombinant S. frigidimarina EG301 did not improve 
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Figure 6.7: Periplasmic extraction to identify FccA54 overexpression 
The samples obtained from the periplasm of non-recombinant S. frigidimarina E0301 (lanes I and 4), 
uninduced recombinant EG30I containing pMB5 (lanes 2 and 5) and recombinant S. frigidiinarina 
EG30I containing pMB5 induced with ITPG (lanes 3 and 6) were analysed using SDS-PAGE 
Coomassie stained for protein. A higher sample concentration was sequentially loaded in lanes 4-6. 
Molecular marker (M) was used to indicate the expected position of the FccA54 flavoprotein. The 
expected position of the FccA54 protein at 52.6 kDa that displays a migration anomaly on SDS-PAGE 
is shown. The results show that there is no detectable periplasmic overexpression of the flavoprotein. 
Following periplasmic extraction, cytochromes targeted to the periplasm of induced 
recombinant S. frigidimarina EG301 containing pMB5 were specifically analysed 
using SDS-PAGE. Haem staining of the SDS-PAGE gel revealed that the putative 
overexpressed Fcc1354 protein was indeed targeted to the periplasm of recombinant 
S. frigidimarina EG301 (Figure 6.8). It was also observed that a small cytochrome of 
approximately 6 kDa prevalent in S. frigidimarina EG301 was less abundant in 
recombinant S. frigidimarina EG301 containing pMIB5 (Figure 6.8). This observation 
led to the hypothesis that gene expression of the unknown 'Lower protein' and 
Fcc1354 is controlled via a common regulatory pathway. This proposed regulatory 
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Figure 6.8: Periplasmic extraction to identify FccB54 
The samples obtained from the periplasm of S. frigiditnarina E0301 (lanes 1 and 4), uninduced 
recombinant S. frigidi,narina EG301 (lanes 2 and 5) and recombinant S. frigidi,narina EG301 induced 
with ITPG (lanes 3 and 6) were analysed using SDS-PAGE haem stained for cytochrome proteins. A 
higher sample concentration was sequentially loaded in lanes 4-6. Molecular marker (M) was used to 
indicate the expected position of the FccB54 cytochrome. An arrow indicates the position of 
overexpressed protein correlating to the predicted size of FccB54 at 13.6 kDa. The 'Lower protein' of 
S. frigidiinarina E0301 at approximately 6 kDa (1 and 4) was less abundant in the presence of 
overexpressed FccB54 (lanes 2-3 and 5-6). 
6.2.8 Characterisation of the putative overexpressed FccB54 protein 
The molecular mass of the putative overexpressed FccB54 protein was determined 
using mass spectrometry to be 13.6 kDa (Figure 6.9) that correlated with the 
predicted mass of FccB54 at 13,611 Da (11,145 Da for apoprotein and 2466 Da for 4 
haem groups). The putative FccB54 protein was sequenced using mass spectrometry 
of an SDS-PAGE gel piece containing FccB54 digested with trypsin. The digested 
fragments that contained a haem-binding motif were not identified using mass 
spectrometry. However, a peak corresponding to an FccB54 trypsin fragment (1112.6 
Da) comprising the sequence 'Leu79-Ala-Ile-Pro-Glu-Ala-His-Pro-His-Lys8 8' of the 
FccB54 preprotein sequence (Figure 1.14) was identified. 
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The sequencing data therefore provided some evidence that the overexpressed 
cytochrome protein is FccB54. 
3635.02 
Mass (rn/a) 
Figure 6.9: Mass spectrometry of FccB54 
The total mass of the putative overexpressed FccB54 tetrahaem cytochrome was identified using 
MALDI mass spectrometry to be 13635.02 Da. 
The molecular mass of the 'Lower protein' (Figure 6.8) was identified using mass 
spectrometry to be 7.4 kDa (Figure 6.10). The unknown S. frigidin'iarina EG301 
cytochrome was sequenced using mass spectrometry of an SDS-PAGE gel piece 
containing the 'lower protein' digested with trypsin. However, no N-terminal 
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Figure 6.10: Mass spectrometry of the 'lower protein' 
The total molecular mass of the unknown S. frigidimarina EG301 'lower protein' was identified using 
MALDI mass spectrometry to be 7.4 kDa. 
6.2.9 Purification trials of the FccA54 and FccB54 subunits 
Overexpression of the FccA54 flavin subunit in S. frigidimarina EG301 remained 
undetected during analysis of the time course experiment, nevertheless, subsequent 
purification steps were undertaken to achieve co-purification of the FccA54 and 
FccB54 subunits. A large-scale culture of recombinant S. frigidimarina EG301 
containing pMB5 was grown to an 0D600 of 0.6 and induced with 1 MM IPTG for 
the optimal duration of 16 hours. The induced cells were subsequently harvested and 
the soluble fraction was isolated to ensure that the purification sample did indeed 
contain soluble FccA54 and FccB54. A cell free extract sample and whole cell 
sample were both analysed using an SDS-PAGE gel haem stained to identify the 
FccB54 cytochrome protein. 
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The majority of the Fcc1354 cytochrome was isolated in the soluble cell fraction 
(Figure 6.11) therefore isolation of this fraction was used as the first step during 
purification. Isolation of the periplasm did not appear to significantly reduce the total 
number of proteins; therefore this additional step was omitted from the purification 
strategy. Coomassie staining of the SDS-PAGE gel did not reveal the presence of 
FccA54, however, the presence of the flavoprotein subunit in the soluble cell fraction 
was previously identified during overexpression and purification of the FccA54 
subunit from E. coli TG1 (5.2.7). Therefore, it was assumed that the FccA54 
flavoprotein subunit putatively associated with FccB54 was also present in the 
soluble fraction of the purification sample. 
I 2 M 
FccB54 14 kDa 
Figure 6.11: Isolation of FccB54 from the soluble cell fraction 
The cell free extract (lane 1) and whole cell sample (lane 2) of recombinant S. frigidirnarilia EG30I 
containing pMB5 were analysed using SDS-PAGE haem stained to identify the FccB54 cytochrome. 
As anticipated, the FccB54 subunit was identified in the soluble fraction of the purification sample. 
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The flavocytochrome formed by association of FccA54 and FccB54 was estimated to 
have a neutral isoelectric point (p1) of 7.28, calculated from a contiguous sequence of 
FccA54 and FccB54 (http://www.expasy.org/tools/protparam.html). Ion exchange 
columns of the BioCAD system were used to ascertain the optimal conditions for 
purification of the flavocytochrome heterodimer. Initially, an HQ anion exchanger 
equilibrated with 10 mM Tris buffer at pH 8.4 was used to provide a positively 
charged matrix for binding of the net negatively charged heterodimer. The soluble 
fraction of recombinant S. frigidimarina EG301 adjusted to pH 8.4 was applied to the 
purification column and proteins that adsorbed to the column were eluted during a 
NaCl gradient. A UV-visible spectrum was measured as a means of determining the 
concentration of proteins collected in the column fractions. 
The fractions that displayed a high UV absorbance at 280 nm were analysed using 
SDS-PAGE that was haem stained to observe cytochrome proteins and silver stained 
to identify all proteins. As an alternative method to Coomassie staining, a highly 
sensitive silver staining technique was used to try and detect FccA54. Protein 
separation of the FccA54 and FccB54 subunits from other S. frigidimarina EG301 
proteins was not achieved using the anion exchanger at pH 8.4. Extremely low levels 
of the FccB54 cytochrome protein were recovered from the purification column and 
many other lower molecular weight cytochrome proteins were also present. Due to 
the presence of many other S. frigidimarina EG301 proteins at approximately 50 
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Therefore, to further investigate the conditions required for purification of the 
putative heterodimer, an US cation exchanger was tested. The column was 
equilibrated to pH 7.0 to produce a system in which the FccA54 and FccB54 protein 
complex was slightly positive (pH 7.28) relative to the column resin. Therefore, it 
was predicted that the protein complex would adsorb to the column matrix and elute 
during a NaCl salt gradient. The soluble cell fraction of recombinant S. frigidimarina 
EG301 containing the putative FccA54 and FccB54 heterodimer was applied to the 
cation exchanger at pH 7.0. A UV-visible spectrum was used to monitor the 
concentration of proteins that were collected in the individual column fractions. 
Fractions 12-14 displayed a high UV absorbance at 280 nm indicative of containing 
protein. These colourless fractions were eluted at a salt concentration of 0.5 M NaC1 
(Figure 6.12). 
cv 
Figure 6.12: A chromatogram of the HS cation exchanger fractions 
Fractions 12-14 collected from the HS cation exchanger displayed a UV absorbance peak at 280 nm 
indicative of containing protein (red). The proteins in these fractions were eluted at a salt 
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The three fractions were analysed using SDS-PAGE that was haem stained to 
identify FccB54 and subsequently silver stained to identify FccA54. A protein 
corresponding to the size of FccB54 was the most concentrated cytochrome protein 
collected in each of the fractions. The other cytochromes present in each of the 
fractions consisted of high molecular weight proteins. Therefore, purification using 
the cation exchanger was particularly successful in separating the FccB54 protein 









subunit at 13.6 kDa 
Figure 6.13: Haem staining analysis of fractions collected from the HS cation exchanger 
The fractions collected from the HS cation exchanger were analysed using SDS-PAGE haem stained 
to identify the FccB54 protein. A putative FccB54 protein was identified in fractions 12-14 (lanes 1-3, 
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A low separation of all proteins eluted from the cation exchanger was identified upon 
silver staining of the SDS-PAGE gel. It was therefore not possible to distinguish 
FccA54 from the many other high molecular weight proteins of approximately 
50 kDa (Figure 6.14). A low molecular weight protein putatively corresponding to 
FccB54 displayed a different migration position (Figure 6.14) compared to the haem 
stained SDS-PAGE gel (Figure 6.13). The different staining procedures may affect 
the observed protein migration pattern on SDSPAGE. 
Figure 6.14: Silver staining analysis of fractions collected from the HS cation exchanger 
Fractions 12-14 collected from the HS cation exchanger were analysed using SDS-PAGE that was 
silver stained for total proteins. A putative FccB54 protein was identified (lanes 1-3). A band 
corresponding to FccA54 flavoprotein was not identified. Molecular marker (M) was used to show the 
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6.2.10 Overexpression and purification of FccA54 and FccB54 
A recombinant plasmid containing the fccAB54 54FRB PCR product was constructed 
for overexpression of the encoded subunits in the periplasm of S. frigidimarina 
EG301. High levels of overexpressed FccB54 protein were identified in the 
periplasm of the host strain. Conversely, overexpression of the putatively associated 
FccA54 subunit was not detected when analysed using SDS-PAGE. Nevertheless, 
purification of the putative heterodimer was attempted by closely monitoring the 
FccB54 cytochrome subunit, analysed using SDS-PAGE. The purification fractions 
could be alternatively analysed using a native polyacrylamide gel to test if the 
FccA54 flavin subunit was associated with FccB54 to form the 66.6 kDa 
flavocytochrome. Should the subunits be dissociated it would be possible to purify 
the Fcc1354 cytochrome subunit and combine this with the purified FccA54 flavin 
subunit (5.2.8) to form the flavocytochrome. The small-scale purification trials of the 
flavocytochrome led to identification of possible methods for purification of the 
FccB54 cytochrome subunit. Purification using an HS cation exchanger gave good 
separation of FccB54 from other low molecular weight cytochromes present in the 
sample. Several high molecular weight cytochromes were also present at a low 
concentration compared to FccB54. Following cation exchange chromatography; the 
higher molecular weight cytochrome proteins could be separated from FccB54 on the 
basis of size using a gel filtration column. Further purification trials are required for 
purification of the putative heterodimer, which may involve exploring various pH 
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6.2.11 Primer design and PCR amplification of fccAB342 
The frcA342 and fccB342 genes of S. oneidensis MR-i are located in the same 
operon and share a similar gene arrangement to fccA54 and fccB54 (Figure i.11). 
The fccA342 gene that encodes a flavoprotein subunit maps ii bp upstream of 
fccB342 encoding a tetrahaem cytochrome c. The encoded flavin and cytochrome 
subunits were hypothesised to associate in the periplasm to form a functional 
flavocytochrome. In order to achieve co-expression of the individual subunits, PCR 
amplification was designed to amplify the contiguous fccA342 and fccB342 genes of 
S. oneidensis MR-i as a single PCR product. 
Primers were designed to initiate amplification of a PCR product that when cloned 
would direct periplasmic expression of both the flavoprotein and cytochrome 
subunits. The forward 342F primer was positioned to include amplification of the 
fccA342 Tat-signal peptide coding sequence necessary for targeting the encoded 
FccA342 preprotein to the periplasm (Figure 6.15). The 5-end of the 342RB reverse 
primer sequence was designed to complement the TAG stop codon of fccB342. PCR 
amplification of the contiguous genes therefore included the fccB342 N-terminal 
sequence encoding the Fcc13342 Sec-dependent signal sequence required for 
targeting to the periplasm. The primer sequences were approximately 20 nucleotides 
in length to promote specific annealing to the fccA342 and fccB342 target genes. The 
primer pair was also designed to lack complementary sequence at the 3 terminus to 
prevent primer-dimer formation. The primer sequences did not contain continuous 
runs of polypurines or polypyrimidines thus avoiding the possible formation of 
internal secondary structure. 
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The 5-end of each primer sequence was modified to contain a restriction 
endonuclease site to facilitate subsequent cloning of the PCR product. A BamHJ 
cleavage site was incorporated in the 5'-overhang of primer 342F and a PstI cleavage 
site was inserted in the 5'-overhang of primer 342RB. The primers were designed to 
initiate PCR amplification offccA342 and fccB342 as a contiguous BamHI/PstI 1864 
bp fragment (Figure 6.15). 
TCAGGATCC MMIM 
14 	 1846bp 	 3' 
5 	 I 
Tat signal peptide 
342RB • 	itI'e1 5' 
PCR 
Amplification 
BamKI 	 RsiI 
5' 	 I 
1864 bpfccAB342 342FRB PCR product 
Figure 6.15: PCR amplification of fccAB342 
PCR amplification was designed to amplify the contiguous fccA 342 and fccB342 genes as a single 
PCR fragment. Primer 342F was specifically designed to initiate amplification of the fccA 342 Tat 
signal peptide coding sequence to direct periplasmic expression of the encoded flavoprotein. The 
reverse 342RB primer was designed to complement the extreme 3' terminus of the fccB342 gene. 
Arrows indicate the primer positions and the direction of PCR amplification. BamHI and PstI 
cleavage sites were incorporated in 5' overhang sequences of the primers (red-boxed sequences). The 
final BamHI/PstI fccAB342 342FRB PCR amplified product was 1864 bp in length. The diagram is 
not to scale. 
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Primers 342F and 342RB successfully initiated PCR amplification of a fragment 
comprising the fccA342 and fccB342 genes from the S. oneidensis MR-i genome. 
The results of PCR were analysed using agarose gel electrophoresis that showed a 
PCR product at approximately 0.06 tg DNA that corresponded to the fccAB342 
342FRB 1864 bp BamHLIPstI fragment. In addition to the desired fragment, a 700 bp 
PCR product at approximately 0.02 tg DNA was PCR amplified, indicative of non-
specific PCR amplification (Figure 6.16). 
2036 bp - 
506 bp - 
1864 bpfccAB342 
342FRB PCR product 
Second PCR product (- 700 bp) 
Figure 6.16: PCR amplification of fccAB342 
Primers 342F and 342RB initiated PCR amplification of the fccA342 and fccB342 genes from the S. 
oneide,isis MR-] genome. The results of PCR were analysed using agarose gel electrophoresis that 
revealed a PCR product correlating to the size of the 1864 bp BamHJJPstI fccAB342 342FRB 
fragment (lane 2). A second PCR product at approximately 700 bp was also PCR amplified due to 
non-specific priming of the genomic template DNA (lane 2). 1 kb DNA ladder (lane 1) was used to 




Fla vocytochrome overexpression and purification 
6.2.12 Cloning of the fccAB342 342FRB PCR product in pGEM-T 
The fccAB342 342FRB 1864 bp BamHJJPstI fragment was cloned into pGEM-T to 
obtain multiple copies of the PCR product. The specific PCR product at the correct 
size of 1864 bp was amplified at a higher concentration than the non-specific PCR 
product. This suggested that insertion of the desired PCR product in pGEM-T would 
occur preferentially, preventing the need for purification of the two PCR products. 
Recombinant pGEM-T plasmid was transformed in E. coli TG1 and positive 
transformants were selected using blue/white colony screening and ampicillin 
resistance. Sixteen colonies with the required phenotype were selected for further 
screening to ensure they contained recombinant pGEM-T plasmid containing the 
correct insert DNA. The isolated plasmid DNA was cut with BamHI and PstI to 
excise insert DNA cloned as a BamHIIPstI fragment. Only 2 of the 16 colonies were 
identified to contain the fccAB342 342FRB PCR product (Figure 6.17). Six of the 
colonies contained the non-specific 700 bp PCR product and the remaining colonies 
contained non-recombinant plasmid. The recombinant pGEM-T plasmid containing 
the desired fccAB342 PCR product cloned as a BamHIIPstI 1864 bp fragment was 
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3054 
2036 
Digested pMB6-14 plasmid 
fccAB342 342FRB 1864 bp 
BamHI/PstI fragment 
Figure 6.17: Restriction digests to show isolation of recombinant pGEM-T 
Recombinant pGEM-T plasmid, named pMB6-14 was isolated from two ampicillin resistant white 
colonies. Double BaniHI/Pst I restriction digests were used to reveal excision of the cloned 1864 bp 
fccAB342 342FRB PCR product from pMB6-14, isolated from colonies I (lane 2) and 2 (lane 3). 1 kb 
DNA ladder (lane 1) was used to indicate that the restriction fragments were of the correct size. 
6.2.13 Sequencing of the fccAB342 PCR product in pMB6-1 4 
The fccAB342 342FRB PCR product cloned in pMB6-14 was checked for possible 
sequence errors introduced by the low fidelity Taq DNA polymerase. Sequencing 
primers, 342P1, 342P2, 342P3, 342P4 and 342P5 were designed to complement the 
fccAB342 PCR product at intervals of approximately 400 bp to provide overlapping 
sequencing data. The sequencing results obtained were compared to the known 
sequences of fccA342 andfccB342 (http://www.tigr.org). Interpretation of the results 
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6.2.14 Cloning of the fccAB342 PCR product in pMB5 
The pMB5 expression plasmid comprising the fccAB54 BamHJIPstI fragment (6.2.6; 
Figure 6.5) was successfully used to obtain high levels of overexpressed FccB54 
(6.2.7). As a modified version of the parent pMMB503EH plasmid, a BamHI site 
resides 5 bp from the ribosome-binding site of pMB5 (6.2.6). The pMB5 plasmid can 
be utilized to express inserts cloned as BamHI fragments that contain the start codon 
11 bp from the ribosome-binding site. The pMB5 plasmid was therefore selected as a 
suitable expression plasmid for cloning of the 1864 bp fccAB342 BarnHJJPstI 
fragment. The aim was to transfer the recombinant expression plasmid into S. 
frigidimarina EG301 to obtain penplasmic co-expression of the FccA342 and 
FccB 342 subunits. 
The fccAB342 correctly amplified PCR product was excised from pME6-14 as a 
BarnHL/PstI fragment and ligated to complementary ends of the pMB5 expression 
plasmid to form plasmid pMB6 (Figure 6.18). Recombinant plasmid was 
transformed into E. coli DH5oc and five positive transformants were selected on the 
basis of streptomycin resistance encoded on the pMMIB503EH plasmid. 
Recombinant pMIB6 plasmid DNA isolated from each colony was identified using 
double BanzHIJIPstI restriction digests. A BamHIIPstI restriction fragment 
corresponding to the 1864 bp fccAB342 PCR product was released upon digestion of 
recombinant plasmid (not shown). The isolated pMIB6 plasmid was identified as a 
suitable recombinant pMMB503EH expression construct for co-expression of 
















Figure 6.18: Construction of the pMB6 expression plasmid 
The fccAB342 342FRB PCR product was transferred from pMB6-14 (A) as a BamHJIPstI fragment to 
pMB5 (B), digested with BantHI and PstI, to form the pMB6 plasmid (C) for overexpression of the 
FccA342 and FccB342 subunits. 
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The pMB6 expression plasmid containing the fccAB342 342FRB PCR product was 
transferred from E. coli DH5ct to the conjugative E. coli SM10 strain. The expression 
plasmid was subsequently introduced by conjugative transfer to S. frigidimarina 
EG301 (KmR, RmR) for co-expression of the encoded flavin and cytochrome 
subunits. Positive S. frigidimarina EG301 transformants exhibiting kanamycin, 
rifampicin and streptomycin resistance were selected to test co-expression of 
FccA342 and FccB 342 in the periplasm of the host strain. 
6.2.15 Flavocytochrome overexpression in S. frigidimarina EG301 
A time course induction experiment was used to identify the optimal conditions for 
overexpression of FccA342 and FccB342 in S. frigidimarina EG301. Recombinant S. 
frigidimarina EG301 containing the pMB6 expression plasmid was grown to an 
0D600 of 0.6 and induced with 1 mM of JPTG for 1 hour, 2 hours, 4 hours and 16 
hours. Samples were also extracted immediately after IPTG induction. A non—
recombinant S. frigidimarina EG301 control was included in parallel to show that 
any overexpressed protein identified in the S. frigidimarina EG301 recombinant 
strain was due to the presence of the pMB6 plasmid. An uninduced recombinant S. 
frigidimarina EG301 control was also included to monitor the regulation of protein 
expression. The samples were analysed using 4-12 % precast SDS-PAGE gels that 
were haem stained to specifically observe cytochrome proteins and Coomassie 
stained to identify all proteins. 
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Upon haem staining of the SDS-PAGE gels, no overexpressed FccB342 protein at 
the predicted molecular mass of 13,247 Da (10,781 Da for apoprotein and 2466 Da 
for 4 haem groups) was observed (Figure 6.19). A protein of approximately 12 kDa 
was apparent but was not specific to recombinant S. frigidimarina EG301 containing 
pMB6. An increase in the duration of IPTG induction (4 hours and 16 hours) did not 
produce overexpression of the FccB342 cytochrome (not shown). The putatively 
associated FccA342 flavoprotein was not observed upon Coomassie staining of the 
SDS-PAGE gel. 
a b c a b c a b c M 
0 hr ------ i ------- 1 hr-----r-- - 2 his 
Duration of IPTG induction 
Figure 6.19: Time course overexpression of FccB342 
A time course induction experiment was used to identify the optimal duration of IPTG induction for 
FccA342 and FccB342 co-expression. The results were analysed using SDS-PAGE haem stained to 
identify FccB342. Recombinant S. frigidintarina EG30I containing pMB6 (c) was induced with IPTG 
and grown for 1 hour and 2 hours. A sample was also extracted immediately following IPTG 
induction. A recombinant uninduced S. frigidiinarina E0301 control (b) and non-recombinant S. 
frigidiinarina EG30I (a) were included in the time course experiment. No overexpressed protein was 
identified corresponding to the predicted mass of FccB342 at 13.2 kDa. Molecular marker (M) was 
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Overexpression of the FccA342 and FccB342 proteins was not detected during the 
IPTG induction time course. PCR amplification of fccA342 and fccB342 was 
designed to include sequence encoding the N-terminal signal peptides for targeting to 
the periplasm. Therefore, the time course induction experiment could be altered to 
include periplasmic isolation following IPTG induction. This procedure may 
improve detection of the co-expressed proteins targeted to the periplasm. Other 
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7.1 INTRODUCTION 
An optimal overexpression system comprising the host strain, expression plasmid 
and cellular location of expression was unknown for each of the novel flavoproteins. 
In order to try different cellular overexpression conditions, four distinct PCR 
products were amplified for each gene sequence encoding a novel Shewanella 
oneidensis MR-i flavocytochrome (FccA54:FccB54 and FccA342:FccB342). 
Primers were designed to specifically amplify the target fccA gene with or without 
the N-terminal Tat (twin arginine translocation) signal peptide coding sequence. The 
two forms of the fccA gene sequence were also optionally PCR amplified with the 
downstream fccB gene sequence. The assortment of PCR products was designed to 
provide expression constructs that would generate periplasmic or cytoplasmic 
overexpression of the flavoprotein subunit, optionally co-expressed with the partner 
cytochrome subunit. Therefore, in addition to the PCR constructs that were primarily 
used for flavoprotein overexpression (Figures 5.1, 6.1 and 6.15), other PCR products 
were synthesised for each target gene. PCR amplification of the putative iron-
induced flavocytochrome named IfcA-1 of S. oneidensis MR-1 was also achieved. 
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7.2 RESULTS AND DISCUSSION 
7.2.1 PCR amplification of the fccA54 preprotein coding sequence 
The fccA54 PCR amplification product encoding mature FccA54 protein that was 
cloned in pMB3 (Figure 5.6) led to overexpression of FccA54 in the cytoplasm of E. 
coli TG1 (5.2.7). PCR amplification was also designed to amplify an fccA54 
fragment that would confer periplasmic overexpression of the FccA54 flavin subunit 
(Figure 7.1). The N-terminal Tat signal peptide coding sequence was included in 
PCR amplification of fccA54 to target the synthesised protein to the periplasm. The 
5-end of the 17-nucleotide primer '54F' was specifically designed to hybridise at the 
N-terminal ATO start codon of fccA54. To facilitate cloning of the PCR product, a 
5-overhang sequence incorporating a BainHI cleavage site was added upstream of 
the 54F primer sequence that corresponded to fccA54. A random sequence of three 
nucleotides was included upstream of the BainHI cleavage site to facilitate restriction 
enzyme digestion. The 54F forward primer was used in combination with the reverse 
54RA primer to PCR amplify the fccA54 gene encoding the FccA54 preprotein as a 
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Figure 7.1: PCR amplification of the fccA54 preprotein coding sequence 
A schematic diagram (not to scale) shows the primer positions of 54F and 54RA that initiated PCR 
amplification of the fccA54 gene as a BamHl/Pstl 54FRA 1539 bp fragment. The 54F primer position 
was designed to include PCR amplification of the extreme N-terminal JcA54 sequence encoding the 
Tat signal peptide. 
Primers 54F and 54RA specifically initiated PCR amplification of the 1539 bp 
fccA54 54FRA preprotein coding sequence from the S. oneidensis MR-i genome. 
However, a very low quantity of PCR product was synthesised, at approximately 
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7.2.2 PCR amplification of an fccAB54 co-expression fragment 
The fccAB54 54FRB PCR amplification product was designed to direct periplasmic 
co-expression of FccA54 and Fcc1354 in Shewanella frigidirnarina EG301 (Figure 
6.1). It was considered that both protein subunits targeted to the periplasm to form 
the flavocytochrome might dissociate during purification preventing isolation of the 
intact heterodimer. Therefore, a second fccAB54 PCR product was synthesised that 
did not contain the fccA54 N-terminal Tat signal peptide coding sequence. This 
intended to produce a cloned fccAB54 PCR product for overexpression of the 
FccA54 flavin subunit in the cytoplasm of the selected host strain. The N-terminal 
sequence encoding the hydrophobic signal sequence of Fcc1354 was PCR amplified 
to direct the co-expressed cytochrome subunit to the periplasm. Overexpression of 
the flavin and cytochrome subunits in distinct cellular locations intended to facilitate 
separate purification of the subunits for subsequent in vitro assembly of the 
flavocytochrome. The alternative fccAB54 54FMRB PCR product was synthesised 
using primers 54FM and 54RB as a BainHJJPstI 1830 bp PCR product (Figure 7.2). 
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Figure 7.2: A schematic diagram offccAB54 PCR amplification 
Primers 54FM and 54RB were used to initiate PCR amplification offccA54 and fccB54. The forward 
primer 54FM was positioned downstream of the fccA54 N-terminal Tat signal peptide. The fccAB54 
54FMRB PCR product was amplified as a BamHI/PstI 1830 bp fragment. 
Primers 54FM and 54RB successfully initiated PCR amplification of fccA54 and 
fccB54 as a single 1830 bp 54FMRB fragment from the S. oneidensis MR-1 genome. 
The PCR result was analysed by agarose gel electrophoresis that revealed a single 
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2036 bp PCR amplification 
of anfccAB54 54FMRB 1830 bp fragment 
Figure 7.3: PCR anipliiicatioii of JccA54 and fccB54 as a single product 
PCR amplification of frcA54 and fccB54 as a single 1830 bp fragment was analysed by agarose gel 
electrophoresis. A single PCR product was observed (lane 2) that corresponded to the expected size of 
the 1830 bp BamHJJPstI 54FMRBfccAB54 fragment. 1 kb DNA marker (lane 1) was used to indicate 
the PCR product amplified using primers 54FM and 54RB was of the correct size. 
7.2.3 Cloning of the PCR products in pGEM-T 
The fccA54 54FRA and fccAB54 54FMRB PCR products were cloned into pGEM-T 
(Figure 5.3) and transformed into E. coli TG1. Positive transformants were selected 
using ampicillin resistance and blue/white colony screening (5.2.2). White ampicillin 
resistant colonies were selected and further screened for recombinant plasmid using 
double BarnHJIPstI restriction digests. A BarnHJIPstI fragment corresponding to the 
size of the 1539 bp fccA54 54FRA PCR product was excised from recombinant 
pGEM-T plasmid referred to as pMB 1-2. The BamHIIPstI restriction digest produced 
a fragment corresponding to the size of the 1830 bp fccAB54 54FMRB PCR product 
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Figure 7.4: Cloning of the alternativefccAs4 and fccAB54 PCR products in pGEM-T 
Recombinant pGEM-T plasmid named pMB1-2 (lane 2) was isolated from ampicillin resistant 
white colonies. A restriction digest analysed by agarose gel electrophoresis was used to show 
formation of recombinant pGEM-T by excision of the BwnHL/PstI PCR product. Plasmid pMB 1-2 
digested with BainHI and PstI produced a restriction fragment that corresponded to the fccA54 54FRA 
1539 bp PCR product (lane 3). 1 kb DNA ladder (lane 1) was used to indicate the restriction 
fragments were of the expected size. 
Plasmid pMB4-11 (lane 1) isolated from ampicillin resistant white colonies was shown to be 
recombinant plasmid DNA. A double Ba,nHI/PstI restriction digest, analysed by agarose gel 
electrophoresis revealed excision of a BainHIJPstI fragment corresponding to the size of the frcAB54 
54FMRB 1830 bp PCR product (lane 2). 1 kb DNA ladder (lane 3) was used to indicate that the 
restriction fragments were of the correct size. 
7.2.4 Sequencing of the fccA54 and fccAB54 PCR products 
The PCR amplified nucleotide sequences of fccA54 54FRA and fccAB54 54FMRB 
were checked for possible mutations incorporated by Taq DNA polymerase. Single-
stranded DNA sequencing template was prepared from plasmids pMB1-2 and 
pMB4-11. The M13 primer (-20) complementary to pGEM-T and primers 54P1, 
54P2, 54P3, 54P4 and 54P5 were designed to provide overlapping sequencing data 
of the entire PCR amplified sequences. Accurate PCR amplification of the fccA54 
54FRA PCR product of pMB 1-2 was shown from interpretation of the automated 
sequencing result. The fccAB54 54FMIRB PCR product of pMB4-1 1 was identified 
to contain a silent mutation that retained a Leucine codon (TIA -> TIG), located 12 
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7.2.5 Future cloning of the fccA54 and fccAB54 PCR products 
A suitable expression system was developed (5.2.6) for overexpression of the 
FccA54 flavin subunit in the cytoplasm of E. coli TG1 (5.2.7). This established 
FccA54 flavoprotein overexpression system could be conveniently used to obtain 
periplasmic overexpression of FccA54. The strategy would involve excision of the 
correctly amplified frcA54 54FRA PCR product from pMB1-2 as a 1539 bp 
Ba,nHJIPstI fragment. Ligation of the fccA54 restriction fragment sticky ends to 
complementary ends of digested pMB3 plasmid would generate an expression 
plasmid suitable for periplasmic FccA54 overexpression. To specifically examine 
FccA54 overexpression levels in the periplasm of E. coli TGI, it would be necessary 
to isolate the periplasm following IPTG induction and monitor FccA54 
overexpression using SDS-PAGE. 
A modified pMMB503EH expression plasmid, named pMB5 was specifically 
constructed for co-expression of FccA54 and FccB54 in the periplasm of S. 
frigidiinarina EG301 (Figure 6.5). Periplasmic overexpression of the FccA54 
flavoprotein was not detected when using the fccAB54 54FRB PCR product of pMB5 
introduced into S. frigidirnarina EG301. This was attributed to the vast number of 
flavoproteins in S. frigidimarina EG301 combined with the low sensitivity of 
Coomassie blue staining (6.2.7). During purification of the FccA54 and FccB54 
subunits targeted to the periplasm, the flavin subunit was not detected which 
suggested possible separation of the subunits (6.2.9). The type of interaction that 
occurs between the FccA54 and FccB54 subunits is not known. 
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It would therefore be advantageous to purify the subunits separately which could be 
achieved using the cloned fccAB54 54FMRB PCR product to direct overexpression. 
Following purification it would be possible to combine the purified subunits to form 
the functional flavocytochrome. 
The constructed pMB5 expression plasmid could be used to obtain overexpression of 
the FccA54 and Fcc1354 subunits in the cytoplasm and periplasm, respectively. This 
would involve digestion of pMB4-l1 and removal of the cloned fccAB54 54FMRB 
PCR product as an 1830 bp Ban2HJIPstI fragment. Subsequent ligation of the 
BamHIIPstI fccAB54 restriction fragment to complementary sticky ends of digested 
plasmid pMB5 would generate a suitable expression plasmid. Conjugative transfer of 
the recombinant expression plasmid into S. frigidimarina EG301 would provide a 
suitable system to test co-expression of the FccA54 flavin subunit in the cytoplasm 
and FccB54 in the periplasm. Overexpression of the FccB54 protein could be 
specifically monitored by isolation of the periplasm prior to protein analysis using 
SDS-PAGE. 
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7.2.6 PCR amplification of the fccA342 flavoprotein encoding sequence 
PCR amplification of fccA342 was designed to favour amplification of two products 
that differed in their N-terminal sequence. PCR amplification of the fccA342 N-
terminal Tat signal peptide coding sequence was determined by the forward primer 
position. Variation of the fccA342 PCR products aimed to provide cloned fragments 
that would direct cytoplasmic or periplasmic overexpression of FccA342 in E. coli 
TG1. The 5-end of the 21-nucleotide forward primer '342F' was specifically 
designed to complement the fccA342 ATG start codon. The 342F primer was ideally 
positioned to initiate PCR amplification of the fccA342 N-terminal sequence 
encoding the Tat signal peptide. The 5-end of the 21-nucleotide forward primer 
'342FM' mapped directly downstream of the predicted peptidase cleavage point to 
generate specific amplification of fccA342 sequence encoding mature flavoprotein. 
The forward primers, 342F and 342FM were both extended to incorporate a 5'-
overhang BamHI cleavage site to facilitate cloning into the expression plasmid. The 
5-end of the 20-nucleotide reverse primer sequence '342RA' was designed to 
complement the C-terminal TAG stop codon of fccA342. The 342RA primer 
sequence complementary to fccA342 was modified to contain a PstI cleavage site 
incorporated as a 5-overhang sequence. PCR amplification of the frcA342 342FRA 
sequence encoding the FccA342 preprotein was designed to synthesise a 1503 bp 
BanzHJIPstI fragment. Primers 342FM and 342RA were designed to amplify the 
fccA342 sequence encoding mature FccA342 protein as a 1443 bp BamHJIPstI 
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Figure 7.5: A schematic diagram offccA342 PCR amplification 
The diagram shows the primer positions of 342F and 342RA that were designed to initiate PCR 
amplification offccA342 preprotein coding sequence as a 1503 bp BamHlIPstI fragment. 
The 342FM primer was positioned downstream of sequence encoding the N-terminal Tat signal 
peptide to initiate amplification of the fccA342 mature protein coding sequence as a 1443 bp 
Barn I-I I/PstI fragment. 
The two distinct forms of fccA342 encoding preprotein and mature protein were 
successfully PCR amplified from the S. oneidensis MR-1 genome. The PCR results 
analysed by agarose gel electrophoresis revealed a high yield of specific PCR 
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Figure 7.6: PCR anipliuication oljcc2l342 from the S. oneidensis MR-i genome 
Primers 342F and 342RA initiated PCR amplification of fccA342 preprotein coding sequence as a 
1503 bp BwnHh/PstI 342FRA PCR product. Analysis of the results by agarose gel electrophoresis 
showed that approximately 0.05 ptg DNA was amplified (lane 2). The fccA342 mature protein coding 
sequence was amplified from the S. oneidensis MR-1 genome using primers 342FM and 342RA (lane 
3). A specific frcA342 342FMRA PCR product at the expected size of 1443 bp was amplified at 
approximately 0.06 ltg DNA (lane 3). 1 kb DNA ladder (lane 1) was used to indicate that the PCR 
products were of the expected length. 
7.2.7 Cloning of the fccA342 PCR products in pGEM-T 
The fccA342 PCR products were inserted into pGEM-T and transformed into E. coli 
TGI. Positive transformants were selected using ampicillin resistance and blue/white 
colony screening. Recombinant pGEM-T plasmid was identified by isolation of 
plasmid DNA and digestion with BarnFH and PstI. A fragment corresponding to the 
1503 bp fccA342 342FRA PCR product was excised from recombinant pGEM-T 
named pMB5-4. Recombinant plasmid, named pMB7A-1 was shown to contain the 
1443 bpfccA342 342FMRA PCR product, excised as a BainHJJPstI fragment (Figure 
7.7). Single-stranded DNA was prepared from plasmids pMB5-4 and pMB7A-1 to 
provide DNA sequencing template. The PCR products were primarily sequenced 
using the M13 (-20) primer complementary to pGEM-T plasmid to yield sequence 
information that proved the fccA342 gene was specifically amplified from the S. 
oneidensis MR-i genome. 
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The PCR product sequences amplified using the low fidelity Taq DNA polymerase 




fccA342 insert DNA 
1636 bp 
Figure 7.7: Cloning of the fccA342 PCR products in pGEM-T 
Recombinant pGEM-T plasmid DNA containing fccA342 was isolated from ampicillin resistant white 
colonies. Plasmid pMB5-4 (lane 2) was shown using double Ba,nHI!PstI restriction digests to contain 
the fccA342 342FRA PCR product, excised as a 1503 bp BarnHI/PstI fragment (lane 3). Recombinant 
pMB7A-1 (lane 4) digested with BamHI and PstI released a restriction fragment corresponding to the 
1443 bpfccA342 342FMRA PCR product (lane 5). 1 kb DNA ladder (lane 1) was used to indicate the 
restriction fragments analysed by agarose gel electrophoresis were of the correct size. 
7.2.8 PCR amplification of fccAB342 from S. oneidensis MR-1 
The fccAB342 342FRB fragment (6.2.11) of pMB6 (Figure 6.18) introduced into S. 
frigidimarina EG301 was used preferentially to generate high levels of 
overexpressed flavocytochrome in the periplasm. In addition to the fccAB342 
342FRB PCR product specifically synthesised for periplasmic overexpression, a 
second fccAB342 PCR product was amplified. An fccAB342 342FMRB 
overexpression fragment was PCR amplified without the N-terminal Tat signal 
peptide coding sequence of fccA342. This fccA342 mature protein coding sequence 
was fused to PCR amplification of fccB342 containing sequence encoding the N-
terminal Sec-dependent signal sequence. 
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The cloned fccAB342 fragment was designed to generate overexpression of the 
FccA342 subunit in the cytoplasm and the FccB342 cytocbrome subunit in the 
periplasm. The production of overexpressed protein in different cellular locations 
aimed to allow separate purification of the subunits. The forward 342FM primer was 
designed to initiate PCR amplification of fccA 342 mature protein coding sequence. 
This primer was used in combination with the reverse 19-nucleotide 342RB primer 
sequence, complementary to the C-terminal coding sequence of fccB342. The 342RB 
primer sequence that annealed to fccB342 was extended to contain a 5'-overhang 
sequence incorporating a PstI cleavage site. PCR amplification using primers 342FM 
and 342RB was designed to initiate amplification ofJècAB342 as a BamHI/PstI 1804 
bp fragment (Figure 7.8). 
5IRMIRRIM  342FM 
ATG 	 1783 bp 	 10 	 3 




Bamffl 	 RclI 
5. 	 13 
1804 bpfccAB342 342FMRB PCR product 
Figure 7.8: PCR amplification offccA342 and fccB342 
A schematic diagram (not to scale) shows the position of primers used to amplify the fccAB342 
fragment from the S. oneidensis MR-I genome. The forward primer 342FM was suitably positioned to 
initiate PCR amplification of the fccA342 mature protein coding sequence downstream of the encoded 
N-terminal Tat signal peptide. The reverse primer sequence 342RB was complementary to the 
extreme C-terminal coding sequence of fccB342. The primers 342FM and 342RB initiated PCR 
amplification offccAB342 as a BamHI/PstI 1804 bp PCR product. 
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PCR amplification of the fccAB342 co-expression fragment was successfully PCR 
amplified from the genome of S. oneidensis MR-1. The PCR result analysed using 
agarose gel electrophoresis revealed a specific PCR product corresponding to the 
1804 bp fccAB342 PCR product. Approximately 0.06 j..tg DNA was PCR amplified 
(Figure 7.9). 
2036 bp fccAB342 342FMRB 
1804 bp PCR product 
Figure 7.9: PCR amplification of fccAB342 from S. oneidensis MR-i 
The fccAB342 342FMRB co-expression fragment was specifically PCR amplified from the genome of 
S. oneidensis MR-1 using primers 342FM and 342RB. The PCR result was analysed by agarose gel 
electrophoresis and revealed a product corresponding to the length of the 1804 bpfccAB342 fragment 
(lane 2). 1 kb DNA ladder (lane 1) was used to analyse the size of the PCR product. 
7.2.9 Cloning of the fccAB342 PCR product in pGEM-T 
The amplified fccAB342 342FMRB fragment was cloned into pGEM-T to provide 
multiple copies of the product. Following ampicillin selection and blue/white colony 
screening, white ampicillin resistant colonies were selected and screened for 
recombinant plasmid. An isolated recombinant plasmid referred to as pMB8-3 was 
shown using BaniHI and PstI restriction digests to contain the fccAB342 342FMRB 
PCR product. The fccAB342 product was excised from pMB8-3 as a BamHTIPstI 
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3054 bp 
2036 bp fccAB342 342FMRB insert DNA 
Figure 7.10: Cloning of the JccAB342 PCR product in pGEM-T 
The frcAB342 342FMRB PCR product was inserted in pGEM-T to form recombinant plasmid named 
pMB8-3 (lane 2). Double BamHJJPstI restriction digests of pMB8-3 analysed using agarose gel 
electrophoresis were used to verify recombinant plasmid was formed. A restriction fragment 
corresponding to the 1804 bpfccA342 342FMRB fragment was produced upon digestion of pMB8-3 
with BamHI and PstI (lane 3). 1 kb DNA ladder (lane 1) was used to analyse the size of the restriction 
fragments using agarose gel electrophoresis. 
7.2.10 Sequencing of the fccAB342 PCR product of pMB8-3 
The fccAB342 342FMRB sequence was amplified from the S. oneidensis MR-i 
genome using Taq DNA polymerase. The cloned sequence of pMB8-3 was therefore 
checked for nucleotide sequence errors introduced by the low fidelity enzyme. The 
M13 primer (-20) complementary to pGEM-T plasmid was primarily used to verify, 
by automated sequencing, that the correct fccA342 and fccB342 target genes were 
amplified. Primers 342RP1, 342RP2, 342RP3 and 342RP4 were designed to 
complement the fccA342 and fccB342 genes to provide overlapping sequencing data. 
The fccB342 amplified nucleotide sequence of pMB8-3 was shown from 
interpretation of the sequencing results to consist of the correct sequence. The 
fccA342 sequence of pMB8-3 requires further sequencing to check that the correct 
sequence was PCR amplified. 
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7.2.11 Future overexpression work of FccA342 
In order to try overexpression of FccA342 it will be necessary to completely 
sequence the fccA342 PCR products cloned in pMB5-4 and pMB7A-1. A suitable 
overexpression system involving plasmid pMB3 was constructed to produce high 
levels of FccA54 flavoprotein in the cytoplasm of E. coli (5.2.7). The pMB3 plasmid 
altered to contain an fccA342 PCR product would provide an ideal system to try 
overexpression of FccA342 in E. coli. To test periplasmic overexpression of 
FccA342 it would be convenient to cut the fccA342 342FRB PCR product from 
pMB5-4 as a BamHLIPstI 1503 bp fragment. Insertion of the fragment in pMB3 by 
ligation of complementary BaniHI and PstI ends would form an ideal expression 
plasmid to direct periplasmic expression. Following IPTG induction of recombinant 
E. coli and isolation of the periplasm, the levels of FccA342 periplasmic expression 
could be analysed using SDS-PAGE. The N-terminal Tat signal peptide of FccA342 
does not contain the twin arginine residues that are essential for recognition and 
targeting to the periplasm via the Tat pathway (Figure 1.12). Therefore, targeting of 
the FccA342 preprotein to the periplasm of E. coli might be problematic and lead to 
low levels of periplasmic expression. To improve the FccA342 overexpression 
levels, insertion of the fccA342 342FMRA PCR product in pMB3 would 
conveniently provide a construct to direct cytoplasmic overexpression. This 
overexpression strategy would involve excision of the fccA342 342FMRA 
BainHIIPstI fragment from pMB7A-1 and insertion into pMIB3 cut with BarnHI and 
PstI. Subsequent to IPTG induction of recombinant E. coli, cytoplasmic FccA54 
overexpression analysed using SDS-PAGE would provide a means of determining 
the optimal overexpression conditions. 
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7.2.12 Future co-expression work of FccA342 and FccB342 
The fccAB342 342FRB co-expression fragment comprising sequence to direct 
periplasmic co-expression of the flavin and cytochrome subunits was cloned in 
pMB6 and transferred into S. frigidimarina EG30 1. However, under the expression 
conditions tested, no overexpression of the flavocytochrome was induced in the 
periplasm of S. frigidimarina EG301 (6.2.15). The fccAB342 342FMRB fragment 
could be alternatively used to produce high levels of the target proteins in S. 
frigidimarina EG301. In order to develop a suitable expression plasmid for fccAB342 
342FMRB, it would be necessary to cut the fccAB342 insert DNA from pMB8-3 as a 
BarnHIJPstI 1804 bp fragment. The fccAB342 restriction fragment ligated to 
complementary sticky ends of pMB6 would form the desired expression plasmid. 
Conjugative transfer of the recombinant expression plasmid from E. coli to S. 
frigidimarina EG301 would provide a suitable expression system for testing 
FccA342 overexpression in the cytoplasm and FccB342 overexpression in the 
periplasm. Following induction with IPTG, isolation of the periplasm contents would 
enable specific detection of Fcc1354 overexpressed in the periplasm. The flavin and 
cytochrome subunits could subsequently be purified in two distinct steps and 
combined to form the flavocytochrome. 
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7.2.13 A putative iron-induced flavocytochrome of S. oneidensis MR-1 
Sequencing of the S. oneidensis MR-i genome (http://www.tigr.org and Heidelberg 
et al., 2002) led to the identification of a gene sequence zfcA-1 (ORF number: 
S01421; Table 7.1) encoding a putative monomeric flavocytochrome comprising an 
N-terminal tetrahaem c-type cytochrome domain and a C-terminal flavin domain 
(Figure 7.11). The predicted amino acid sequence of IfcA-i was identified to share 
striking amino acid sequence identity to Fcc3 (40 %) and the iron-induced 
flavocytochrome Ifc3 (41 %) of S. frigidimarina NCIMB 400 (Dobbin et at., 1999; 
http://www.ncbl.nim.nih.gov/blasUbl2seq/bl2.html). The N-terminal sequence of 
IfcA-1 constituting the cytochrome domain was shown to contain four CxxCH motifs 
for hacm attachment (where x is any amino acid residue; Figure 7.11) that aligned 
with those of the related flavocytochromes, leading us to the hypothesis that IfcA-1 
is also a tetrahaem c-type cytochrome. Furthermore, a histidine residue of Fcc3 that 
serves as the sixth ligand to form c3-haems (Pealing et at., 1995) is conserved in 
IfcA-1 and Ifc3 (Figure 7.11). The N-terminal flavoprotein sequence of IfcA-1 
contains the conserved FAD adenine binding motif that appears to provide a non-
covalent attachment site, as shown by the conserved substitution of the essential 
histidyl residue required for covalent attachment (Weiner and Dickie, 1979; Cole, 
1982) with asparagine (Figure 7.11). The extreme N-terminal sequence of IfcA-1 
was identified to comprise a signal sequence of 22 amino acid residues 
(http:!/www.cbs.dtu.dklservices/SignalP/; Nielsen et at., 1997) that is characteristic 
of proteins targeted to the periplasm via the Sec-dependent pathway (Figure 7.11; 
von Heijne and Abrahmsén, 1989). 
we 







Protein length (aa) Molecular weight (Da) p/ 
Preprotein Mature Preprotein Mature 
iicA-1 ifrA-I S01421 589 567 63,025 60,590 7.72 
Table 7.1: Predicted properties of a putative iron-induced flavocytochrome 
The open reading frame (ORF) number corresponding to ifcA-1 (http://www.tigr.org) encoding the 
putative iron-induced flavocytochrome, IfcA-1 of S. oneidensis MR-1, is shown. The amino acid (aa) 
sequence lengths of the preprotein and mature protein are also shown. The preprotein length was 
calculated using SignalP (http://www.cbs.dtu.dk/services/SignalP/; Nielsen et al., 1997). The 
estimated molecular weight of the apoprotein (preprotein and mature protein) and isoelectric point (p1) 
for the mature protein (http:!/www.expasy.org/tools/protparam.html) are also shown. 
The catalytic and substrate-binding residues of Fcc3 that are conserved in the family 
of fumarate reductases; Arg402, His504, and Arg544 (S. frigidirnarina NCIMB 400 
Fcc3 numbering; Pealing et at., 1992) are strictly conserved in the flavin domain of 
IfcA-1 and Ifc3 (Figure 7.11). An arginine residue equivalent to Arg381 of Fcc3 that 
forms the proton delivery pathway to reprotonate the Arg402 active site acid 
(Doherty et at., 2000) was also identified in IfcA-1 and Ifc3. However, G1u378 of 
Fcc3, another residue of the proton delivery pathway (Doherty et al., 2000) is not 
conserved in IfcA-1 (Figure 7.11), which leads to the suggestion that an alternative 
proton pathway operates in IfcA-1. Furthermore, His365 of Fcc3 that is a key 
substrate-binding residue of the active site (Taylor et at., 1999) is not conserved in 
IfcA-1 and is substituted with Phenylalanine (Figure 7.11). Thr377 is the second key 
substrate-binding residue of Fcc3 that is located in the clamp domain and is 
conservatively substituted with Serine in both isozymes (Figure 7.11). 
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FccSF MKKMNLAVCIATLMCTAGLMGTAVAADNLAEF VQNQE-CDSCHTPDGELSNDSLTYENT 
IfcSF MKLKYLVSAMALVVLSSGTA---MANTPDMGS 	DMGS-CQSCHAKPIKVT-DSETHENA 
IfcSO ----MLNTKLLPLAMSAFFISTFSYGQSLSE IDKGNNCQTCHTKPIKVD-DAENHENK 
FccSF QCVSCI-IGTLAEVAETTKHEHYN 	AS FPGEVACTSCHS 	EKSMVYCDSCHSFDFN-MP 
IfcSF QCKSCHGEYAELAN--DKLQFDP NS LG-DINCTSCHKG EEPKFCNECHSFDIKPMP 
IfcSO 
	
SCESCHGTMGELAAK-SKSKLSP HS LI-DVSCTSCHS 	KQPVFVCQTCHDSFKNEFK 
.*:* 	.: 	..c 	**: 	:: 	k*• .*::. 	. : 	: 
FccSF YAKKWLRDEPTIAELAKD-KSERQAALASAPHDTVDVVVVGSGGAGFSAAISATDSG-AK 
IfcSF FSDAKKKKS --- WDDGWD-QDKIQKAIAAGPSETT QVLVVGAGSAGFNASLAAKKAG-AN 
I fcSO IPFSNDKPVLDNYQFPEVTQEMIETALAKAPLEc)f!QVIVIGAGAAGFIAAArSARQHGvAD 
FccSF VILIEKEPVIGGNAKLAAGGMNAAWTDQQKAKKITDSPELMFEDTMKGGQNINDPALVKV 
IfcSF VILVDKAPFSGGSMISAGGNNAVGTKQQTAHGVEDKVEWFIEDANKGGRQQNDIKLVTI 
I fcSO VVILEKQPYIGGNSMLAAGGMSAAETVTQALKHYPDSKALWYEDTMKGGHNINNPDLVKI 
236 
FccSF LS SHSFDSVDWMTAMGADLT DVGMMGGAS VNBAHRPTGGAGVGAHVVQVLYDNAVKRNI D 
IfcSF LAEQSADGVQWLESLGANLDDLKRSGGARVDRTHRPHGGKSSGPEIIDILRKAAKEQGID 
I fcSO LTENGSAGVDWLQAMGADLTSASSAGGHNAERLHRPTGGAKSGPEIVNTLKETAQKLGVE 
FccSF LRMNTRGI EVLKDDKGTVKGI LVKGMYKGYYWVKADAVI LATGGFAKNNERVAKLDPSLK 
IfcSF TRLNSRVVKLVVNDDHSVVGAVVHGKHTGYYMIGAKSVVLATGGYGMNKEMIAYYRPTMK 
I fcSO TRTNSKVIQLVQNKQGVITGVLVQGKHSKLHILGAKAVI IASGGFARNNELVAKYRPDLK 
365 	375 377378 	381 
FCCSF GFI STNQPGAVGDGLDVAENAGGALKDMQYIQAHPTLSVKGGVMVTEAVRGNGAILVNRE 
IfcSF DMTSSNNITATGDGVLMAKEIGASMTDIDWVQAHPTVGKDSRILISETVRGVGAVMVNKD 
I fcSO GVDATNNPGNVGDALTFAPKVGADIVDVKEIQAFPTAAAG-KMVISGTARGAGAIMLNND 
402 
FccSF GKRFVNEITTRDKASAAILAQTGKSAYLI FDDSVRKSLSKIDKYIGLGVAPTADSLVKLG 
IfcSF GNRFISELTTP.DKASDAILKQPGQFAWI IFDNQLYKKAKNVRGYDHLEMLYKGDTVEQLA 
I fcSO GERFCDEMGPRDKVSECIWAQKGKDAWLVFDETVLDRLGQLRGMLDLGI I FKGNSADEMA 
504 
FccSF KMEGI DGKALTET VARYNSLVS SGKDTDFERPNLPRALNEGNYYAI EVTPGVHHTMGGVN 
IfcSF KSTGMKVADLAKTVSDYNGYVASGKDTAFGRADMPLNMTQSPYYAVKVAPGIHHTMGGVA 
I fcSO KATKMNAQKFDQAIKRYNDFKVKGKDADFARKNMADDLQY-PIYAVKIKPAVHHTMGGLK 
534 	 544 




Figure 7.11: 'ClustaIW' multiple sequence alignment of IfcA-1 and related proteins 
The preprotein sequence of IfcA (S. oneidensis MR-1; IfcSO) was aligned with Ifc3 (S. frigidimarina 
NCIMB 400; IfcSF) and Fcc3 of S. frigidirnarina NCIMB 400 (FccSF) using 'ClustaiW' (Thompson 
et al., 1994). The predicted signal sequence for targeting to the periplasm is shown in red (Nielsen et 
al., 1997; http://www.cbs.dtu.dklservices/SignalPI). The CxxCH motifs that are characteristic of c-
type cytochromes are shown in yellow and histidine residues that may provide the sixth ligand to the 
haems are also shown (green). The FAD binding site and asparagine (bold, black) indicate that lfcA-1 
also binds to FAD non-covalently. The active site residues that are conserved in the related enzymes 
(magenta) and the residues that are not conserved (cyan) are shown. The active site residues are 
numbered according to Fcc3 (S. frigidimarina NCIMB 400). 
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The data interpreted from the multiple sequence alignment of IfcA-1 against Fcc3 and 
Ifc3 of S. frigidin'iarina NCIMB 400 leads us to the conjecture that IfcA-1 of S. 
oneidensis MR-i is also a tetrahaem flavocytochrome c3. The particularly high 
sequence identity of IfcA-1 with Ifc3 combined with the apparent presence of two 
fumarate reductases in S. oneidensis MR-i (http://www.tigr.org), tentatively suggests 
that IfcA-1 is not a fumarate reductase but rather is induced by iron respiration and 
shares an in vivo function similar to Ifc3. However, the in vitro fumarate reductase 
catalytic activity of Ifc3 (Dobbin et al., 1999) may not be a conserved feature of the 
related IfcA-i flavocytochrome due to the substitution of His365—*Phe365, which 
may impede binding of fumarate due to steric constraints. 
To investigate the cellular expression and catalytic activity of the unusual IfcA-1 
flavocytochrome, the ifcA-1 gene was PCR amplified from the S. oneidensis MR-i 
genome. This intended to provide a suitable DNA template for insertion into an 
appropriate expression plasmid for overexpressi on, purification and characterisation. 
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7.2.14 PCR amplification and cloning of jfcA-1 
Primers were designed to specifically amplify the putative iron-induced 
flavocytochrome from the S. oneidensis MR-1 genome. The 5'-end of the forward 
23-nucleotide primer 'IFC3F' was designed to hybridise at the ATG start codon of 
the gene that encoded the cytochrome domain. The 24-nucleotide reverse primer 
'IFC3R' was designed to complement the extreme C-terminal coding sequence of the 
flavin domain. The 5' forward primer sequence complementary to ifcA-1 was 
modified to contain a BamHI cleavage site and a PstI cleavage site was incorporated 
at the 5-end of the reverse primer to allow direct cloning of the PCR product. The 
primers were designed to initiate PCR amplification of ifcA-] as a 1788 bp 
BamHI/PsII fragment (Figure 7.12). 
5.  
IFC3F 
Cvtochrorne domain 	 Flavin domain"  
PCR amPiificatioII 	
5' 




1788 bp PCR product 
Figure 7.12: PCR amplification of?fcA-1 from S. oneidensis MR-1 
A schematic diagram (not to scale) shows the forward and reverse primer positions used to initiate 
amplification of fcA-1. The primer sequences were modified to contain BamHI and PstI cleavage 
sites for direct cloning of the fcA-I PCR product amplified as a 1788 bp fragment. 
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PCR amplification using primers IFC3F and IFC3R specifically amplified a PCR 
product from the S. oneidensis MR-1 genome that corresponded to the expected size 
of zfcA-J. The PCR result was analysed by agarose gel electrophoresis that revealed a 
single PCR product correlating to the 1788 bp iftA-1 PCR product at approximately 
0.06 jig DNA (Figure 7.13). 
2 
2036 bp 
4 	zfcA-1 PCR product at 1788 bp 
Figure 7.13: PCR amplification of ifcA-1 from the S. oneidensis MR-i genome 
Primers IFC3F and IFC3R initiated PCR amplification of the ifcA-1 gene from the S. oneidensis MR-
1 genome. A single PCR product corresponding to the ifcA-1 1788 bp BamHIIPstI fragment (lane 2) 
was shown using agarose gel electrophoresis. 1 kb DNA ladder (lane 1) was used to indicate the PCR 
product was of the correct size. 
The ifcA-1 PCR product was cloned into the high copy number pGEM-T plasmid and 
transformed into E. coli TG1. Recombinant pMB9-5 plasmid was isolated from a 
positive transformant that was initially identified using ampicillin resistance and 
blue/white colony screening. The recombinant pMB9-5 plasmid was identified using 
double BamHIJPstI restriction digests that were subsequently analysed using agarose 
gel electrophoresis. A restriction fragment corresponding to the length of the ifcA-1 
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:1 	2 	3 
i/ I I mcri DNA ________ 2036 bp 
Figure 7.14: Cloning of the {fcA-1 PCR product in pGEM-T 
Recombinant pMB9-5 plasmid (lane 1) was isolated from a white ampicillin resistant colony and was 
shown to be recombinant using double BainHI/PstI restriction enzyme digests. A BamHI/PstI 
restriction fragment corresponding to the 1788 bp ifcA-1 PCR product was excised from pMB9-5 
(lane 2). 1 kb DNA ladder (lane 3) was used to indicate the size of the restriction fragments using 
agarose gel electrophoresis. 
7.2.15 Future overexpression work of IfcA-1 
The rfrA-]  fragment cloned in pGEM-T to form pMB9-5 was primarily sequenced to 
identify that the correct target gene was amplified from the S. oneidensis MR-i 
genome. Single-stranded template DNA was prepared from pMB9-5 and the M13 
(-20) primer complementary to pGEM-T was used to identify that the correct gene 
was amplified. For overexpression purposes, it will be necessary to completely 
sequence the cloned ifcA-] PCR product for potential errors incorporated by Taq 
DNA polymerase. The modified pMIMB503EH plasmid, pMB5, could be 
conveniently used for overexpression of IfcA-1. Formation of the ifcA-J recombinant 
expression plasmid would involve digestion of plasmid pMB9-5 with BarnHI and 
PstI to release ifcA-1 as a Ba,nHTIPstI 1788 bp overexpression fragment. Ligation of 
the ifcA-1 restriction fragment to complementary sticky ends of pMB5 would 
generate an expression plasmid specific to IfcA-1 overexpression. 
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Conjugative transfer of the recombinant expression plasmid into S. frigidiniarina 
EG301 would provide a suitable system to test overexpression of IfcA-1. 
7.2.16 Summary 
A variety of PCR products were amplified to achieve protein overexpression of 
FccA54 and FccA342 as separate flavin subunits and for co-expression with the 
putative partner cytochrome subunit. In addition to the fccA54 54FMRA PCR 
construct synthesised for cytoplasmic overexpression of FccA54 (Chapter 5), a 
second fccA54 54FRA PCR product was amplified. However, high yields of 
overexpressed FccA54 flavoprotein were obtained from the cloned fccA54 54FMRA 
product. Therefore, FccA54 overexpression in the periplasm of E. co/i was 
unnecessary and the cloned fccA54 54FRA product was not required. 
The findings obtained from overexpression (5.2.7) and purification (5.2.8) of the 
FccA54 flavin subunit led to the suggestion that these novel flavoenzymes only 
function with the partner cytochrome subunit. Therefore, further cloning of the 
fccA342 fragments and overexpression of the FccA342 flavin subunit in the 
cytoplasm or periplasm was not attempted. However, purification of the flavin 
subunit in E. coli may provide the best means of obtaining the flavoprotein subunit, 
which could subsequently be combined with the independently purified partner 
cytochrome subunit. Alternatively, cloning of the other PCR products, fccAB54 
54FMRB and fccAB342 342FMRB in pMB5 to direct expression of the subunits in 
distinct cellular locations may provide a suitable method to facilitate purification of 
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S. oneidensis MR-1 is a respiratory versatile bacterium that can couple anaerobic 
growth to the reduction of many substrates and consequently has received 
considerable interest due its potential role in bioremediation. The completely 
sequenced S. oneidensis MR-i genome (http://www.tigr.org; Heidelberg et al., 2002) 
has recently provided us with the fundamental tool for identifying and exploring the 
role of respiratory proteins involved in the complex anaerobic respiratory pathways. 
Inclusive of the 39 c-type cytochromes that were identified from genome sequencing, 
four novel putative flavocytochromes of S. oneidensis MR-1 were identified and 
selected for further study in this thesis. 
8.1 Molecular modelling 
The four novel flavocytochromes comprise separately encoded flavin (FccA) and 
cytochrome (FccB) subunits that were identified to share striking sequence identity 
to Fcc3 of Shewanella, suggesting that the novel flavoproteins are also periplasmic, 
tetrahaem flavocytochrome c3 enzymes containing non-covalently bound FAD. The 
active sites of the novel flavoproteins have been identified to contain only one set of 
substrate binding residues required for binding the dicarboxylate groups of fumarate 
in Fcc3. This finding leads us to the theory that the related flavoenzymes bind to 
acrylate-like substrates that contain one carboxylate group. Molecular models of the 
novel flavoenzymes have been constructed based upon the known X-ray crystal 
structure of Fcc3 (Taylor et al., 1999), to provide a three-dimensional insight into the 
architecture of each enzyme active site. 
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The molecular models predict a putative spatial arrangement of residues in each 
enzyme active site and have shown that the structural topology and orientation of 
active site residues are conserved in the flavin domains but less well conserved in the 
clamp domains, consistent with the findings obtained from sequence analyses. The 
molecular models have been used as structural templates for screening enzyme 
substrates of the novel flavoproteins. A wide variety of acrylates have been identified 
as potential, biologically relevant substrates, including methacrylate, crotonate, and 
tiglate. One of the novel flavoproteins (FccA56) has been shown to accommodate 
phenylacrylates such as cinnamate produced from degradation of phenylalanine. A 
number of these candidate substrates have been identified to support anaerobic 
growth of wild-type S. oneidensis MR-1. 
8.2 A mutant strain of S. oneidensis MR-1 
A knockout strain of S. oneidensis MR-1 deficient in expressing one of the novel 
flavocytochromes (FccA54; FccB54) has been constructed and named S. oneidensis 
MB5415. This represents the first report of an S. oneidensis MR-i mutant that lacks 
the entire gene-coding sequences of an enzyme implicated in anaerobic respiration. 
S. oneidensis MB5415 has been used to test which of the acrylates fails to support 
growth of this mutant strain in comparison to wild-type S. oneidensis MR-1. This 
approach was used as a means of identifying the target protein function, where a 
growth defect of the null mutant on a particular acrylate is associated with absence of 
the novel flavocytochrome. 
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Deletion of the genes encoding the novel flavocytochrome had no detectable 
physiological effect on anaerobic growth of S. oneidensis MB5415 compared to the 
wild-type strain. However, the anaerobic growth experiments need to be improved, 
particularly, the oxygen levels in the growth jars need to be consistent and this could 
be achieved with higher accuracy by conducting the experiment in an anaerobic 
growth chamber. It would also be advantageous to examine the effect of the substrate 
concentration on anaerobic growth of S. oneidensis MR-1 to ascertain the optimal 
acrylate concentration that supports growth. Obtaining strictly anaerobic growth 
cultures of S. oneidensis MR-i supplemented with the optimal concentration of 
acrylate would provide an accurate control for comparing growth of the null mutant 
strain. 
The related novel flavocytochromes may have similar functions in vivo and deletion 
of genes encoding one flavocytochrome is perhaps negated by the presence of the 
other flavocytochromes. Therefore, it may be unfeasible to determine the biological 
function of these novel flavocytochromes by constructing gene knockouts and 
conducting anaerobic growth experiments of a mutant strain compared to wild-type 
S. oneidensis MR-1. Alternatively, S. oneidensis MB5415 and S. oneidensis MR-1 
grown under acrylate reducing conditions could be subjected to DNA microarray 
analyses in order to examine and compare the complete gene transcription profiles. A 
relative decrease in the mRNA levels of certain S. oneidensis MB5415 genes 
compared to S. oneidensis MR-i may indicate that these genes are involved in the 






Two-dimensional polyacrylamide gel electrophoresis (2-D-PAGE) could also be 
used to analyse and compare the protein expression profiles of the null mutant and 
wild-type strains under acrylate reducing conditions to complement the findings of 
the microarray analyses. 
The growth conditions of S. oneidensis MR-i that induce expression of the novel 
flavocytochromes could be determined by using Northern blotting. It would be 
necessary to isolate total RNA from wild-type S. oneidensis MR-i grown 
anaerobically with various acrylates as terminal electron acceptor and use RNA 
isolated from aerobically grown cells as a control. Following electrophoresis of the 
isolated RNA, hybridisation of a labelled DNA probe specific for each novel 
flavocytochrome would signify the presence of the protein under the conditions 
tested. 
The S. oneidensis MB5415 null mutant constructed in this work has further potential 
to be used as a host organism for future expression of site-directed mutant forms of 
the novel flavocytochrome not expressed in this deletion strain. 
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8.3 Protein overexpression and purification 
The genes encoding two of the novel flavocytochromes (FccA54; FccB54 and 
FccA342; FccB342) have been PCR amplified from the S. oneidensis MR-i genome. 
A variety of PCR products have been amplified to allow periplasmic or cytoplasmic 
expression of the flavin subunits (FccA) and optional co-expression with the partner 
cytochrome subunits (FccB). The gene encoding a putative iron-induced 
flavocytochrome has also been PCR amplified from the S. oneidensis MR-1 genome. 
An expression plasmid has been constructed for maximising overexpression of the 
novel flavin subunits in E. coli. A novel flavoprotein subunit (FccA54) has been 
overexpressed in E. coli TG1 and the holoenzyme has been purified to high purity. 
Purification of the FccA54 flavin-containing subunit followed by gradual conversion 
to the apoform has shown that the flavoprotein is unstable in the absence of the 
partner cytochrome subunit. Therefore, it has been postulated that the cytochrome 
subunit associates with the flavin subunit to cap the FAD binding site. It was 
anticipated that the novel flavoprotein would be able to turnover fumarate (Atanasiu, 
2001), however, the inability of the purified holoenzyme to catalyse fumarate 
reduction has led to the suggestion that haem groups of the cytochrome subunit are 
essential for electron transfer from reduced methyl viologen to flavin. The results 
presented here have provided supporting evidence that the separately encoded flavin 
and cytochrome subunits do indeed associate to form a flavocytochrome, where the 
flavin subunit is dependent on association with the cytochrome subunit for catalysis. 
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To further test the requirement of the cytochrome subunit for electron transfer, it 
would be necessary to supplement the inactive apoenzyme with FAD and monitor 
reduction of acrylates, e.g. methacrylate, that may serve as the native substrate. 
To overexpress and purify a novel flavocytochrome, a recombinant expression 
plasmid has been constructed for co-expression of the flavin and cytochrome 
subunits in the periplasm of S. frigidimarina EG301. High periplasmic expression 
levels of the FccB54 cytochrome subunit have been attained, however, the putatively 
associated FccA54 flavin subunit was not detected. Detection of the co-expressed 
flavin and cytochrome subunits could be improved by using native polyacrylamide 
gel electrophoresis to avoid dissociation into the respective protein subunits. Suitable 
conditions have been tested for purification of the overexpressed FccB54 cytochrome 
subunit and a protein at the expected size has been detected at each stage. It will be 
necessary to confirm by N-terminal sequencing that the cytochrome protein detected 
is indeed FccB54. Further purification trials are required to attain optimal 
purification conditions for the cytochrome subunit. It would be most convenient to 
purify the FccB54 cytochrome subunit and combine this with the previously purified 
FccA54 flavin subunit to produce the functional flavocytochrome for further 
analysis. 
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This work aimed to overexpress and purify one of the novel flavocytochromes to 
ultimately determine the enzyme structure and function by means of X-ray 
crystallography and kinetic analysis. In this work, purification of the FccA54 
flavoprotein has been achieved and molecular models of the flavoprotein subunit 
have provided a three-dimensional insight into possible enzyme substrates. 
Overexpression and purification conditions have been established for purification of 
the partner FccB54 cytochrome subunit. It is anticipated that the separately purified 
flavin and cytochrome subunits can be successfully combined to produce the desired 
flavocytochrome. Therefore, this work has overcome the challenges involved in 
overexpressing and purifying a novel dimeric flavocytochrome and has provided the 
working foundations for producing a novel S. oneidensis MR-i flavocytochrome for 
future analyses. Furthermore, a null mutant of a novel flavocytochrome (FccA54; 
Fcc1354) has been constructed which is fundamentally important for further genetic 
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